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ABSTRACT 
I conducted a review to show that smoking cessation in TB patients can have positive TB 
outcomes. Behavioural interventions (BI) for smoking cessation are known to be effective and 
cost effective but there are important variations in quit rates that are hard to explain. My aim 
was to develop and validate a fidelity index for BIs in smoking cessation, and use it to explore the 
extent to which variations in smoking quit outcomes reflect the degree to which providers 
implement the various components and the quality of delivery of a smoking cessation programme 
in TB treatment settings. 
I developed and tested a theoretically mapped fidelity index comprising two sub-indices: 
‘Adherence’ for measuring compliance (37 items) and ‘Quality’ for measuring provider 
competence (8 items). Items were rated as fully, partially, or not, implemented against a 
behaviourally anchored response scale. Fidelity was measured in a prospective study of 18 
providers in TB clinics in Pakistan (154 patients) whose sessions were audio-recorded and then 
coded. These providers had participated in delivering the same BIs as part of the ASSIST trial 
four years earlier.  
Reliability was assessed in three ways. There was good inter-coder reliability using Kripendorff’s 
alpha, Principal Components Analysis showed the items of the index were coherent in measuring 
fidelity and Generalisability theory showed that the index reliably differentiated between 
providers by capturing the variation in their BI delivery practice. 
Provider Adherence and Quality of provision were positively correlated. I tested the assumption 
that relative provider practice was consistent between the ASSIST trial in 2010 and the fidelity 
study in 2014. Using Kendall’s W coefficient of concordance on data from a self-recorded 
checklist used in both studies, I found moderate to strong concordance. I then used binomial 
regression analysis to estimate the relationship between fidelity and ASSIST trial provider-level 
quit rates. This showed that the provider-level quit rate was positively associated with Quality of 
interaction (odds ratio: 2.15; 95% CI, 1.43 to 3.24) but negatively associated with Adherence to 
BI content (odds ratio: 0.55; 95% CI, 0.40 to 0.77). A negative interaction was found between 
Adherence and Quality and quit rates.   
This research makes several contributions to the field. We have a better understanding of the 
impact of smoking on TB. I developed and validated a new, theoretically-informed, fidelity index 
which can be used to quantify and score delivery of BI ingredients in a standardised way and used 
to better understand how BIs influence outcomes. I report that the quality of delivery of BIs 
maybe as important as content in influencing smoking cessation. 
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PART I- BACKGROUND 
This section provides the background and context for the thesis. This discusses the significance of smoking 
cessation in high tuberculosis (TB) burden countries, implementing cessation interventions within existing 
TB care settings, variation in patient quit rates across implementation sites and the sources that potentially 
contribute to this variation; measuring fidelity to intervention delivery and its utility in explaining 
variation in outcomes. 
 
I present 4 chapters in this section: 
Chapter 1 provides an introduction to the thesis and outlines the focus of my research. This 
includes an introduction to important terms, such as fidelity, and describes complex interventions 
used in the thesis and their conceptualisation in terms of smoking cessation; and a brief overview 
of fidelity as a method for exploring variation and how behaviour change science contributes to 
it. I end the chapter by presenting an outline of the thesis and overview of the studies planned. 
Chapter 2 provides literature on the association between smoking and TB outcomes. 
Furthermore, it introduces behavioural intervention as a cost-effective alternative to 
pharmacotherapy for cessation services in low-and-middle income countries (LMIC). It states the 
relevance of integrating such interventions within national TB programmes and supplies 
findings from a large cluster Randomised Controlled Trial (RCT) highlighting the implications 
of variation in smoking quit rates on the wider implementation of complex BIs. 
Chapter 3 describes the sources of variation in the outcomes of the ASSIST study, using a 
framework to characterise them by: i) factors intrinsic to the intervention, such as its substantive 
features, ii) methods of evaluation, such as cluster RCT and iii) factors extrinsic to the 
intervention such as research context. I end the chapter by elaborating further on sources of 
variation due to intrinsic factors affecting the intervention. 
Chapter 4 provides an insight into the elements of fidelity that need consideration for explaining 
the mechanism of impact of complex BIs on their outcomes. The literature reviewed pertains 
mainly to measurement of fidelity and its conceptualisation in terms of complex BIs, particularly 
focusing on identification of the active features of the intervention. 
  
 
Chapter 1. Introduction 
Smoking behaviour is common in countries with high TB burden and adversely impacts on the 
health of people living in these Low-and-Middle Income Countries (LMICs) (Siddiqi, 2014, 
Dogar et al., 2013). Implementation of smoking cessation interventions within national TB 
programmes is of utmost relevance to these countries (Dogar et al., 2013). Behaviour change 
interventions (or BIs) are a low-cost alternative to pharmacotherapies (alone) for smoking 
cessation in low resource countries. However, evaluations of these interventions are often limited 
in their description of what works and how it works. 
RCTs evaluating such ‘complex interventions’ may provide evidence of their overall effectiveness 
in achieving smoking cessation, but the interventions being tested are frequently described as a 
‘black box’, with little information about individual features (Craig et al., 2013). They do not 
indicate how the intervention works- what the ‘active ingredients’ are, and how they exert their 
effect (Lorencatto et al., 2013c). Neither do they attempt to explain the variation in effect within 
or between implementation sites. In order to identify and quantify the active ingredients of an 
intervention, first a fuller description of individual features of the intervention is needed 
(Lorencatto et al., 2013b). We then need a ‘measure’ of the delivery or implementation of these 
features, which would not only be reliable in measuring this construct (fidelity of delivery) under 
study but would also have the potential to explain variation in quit rates. This measure could 
help optimise intervention delivery for wider implementation, by facilitating identification of the 
active intervention ingredients and their respective effect on quit rates.  
My aim in this thesis is to design a method for quantitative measurement of fidelity and then to 
use these quantitative scores to explore variation in smoking quit rates. This requires developing 
a measure that is reliable and takes into account the complexity of BIs. Developing a measure for 
an intervention with multiple facets requires wide-ranging knowledge, not only on scale 
construction but also on ways to capture intervention ingredients, aspects of patient-provider 
interaction and linkage with behaviour change in the patient, in a quantifiable manner. 
Accurately recording behaviour change and its underpinning causal mechanisms is challenging 
and requires a range of strategies. Process evaluation can give valuable insights into the causal 
mechanisms underlying the success of complex BIs and how they can be optimised (Craig et al., 
2013). 
I chose, therefore, to use the Medical Research Council (MRC) framework for process evaluation 
of complex interventions (Moore et al., 2015) to guide the methodology for examining variability 
in patient outcomes, based on provider fidelity of a BI. There is no single approach for carrying 
out this piece of work described in the MRC guidance. However, the guidance recognises fidelity 
as one of the key dimensions of implementation i.e. the quality and quantity of what is actually 
delivered as part of the intervention. It provides a framework linking fidelity to the broader 
functions of process evaluation, such as mechanism of impact and contextual factors. Although 
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this framework could not be applied in its entirety to quantify fidelity, some of its aspects could 
help design such a measure. For example, it describes approaches to delineate complex 
interventions in terms of active ingredients and how these act on behavioural determinants, 
introducing the use of logic models. It also introduces frameworks and methods for assessing 
fidelity that could be applied to BIs. I will describe some of these approaches in further detail 
here, as it helps explain the structure and process used in my thesis. 
1.1 COMPLEX BEHAVIOURAL INTERVENTIONS 
An intervention may be ‘complex’ in terms of the number of features, the nature of interactions 
between its features, challenges in its implementation, and how it interacts with its contexts 
(Craig et al., 2013). Complex interventions are more than the sum of their parts (Hawe et al., 
2004). An intervention is more likely to be complex when it is difficult to precisely define its 
‘active ingredients’ and how they relate to each other (Medical Research Council, 2000).  
Complexity is a scientific concept, which asserts that some interventions comprise behavioural 
phenomena that are more complex than just the constituent parts of that intervention. 
Interventions aimed at changing behaviour add to their complexity in implementation, by the 
number and difficulty of behaviours (and skills) required on the part of the provider and the 
recipient of the intervention (Craig et al., 2008).  
The complexity of BIs is determined, in part, by the number of features involved. Features 
include, the Behaviour Change Techniques (BCTs) or ‘active ingredients’, defined later in section 
1.3.2, to facilitate behaviour modification, as well as procedures for delivery of the BCTs. 
Procedures for delivery include who delivers the intervention, to whom, how often, for how long, 
in what format, and in what context. The competences required to deliver the BCTs also 
contribute to the complexity of such interventions. To undertake specification of an intervention 
into its constituent ingredients, it is important to first understand all of its dimensions and its 
theoretical basis. 
1.2 DELINEATING BEHAVIOURAL INTERVENTIONS 
According to the MRC framework (Moore et al., 2015), a clear description of the causal 
assumptions of an intervention is a vital step in framing the pathways linking intervention to 
outcomes. Michie and colleagues (2009) argue that adoption of a uniform description of complex 
BIs may help evaluators in achieving this. In subsequent sections, I will present the behaviour 
change concepts, terminologies and their descriptions, including a logic model of behaviour 
change. This work is broadly based on behaviour change for smoking cessation.   
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1.2.1 Behaviour Change Theories 
Theories that explain behaviour help to identify the determinants that can influence it to change 
(Michie et al., 2008) e.g. the theory of planned behaviour (Ajzen, 1991), health belief model 
(Green and Murphy, 2014), and the theory of reasoned action (Fishbein, 1979). These theories 
support a range of constructs which affect behaviour including, intention, self-efficacy, 
anticipated outcomes/attitude, norms (Fishbein et al., 2001), knowledge, skills, belief about 
consequences and capabilities, motivation and action planning (Michie and Abraham, 2004). 
Other theories help explain the process of change and the importance of tailoring interactions 
with patients e.g. the trans-theoretical (stages of change) model (Prochaska and DiClemente, 
1984) and the social cognitive theory (Bandura, 1997).  
Prochaska and DiClemente (1984) recommend assessing patient readiness to act on a new 
healthier behaviour, and providing strategies to guide them through the stages of action and 
maintenance of their changed behaviour. In this model, individuals can be characterised as 
belonging to one of the five ‘stages’, namely ‘pre-contemplation’, ‘contemplation’, ‘preparation’, 
‘action’ and ‘maintenance’. Although widely used, more recently this ‘stages of change’ model has 
received criticism for not being founded on evidence (West, 2005); mainly because the concept of 
‘stage’ draws arbitrary dividing lines between stages which are not real, and represent traits of 
individuals rather than their ‘states’ of mind. Secondly, this model focuses on conscious decision-
making, neglecting the fact that unhealthy habit patterns become entrenched and semi-
automated through repeated reward and punishment - processes that fall outside conscious 
awareness and do not follow decision-making rules (West, 2005). Finally, the model gives no 
consideration to the concept of addiction, which is clearly an important determinant of behaviour 
change when it comes to behaviours like smoking (West, 2005). 
All these constructs covered by different theories envelop the determinants of behaviour change. 
Some are described by overarching concepts, others by completely separate concepts and still 
others by similar concepts but different terminologies (Michie et al., 2008). This disparity in the 
classification of behavioural determinants limits the conceptualisation of activities within a BI in 
terms of causal assumptions underlying change in a particular behaviour.   
1.2.2 Recent Advances in Behaviour Change Science 
Recent progress in the science of behaviour change (Michie et al., 2009b, Abraham and Michie, 
2008) has helped identify key behavioural determinants of healthy life-style changes including 
smoking cessation and the techniques that could influence these. Michie and Abraham (2008) 
identified determinants that could be targeted for modifying behaviour, e.g. knowledge, skills, 
attitudes, belief about capabilities, social influences etc. Similarly, the BCTs, defined in section 
1.3.2, that have been established to address these determinants, show how to target particular 
behaviours, e.g. by providing information on consequences, setting goals, coping with triggers 
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and withdrawal symptoms, reward etc. (Michie and Johnston, 2012, Michie et al., 2011c). Both 
behavioural determinants and techniques that act on changing them can prove useful in 
disentangling ingredients within a complex BI and describing its activities.    
1.3 THE ‘LOGIC MODEL’ OF BEHAVIOUR CHANGE 
Modelling theory (commonly known as causal or logic modelling) involves hypothesising the 
concepts of what is targeted (for example, the behavioural determinants of smoking) and how 
these are targeted (Michie et al., 2008). A generic model linking behavioural determinants, 
causally through behaviour to physiological or biochemical measures, and eventually to health 
outcomes has been proposed (Hardeman et al., 2005). Michie et al. (2008) adapted this model 
(Figure 1.1) to explain behaviour change by identifying the behavioural determinants (Cane et al., 
2012, Michie et al., 2008), the BCTs that are likely to be effective (Michie et al., 2009a, Michie et 
al., 2011b, Michie et al., 2011c, West et al., 2010) and link between the two (Michie et al., 2014-
2017). In the illustration (Figure 1.1), each blue arrow represents a causal process and 
interventions are targeted at changing these causal processes (Hardeman et al., 2005). I added the 
blue circles to show the overarching work on behaviour change in the context of smoking 
cessation that has emerged in recent years.  
 
Figure 1.1: The logic model of behaviour change adapted for smoking cessation 
*Adapted from: Hardeman, et al (2005), and Michie et al. (2008) 
Subsequent sections provide an insight into the behavioural determinants of smoking cessation 
(Michie et al., 2011c), using the PRIME theory of motivation, (that provides a model to 
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encapsulate mechanisms in connection to tobacco dependence behaviour (West, 2009)) and the 
theoretical domains framework (TDF), (that provides a classification and categorisation method 
for behavioural determinants (Cane et al., 2012, Michie et al., 2005)). In these sections, I also list 
the relevant BCTs likely to influence these determinants (Michie et al., 2011b, Michie et al., 
2011c, West et al., 2010). 
1.3.1 Behavioural Determinants 
Determinants identified by the TDF are generally applicable to healthy life-style behaviours 
(Cane et al., 2012). Determinants specific to smoking cessation that are used for developing the 
taxonomy of BCTs (Michie et al., 2011c) are conceptually derived from the PRIME theory 
(West, 2009). Both the TDF and the PRIME theory of motivation are briefly discussed, to shed 
light on their key parameters, as this is important for later descriptions of the BI in developing a 
fidelity measure. 
Theoretical Domains Framework 
Simplification of theoretical constructs based on the fact that theory can predict behaviour 
(Fishbein et al., 2001) shows good agreement on important behavioural determinants (Michie et 
al., 2008). However, overlapping theoretical constructs between theories hamper the 
identification of techniques specifically targeting individual determinants. The TDF was 
developed to categorise similar theoretical constructs into behavioural determinants and label 
them across all relevant theories of behaviour change. 
Initially, the TDF comprised  12 behavioural determinants extracted from repeated evaluations 
of several theories (Michie et al., 2005). It was further validated for the number of extracted 
determinants, the constructs represented by each determinant, and its label (Cane et al., 2012). 
The revised framework consists of 14 determinants and 84 constructs including, but not limited 
to; knowledge, skills, identity, beliefs about capability, beliefs about consequences, intentions, 
goals and behavioural regulation.   
The PRIME Theory of Motivation 
Determinants critical to behaviour change for smoking cessation derive from the TDF, based on 
the PRIME theory of motivation (Michie et al., 2011c). Behavioural determinants of smoking and 
cessation are classified broadly into psychological (attitudes and beliefs), physiological (nicotine 
dependence) and social (normative behaviour). Nicotine dependence has multiple facets and 
requires understanding of the person’s intention and motivation to change their behaviour (West, 
2009). Dependence or addiction is a result of powerful motivation to carry out certain activities 
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repeatedly, to an extent that can be harmful and is often accompanied by impaired self-control 
(West, 2009).  
Motivation means a reason for acting in a particular way (Oxford Dictionaries, 2015) i.e. deciding 
to do or not to do a certain activity, based on the known consequences. However, behaviour is 
often driven by habit or impulse and results in responding without thinking about the 
consequences. Actions of a particular behaviour might be merely driven by desire, ruling out the 
sense to make appropriate judgment about the best options (Mook, 1996). These actions often 
rely on instinctive thinking based on a previous idea or set rules, so that the brain does not have 
to think about the consequences each time (Mook, 1996). Enhancing a person’s capability to 
achieve self-control based on self-imposed rules can lead to targeted behaviour change (West, 
2009).  
The PRIME Theory of motivation (West, 2009) provides a model to counter ‘dependence 
behaviour’ through stimulus-impulse associations, past experiences of pleasure, feelings of desire, 
beliefs about what is good or bad, self-conscious plans, rules or intentions and the ability for self-
control. A key feature of this theory is that behaviour at each moment arises from the strongest 
of competing impulses at that moment and feelings of anticipated pleasure, satisfaction, or relief. 
These competing impulses and feelings are driven by past beliefs about what is good or bad, 
which in turn results from self-conscious intentions (West, 2009, West et al., 2010). 
Behaviour change requires self-control, which requires generating sufficiently strong needs and 
wants from self-conscious intentions to overcome competing impulses (West, 2009). According 
to PRIME Theory, this involves a sense of self that creates ‘rules,’ which can generate motives 
from past experiences and beliefs about what is good or bad. For example, the belief that smoking 
is harmful does not usually in itself stop someone from smoking, but occasionally it causes the 
smoker to want self-consciously to create a rule not to smoke, which then generates the need not 
to smoke. While exercising self-control, the stronger the impulse against which it has to 
compete, the greater will be the effort required. The desire or habit to ‘want’ and motive or 
dependence to ‘need’ to smoke both determine the process of intended behaviour change and act 
as competing impulses against quitting.  
In terms of dependence, nicotine from tobacco generates the impulse to smoke and undermines 
self-control by interacting with all of the levels of motivation (West, 2009). It leads to cue-driven 
urges, impairs inhibitory control and gives enjoyment, resulting in ‘wanting’ to smoke. It causes 
nicotine craving, withdrawal symptoms and beliefs about benefits of smoking (e.g. stress relief), 
all of which can result in a ‘need’ to smoke. Wanting to smoke is a major deterrent to ‘making quit 
attempts,’ but does not influence success. On the other hand, ‘need’ to smoke affects quit success, 
due to the cue-driven impulses to smoke, nicotine craving, adverse mood and beliefs about the 
benefits of smoking.  
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1.3.2 Behaviour Change Techniques 
Behaviour Change Techniques (BCTs) form an integral part of BIs (Michie et al., 2011a, Albrecht 
et al., 2013), considered as coordinated sets of activities designed to change targeted behavioural 
patterns, based on an individual’s capability, opportunity and motivation (Michie et al., 2011d). 
For BIs aimed at smoking cessation these can be defined as the ingredients that alter and redirect 
causal processes regulating behaviour connected to smoking e.g. feedback, self-monitoring and 
reinforcement (Michie et al., 2011a).  
The Taxonomy of Behaviour Change Techniques for Smoking Cessation 
Michie et al. developed a generic list of BCTs based on two published reviews (Abraham and 
Michie, 2008, Hardeman et al., 2000) and relevant text books (Michie et al., 2008). These BCTs 
aim at several health interventions including weight management, physical activity and healthy 
eating and are not specific to smoking cessation.   
The goal of behaviour change in smoking cessation is to alter the balance of impulses and 
motivations by reducing impulses to smoke and increasing motivation and capacity to resist them 
(Michie et al., 2011c). This involves minimising motivation to smoke, maximising motivation not 
to smoke, maximising skills and capacity for self-control, and optimising use of smoking 
cessation medications. This is achieved in different ways, e.g. changing beliefs about what is good 
or bad, changing drivers of want or need to engage in the smoking behaviour, and changing 
exposure to stimuli that trigger the impulse to engage in smoking (Michie et al., 2011c).  
The taxonomy for classifying BCTs of smoking cessation by their causal determinants was 
established (Michie et al., 2011c) from two source documents (McEwen et al., 2006, McEwen, 
2008). Forty-four BCTs were classified (Michie et al., 2011c, West et al., 2010) according to four 
broad ‘theoretical determinants’ that can be mapped to the fundamental concepts of PRIME 
theory of motivation:  
i. Directly addressing/boosting motivation e.g. by providing rewards dependent on abstinence,  
ii. Maximising self-regulatory capacity e.g. facilitating barrier identification and problem 
solving,  
iii. Promoting adjuvant activities e.g. advising on stop-smoking medication, and 
iv. Supporting other BCTs or general aspects of the interaction e.g. building general rapport.  
This taxonomy of BCTs for smoking cessation was further used to establish competences 
required by the BI providers in a manner similar to that achieved with cognitive behavioural 
therapy (Roth and Pilling, 2008), described below.  
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Competences identified to effectively deliver Behavioural Interventions 
A list of competences for effective delivery of BIs was identified from relevant national and 
international guidance documents and Stop Smoking Service treatment manuals, centred on 
individual- and group-based sessions (Michie et al., 2011b). The main objective was to categorise 
the competences in terms of focus on ‘skill versus knowledge’ and their function in supporting 
smoking cessation. The competency for each BCT was derived simply to affirm that the provider 
should ‘be able to’ undertake this activity. For example, if the BCT was ‘Measuring expired 
Carbon Monoxide (CO) level’, then the competency would be the ‘Ability to measure CO level’. 
The list was classified in terms of the key behavioural determinants of competences in promoting 
smoking cessation (Michie et al., 2011b):  
i. BCTs that specifically target the behaviour e.g. intervention content that directly promotes 
abstinence  
a) Address motivation: maximise motivation to abstain or minimise motivation to smoke  
b) Maximise self-regulatory capacity and skills: promote mental and physical activities that 
either reduce exposure to smoking cues or help with resisting motivation to smoke 
ii. Adjuvant activities e.g. intervention content that promotes activities that indirectly facilitate 
abstinence  
iii. General aspects of the interaction e.g. competences necessary for effective delivery of specific 
BCTs and adjuvant activities  
a) Delivery of the intervention: adapt the intervention according to the client and context.  
b) Information gathering: acquire relevant information.  
c) General communication: give relevant information and verbal and non-verbal behaviour 
underpinning effective delivery of specific BCTs and adjuvant activities.  
d) Professionalism: general aspects of conduct as a health professional working in the field. 
According to the proponents of motivational interviewing (MI) (Hardcastle et al., 2016), another 
behaviour change approach (Heckman et al., 2010, Lai et al., 2010), the behaviour change 
taxonomies (Michie et al., 2011b, Michie et al., 2011c) have exclusively focused on describing the 
intervention content. They believe that the techniques classified in the above taxonomies do not 
include the interpersonal aspects of the intervention, that is, the manner or ‘way’ in which 
intervention content is delivered or expressed to the smoker (Hardcastle et al., 2016). They 
classify BCTs according to their function as ‘content-based’ or ‘relational’ for those related to the 
quality of interaction (Hardcastle et al., 2016). In Chapter 4, I will present an in-depth study of 
these ideologies, incorporating the content-based and relational techniques for describing 
features of a BI, the distinction between ‘relational’ techniques and ‘generic competences’, and 
whether these generic competences can afford specification of the interpersonal aspects of the 
intervention.  
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1.4 MEASUREMENT OF FIDELITY FOR BEHAVIOURAL INTERVENTIONS 
The term ‘fidelity’ (also referred to as ‘implementation’, ‘adherence’ and ‘integrity’) describes the 
actual delivery of an intervention, versus the intended delivery (Moore et al., 2015). It is defined 
as the degree to which an intervention is implemented as it was designed in the original protocol 
(Peters et al., 2013). While it may be worthwhile to apply a common framework for evaluating 
fidelity (e.g. RE-AIM, Realist Evaluation or others (Pawson and Tilley, 1997, Glasgow et al., 
1999, Carroll et al., 2007, Weiss, 1997)), it would be difficult to explain the variability in smoking 
quit rates using these approaches, for three reasons:  
1) Linking behaviour change theory with fidelity: the lack of a methodology to capture the active 
features of a BI including provider expertise, in a measurable way;  
2) Measuring fidelity: the lack of a measure to quantify fidelity objectively; and,  
3) The extent to which fidelity predicts outcomes: lack of studies linking fidelity scores of BIs 
with quit rates.  
Despite the potential importance of fidelity measurement in evaluations of BIs for smoking 
cessation, research focusing on developing fidelity measures to identify potential causal 
mechanisms of impact on effectiveness is rare. There is, however, a range of theories in 
behavioural science (Lorencatto et al., 2013b, Michie et al., 2011c), as described in section 1.3, 
that provides a consistent common taxonomy for describing the content of BIs for smoking 
cessation and the generic competences to deliver these in an effective manner (Michie et al., 
2011b). The taxonomy of BCTs has so far been used to assess fidelity by coding and comparing 
the presence/absence of BCTs in English Stop Smoking services against the practice manuals 
(Lorencatto et al., 2013a), but this is not structured in a quantifiable way that can be used for 
rating and scoring for fidelity. Similarly, the competences required to deliver BIs have not been 
applied to assess the interpersonal aspects of delivery in a structured rating format (Michie et al., 
2011b).  
Fidelity indices can be used to document deviations from an intended practice and differences 
among the variations in practice (Bond et al., 1997b). Indices (also known as ‘scales’ or ‘criteria’) 
have been used conventionally for quantifying fidelity to compare an intervention, as 
implemented, to the empirically tested theory on which it is based (Drake et al., 2001, Mowbray 
et al., 2003). Some researchers have described common elements of fidelity to an intervention in 
the context of health behaviour change (Bellg et al., 2004, Borrelli et al., 2005, Borrelli, 2011). 
Others have provided models for developing measures of fidelity (Mowbray et al., 2003, Carroll 
et al., 2007). However, approaches combining the elements of fidelity specific to BIs and a 
measure predictive of quit rates do not exist. Further literature on fidelity and its application for 
BIs is provided in Chapter 4.  
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With guidance from the MRC framework for process evaluation, existing fidelity literature and 
the advent of BI specification taxonomies, I set out to develop a method for capturing active 
ingredients of a BI for smoking cessation in a format that would allow scoring based on fidelity.   
1.5 FIDELITY TO BEHAVIOURAL INTERVENTION AS A METHOD OF INFORMING VARIATION 
IN OUTCOMES 
The second part of my research concerns understanding of the mechanisms of impact of 
intervention features on the quit rates of the patients. To clarify, understanding the mechanisms 
of impact means establishing which of the techniques (content-based or interpersonal) that were 
actively delivered to the patients triggered change in the targeted behaviour.  
1.5.1 Fidelity – as an intermediate implementation variable 
The characteristics or different aspects of implementation response often studied in process 
evaluations are referred to as the implementation variables, e.g. acceptability, feasibility, fidelity 
etc. (Peters et al., 2013). In effectiveness evaluations, these variables are considered as 
intermediate factors that explain other important outcomes like smoking cessation, which are the 
prime target of the intervention (Brownson et al., 2012, Proctor et al., 2011). However, not all 
these variables are of equal importance in the delivery of an intervention (Proctor et al., 2011). In 
novel interventions, the focus remains mainly on factors relating to acceptability and feasibility, 
while in existing interventions, the degree to which the intervention is implemented as it was 
originally designed, or is faithful to the original (measured by the fidelity variable), is considered 
vital (Peters et al., 2013). For this thesis, the implementation variable of importance is fidelity, as 
I am interested in exploring variation in outcomes of an existing BI for smoking cessation. The 
requisite elements of fidelity in relation to BIs will be discussed in detail in Chapter 4. 
1.5.2 Approaches to examining fidelity 
Interventions in health services should be supported by evidence, with robust evaluation before 
widespread implementation. However, developing this evidence, where the interventions are 
complex is by no means straightforward. Evaluation purports to measure ‘effectiveness’, ‘worth’ 
and ‘value’. Yet not only are these concepts value-laden, and subject to evaluation design, but also 
concern the nature of complexity in behavioural interventions and how these shape what works 
and how it works in reality. The necessary ‘active ingredient’ of the intervention may not be 
easily identifiable, and may influence outcomes through interactions with implementation in 
complex ways. In designing my evaluative research, I needed, therefore, to clarify my underlying 
assumptions in view of the aim of the proposed work. 
I aimed to adopt a pragmatic paradigm, which is not committed to any one system of philosophy 
or reality. This paradigm places ‘the research problem’ as central and applies all approaches to 
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understanding the problem (Morgan, 2007). Data collection and analysis methods are chosen as 
those most likely to provide insights into the question, with no philosophical loyalty to any 
particular paradigm. The key point in evaluating complex interventions is whether they will 
work in real life scenarios, therefore making it important to understand the whole range of effects 
and how they vary among the recipients or across the sites (Craig et al., 2008). 
Different approaches to examining the implementation process of an intervention exist, and the 
most commonly used term to describe such an exploration is ‘process evaluation’. In the 
following paragraphs, I will briefly introduce the approach for linking fidelity with quit rates in 
relation to my thesis, which is a similar but distinct concept to process evaluation.  
The theoretical models (Carroll et al., 2007, Linnan and Steckler, 2002, Grant et al., 2013), 
presented in Chapter 4, for process evaluation of complex interventions mostly apply formative 
or developmental research approaches (Moore et al., 2015). These approaches to process 
evaluation are undertaken during the design and pre-testing stages of interventions, targeted at 
improving the intervention theory and development (Rossi et al., 2003). Interpretive evaluation, 
on the contrary, employs some of the same concepts and methods as process evaluation, but its 
role is to illuminate the mechanism of action of the delivered intervention and enhance 
understanding of its impact or worth (Stetler et al., 2006).  
Interpretive evaluation is a form of process evaluation that attempts to understand the 
complexity of an intervention (Neutens and Rubinson, 2001, Stetler et al., 2006). It attempts to 
understand the impact of an intervention, as opposed to experimental evaluations, which are used 
to validate simplified effects of the intervention through controlled comparisons (Neutens and 
Rubinson, 2001). It provides alternative explanations for results, helps to clarify the mechanisms 
of impact of the ‘‘black box’’ of an intervention, often, including associational relationships with 
outcomes (Stetler et al., 2006). Such interpretation occurs through the end point triangulation of 
qualitative and quantitative data collected for intermediary factors (i.e. fidelity) and the effect 
outcomes e.g. smoking cessation, including associational links between the two to furnish 
understanding of intervention impact. 
MRC recommends validating association of fidelity with effectiveness outcomes of interventions 
where quantitative data is available (Moore et al., 2015). This could inform whether fidelity 
varied substantially between implementation sites or providers and if better delivery produced 
better outcomes. However, issues concerning timing of analysis play a significant role in 
interpretive approaches to process evaluation and the use of fidelity- as intermediate factor- with 
outcomes (Moore et al., 2015). Some perspectives advocate analysing fidelity data independent of 
trial outcomes, to avoid biasing these analyses (Oakley et al., 2006b). Others highlight the value 
of post-trial analysis of causal pathways and intervention fidelity in allowing emerging issues to 
be explored (Kinmonth et al., 2008).  
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1.5.3 Potential methods for examining fidelity 
Process evaluation is a rapidly evolving science, which does not have a narrow set of specific 
research methods but rather it draws on a wide variety of qualitative, quantitative, and mixed-
methods approaches (Peters et al., 2013). Mixed-methods approaches are highly recommended 
for studying fidelity, to maximise the interpretation of findings using different methods to 
complement each other (Leech and Onwuegbuzie, 2010). While these different approaches 
provide a basic toolkit for examining fidelity, it is the research question that is paramount in 
determining the type of research methods to be used (Peters et al., 2013). 
Most process evaluation approaches use a combination of qualitative and quantitative methods 
(Moore et al., 2015). Qualitative methods and participatory action research approaches are 
suitable for research questions concerned with ‘exploring’, ‘describing’, or ‘adequacy’ of 
implementation of an intervention (Peters, 2009, Peters et al., 2013, Habicht et al., 1999). Realist 
review, on the contrary, provides an excellent approach to synthesising theoretical 
understanding and empirical evidence from documentary review, and is best suited to informing 
policy interventions (Onwuegbuzie and Collins, 2007). When studying questions concerned with 
‘plausibility’, or ‘probability’ that the outcome is due to the implemented intervention, then trials 
are considered as the gold-standard (Curran et al., 2012). Eventually, research questions 
requiring ‘explanation’ of the mechanism of action of an intervention on its outcome, can be 
addressed through convergence of data and analysis using both quantitative and qualitative 
methods (Peters, 2009, Peters et al., 2013). Depending on the research focus, the study methods 
can weigh more towards qualitative or quantitative inquiry (Peters et al., 2013).  
Fidelity can be assessed using quantitative monitoring and qualitative exploration during 
intervention implementation, while contextual factors can be explored qualitatively before and 
after the intervention is implemented (Grant et al., 2013). Grant et al. (2013) further highlight 
the use of quantitative data collected post implementation for exploring the potential effect of 
theory-linked causal mechanisms of an intervention on its outcomes. Common quantitative 
methods used for measuring fidelity to complex interventions include structured observations, 
self-record questionnaires, and secondary analysis of routine data (Moore et al., 2015). The 
qualitative methods combined with these often include one-to-one interviews, focus groups and 
non-participant observation. Subsequently, inferential statistics can be used to test significant 
associations using data collected from different sources by these methods (Stetler et al., 2006).  
Most of the aforementioned methods provide insights into understanding implementation of an 
intervention and its mechanisms of impact on the outcome, which are defined as the key functions 
of process evaluation by MRC (Moore et al., 2015). I have adapted these key functions of process 
evaluation within an interpretive evaluation model (Figure 1.2). I will present the methods for 
designing a fidelity measure and using it to interpret variation in quit rates of smoking cessation, 
in detail, in respective chapters of the thesis. 
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Figure 1.2: Interpretive Evaluation Model 
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1.6 THESIS OUTLINE AND OVERVIEW OF PLANNED STUDIES 
In this thesis, I will first present four reviews of the relevant literature describing:  
i. Smoking in TB patients- evidence synthesis,  
ii. Smoking cessation in high TB burden countries,  
iii. Sources of variation in smoking cessation-ASSIST study, and  
iv. Description of intervention fidelity;  
Reviewing the literature will help justify my research aims and build the foundation for 
designing a fidelity measure and evaluating fidelity as an intermediary factor in explaining quit 
rates. This work will lead into the three linked primary studies planned for the thesis: 
Study A- describes the steps in the development of a fidelity measure for BIs in smoking 
cessation  
Study B- describes reliability testing of this fidelity measure to see if it is fit for measuring 
fidelity to BIs as intended, and,  
Study C- evaluates the intermediary role of fidelity in explaining quit rates of a BI.  
All three studies use different methods, mainly quantitative, incorporating several linked 
investigations. Figure 1.3 gives an overview of the studies in the thesis. 
A word of explanation is necessary before I present the case of variability in quit rates of a BI for 
smoking cessation. In this thesis I used data from a large cluster RCT- Action to Stop Smoking 
In Suspected TB (ASSIST), and linked it with fidelity scores obtained in a prospective 
observational study (see Figure 1.3). The decision to explore the wide variation in quit rates of a 
BI came out of findings from the ASSIST study. Therefore, I have presented an overview of the 
ASSIST study and the reported variability in quit rates first, in order to illustrate the process of 
arriving at this decision. In addition, given the paucity of research on fidelity measures for BIs, in 
developing a reliable and valid tool, I relied predominantly on extrapolating from the relatively 
richer literature on behaviour change science and applying it to conventional scale (or index) 
construction methods.  
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Figure 1.3: Overview of studies in thesis 
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Chapter 2. Smoking cessation in high TB burden countries 
In this Chapter, I first give a brief overview of the association between smoking and TB, highlighting the 
uncertainty in this evidence. The review on smoking and TB is provided as an appendix. I then give a brief 
overview of behavioural interventions (BIs) as a cost-effective solution for cessation services in LMICs. I 
provide the significance of integrating BIs within routine TB care services (commonly called ‘National TB 
programme’). I end the chapter by highlighting challenges of variation in cessation outcomes and the 
implications on wider implementation of smoking cessation, using a cluster RCT (ASSIST) as the case-
study. 
Tobacco consumption and TB both contribute sizably to the disease burden in LMICs (Dogar et 
al., 2013, Siddiqi, 2014). In the past, some systematic reviews have attempted to summarise the 
effect of smoking on TB outcomes (Bates et al., 2007, Lin et al., 2007, Slama et al., 2007). There 
remains an uncertainty in the conclusions drawn, in these reviews, due to the quality of 
observational studies included and the limitations in methods used to appraise them. Hence the 
usefulness of the evidence presented in these reviews in convincing policy makers and TB 
managers of the importance of smoking cessation in TB patients remains limited. 
This is particularly true when drawing conclusions from evaluations of smoking cessation 
interventions in patients with conditions like TB. Smoking cessation trials often use quit rates as 
the primary endpoint, leading to a lack of direct evidence for the effects of smoking cessation on 
health outcomes like TB outcomes. Hence, it is important to synthesise all available evidence 
linking smoking with TB to inform policy and public health practice for integrating smoking 
cessation interventions in TB programmes of LMICs. I, therefore, carried out a review of the 
literature on the association between smoking and TB outcomes (Appendix A).  
Regardless of the TB burden in any country, all those who use tobacco and who have TB may 
suffer excess mortality and morbidity (Lin et al., 2007, Bates et al., 2007). Understanding the 
mechanisms by which smoking cessation might alter TB disease in its natural course and 
identifying the most effective and cost-efficient means of influencing the two epidemics where 
these converge could hugely benefit research and policy directions in the area (Siddiqi, 2014). 
Effective smoking cessation interventions exist; however, their effectiveness and cost-
implications for LMICs, particularly for TB patients, are under studied (Siddiqi, 2014). In 
contrast, well-established national TB programmes in these countries offer a unique opportunity 
for optimising smoking cessation within TB care and evaluating the effects of such integration.   
One such smoking cessation BI (Action to Stop Smoking In Suspected TB [ASSIST] - a cluster 
RCT) was designed for a high TB burden LMIC and was found to be highly effective (Siddiqi et 
al., 2013). However, there was a wide variation in patient smoking quit rate between TB clinics 
(clusters) that could not be explained. 
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2.1 SMOKING AND TUBERCULOSIS  
Smoking and TB both contribute significantly to the global burden of disease, not only 
individually but also by adversely influencing each other. Historically, both smoking and TB 
have been prevalent for centuries, but it was not until 1881 that tobacco smoking started to 
become widespread, after the invention of cigarette rolling machine. Coincidently, Mycobacterium 
tuberculosis was first isolated by Robert Koch in 1882 as the causative agent for TB. The potential 
association between the two (tobacco smoking and TB) was first hypothesised in 1918 (Webb, 
1918).  
2.1.1 Tobacco smoking 
Tobacco smoking alone causes more deaths than any other preventable risk factor in the world. 
It kills one in two users, leading to approximately 5.7 million deaths in 2010. When second-hand 
smoke was included, the global burden of disease increased to 6.3 million deaths in that year 
(Institute for Health Metrics and Evaluation, 2010, Lim et al., 2013). It is a risk factor for six out 
of the eight leading causes of death worldwide, i.e. ischaemic heart disease, cerebrovascular 
disease, lower respiratory infections, chronic obstructive pulmonary disease, TB, and cancers of 
trachea, bronchus and lung (Mathers and Loncar, 2006). 
Globally, 1.1 billion people in the world currently smoke tobacco, and 70% of these reside in the 
LMICs (Ng et al., 2014). Between 1980 and 2012, a large reduction (41% to 31% in men and 11% 
to 6% in women) in the prevalence of daily smoking was estimated, globally. However, the 
population growth contributed to an increase in the number of smokers worldwide from 4.96 
trillion to 6.25 trillion during this time period (Ng et al., 2014). Moreover, as smoking prevalence 
declined in the high-income countries (HICs) overtime, an increase has been observed in the 
LMICs (Ng et al., 2014). 
2.1.2 Tuberculosis 
TB is a widespread, and in many cases fatal, infectious disease typically affecting the lungs, but 
can also attack other parts of the body. Every year 8.8 million new cases of TB are diagnosed 
worldwide, and 81% of these are from LMICs (World Health Organisation, 2014b). 
Approximately 3.9 million of these newly diagnosed cases are confirmed pulmonary TB on 
sputum smear microscopy, the most infectious and transmissible form of the disease (World 
Health Organisation, 2014b, Dye, 2006). Globally, TB is the leading cause of death from a 
curable infectious disease, causing 1.7 million deaths per year (Dye, 2006). The resurgence of TB 
in Eastern Europe and the advent of multi-drug resistant TB are some of the emerging 
challenges for the global TB control (Dye, 2006). Tuberculosis remains prominent on the 
international agenda to combat preventable diseases, as it kills people in economically productive 
age-groups.  
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2.1.3 Impact of smoking on TB burden 
An estimated 15% of the pulmonary TB cases in the world each year could be attributed to 
smoking alone (Pai et al., 2007). This has been estimated from prevalence of exposure to tobacco 
smoke (30%) and the relative risk of developing TB (1.5), giving a global Population Attributable 
Risk of 15%. If the current rate of smoking persists, it is projected to cause 18 million additional 
cases of TB and 40 million excess TB related-deaths between 2010 and 2050, globally (Basu et 
al., 2011). Projections from these mathematical models of current smoking trends suggest 
increases in TB incidence ranging from 5%, in the western Pacific region, to 42%, in the Eastern 
Mediterranean region by 2050. Similarly the increases in TB related deaths are likely to range 
from 64% in Europe to 135% in Eastern Mediterranean region by mid-century (Basu et al., 2011). 
2.1.4 The biological link between smoking and TB 
Tobacco smoke influences the systemic and lung defences of the human body. Some biologically 
plausible explanations of how smoking affects these defences are given below. 
Mechanical defences 
Exposure to tobacco smoke impairs the function of cilia (tiny hairs) lining the inside surface of 
airways. This alters the normal clearance of secretions, leading to mucus hyper-secretion. 
Impaired bacterial clearance leads to increased peri-bronchial inflammation and permeability 
caused by epithelial damage to the airways (Di Stefano et al., 2012, van Zyl-Smit et al., 2010). 
Peripheral immune defences  
Tobacco smoke alters the function of innate and adaptive immune cells that collectively defend 
the body from invading bacteria (Di Stefano et al., 2012, Kumari and Meena, 2014). An important 
function of CD4+T cells is that they produce interferon gamma (INF-gamma) which signals 
phagocytic cells (like macrophages) and activates them to engulf the bacteria (Di Stefano et al., 
2012). Exposure to tobacco smoke decreases the CD4+ T cell counts  (van Zyl-Smit et al., 2010, 
Stead and Lancaster, 2012), predisposing individuals to respiratory infections. Nicotine and 
acrolein are constituents of tobacco smoke that increase the number of viable Mycobacteria inside 
host cells (Kumari and Meena, 2014). Nicotine also impairs antigen (bacteria related) mediated 
signalling in lymphocytes and T cells, leading to reduced responsiveness and antibody formation 
(Di Stefano et al., 2012). 
Local alveolar immune defences 
Tar is a by-product of tobacco smoke that inhibits the production of important markers of 
inflammation (IL-1b, IL-2), INF-gamma and Tumour Necrosis Factor alpha, which are 
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responsible for activating the body’s defence mechanisms (Di Stefano et al., 2012, Kumari and 
Meena, 2014). Smoke from tobacco impairs the function of lung alveolar macrophages, which 
form an integral early defence mechanism to prevent the spread of bacteria by walling them off 
(Di Stefano et al., 2012). In addition, nicotine (Di Stefano et al., 2012) and acrolein (Kumari and 
Meena, 2014) inhibit the production of pro-inflammatory cytokines, leading to increased 
replication of bacteria.  
Macrophages in lungs of smokers contain elevated amounts of iron (5-fold to 7-fold) in 
comparison to non-smokers (Boelaert et al., 2003). Macrophage iron overload impairs defence 
against bacteria through reduced production of inflammatory markers (Boelaert et al., 2003). 
This iron overload could be related to the high iron content of tobacco, leading to inhalation of 
1·12 g of iron per pack of cigarettes smoked (Boelaert et al., 2003, Mateos et al., 1998).  
2.1.5 The behavioural link between smoking and TB 
In addition to the biological mechanisms that support the causal chain of adverse effects of 
smoking on TB, smoking and TB also interact and enhance the behavioural risk for each other.  
The prevalence of smoking is found to be higher (OR: 1.9, 95%CI: 1.5 to 2.5) in TB patients than 
the general population (Wang and Shen, 2009). A high number of TB patients quit smoking 
when diagnosed with TB, however, 18% (OR: 3.5, 95% CI: 1.3 to 9.5) of these go back to smoking 
within the next 15 months.  
TB patients’ smoking pattern and smoking cessation behaviour can alter their clinical disease 
outcomes (Wang and Shen, 2009). Poorer compliance to TB treatment and thus default among 
TB patients has been associated (OR 1.8; 95%CI 1.0 to 3.3) with smoking (Lavigne et al., 2006). 
Poorer compliance to TB treatment in turn prolongs infectiousness and increases the chances of 
drug resistance, relapse and death (Zignol et al., 2006, Schneider and Novotny, 2007).  
2.2 EFFECTIVE SMOKING CESSATION INTERVENTIONS 
There is a substantial body of evidence on the efficacy of a range of pharmacological 
interventions and BIs offered by healthcare professionals for smoking cessation (Lancaster and 
Stead, 2005, Stead and Lancaster, 2012). However, the evidence of effectiveness and cost-
efficiency for offering these interventions to TB patients is limited (Siddiqi, 2014, Piné‐Abata et 
al., 2013). In high TB burden countries, well-developed TB programmes harness the primary 
health care (PHC) systems, providing TB diagnosis and treatment care nationwide. In countries 
with concomitantly high tobacco use, such systems offer a unique opportunity to integrate 
smoking cessation into routine TB diagnosis and treatment care. 
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2.2.1 Offering help to quit smoking- MPOWER  
Globally, there are six highly promoted policies designed to prevent young people from initiating 
smoking, helping current smokers quit, protecting non-smokers from exposure to second-hand 
smoke, warning people about the harms of smoking, raising taxes on tobacco and enforcing bans 
on tobacco promotion (World Health Organization, 2008). One of these policies is to offer help to 
quit smoking.  
The majority of the smokers who wish to stop, find it extremely difficult to give up on their own 
without proper professional support, leading them into several but futile quit attempts (Fiore, 
2000). Those who seek professional support to stop smoking are four times more likely to give up 
their habit successfully than those attempting to stop on their own (NICE, 2008).  
2.2.2 Treatments for cessation 
Behavioural support (based on BIs) for smoking cessation refers to any form of advice, discussion, 
encouragement and activity designed to increase the probability of success in quit attempts 
(Lancaster and Stead, 2005). Behavioural support for smoking cessation is found to be effective 
either alone, (relative risk (RR) of stopping being 1.39 (95%CI: 1.24 to 1.57) (Lancaster and 
Stead, 2005)) or in combination with pharmacotherapies including Nicotine Replacement 
Therapies-NRTs, Bupropion and Varenicline, (RR: 1.82 (95%CI: 1.66 to 2.00), respectively) 
(Dogar and Siddiqi, 2013, Stead and Lancaster, 2012). 
2.3 CONTEXTUALISING SMOKING CESSATION IN LMICS 
Epidemiologic transition in the past has been described by the changing patterns of health and 
disease over time as populations tend to age (Omran, 1971). However, this concept of 
demographical transition entailing population growth and longevity of life has not consistently 
explained the epidemiological transition from communicable diseases to Non-Communicable 
Diseases in developing countries. Changing life-style, food market globalisation, increasing 
urbanisation and economic development are shown to predict the current epidemiological 
situation in developing countries (Stuckler, 2008). The sharp demarcation between communicable 
diseases and Non-Communicable Diseases seen in the past now appears to be merging, as both 
types of disease affect the same individuals and populations (Bygbjerg, 2012). Many LMICs are 
worst impacted by this convergence, attempting to contain the communicable diseases, while at 
the same time being faced with the rise in Non-Communicable Diseases (Stuckler et al., 2010).  
2.3.1 Conceptualising the ‘Syndemic’ 
‘Syndemic’ is a relatively new concept used to describe the synergistic interaction of two or more 
conditions at multiple levels of causation and linkage contributing to a greater burden of disease 
in a population. It includes not only the impact due to interaction between the two conditions but 
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also the forces that cluster these conditions in persons, places and/or times (Littleton and Park, 
2009). Conceptualising tobacco and TB as a syndemic allows understanding of the synergies at 
multiple levels between both epidemics, whereby their mutual presence has an amplified negative 
impact on population health (Littleton and Park, 2009). It acknowledges the burden of these two 
mutually enhancing epidemics as borne by those countries that are the most marginal, globally. 
Both tobacco and TB tend to interact with other aspects of socio-economic and environmental 
context in these populations, such as HIV-infection, Non-Communicable Diseases, malnutrition, 
poor housing and indoor air pollution (Lonnroth et al., 2009). Thus, the concept allows 
recognising that over time this burden might become still more concentrated, due to the additive 
effects of the intergenerational deprivation if not intervened effectively (Littleton and Park, 2009, 
Lonnroth et al., 2009). A number of possible pathways linking the two conditions (tobacco and 
TB) and the co-existence of multiple inter-linking factors/diseases point towards the syndemic 
context of the situation in LMICs (Littleton and Park, 2009).  
2.3.2 Smoking trends in LMICs 
The health related effects of smoking in any population pertain to the intensity of its 
consumption and its prevalence. In LMICs, the prevalence of smoking is rising at a fast pace 
compared to the HICs, where it is either stable or decreasing over time (Esson and Leeder, 2004). 
Between years 1970 and 2000, the smoking prevalence has more than doubled in the middle-
income countries and is expected to rise further by 60% between 2000 and 2025 (Esson and 
Leeder, 2004). Similarly, prevalence in low-income countries has shown a steep increase since 
1990, which is expected to increase by more than 100% by the year 2025, if this trend of smoking 
continues (Esson and Leeder, 2004).  
This increasingly high prevalence of smoking in LMICs may impact TB disease incidence and 
treatment outcomes substantially (Patra et al., 2015, Bates et al., 2007, Lin et al., 2007). Tobacco 
smoking is associated with a higher risk of developing TB and poorer TB treatment outcomes, 
such as death, default (non-adherence to treatment), and treatment failure or relapse (Lin et al., 
2007, Bates et al., 2007, Slama et al., 2007). Second-hand smoking is also associated with an 
increased risk of acquiring TB infection and developing TB disease (Patra et al., 2015, Dogar et 
al., 2015). These moderate increases in relative risks of TB due to tobacco smoking could 
translate into marked increases in the absolute risks at the population level, due to the high 
smoking prevalence. 
 
Nevertheless, the intensity of smoking consumption in LMICs remains low (i.e. < 10 cigarettes 
per smoker per day) (Ng et al., 2014). This low consumption of tobacco smoking in most LMICs 
is remarkable, given its high prevalence contrary to the pattern of consumption and prevalence in 
HICs (Ng et al., 2014). Although, the less harm attributed to the lower intensity of consumption 
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is offset by the high rates of smoking prevalence in these LMICs, the low tobacco consumption  
could be used to advantage for promoting smoking cessation. A combination of cost-effective 
smoking cessation interventions and approaches to promote health behaviour change e.g. 
teachable moments targeted at this potentially susceptible population in TB clinics can have a 
multiplicative effect on smoking cessation impact.  
2.3.3 Smoking cessation in TB patients 
An established evidence-base exists for effective smoking cessation interventions in HICs 
(Lancaster and Stead, 2005, Stead and Lancaster, 2012), however, very little evidence is found for 
LMICs. Incorporating cost-effective smoking cessation interventions within TB programmes 
might have the potential to improve outcomes in confirmed TB cases. Additionally, it could be a 
means to reach and benefit the much larger group of those with suspected disease presenting to 
TB clinics in LMICs. Three distinct benefits of offering smoking cessation in TB patients are:  
1. Greater health benefits than the general population 
2. Opportunity of ‘teachable moments’ 
3. Potential to integrate smoking cessation within TB programmes 
Greater health benefits 
Most of the immunological abnormalities in TB patients induced by smoking tobacco are shown 
to reverse within six weeks after stopping smoking (Arcavi and Benowitz, 2004). Findings from 
the 50 year cohort of British doctors showed that for men born in 1900–1930, stopping smoking 
at the age of 50 reduced their risk of premature smoking-related death by half, compared to 
persistent smoking; while stopping at the age of 30 avoided almost all associated risk (Peto et al., 
1999, Doll et al., 2004). There are only a handful of empirical studies evaluating smoking 
cessation interventions aimed at smokers attending TB clinics in LMICs. All of these studies 
have a more pragmatic focus in terms of evaluating cessation interventions in public health 
programme settings. The evidence from these studies is summarised in the following paragraphs.  
A quasi-experimental (non-randomised) multi-centre study conducted in Malaysia found that the 
impact of integrating smoking cessation services in conventional Directly Observed Treatment 
Short-course (DOTS) TB programmes may confer advantages for short-term TB treatment 
outcomes in these patients and possibly for their long-term lung health (Awaisu et al., 2011). 
High smoking cessation rates (77.5% vs. 8.7%) and improved TB treatment response (no cavitary 
lesion at treatment completion: 68% vs. 35%), treatment adherence and significant reductions in 
treatment failure rate were also observed among the TB patients assigned to the intervention 
condition (behavioural support and Nicotine Replacement Therapy-NRT) compared to the 
standard care.  
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Another feasibility study was conducted in PHCs in Brazil, to determine whether TB DOTS 
paramedics could be trained to deliver smoking cessation support effectively in a TB clinic 
(Sereno et al., 2012). This study found a dose-response effect between the duration of individual 
face-to-face patient-provider interaction session and successful cessation outcomes.  
A cluster RCT (see ‘Overview of ASSIST study’- Appendix B) in Pakistan found that an 
inexpensive behavioural intervention to stop smoking was effective in supporting patients who 
attend PHCs for diagnosis and treatment of TB, to achieve sustained smoking cessation (Siddiqi 
et al., 2013).  
Teachable moments 
‘Teachable moments’ is a strategy advocated for promoting health behaviour change in a variety 
of settings (Lawson and Flocke, 2009). It is often conceptualised as events or a set of 
circumstances which leads patients to alter their health behaviour positively; it can also be 
created by the provider in a face-to-face interaction with the patient as an opportunity to promote 
healthy behaviour (Lawson and Flocke, 2009). Utilising the ‘teachable moments’ to promote 
smoking cessation in TB patients can markedly benefit them from cessation advice and success in 
quitting compared to general smokers (McBride et al., 2003). General smokers do not face the 
same level of anxiety or fear of death and the possibility of infecting others, as those with TB. 
This often-missed opportunity can be utilised by health professionals to tailor their smoking 
cessation advice for TB patients and reinforce the benefits of stopping tobacco smoking in those 
with TB.  
Integrating smoking cessation in TB programmes 
Very few LMICs have the basic infrastructure and systems in place to offer cessation support to 
tobacco users (Siddiqi, 2014). In a recent survey of smoking cessation services in 121 countries, 
only a quarter of the low income countries were found to have an official national smoking 
cessation strategy; one-fifth had an official responsible for it; one-tenth had treatment guidelines; 
none had an identified budget for cessation; 5% had quit-lines; and few had any specialist 
behavioural support (Piné‐Abata et al., 2013). 
While setting up specialist cessation services could be costly and require an infrastructure that 
does not currently exist, integrating smoking cessation within existing public health 
programmes like a TB programme is feasible and could be highly cost-effective in these resource- 
limited countries. Moreover, the TB programmes often run laterally with the health care systems 
in these countries for successful identification and treatment of TB and can be utilised for 
targeted smoking cessation. These National programmes deliver TB clinics as part of the health 
infrastructure of the country at all health care levels (tertiary, secondary and primary). The 
programme appoints a ‘TB DOTS facilitator’ at each government health centre. These paramedics 
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are responsible for: (a) assisting in identifying, recording and reporting new TB patients; (b) 
educating them about TB; and (c) ensuring direct observation during the intensive phase of their 
TB treatment. Health care providers, being closely involved in the vast majority of clinical 
contacts with their patients, have an opportunity to influence the patients’ smoking behaviour 
and reduce related harm (Whyte and Kearney, 2003, Rice and Stead, 2008). 
In the ASSIST study, it was found that an inexpensive behavioural support intervention 
embedded in TB care was very effective in supporting patients attending PHCs to achieve 
sustained smoking cessation (Siddiqi et al., 2013). Such integration is not only likely to be cost-
efficient, because it brings together two different services utilising the same infrastructure, but 
also implies the utilisation of the ‘teachable moment’ concept in addressing smoking cessation 
within TB programmes (Siddiqi, 2014). 
2.4 VARIATION IN SMOKING CESSATION EFFECT 
ASSIST was a pragmatic cluster RCT designed for testing behavioural support (with and 
without bupropion) in a high TB burden LMIC (see ‘Overview of ASSIST study’- Appendix B). 
The overall effect estimate for the intervention was significantly large; however, there was a wide 
heterogeneity in patient quit rates when the effect sizes were disaggregated by TB clinics 
(clusters).  
The intra-cluster correlation co-efficient (ICC) (described in Chapter 3) for the effect estimate 
was 0.28, denoting the presence of a large clustering effect and indicating a strong influence of 
clinics in determining the success of the intervention. Despite overall highly effective cessation 
rates, they were seen to vary substantially across individual clinics, especially in the intervention 
groups (Table 2.1). Therefore, some clinics delivering the intervention had an average quit rate 
as low as 7%, while others had cessation rates as high as 72% at the intervention sites.  
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Table 2.1: Proportion abstinent by TB clinics (intervention groups)- ASSIST study (2010- 2011) Pakistan 
Clinic ID 
Proportion abstinent†  
 n/N (%) 
 
26 41/57 (71.9) 
28 37/55 (67.3) 
25 34/55 (61.8) 
01 35/61 (57.4) 
11 34/60 (56.7) 
03 33/60 (55.0) 
21 33/60 (55.0) 
19 34/62 (54.8) 
23 31/57 (54.4) 
05 31/60 (51.7) 
09 27/59 (45.8) 
04 26/64 (40.6) 
22 22/55 (40.0) 
27 19/54 (35.2) 
02 19/60 (31.7) 
10 17/60 (28.3) 
24 16/61 (26.3) 
07 12/60 (20.0) 
08 11/59 (18.6) 
06 7/60 (11.7) 
12 6/60 (10.0) 
20 4/60 (6.7) 
† Number abstaining among the total 
participants in the TB clinic. Figure 2.1: Variation in quit rates (RR of abstinence) across 
all TB clinics- ASSIST study (2010- 2011) Pakistan 
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Although there was some variation between the clinics in the control group, in general, these 
clinics had lower-than-average cessation rates (refer to Relative Risks of abstinence by clinics, 
Figure 2.1; Siddiqi et al., 2013). 
The ICC value of 0.28 means that 28% of the total variance in cessation rates was due to the 
differences between TB clinics rather than the true effect of the intervention itself. Risk estimates 
for smoking cessation were characterised by large variation across the clinics in the three trial 
groups. In general, clinics assigned to the control had lower-than-average cessation rates. 
However, some control clinics (HC 29 and HC 33) reported cessation rates similar to those of the 
best performing clinics in intervention groups.  
Achieving a significant effect of an intervention in the ASSIST study means that the intervention 
works. However, it is also very important to understand the context and conditions in which that 
intervention worked best and to explore the conditions that are necessary for delivering 
intervention in the best possible way to achieve the optimal effect  (Petticrew et al., 2013).  
2.5 SUMMARY 
Inexpensive BIs are effective in supporting patients to quit smoking during their visit to PHCs 
for diagnosis and treatment of TB, as indicated in the ASSIST study. Incorporating such cost-
eﬀective smoking cessation interventions within TB programmes has the potential to improve 
outcomes in patients attending TB clinics in the affected countries. However, there is a 
knowledge gap about the factors that are likely to cause variation in outcomes of complex BIs 
and research to address this gap is clearly needed. More importantly, variation in an 
intervention’s effect might have programmatic and policy implications for a wider 
implementation of smoking cessation within an existing health service such as a TB programme. 
Research into the sources of variation in the outcomes of smoking cessation will help focus on 
factors to improve intervention delivery and selection of the active ingredients for wider scale-up, 
which could potentially lead to conservation of resources.  
 
  
 
Chapter 3. Sources of Variation in smoking cessation- ASSIST study 
In this Chapter, I first describe the phenomenon of clustering of individual level outcomes in evaluations 
using cluster RCT design. I explore the potential sources of variation in smoking cessation using relevant 
literature and data from the ASSIST study. I provide the significance of factors intrinsic to the 
intervention in shaping outcomes of complex BIs. In the end, I summarise the sources likely to contribute to 
the differential effect of BI on smoking quit in the ASSIST study that need further investigation. 
An insight into the between clusters differences in outcomes could further aid the applicability 
and validity of findings from RCTs of complex interventions (Bellg et al., 2004). However, the 
sources of variation in outcomes of complex BIs for smoking cessation have rarely been explored. 
Interpretation of findings from well-conducted RCTs of complex interventions can be 
misinforming, given that the reasons for wide variations in outcomes are not explored and 
reported. The findings from these RCTs are not only hard to interpret, but also challenging to 
generalise, unless a better understanding of the active ingredients of the intervention is gained 
(Craig et al., 2008). The term ‘cluster’, for the purposes of description in this thesis refers to a TB 
clinic, unless otherwise specified. 
Therefore, evaluating the effectiveness of a complex intervention entails more than just assessing 
whether or not it works. It involves the characterisation and examination of the potential sources 
of variation (Pigott and Shepperd, 2013). Exploration of these sources requires taking into 
account the various dimensions of complexity of BIs, in order to understand the causal 
mechanisms through which the intervention exerts its effect. Disaggregating sources of variation 
can also help understand the differences in outcomes between multiple sites of implementation 
and help optimise intervention delivery.  
Achieving a significant effect of an intervention is the first step in establishing that it works, 
prior to further exploration about how it actually works (Petticrew et al., 2013). Complex 
interventions (as outlined in Chapter 1) are made up of several interacting features and the range 
of their effects may vary by the number and difficulty of behaviours required by those delivering 
or receiving the intervention, the number of groups or levels targeted by the intervention, the 
number and variability of outcomes and the degree of adaptation of the intervention allowed 
(Craig et al., 2008). Such interventions are consequently difficult to describe, standardise and 
administer consistently to all patients (Boutron et al., 2008). 
Behaviour change interventions often contain several features, and do not merely comprise a sum 
of these features but much more complex interactions between them (Hawe et al., 2004). There 
can be many potential sources of complexity in the relationship between a BI and its outcomes. 
Two key factors that might contribute to this variation are the interacting nature of its features 
and the potential variation in the way these are delivered (Craig et al., 2008). 
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3.1 CLUSTERING OF INDIVIDUAL OUTCOMES BY UNIT OF INTERVENTION ALLOCATION 
The cluster RCT design is increasingly being used for evaluating effectiveness of complex 
interventions where health-care provider, health centre or community is the unit of allocation, 
rather than the individual participants (Eccles et al., 2003). Variation in outcomes is a different 
and more difficult type of problem in cluster trials compared with simple RCTs. When a cluster 
is the allocation unit for the intervention, standardising the way that the intervention is delivered 
across all clusters can be challenging; potentially leading to clustering of individual outcomes 
(Hawe et al., 2004). Conversely, cluster design offers the utility for further exploration of such 
variations in individual outcomes between clusters, by allowing identification and examination of 
factors influencing at cluster-level (Grant et al., 2013). 
3.1.1 Understanding clustering effect 
The Intra-Cluster correlation Coefficient (ICC) is calculated from the variance in the outcome. 
This parameter can be understood in the analysis of variance (ANOVA) framework as the 
proportion of the total variation in outcome that can be attributed to the difference between the 
clusters, i.e. ICC =
σB
2
(σB
2 +  σe
2)
⁄  where σB
2   represents variance between clusters, and σe
2 the 
variance within clusters. Strictly speaking it measures the correlation between units (e.g. 
individuals) within a higher level of unit (e.g. TB clinics), ranging between 0 to1. The lower 
(approaching 0) the value of ICC, the more independently the individuals within clusters act, and 
higher (approaching 1) values of ICC demonstrate that the individuals within clusters act as a 
pact i.e. they act similarly to each other, thus introducing a higher clustering effect in the study.  
Furthermore, the higher the ICC is (towards 1) the more variability between the TB clinics it 
represents and thus it contains more information and there is less chance of this variation being 
due to measurement error.  
3.1.2 Factors affecting the magnitude of clustering 
The variability or the magnitude of an ICC might increase, due to a variety of factors including; 
the type of the primary study endpoint (e.g. intermediate factors vs. outcome), the effect of 
setting (community vs. clinical), the prevalence of the endpoint (e.g. smoking quit rate, as 
variability is low at both extremes of prevalence), the size of the clusters, and the characteristics 
of individuals and clusters (Adams et al., 2004, Campbell et al., 2005).  
Effectiveness studies of complex interventions usually focus on measures of behaviour change 
dependent on process variables, such as adherence to protocol or compliance with recommended 
best practice amongst the intervention providers, rather than on the ultimate goal of behaviour 
change i.e. change in patient outcomes such as smoking quit (Mason et al., 1999). However, the 
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ASSIST study outcomes were focused on the quit rates of the individual participants who 
received BI from the TB care providers. Observations depending on measures of behaviour 
change or process outcomes tend to be more correlated and thus give ICCs of higher magnitude 
(Marion et al., 2001).  
3.2 EXPLORING SOURCES OF VARIATION- ASSIST AS A CASE STUDY  
A useful framework for characterising sources of variation in complex interventions consists of 
three components: firstly, substantive features of the complex intervention and how it is 
delivered in a given study; secondly, the procedures and methods used to conduct its evaluation 
such as the cluster RCT design (as discussed above); and thirdly, factors extrinsic to the 
intervention, such as research context (Pigott and Shepperd, 2013). I used this framework for 
conceptualising and describing the sources of variation in quit rates in the ASSIST study (Figure 
3.1), in subsequent sections. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: Factors that can lead to variation in quit rates of ASSIST study 
3.2.1 Target participants 
Clustering of individuals’ smoking quit rates by TB clinics as observed in the ASSIST study (ICC 
of 0.28) is considerably higher than the usual ICC of 0.036 seen in other studies conducted in 
similar settings (Parker et al., 2005). Differences in individuals’ characteristics (i.e. their 
demographics and personal attributes, socio-economic status, education level, motivation level 
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etc.) may contribute to clustering of similar outcomes, thus it is important to take account of 
these factors while exploring sources of variation in outcomes of complex interventions (Craig et 
al., 2008).        
More commonly, individuals clustered by sites or providers tend to interact frequently and as a 
result may respond in a similar manner (Donner and Klar, 2000). This is more likely to be an 
issue in group therapies. The patients recruited in the ASSIST study were not related to each 
other and they received individual face-to-face BI sessions, making it less likely for them to 
interact with each other during or after the sessions. On average, one patient was delivered 
behavioural support on any given day. 
To explore the variation in quit rates and control for its effect, the target participant’s 
characteristics (age, gender, duration of smoking, income and quantity smoked) in the ASSIST 
data were accounted for in a statistical model. However, adjusting for the patient characteristics 
only increased the variation further to 32% (ICC= 0.32) from the crude association, showing 28% 
clustering effect (refer to Table 3.1; Siddiqi et al., 2013).  
Table 3.1: Quit rates at 6 months adjusted for individual level characteristics- ASSIST study (2010- 2011) 
Pakistan 
Trial Group Relative Risk Ѣ (95% CI) p-value ICC 
Behavioural support + bupropion (BSS+) 9.3 (4.0-21.6) <0·0001 
0.32 
Behavioural support alone (BSS) 8.5 (3.7-19.6) <0·0001 
Ѣ Adjusted for age, gender, income, smoking duration & quantity smoked per day 
 
Hence, the variation in quit rates by TB clinics in the ASSIST study could not be explained or 
reduced by controlling for the individual characteristics of the TB suspects. 
3.2.2 Context 
Context in terms of complex interventions means any factor extrinsic to the intervention itself 
that tends to hinder or bolster its effects (Moore et al., 2015). An intervention might have 
different results if delivered in different settings, as causal pathways underlying the issues 
targeted by the intervention might differ from one context to another (Bonell et al., 2006).  
A provider’s ability to change is predetermined by factors like skills, training, resources and 
attitudes. Similarly, pre-existing factors determine to an extent the response of a target group to 
a certain intervention. It is this mutual ability to transform and adapt between an intervention 
and its immediate context that partly determines the effect estimates (Jansen et al., 2010). 
However, interventions that appear outwardly simple may still be considered highly complex 
when they interact with their context. According to Donner and Klar (2000), the variation in 
outcomes seen in cluster RCTs could be due to individuals tending to select the clusters to which 
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they belong more often (e.g. preference in being seen by a particular provider) but more 
importantly it could also be due to factors at the cluster level that affect all enrolled individuals 
similarly, e.g. provider practice (Donner and Klar, 2000). 
Context at the micro-level for an intervention, including training and technical support to the 
providers, is likely to have a bearing on the mechanism of impact of its key features on the 
cessation outcomes. At a macro-level, an implementer’s engagement in the preplanning and 
planning stages of the intervention development, integration with the goals and missions of the 
implementer’s organisation, and the organisational environment all can impact outcomes (Dane 
and Schneider, 1998) 
A final aspect of implementation regards the motivations for adopting an intervention that often 
dictate its success or failure in being delivered as intended (Dane and Schneider, 1998). 
Interventions initiated within organisations that are deemed relevant after empirically 
documenting needs, and are in line with the stated goals and missions of the implementing 
organisation, are more likely to be delivered, with better quality, than those initiated by forces 
external to it (Dane and Schneider, 1998, Durlak and DuPre, 2008). Moreover, positive 
organisational climate, stability, shared decision making and staff support all influence the 
mechanism of impact of an intervention (Durlak and DuPre, 2008). Some of these macro- or 
organisational level contextual factors important in the integration of complex behavioural 
interventions in LMICs settings were explored using ASSIST as a case-study (Dogar et al., 
2016). These factors will not be discussed in detail here as they deviate from the focus of the 
current research. 
Potential cluster level factors like its size (big/ small) and locality (urban vs. rural) might also 
contribute to the clustering of outcomes. Studies with larger cluster sizes (the number of 
individuals within each cluster) tend to have  lower clustering effects than those with smaller 
cluster sizes, as one would expect greater similarity of response in smaller clusters (e.g. 
households), compared to larger clusters (e.g. diverse communities) (Siddiqui et al., 1996). The 
size of clusters in the ASSIST study ranged between 55 and 74 patients per clinic, which is much 
less likely to produce greater similarity of responses between individuals.  
PHC settings act largely autonomously compared to secondary or more specialised care facilities 
that have better standardised and consistent management practices across hospitals, thus leading 
to higher clustering within these settings (Campbell et al., 2005). Seven out of the 33 TB clinics 
in the ASSIST study were secondary care clinics, while the rest were primary care clinics, 
classified as urban/rural for reference. However, when explored in a cluster-level statistical 
model for urban vs. rural this did not significantly predict the quit rates (refer to Table 3.2; 
(Siddiqi et al., 2013)). To explore the cluster-level variation further, all known study 
characteristics (mean age, proportion of men, mean duration of smoking, median quantity smoked 
and median household income) summarised by clusters, were statistically modelled to adjust for 
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the unexplained variation and none were found to be significantly associated with the quit rates 
(refer to Table 3.2; (Siddiqi et al., 2013)). 
Table 3.2: Cluster-level characteristics and Relative Risks with quit rates at 6 months- ASSIST study (2010- 
2011) Pakistan 
Site ID Location Mean (SD) 
age in years 
Number (%) 
males  
Mean (SD) 
duration of 
smoking in 
years 
Median (IQR) 
quantity smoked 
per day 
Median 
(IQR) 
*household 
income  
1 Rural 32.4 (10.6) 61/61 (100) 15.5 (10.1) 20 (10) 116 (81) 
2 Rural 44.1 (11.9) 54/60 (90) 18.9 (8.8) 20 (13) 116 (105) 
3 Rural 36.9 (12.1) 58/60 (97) 18.8 (12.3) 20 (18) 96 (67) 
4 Rural 38.1 (13.2) 62/64 (97) 19.4 (10.6) 20 (14) 70 (47) 
5 Urban 42.6 (13.5) 54/60 (90) 21.1 (10.7) 17 (12) 116 (116) 
6 Rural 35.9 (9.5) 59/60 (98) 15.7 (8.8) 27 (23) 105 (47) 
7 Rural 39.4 (10.2) 56/60 (93) 20.7 (10.2) 20 (13) 58 (58) 
8 Rural 39.1 (11.2) 59/59 (100) 19.5 (9.6) 20 (30) 116 (81) 
9 Rural 40.4 (11.5) 57/59 (97) 21.3 (10.7) 20 (25) 128 (116) 
10 Rural 43.6 (16.1) 58/60 (97) 21.1 (16.5) 17 (14) 105 (105) 
11 Urban 44.2 (11.9) 59/60 (98) 22.5 (14.1) 20 (23) 105 (110) 
12 Rural 40.2 (6.2) 56/60 (93) 16.5 (6.2) 10 (6) 174 (70) 
13 Rural 41.0 (13.3) 59/61 (97) 21.5 (12.2) 20 (10) 64 (47) 
14 Rural 40.2 (12.2) 59/60 (93) 19.5 (11.6) 21 (11) 47 (41) 
15 Rural 38.4 (14.9) 60/60 (100) 18.7 (13.5) 10 (7) 93 (38) 
16 Rural 37.7 (12.1) 59/59 (100) 22.0 (12.3) 20 (7) 70 (47) 
17 Urban 45.3 (13.1) 73/74 (99) 23.6 (12.8) 20 (18) 58 (70) 
18 Urban 42.6 (13.7) 60/60 (100) 22.5 (13.9) 18 (15) 81 (86) 
19 Rural 40.7 (13.7) 57/61 (93) 24.3 (12.2) 20 (12) 70 (47) 
20 Rural 37.9 (10.6) 60/60 (100) 20.5 (11.2) 20 (10) 116 (105) 
21 Rural 32.9 (9.3) 57/57 (100) 12.1 (9.9) 17 (10) 93 (47) 
22 Urban 43.7 (13.8) 47/55 (86) 17.6 (10.8) 20 (8) 93 (47) 
23 Urban 36.8 (11.9) 50/51 (98) 15.9 (11.2) 20 (22) 81 (58) 
24 Rural 44.4 (16.9) 54/61 (89) 25.9 (17.0) 20 (30) 58 (23) 
25 Rural 42.2 (12.1) 53/55 (96) 22.6 (11.8) 20 (14) 58 (41) 
26 Rural 50.0 (14.5) 47/53 (89) 27.5 (12.4) 39 (10) 116 (58) 
27 Urban 44.6 (16.4) 52/53 (98) 24.4 (16.0) 20 (5) 70 (67) 
28 Rural 43.4 (14.8) 47/55 (86) 23.8 (13.8) 24 (18) 64 (47) 
29 Rural 44.6 (16.2) 55/55 (100) 24.5 (15.2) 12 (12) 58 (47) 
30 Rural 41.2 (12.0) 59/60 (98) 20.5 (10.2) 25 (15) 93 (41) 
31 Rural 38.4 (12.3) 52/55 (95) 15.9 (8.5) 20 (5) 47 (29) 
32 Rural 44.8 (11.7) 48/55 (87) 20.7 (9.9) 20 (9) 140 (81) 
33 Rural 43.7 (13.9) 48/56 (86) 20.6 (12.6) 12 (7) 81 (58) 
ǂ RR 
 (95% CI) 
0.88  
(0.44-1.73) 
1.05  
(0.91-1.21) 
0.96  
(0.91-1.02) 
1.06  
(0.92-1.22) 
0.97 
(0.92-1.01) 
0.99  
(0.98-1.00) 
* Based on monthly household income in USD ($1= 86 Pakistani Rupees) 
ǂ Multilevel modelling for level 2 (cluster) predictors 
IQR is inter-quartile range 
RR is Relative Risk 
 
Hence, the variation in quit rates could not be explained by the individual or the cluster-level 
characteristics explored using data from the ASSIST study.  
 Chapter 3- Sources of variation 
49 
 
3.2.3 Intervention  
Variation in quit rates across clusters has been linked with variations in the process of delivery 
and the content of complex BIs (Boutron et al., 2008, Craig et al., 2008). The variation in 
smoking quit rates between TB clinics in the ASSIST study might possibly be explained by these 
two factors, in addition to the individual participant and cluster level characteristics. However, 
process evaluation of the BI was not considered in the ASSIST study.   
Some brief insights into the factors that can contribute to variability in the delivery of a BI, and 
hence to the variation in quit rates in ASSIST study, are considered in the following paragraphs. 
These factors are explored further in section 3.3. 
Complexity of the intervention features  
Complex interventions do not simply comprise checklists of things to read out to the individual, 
they are more focused on how the message in the checklist is delivered to the patient. (Moore et 
al., 2015). In the case of ASSIST study, the BI was not only complex as it involved behaviour 
change and was adapted from the developed world settings, but also because it targeted 
vulnerable population (TB suspects), was implemented in health care settings and was embedded 
in a public health programme. The competences of the TB paramedics and their skills to deliver 
behavioural support, their motivation and intention to provide cessation support, the efficiency of 
the systems and organisational structure, stretching practice time to include additional cessation 
provision and their own smoking status all supplemented the complexity of the devised 
intervention (Dogar et al., 2016).  
Intervention delivery 
Whether the intervention is delivered in the intended way may be affected by the provider’s 
competences in the use of intervention techniques or their behavioural attributes (e.g. empathy or 
being a smoker themselves) (Bellg et al., 2004, Hardeman et al., 2008). Patient-provider 
interaction is the mutual behaviour of the person delivering the intervention and the one 
receiving it that develops in a face-to-face intervention session, where this behaviour then 
influences the effect of the intervention on the intended outcomes.  
One of the factors that can influence this mutual behaviour is the health care provider’s 
motivation to change behaviour that can alter ways in which intervention is delivered (Lennox et 
al., 1998). The degree of training required by the intervention provider to learn essential skills 
for application of complex intervention models can also influence patient-provider interaction 
(Lennox et al., 1998). In addition to the expertise of the providers, the volume of patients 
attending the clinics for care might also influence the interaction, thus leading to unintended 
changes in the estimate of the intervention effect (Boutron et al., 2008).The complexity of 
 Chapter 3- Sources of variation 
50 
 
intervention ingredients, the provider’s skill in delivering complex ingredients to the patients 
and the interaction between these two can impact on the estimate of intervention effect.  
Degree of standardisation 
Standardisation is likely to be less stringent in pragmatic RCTs that attempt to evaluate whether 
an intervention works under the usual conditions in which it is applied. However, to allow 
adequate replication of intervention ingredients, it is essential to have some degree of consistency 
in its delivery (Boutron et al., 2008).  
Practice manuals or protocols are often developed for a structured execution of an intervention; it 
outlines the rationale, goals and the recommended content (e.g. the BCTs) to be delivered 
(Lorencatto et al., 2013a). These manuals are widely used in BIs for smoking cessation. However, 
it is seen that different providers delivering a BI for smoking cessation using the same manual 
can have widely varying cessation outcomes for the respective patients (Brose et al., 2012). It is 
often believed that the outcomes of interest ought to be consistent across various sites of 
implementation in a RCT, for it to be considered standard practice, giving higher confidence in 
its effect estimates (Tones, 2000, Nutbeam, 1998). However, this does not mean that the 
intervention should look exactly the same or completely ‘standardised’ in terms of its content and 
delivery across implementation sites, as has been thought to be paramount in the past (Campbell 
et al., 2000). Recent thinking on the subject projects ‘standardisation’ as allowing the form to be 
adapted while keeping the process and function of delivering it consistent (Hawe et al., 2004).  
In the ASSIST study, which was a pragmatic cluster RCT, the BI was not strictly standardised, 
although implementation of the research protocol was strictly monitored.  
3.2.4 Focus of the outcome  
Outcomes might also cluster due to a specific behaviour or behaviour change that is similar in a 
group of people. Therefore, it is necessary to consider this factor as a likely contributor to any 
clustering effect in trials of BIs. It is theorised that rare behaviours with lower prevalence are 
associated with smaller clustering effects than behaviours with higher prevalence (Taljaard et al., 
2008). Theoretically, clustering for factors with prevalence near zero or near 100 percent (i.e. 
everyone behaving exactly alike or absolutely different from each other) tend to be smaller than 
those for factors with mid-range prevalence (Campbell et al., 2005). Therefore, in minimally 
prevailing behaviours (where the prevalence is near zero), cues are difficult to establish; leading 
to less variation in human behaviours and smaller clustering effects. On the contrary, behaviours 
that show more variety in performance tend to cluster together more. (Campbell et al., 2005). 
This might provide an insight into the behaviour of intervention providers, as the process or 
intermediate variable that can lead to clustering of individual outcomes of the patients attending 
their practice. 
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3.3 EXAMINING SOURCES OF VARIATION FOR COMPLEX BEHAVIOURAL MECHANISMS 
The intermediate procedures through which intervention activities produce intended (or 
unintended) effects make up the mechanisms of impact of an intervention on outcomes of interest 
(Moore et al., 2015). From exploration of sources of variation in the ASSIST study, it seems 
plausible that substantial variation is contributed by factors intrinsic to the intervention i.e. the 
extents to which providers follow the protocol, and the quality of delivery. These factors and 
their contribution to variation in outcomes of complex BIs can be captured by assessing 
intervention fidelity based on content-related and interpersonal behaviour change techniques 
(described in Chapter 4). In this section I briefly look at factors within the intervention or closely 
connected to it (referred to as ‘intrinsic’ throughout this thesis) that can affect its mechanism of 
action on the outcome. The literature I present here pertains mainly to the mechanisms of action 
of complex BIs and the factors that might influence these processes. More detailed discussion of 
these factors within a fidelity measurement frame will be covered in the next chapter. 
3.3.1 Delivery mechanics of Behavioural Interventions and the variation 
In an ideal situation, a BI containing BCTs A, B and C would be delivered consistently to the 
participants; in the same way and the same order as pre-specified in the practice manual (Knittle, 
2014). However, in real life scenarios: i) some participants might not receive C as the time 
allocated for the session might have run out; ii) others might have received A, B & C in a different 
order (e.g. BAC, CBA); and iii) others still might have received A, B & C, but also received D, E & 
F that were not pre-specified in the manual. This could be considered a ‘drift’ rom the practice 
manual or an ‘innovation’ as described by Bumbarger et al. (2008), depending on whether the 
additional BCTs were as effective or less so than A,B & C (described further in chapter 4). 
Alternatively, the order in which they were delivered might have been tailored by the provider 
according to participant’s choice. Such variations in delivery of a BI can affect outcomes and 
intervention effectiveness overall. If not accounted for and explained, such variations could 
hinder the application of the findings from high quality studies (Knittle, 2014).  
3.3.2 Controlling variation in intervention delivery practice 
In addition to the content that is delivered, an important factor affecting variation in outcomes 
depends on how delivery of this content is achieved (Carroll et al., 2007, Montgomery et al., 
2013). Facilitation or support strategies are sometimes used to enhance intervention delivery 
according to protocol, with an aim to reduce variation in practice (Carroll et al., 2007). The 
adequacy of these strategies to standardise practice depends on the degree of complexity of an 
intervention. These are considered even more important for complex interventions, which are 
often multi-faceted and, therefore, more vulnerable to variation in the delivery process (Medical 
Research Council, 2000).The crux of standardising practice across implementation sites is a clear 
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specification of the intervention features (both its content and interaction quality), as well-defined 
interventions are more likely to be delivered uniformly than less well-structured interventions 
(Dusenbury et al., 2003, Carroll et al., 2007).  
Strategies that can facilitate uniform intervention delivery practice include practice manuals, 
guidelines, training, monitoring, cultural considerations and feedback (Bellg et al., 2004, Gearing 
et al., 2011). These strategies, if not used adequately, can themselves lead to more variation in 
delivery practice and hence, differential effects of the intervention on respective outcomes.  
3.3.3 The impact of provider expertise on variation 
Differences in delivery practice between providers can be related to the provider’s expertise. 
Controlling for these can ensure standard quality across various implementation sites (Bellg et 
al., 2004). The characteristics and behavioural interactions of the intervention provider and their 
qualifications and expertise play a significant role in delivering the intervention as intended. 
Providers who are motivated for the change, and believe that it is specifically needed to bring 
about the desired benefits, feel more confident in their ability to deliver the intervention (Durlak 
and DuPre, 2008). Those who have the requisite skills are also more likely to deliver it with 
better quality (Dane and Schneider, 1998). There is evidence that, although the concepts of such 
models (complex BIs) themselves are easy to grasp, it is much more difficult to acquire a useful 
knowledge of the associated intervention delivery skills (Hall et al., 1997). Therefore, short 
training sessions (e.g. one day) might not be enough to gain and retain effective skills for 
delivering  complex interventions, even for those intervention providers who are motivated to 
change behaviour (Sereno et al., 2012, Lennox et al., 1998). 
BIs are complex, as they involve several interacting features targeting different behaviours, but 
implementing them to have the intended impact is even more complex, because it relies on a 
certain degree of skill of the provider. Moreover, it requires an in-depth understanding of the 
behaviour that needs changing e.g. a proper understanding of the concept of ‘tipping points’ in 
smoking cessation and utilising this knowledge to the advantage of the recipient. Tipping points 
refer to a sudden successful attempt as a result of a single event (or perfect motivational level 
achieved) by an individual who might have tried several times to quit smoking in past but failed 
(Resnicow and Vaughan, 2006). BIs may therefore be delivered at the ‘right’ moment to trigger 
change, whereas delivery to the same individual at a different time might not have the desired 
effect (West, 2013). Also, understanding or identifying this ‘right’ moment tailored to each 
individual’s situation requires knowledge of the latest techniques that are effective for behaviour 
change, to build on relevant skills.  
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3.3.4 Aspects of patient-provider interaction and the variation 
The concept of ‘patient-centred focus’ appropriate for negotiating behaviour in complex 
interventions is not new e.g. motivational interviewing (Miller and Rollnick, 2013), but it is very 
different from the predominantly practised ‘professional-centred focus,’ where the health 
professional is the expert giving advice. In PHC settings, the latter is the usual case, which could 
be an important factor in the consistent application of  intervention features and might lead to 
variations in their delivery (Lennox et al., 1998). 
Participants tend to interact in context with interventions, resulting in outcomes produced by 
these interactions, rather than passively receiving them (Pawson and Tilley, 1997). Therefore, 
the mechanism of impact of an intervention on the outcome cannot simply be controlled by 
setting standards of practice and adequate expertise of the provider, but also requires an in-depth 
understanding of and training on patient-provider interaction features and how these work in 
regard to BIs. In the context of individual BIs delivered in settings like a TB programme in a 
LMIC, in a PHC by personnel not primarily skilled in behaviour change counselling (e.g. the TB 
paramedics), an emphasis on building efficacy on relevant patient-provider interaction skills can 
be beneficial in reducing variation. 
3.4 SUMMARY 
In summary, description of data and analysis of the individual and cluster level characteristics 
from the ASSIST study, do not reveal any contribution of these factors to the clustering effect. 
The literature and empirical evidence on the subject of clustering, in outcomes of complex 
interventions, highlights factors more intrinsic to the intervention. As discussed in this chapter, 
these factors might relate to behaviour change focus of the intervention, the nature of the 
ingredients, the way these ingredients are delivered, and the level of their standardisation across 
clusters, as highlighted below in Figure 3.2.  
Even when interventions are designed in a standard format, implementation occurs differently in 
different contexts, showing many different effects (Peters et al., 2013). Understanding the 
variation in cessation outcomes of complex interventions is critical to making these interventions 
work as well as possible. Cluster RCTs, in which the same intervention may be delivered and 
received in different ways, might present an opportunity to characterise and examine several 
potential sources of variation, including those explored in this chapter. However, before setting 
out to evaluate these effects to interpret variation, identifying the sources of variation and 
mapping aspects of complexity in the intervention onto the appropriate sources is a necessary 
step (Petticrew et al., 2013). 
Such features, intrinsic to a complex intervention involving behaviour change, and the ways to 
capture or assess their role in explaining variation in patient outcomes, will be studied further in 
the next chapters of this thesis.  
 Chapter 3- Sources of variation 
54 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Sources of variation in quit rates as identified for further exploration 
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Chapter 4. Description of Intervention Fidelity 
As the intervention delivery process can introduce variation in smoking quit rates, this chapter presents the 
evidence for assessment of fidelity to intervention delivery. The literature reviewed pertains mainly to 
measurement of fidelity and its conceptualisation in terms of complex BIs. The focus remains on the 
identification of active ingredients of the intervention, including the quality related aspects of its delivery.  
The appraisal of evidence on the link between smoking and TB (Appendix A) demonstrates the 
need for integrating smoking cessation interventions in TB care and management practice. 
Scientifically tested and effective BIs to support smoking cessation exist, both in general smokers 
and in those with TB symptoms. However, as highlighted in the previous chapters (2 & 3), 
optimizing delivery of such interventions is hindered by the limited understanding of variation in 
their effect- partly because the active ingredients of the intervention are not known. To 
understand this variation in effect with complex BIs, potential contributing factors need to be 
examined, as theorised in Chapter 3. 
Intervention ‘fidelity’, an implementation variable (Peters et al., 2013), encompasses the three 
main contributing factors related to intervention delivery: namely ‘what’ is delivered, ‘who’ 
delivers it and ‘how’ it is delivered (Carroll et al., 2007). As conceptualised and presented in 
Chapter 1 (see Figure 4.1), intervention fidelity forms the core of the interpretive evaluation 
model for studying intervention effect in all of its variation. The term ‘fidelity’ in this thesis will 
refer to two main concepts: providers’ adherence to intervention content (‘depending on what’ is 
delivered) and the quality of interaction (depending on ‘who’ delivers and ‘how’ it is delivered). 
 
Figure 4.1: Interpretive Evaluation Model 
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4.1 THE CONCEPT OF FIDELITY MEASUREMENT 
The key research question for my thesis, regarding explaining variation in smoking quit rates 
(presented in Chapter 5), emerged from the ASSIST study. Since, individual patients’ responses 
(i.e. the quit rates) were clustered by implementation sites (single intervention provider per site); 
an inquiry into the reasons for this clustering of outcomes would require measurement of factors 
influencing intervention delivery. As hypothesised (in chapter 3), fidelity measurement might 
help describe the mechanism of impact of the BI on its outcomes (Moore et al., 2015). However, 
first I will describe the concept of measurement of fidelity and the things to consider when 
measuring fidelity for complex behavioural mechanisms.  
4.1.1 Quantifying fidelity as opposed to subjective assessment 
Despite the preference of using objective measures of fidelity for BIs (Knittle, 2014), progress in 
developing fidelity measures (including scales and indices) has been hampered by several factors 
in the past. Similar to the psychotherapy literature, complex BIs have lacked even basic 
descriptions of intervention models and details of their active ingredients (Lorencatto et al., 
2013a). The description of BIs is further complicated by the complexity of interactions of 
behaviour change, such as the causal linking of BCTs with the behavioural determinants of the 
targeted individuals, as discussed in chapter 1 (under ‘The logic model of behaviour change’).  
Nonetheless, psychotherapeutic research realised the potential of fidelity measures much earlier 
than behavioural or health sciences research. The actualisation of this concept of objectivity in 
fidelity measurement for BIs targeting tobacco use derives from this literature (Bond et al., 
2000b). Additionally, concepts and methods from fidelity assessment in health and education will 
also be used (Mowbray et al., 2003, Streiner and Norman, 2008). 
4.1.2 Origination of fidelity measures 
Fidelity measures originated in psychotherapeutic research in the 1960s, when the need to 
measure elements of psychosocial interventions was first recognized, due to the difficulty in 
interpreting outcomes in studies (Moncher and Prinz, 1991). Psychotherapy approaches were 
fundamentally different from each other and poorly defined, while practice varied greatly among 
therapists (Bond et al., 2000b); which is similar to the observations from ASSIST study. This led 
to the development of the first ‘fidelity measures’ in a scale format: the process rating scales for 
client-centred therapy (Bond et al., 2000b).  
Fidelity measurement advanced in two directions, the intervention integrity, ‘extent to which 
intervention is implemented as intended ’, and its differentiation, ‘whether interventions differed 
from one another in the intended manner’ (Moncher and Prinz, 1991). Concurrently, two aspects, 
the provider ‘competence’ (Waltz et al., 1993) and the ‘dose delivered’ (Scott and Sechrest, 1989), 
started being considered as elements essential to measuring fidelity. Soon the need to disseminate 
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active intervention ingredients was recognized, resulting in operationally defining intervention 
features and linking them to the theory (Bond et al., 2000b).  
4.1.3 Where does the science of behaviour change stand? – Articulating the causal 
assumptions of complex behavioural interventions 
A decade later, complex BIs for smoking cessation are at an identical stage. The potential of 
fidelity measures having valid links to theories of behaviour change is acknowledged (Hardeman 
et al., 2005, Cane et al., 2012, Lorencatto et al., 2013a, Michie et al., 2014-2017), and progress to 
operationalise these ideas using reliable methodologies is underway (Nelson et al., 2012, Moore 
et al., 2015, Bellg et al., 2004, Borrelli et al., 2005).  
The taxonomies of BCTs (Michie et al., 2011c, Lorencatto et al., 2013b, Michie et al., 2013) have 
so far been used to assess fidelity (Lorencatto et al., 2013a) in terms of presence or absence of 
BCTs. These provide a coding framework for identifying and categorizing the BCTs within a BI 
and have been used reliably to code English Stop-Smoking Service treatment manuals (Michie et 
al., 2011b, West et al., 2010) and transcripts of audio-recorded BI sessions delivered by these 
services (Lorencatto et al., 2013b).  
Behaviour change is complex and a description of the features of a BI by simply coding ‘absent’ 
vs. ‘present’ might not be adequate for identifying active ingredients and processes by which the 
intervention leads to behaviour change (Hardcastle et al., 2016). The above taxonomies, although 
used to describe BIs ‘compositionally’ have not been used to score fidelity of BIs in relation to the 
‘functionality’ (explained in the next section) of BI features. This later concept surpasses the 
simplicity in coding ‘present vs. absent’ for fidelity assessment and could help identify the active 
ingredients of a BI, assuming that the devised fidelity measure is found to be reliable and 
psychometrically valid.  
The MI approach for behaviour change proposes that a description of an intervention should 
entail both content and relational techniques (as briefly mentioned in Chapter 1). That is, 
techniques that relate to what is included in an intervention (its content) and how it is delivered 
(interaction quality) (Hardcastle et al., 2016, Hagger and Hardcastle, 2014). Coding systems 
(including ‘motivational interviewing treatment integrity-MITI’ and ‘motivational interviewing 
skill code-MISC’) designed to assess specific domains of patient-provider interaction within the 
MI approach have been developed to assess provider adherence to and competence in 
intervention delivery (Moyers et al., 2010, Moyers et al., 2005, Madson and Campbell, 2006). 
These, however, remain true to the ‘spirit’ of MI (Hagger and Hardcastle, 2014), which comprises  
four components: collaboration, evocation, autonomy and compassion (Miller and Rollnick, 
2013), described using the ‘relational’ techniques (Hardcastle et al., 2016). Furthermore, these 
fidelity measures were designed with the intention of using them in a training and supervision 
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environment and not for research into the mechanisms of impact of an intervention (Madson and 
Campbell, 2006). Further insight into existing fidelity indices is provided in Chapter 6. 
The importance of generic or inter-personal competences, focusing on the actions of the provider 
in delivering BI content to individuals (Roth and Pilling, 2008), such as those identified for 
smoking cessation (Michie et al., 2011b) is also acknowledged by behaviour change scientists. 
However, these competences have not been used to describe interaction quality, particularly in 
relation to its ‘functionality’.  
Of further note is that these taxonomies have not been used to code BIs outside of the UK 
context and it is not known if they can reliably code such interventions for the purpose of 
assessing fidelity.  
4.1.4 The fidelity and adaptation debate 
Most of the theoretical models and concepts recommended by UK MRC for evaluating complex 
interventions emphasise the need to understand ‘what’ was delivered and ‘how’ it was delivered 
(Moore et al., 2015). These models assume that the intervention must have some standardised 
features in different settings (Moore et al., 2015), that can form the basis of the evaluation. 
However, as discussed in Chapter 3, standardising the practice of delivering complex 
interventions is a subject of controversy among researchers and one to be carefully considered 
when measuring intervention fidelity.  
Fidelity measurement is not straight forward for complex interventions. In evaluations where 
active ingredients need to be identified and selected, strict standardisation may be required across 
practices (Craig et al., 2008). However, some aspects of the intervention might require adaptation 
to the local context or individual patients and would not be possible to standardise completely 
(Craig et al., 2008). Some researchers argue that when little is known about the active 
ingredients of an intervention, allowing adaptations in the content to be delivered might inhibit 
effectiveness (Mihalic, 2004). Others advocate distinguishing between the fixed and variable 
aspects of an intervention, for example, the BCTs might be considered as fixed, while their 
structure and application process in different contexts might be considered as variable (Hawe et 
al., 2004). Variable aspects can then be adapted to the local context. Yet another school of 
thought suggests keeping the core intervention features as fixed and less critical features as 
variable (Durlak and DuPre, 2008, Firpo-Triplett and Fuller, 2012). Working towards a 
compromise, this last concept can help achieve the balance between fidelity and degree of 
standardisation permitted.  
A slightly different concept  from distinguishing between the fixed and variable ingredients or 
the core and less critical ingredients is looking at fidelity and adaptation under the same 
spectrum, while distinguishing between ‘innovation’ and ‘drift’ (Bumbarger and Perkins, 2008). 
‘Innovation’ is described as the skilful attempts at tailoring intervention to better fit the target 
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population or local context needs, while ‘drift’ is considered as the unintentional shortcomings 
that can act as the barriers to full implementation (Bumbarger and Perkins, 2008). Hence, 
according to this concept, skilful providers are permitted to deviate from the protocol in response 
to feedback from the participants, while carefully remaining consistent with the underlying 
intervention theory. This concept is more easily applicable to the theories of BIs, as the delivery 
of intervention relies heavily on the skill of the provider.   
In addition, integrity of an intervention is described as having the ‘dose’ delivered at an 
acceptable level and in the same way at each site (Hawe et al., 2004). Integrity in terms of a 
complex intervention needs to be defined ‘functionally’ rather than ‘compositionally’ (Hawe et al., 
2004). Therefore, standardisation by means of ‘delivering the same intervention consistently 
across sites’ for a complex intervention is an oversimplification of the concept. In complex 
interventions, the ‘functionality’, which can be described as the process of delivery, can be 
standardised, while keeping the intervention content (‘composition’) adaptable (Hawe et al., 
2004). 
In my thesis the balance between standardisation and adaptability of intervention features, in 
establishing a quantitative measure of fidelity for BIs, is based on the concepts of functionality 
and innovation/drift theory by Hawe et al. (2004) and Bumbarger et al. (2008).  
In order to identify and quantify the active ingredients of an intervention, first a fuller 
description of individual features of the intervention is needed (Lorencatto et al., 2013b). We then 
need a ‘measure’ of the delivery of these features, which would not only be reliable in measuring 
this construct (fidelity to BI) under study, but would also have the potential to explain variation 
in quit rates.  
4.2 DERIVATION OF A FIDELITY MEASURE FOR BEHAVIOURAL INTERVENTIONS 
From discussions in previous chapters, it is clear that adherence to BI content and the quality of 
its interaction may influence smoking cessation outcomes amongst intervention recipients. The 
concepts exist for evaluating the delivery process of complex interventions (Hawe et al., 2004, 
Bumbarger and Perkins, 2008) and the methods for quantifying fidelity in general (Bond et al., 
2000b, Mowbray et al., 2003, Streiner and Norman, 2008). But how do we judge that the BI is 
being delivered as intended? This will first require some degree of ‘description’ of the intended or 
planned features of the intervention. 
In this thesis, fidelity is conceptualised as a combination of ‘what’ is delivered and ‘how’ it is 
delivered; two very important aspects of the process of intervention delivery. Answering these 
questions requires understanding the ‘intended or planned’ practice and the ‘actual’ practice.  
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4.2.1 Intervention delivery: ‘Intended practice’ 
Intended practice is the specification and description of the intervention content and the 
processes involved in its delivery, often in the form of practice manuals and the training offered 
to enhance effective delivery skills. Practice manuals are structured, procedural booklets 
outlining the rationale and goals of an intervention, as well as the recommended content to be 
delivered while administering an intervention (Lorencatto et al., 2013a).  
Going back to the concept of ‘what’ is delivered, ‘who’ delivers it and ‘how’ it is delivered, it is 
clear that although intervention features can be simple, the interaction between them and 
behaviours of those involved can be complex; leading to variation in these concepts. Nevertheless, 
the starting point for fidelity measurement can be the specification of the features of an 
intervention that are key to its execution. This entails classification and labelling of the content 
and the interaction quality of the BI.  
Clear definitions and descriptions of an intervention are vital to gain an accurate appraisal of 
applicability and validity of the findings from its evaluations (Moore et al., 2015). Considerations 
for describing complex interventions include description of its key features and processes, as well 
as uniform labelling of the active ingredients. Describing complex interventions is a science in 
itself; frameworks to guide this scientific process are also summarised in this section. 
Adequacy of intervention description 
Inaccurate descriptions of an intervention can lead to its content being replicated with poor 
fidelity (Lorencatto et al., 2013a). Interventions with clear specification of the core effective 
ingredients are more likely to result in uptake in practices that require cessation services (Michie 
et al., 2009c). Published descriptions of BIs for smoking cessation are found to report less than 
half of the BCTs specified in the intervention manuals (Lorencatto et al., 2013c). Failure to 
adequately report intervention features could undermine attempts to replicate and optimize 
intervention delivery in practice (Lorencatto et al., 2013c). Furthermore, it could jeopardise the 
development of a fidelity measure, if it fails to capture all of the key intervention features. Hence, 
incomplete descriptions of an intervention would leave the reader confused about whether or not 
that intervention works, with very little indication of the active ingredients that worked and why 
(Lorencatto et al., 2013c).   
Frameworks for describing interventions 
Intervention description involves more than merely labelling and providing a list of the various 
ingredients (Hoffmann et al., 2014). Key characteristics, including duration, intensity, mode of 
delivery, essential processes and monitoring, could all influence the replicability and ideal 
implementation of an intervention (Hoffmann et al., 2014).  
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An extension of the CONSORT (Consolidated Standards of Reporting Trials) statement for 
Non-pharmacologic treatments (pertaining to BIs) indicates reporting on the following 
intervention features (Boutron et al., 2008): 
 Precise details of the intervention and comparator, as intended and as implemented 
 Description of the various ingredients of the interventions 
 Description of the procedures for tailoring the intervention to individual participants 
 Details of how the intervention was standardised  
 Details of how adherence of providers with the protocol was assessed or enhanced 
 Description of the providers (case-volume, qualification, expertise etc.) 
Another useful guide, ‘The Template for Intervention Description and Replication’ (TIDieR) 
provides a checklist for improving the completeness of reporting for health care interventions 
(Hoffmann et al., 2014). The 12 item TIDieR checklist is an extension of the CONSORT 2010 
statement (http://consort-statement.org) and the SPIRIT 2013 statement (http://spirit-
statement.org), consisting mainly of items on: brief name, why (rationale, theory or goal of the 
key features), what (materials/tools used), what (procedures, activities and/or processes), who 
provided (provider expertise, background, training), how (mode of delivery), where (settings and 
location), when and how much (number of sessions, schedule, duration and intensity of dose), 
tailoring (if intervention was personalised, titrated or adapted), modifications (any changes made 
in the intervention), how well-planned (how fidelity was assessed and by whom), and how well-
actual (the extent to which intervention was delivered as intended). 
Of particular interest to BIs reporting and perhaps most challenging to describe are the items, 
namely, ‘what procedures’ and ‘who provided’ (Johnston, 2014). The TIDieR item ‘what 
procedures’ basically involves both the processes that reflect the content and the way this is 
delivered. The TIDieR item ‘who provided’ also relates to the inter-personal aspects of the 
interaction and hence the quality of delivery.   
Therefore, in short, intervention features according to the above mentioned frameworks fall into 
two broad categories: one, mode and style of delivery that relate to the quality of the interaction, 
and two, the content that is delivered (Lorencatto et al., 2013c).  
Uniformity in intervention description 
A classification or labelling standard for specifying BIs is the ultimate goal towards standardising 
intervention delivery practices (as outlined in ‘Controlling variation in intervention delivery 
practice’ in 3.3.2). Additionally, it finds its use in reporting of findings and replication of the 
content of interventions, which is vital to designing process evaluations of complex 
interventions.  
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The taxonomies of BCTs (Michie et al., 2011b, Michie et al., 2011c) are theory-linked 
nomenclatures (Michie et al., 2011a) that provide a common language for uniform coding of 
intervention ingredients in manuals and transcripts of BIs, both in research and in practice 
(Lorencatto et al., 2013c). Forty-three BCTs have been identified (so far) and labelled for use in 
describing content of BIs for smoking cessation (Michie et al., 2011c). Each BCT has a specified 
criterion for its operationalization, is defined using consistent terminology, and has a clear label 
that can be used to categorize and consistently report intervention features.  
The taxonomies for BCTs concerning smoking cessation and the competences to deliver these 
BCTs have been described in detail in Chapter 1 (section 1.3.2). Whilst the BCTs focusing on 
individual behaviour change ‘content’ reflect the information and knowledge provided to 
intervention recipients to promote behaviour change (e.g. exploration of pros and cons), the 
competences for specifying ‘quality of delivery’ reflect the inter-personal way in which the 
content-based BCTs are presented by the provider to increase their effectiveness (Hardcastle et 
al., 2016).  
The interpersonal aspects, that is, ‘who’ delivers it and ‘how’ it is delivered can be described using 
the generic competences (Michie et al., 2011b) for intervention delivery (as summarised in 
Chapter 1) and content-based aspects, that is, ‘what’ is delivered can be described using the BCTs 
specific for smoking cessation (Michie et al., 2011c, Lorencatto et al., 2013b).  
Clarifying assumptions about how the Behavioural Intervention works 
I have previously (in Chapter 1) presented the ‘advances in behaviour change science’ by 
providing details of the logic model of behaviour change (Hardeman et al., 2005, Michie et al., 
2008), the PRIME theory of motivation for smoking cessation (West, 2009), identification of the 
behavioural determinants using the TDF framework (Cane et al., 2012, Michie et al., 2005) and 
the development of taxonomies to label the BCTs (Michie et al., 2011b, Michie et al., 2011c).  In 
this section I briefly describe the ‘basis of behaviour change science’ in an attempt to bring 
together the various concepts and frameworks described so far.  
The core of the taxonomies (Michie et al., 2011b, Michie et al., 2011c) for behaviour change is 
formed from the COM-B model (Figure 4.2), which acts as a ‘behaviour system’ analysing 
behaviour in terms of the extent to which an individual’s capability, opportunity and/or 
motivation need to change for a certain behaviour to change (Michie et al., 2011d). This COM-B 
system forms the hub of the Behaviour Change Wheel, which is a synthesis of 19 frameworks of 
behaviour change interventions.  
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Figure 4.2: The COM-B system- a framework for understanding behaviour  
(Adopted from: Michie S, et al. The behaviour change wheel: a new method for characterising and designing behaviour 
change interventions. Implementation Science. 2011;6:42.) 
The Behaviour Change Wheel was developed to inform the process of selection of interventions 
according to an analysis of the nature of a certain behaviour, the mechanisms that need to change 
in order to change that behaviour, and identification of the points to intervene with those 
mechanisms (Michie et al., 2011d). The behavioural determinants identified using the TDF have 
also been mapped to the COM-B system (Figure 4.3) (Cane et al., 2012, Michie et al., 2011d).  
 
Figure 4.3: Mapping of the behaviour change wheel’s COM-B system to the TDF  
(Adopted from: Cane J, et al. Validation of the theoretical domains framework for use in behaviour change and 
implementation research. Implement Sci. 2012;7(1):37.) 
The taxonomies of BCTs and competences to deliver them are standardised nomenclatures 
developed to facilitate communication in literature and to label ingredients of intervention 
models (Michie et al., 2011c). These cannot be considered fidelity criteria. They can, however, 
serve as the basis for developing a standard measure for scoring fidelity of BIs for smoking 
cessation.  
In summary, a reasonable account of fidelity for BIs will entail standardising the functionality of 
the intervention represented by the procedures (mode and style) of its delivery, while keeping its 
composition or intervention features adaptable. Working on the principles for describing 
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interventions, as discussed in this section, the taxonomies can be used to code BIs and 
disaggregate the intervention features into ingredient BCTs and competences, in a standard 
format that can be potentially scored for fidelity. 
4.2.2 Intervention delivery: ‘Actual practice’ 
Once intervention description is uniform and adequate and in line with the causal assumptions of 
the underlying theory about how the intervention works, the core structure is ready on which to 
base fidelity measurement. ‘Actual practice’ represents the extent to which BCTs and 
competences mapped to the BI (the core structure) are subsequently delivered. It refers to the 
extent to which intended practice is actualised adhering to specifications in the practice manual 
(Bellg et al., 2004, Borrelli, 2011) and competences acquired through training.  
In essence, actual practice is the fidelity to the intended practice.  
In this section, I will explore the elements of fidelity essential to capture the actual practice that 
can be applied to the core structure of intervention features for scoring. The elements, as used by 
others to assess fidelity, will be described and appraised for inclusion in my research, with a 
particular focus on BIs and the elements that are intrinsic to the intervention delivery process. 
Theoretical perspectives for examining fidelity 
Early evaluations of intervention delivery process aimed at monitoring whether interventions 
were delivered as intended, in order to determine the extent to which changes in the outcomes 
were a true reflection of the effect of  intervention theory (McGraw et al., 1989, Pirie et al., 1994). 
Several theoretical perspectives have since emerged, as the demand for process evaluation 
increased, shifting the focus towards understanding how implementation is achieved and moving 
away from simply monitoring what is delivered (Moore et al., 2015). While it is beyond the scope 
of this chapter to provide an exhaustive review, this section briefly describes concepts that are 
commonly used in examining fidelity to complex interventions.  
At the start of this century, 11 priority areas for understanding the process of intervention 
delivery were identified: recruitment, maintenance, context, resources, implementation, reach, 
barriers, exposure, initial use, continued use and contamination (Baranowski and Stables, 2000). 
Soon after, Steckler and Linnan (2002) narrowed down the focus to six priority functions for 
evaluation, namely: context, fidelity, dose delivered, dose received, reach and recruitment 
(described in next section). Later, a theoretical model which defines fidelity as a combination of 
content, frequency and duration of delivery, and coverage was proposed (Carroll et al., 2007). 
This is very similar to Steckler et al’s. (2002) definition of implementation being a combination of 
‘fidelity, dose and reach’.  
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However, Carroll et al’s. (2007) model goes further and describes the ‘moderators’ of fidelity, as 
essential elements to be considered in addition to adherence. It describes intervention 
complexity, facilitation strategies, quality of delivery and participant responsiveness as the main 
factors that may moderate the degree of fidelity with which the intervention is delivered. As 
described by the UK MRC framework for process evaluation, these present-day models typically 
focus on quantification of fidelity, receipt and context (Moore et al., 2015). However, when 
studied in depth these models only describe the key priorities for investigating intervention 
delivery process and not necessarily the methods suitable for carrying out such assessments. 
A recent model introduced for cluster RCTs demonstrates methods suitable for investigating 
these key priorities and the consideration of different timings in the process being evaluated 
(Grant et al., 2013). Besides, it outlines the methods for evaluating the processes during trial 
execution that can be used to explore variations in effectiveness between implementation sites. 
Despite the fact that these focus primarily on design and reporting of process evaluation 
conducted parallel to the trial execution, some of the aspects (e.g. the mechanism of impact) have 
the potential to be adapted for a post-hoc (after completion of trial) exploration.  
These models provide a comprehensive list of elements important for assessing intervention 
fidelity. The selection of elements for any evaluation, however, depends completely on the 
purpose of the fidelity assessment (Peters et al., 2013); i.e. monitoring delivery versus 
understanding the mechanism of impact of delivery. These latest models for understanding what 
was delivered in an intervention, how it was delivered, and its mechanism of impact can be 
promising for the design and conduct of an appropriate exploration of the intervention delivery 
process and might help understand the range of its effects on smoking cessation. 
‘What’ is delivered: Intervention content  
Intervention fidelity is noted as a potential moderator of the relationship between an intervention 
and its intended outcomes (Carroll et al., 2007). Fidelity has been defined as the ‘adherence of the 
intervention delivery to the specifications in intervention manuals’ (Bellg et al., 2004).  
Multiple descriptions of the important aspects of fidelity have been in use in the literature. Some 
define fidelity as the quality of delivery, emphasising the need to capture the qualitative nature of 
what was delivered, not just the technical aspects of delivery (Linnan and Steckler, 2002). Others 
argue that fidelity specifically concerns whether core, prescribed intervention ingredients are 
delivered, rather than the separate yet associated question of how they are delivered, for example, 
in terms of quality and tailoring of delivery (Lorencatto et al., 2013a). In respect to capturing 
intervention content adequately, the most recent thinking on the elements of fidelity for 
consideration is discussed below. 
Elaborating on the elements for understanding the process of intervention delivery put-forward 
by Linnan and Steckler (2002), I attempt to describe these elements one-by-one, in the next few 
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paragraphs, and provide justification for selecting those that are important for fidelity 
measurement of a BI, particularly keeping the focus on those elements that relate to the 
intervention delivery.  
‘Context’ can include anything external to the intervention e.g. the organisational structure or 
environment, the provider’s readiness or ability to change that can be influenced by pre-existing 
circumstances, skills, resources and attitudes (Lawton et al., 2015, Moore et al., 2015). For the 
purpose of accounting fidelity in the current research, context encompasses contributing factors 
at the cluster (organisational) level, which might influence fidelity or moderate its effect but is 
not considered an element of fidelity. This is based on the fact that cluster-level variables were 
not found to explain the variation in quit rates in the ASSIST study, as described in Chapter 3. 
The other connected but separate concept of providers’ skill and attitude being considered a part 
of ‘context’ (Lawton et al., 2015), makes sense when looking at the micro and meso factors 
concerning intervention delivery. However, this concept of the context for an intervention in 
intrinsic terms better fits with the quality of delivery (‘how it is delivered’), and will be discussed 
in the next section. 
‘Adherence’ refers to the extent to which the intervention is delivered as planned according to 
the protocol (Dane and Schneider, 1998). Adherence is the most fundamental element of fidelity; 
if an implemented intervention adheres completely to the content, frequency and duration as 
designed, then the fidelity is likely to be high (Carroll et al., 2007). The content of an 
intervention may be seen as its ‘active ingredients’, while frequency and duration of the 
intervention (sometimes referred to as ‘dose delivered)’ are essentially sub-categories of 
adherence (Carroll et al., 2007). Dose delivered or intensity of intervention, also called ‘provider 
commitment’ (Lawton et al., 2015) is the time spent in delivering the intervention. It is 
sometimes quantified by the number of sessions of therapy given, in addition to the duration of 
each session. Adherence will form an integral aspect of the fidelity measurement in this thesis; it 
will help establish scoring criteria for the core structure (intended practice) described for the BI. 
‘Dose received’ or exposure is the extent to which the recipients of intervention report receiving 
the intervention features (Dane and Schneider, 1998, Lawton et al., 2015). Intervention receipt 
could be assessed by monitoring session attendance and key features delivered in the session, 
along with comprehension of these features by the recipient (Gearing et al., 2011). In my 
research, devising a measure that can cover this aspect of fidelity is difficult, as it could not be 
directly observed and would require comprehension by the intervention recipients. However, 
considering the complexity of behavioural interactions between the provider and the recipient in 
BIs, this element can be affected by the quality of delivery. It can be considered an indirect 
consequence of patient-provider interaction, rather than a direct product of fidelity itself and, 
therefore, might be covered under quality of intervention delivery.   
‘Reach’ is the extent to which the intervention programme is received by the targeted group and 
‘recruitment’ relates to strategies used to attract participants for the intervention programme 
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(Linnan and Steckler, 2002). Despite its importance in implementation for scale-up at a wider 
level, the extent to which reach can be considered a necessary aspect of intervention fidelity 
depends on how strongly it is linked to the effectiveness of a specific intervention. To elaborate 
on this point, consider the example of a smoking cessation referral scheme which cannot be 
implemented if no one attends, while a national tobacco taxation policy will impact even those 
who do not know such a policy exists (Moore et al., 2015). For the purposes of the current 
research, and considering the nature of individual BIs, as compared to mass interventions for 
smoking cessation, (where coverage for an optimal impact is necessary), this element falls outside 
the scope of the proposed fidelity measurement. 
Therefore, adherence to the intended content for delivery is one of the main elements of fidelity 
that will be considered for measuring ‘what’ is delivered in my research work.  
‘Who’ delivers and ‘How’ it is delivered: Quality of interaction 
Quality of interaction is another important aspect of fidelity with which the intervention is 
delivered. It is considered by some as an element of fidelity (Lawton et al., 2015, Mihalic, 2004, 
Dane and Schneider, 1998), while by others it is regarded as an associated factor that moderates 
fidelity to intervention delivery (Carroll et al., 2007, Lorencatto et al., 2013a).  
Quality of interaction necessarily concerns whether the content of an intervention is delivered in 
a way appropriate to achieving what was intended and relies on factors like provider expertise 
(skill and competence) (Gearing et al., 2011), training, enthusiasm, attitude and ongoing 
supportive monitoring (Resnick et al., 2005, Dane and Schneider, 1998, Lawton et al., 2015).  
If the content of an intervention is delivered badly, then this may affect the degree to which full 
fidelity can be realised (Carroll et al., 2007). The way in which intervention content is expressed 
to the recipient can mediate (explain the relationship between an intervention and outcome) 
(Hasson, 2010, Carroll et al., 2007) the impact of the intervention on cessation outcomes or 
moderate (influence the strength of relationship between the intervention and outcome) the effect 
of adherence to its content in explaining this mechanism (Pawson and Tilley, 1997). As 
taxonomies evolve, they need to identify and incorporate the inter-personal techniques or 
competences that fulfil the conditions to be satisfied if the intervention is to be effective (Hagger 
and Hardcastle, 2014). It is also important to determine whether these inter-personal 
competences moderate the effect of the content-based BCTs (Hardcastle et al., 2016).    
All these factors as sources of variation in outcomes of complex interventions have been 
discussed previously in detail, in Chapter 3. 
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4.3 SUMMARY 
Fidelity is delivery of the intervention according to the plan or protocol. In this chapter, I have 
described the concept of fidelity and its elements important for assessing the process of 
intervention delivery.  
Two main concepts covering fidelity in connection to the intrinsic nature of an intervention are: 
‘what’ is delivered, or the individual behaviour change content and ‘how’ it is delivered, or the 
quality of interaction. The extent to which adaptation of the intervention to local context 
represents poor fidelity or beneficial tailoring to client needs, is a consequential consideration 
when prioritising elements to assess fidelity (Moore et al., 2015). An acceptable account of 
fidelity for BIs might be achieved by standardising the functional features of the intervention, 
such as the interaction style, while keeping its compositional features (both content and quality of 
interaction) adaptable to the patient need.  
Quantifying fidelity or developing a measure on which fidelity can be scored is more complicated 
than assessing fidelity subjectively. It is further complicated for BIs because of the interacting 
nature of the behaviours and intervention features involved. Therefore, to account for fidelity of a 
BI quantitatively it is essential to first describe the intervention features using a standard 
nomenclature. This gives the fidelity measure its core structure or the back bone, which can be 
referred to as the ‘intended’ practice. 
The elements of fidelity deemed important for the current research include adherence to the 
content of the BI intended for delivery and the quality of the interaction with which the content 
is delivered. This can be referred to as the ‘actual’ practice and thus represents intervention 
fidelity.  
The theoretical perspectives and concepts described in this chapter will help establish the 
methods for measuring fidelity to BIs (chapter 6 & 7), and whether fidelity is associated with 
smoking quit rates (chapter 8). Such a fidelity measure does not exist for BIs, particularly in 
connection to smoking cessation. Furthermore, it provides an opportunity to step forward, in the 
science of fidelity measures, and establish a method for accounting the quality of interaction as an 
aspect of fidelity within implementation and execution of a BI. 
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PART II- AIMS & OBJECTIVES 
This section contains one chapter, in which I will outline the overall aim and describe the specific objectives 
of this thesis. 
 
  
 
Chapter 5. Aims and Objectives 
From the literature presented in previous chapters, it is evident that smoking is associated with 
significantly poor outcomes of TB disease, mortality and recurrence. Despite its proven 
significance, there is poor uptake and implementation of smoking cessation within TB care and 
management services in LMICs. This is partly due to our limited understanding of what works 
in these settings. Policy makers and programme managers are likely to implement shorter 
versions of interventions if they do not have enough staff or resources to implement the full BI 
package. Giving them options to select the most effective features of a BI delivered in the most 
efficient manner might improve the uptake of smoking cessation services in routine clinical care. 
A quantitative scale, with the capability to measure what is being delivered (fidelity) and which 
components are effective, is likely to help. However, fidelity to BIs for smoking cessation is rarely 
assessed and our understanding of the contribution made by the fidelity to patient quit rates is 
limited. Moreover, the research tools necessary to carry out a robust measurement of 
intervention fidelity are also lacking.   
My overall research goal, therefore, is to investigate whether smoking quit rates are associated 
with the fidelity with which a BI for smoking cessation is delivered.  
My aim, in this thesis, is to carry out the preliminary research required to answer the above 
question. This includes first designing a fidelity index, and then delineating features of a BI for 
smoking cessation in a format suitable for rating. This could determine those features that are 
effective, ready to be replicated and validated in future research studies. I also aim to explore any 
association between intervention fidelity and the smoking quit rates, in order to generate 
hypotheses and inform the methods for further explanatory work in a future trial.  
Three aims of my thesis are: 
 To develop an index to measure fidelity to a BI for smoking cessation  
 To validate the fidelity index by assessing its psychometric properties  
 To explore whether fidelity to a BI explains variation in quit rates 
I will describe each of these aims and their specific objectives (summarised in Table 5.1) in 
further detail below. 
5.1 DEVELOPMENT OF THE FIDELITY INDEX- AIM I 
The first aim is to develop an index to measure fidelity to BIs for smoking cessation. I have 
already discussed the paucity of the published research, on which to base the fidelity index 
(Chapter 4). What evidence there is suggests that when used in research, as opposed to use in 
practice as conventional monitoring checklists, fidelity measures can be efficient and effective 
tools to measure intervention adherence in process evaluations, to facilitate communication of 
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intervention content in literature, to interpret effectiveness findings and to identify critical 
ingredients of the intervention (Bond et al., 2000b). In developing a fidelity index, it makes sense 
then, to focus on the research utilisation of the measurement tool. 
I have also described (in Chapters 1, 2 and 3) how BIs for smoking cessation are complex, and the 
difficulties this poses for successful implementation. In developing an appropriate fidelity 
measure, I will define the functional and compositional features of the intervention. This is to 
take account of the factors affecting implementation that are intrinsic to the intervention, and to 
balance standardisation versus adaptation to local context. I have reviewed these concepts above, 
in Chapters 3 & 4, and the aim will be to integrate these concepts in conjunction with the 
fundamental elements of fidelity.  
Further objectives in developing the fidelity index are: 
 To describe the features of BI for smoking cessation, including its content and quality 
of interaction related aspects, to inform the ‘intended’ practice 
 To map these intervention features to theories of behaviour change utilising the 
taxonomies of BCTs to understand their mechanism of action or potential effectiveness 
 To formulate a rating scale for measuring fidelity to each intervention feature to 
inform the ‘actual’ practice 
5.2 PSYCHOMETRIC PROPERTIES OF THE FIDELITY INDEX- AIM II 
The second aim is to assess the psychometric properties of the fidelity index to assess its 
reliability when used in research. In determining the reliability of a measure, the consistency in 
its use by different people, coherence of independent intervention features within the fidelity 
construct, and its ability to capture variation in intervention delivery practice, are considered 
important. 
Specific further objectives, then, are: 
 To test the feasibility of use in primary research  
 To determine its replicability for use by people with diverse backgrounds, to inform its 
stability as a research tool 
 To determine the coherence of items in the index, to refine its structure and inform its 
reproducibility in future research  
 To investigate the underlying dimensions of the fidelity construct within a behaviour 
change framework that the index can capture, to inform its utility in explaining 
variations in smoking cessation outcomes 
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5.3 EXPLAINING VARIATION IN QUIT RATES- AIM III 
As described in Chapter 2, there are particular challenges in wider scale-up of effective BIs, due 
to the variability in their outcomes. These include identification of the active intervention 
ingredients and identification of the competences that in turn determine the training 
requirements of the providers of these complex interventions.  
Specific objectives are, therefore: 
 To describe intervention fidelity to the BI used in the ASSIST study 
 To assess provider consistency in practice behaviour over time 
 To explore any association between provider fidelity to the BI and the patient quit 
rates, to explain the observed variation 
 To explore the relationship between Adherence to intervention content and Quality 
of interaction, to generate hypotheses for appropriate mediation or moderation 
pathways 
The research goal is to use the outputs from this work to inform the detailed methodology of 
robust evaluations of BIs for smoking cessation, and to provide information on methods for 
identifying the active intervention features through hypothesised mediation or moderation 
pathways in future studies. In addition, further validation of the fidelity index in future trials of 
smoking cessation, based on the psychometric assessments in this thesis, will determine if fidelity 
predicts quit rates.   
Table 5.1: Aims and Objectives of the thesis 
Study Aims Specific Objectives 
I- To develop an index 
to measure fidelity to a 
BI for smoking 
cessation 
(Study A, Chapter 6) 
1. To describe the features of BI for smoking cessation, including its content and 
quality of interaction related aspects to inform the ‘intended’ practice 
2. To map these intervention features to theories of behaviour change utilising 
the taxonomies of BCTs to understand their mechanism of action or potential 
effectiveness 
3. To formulate a rating scale for measuring fidelity to each intervention feature 
to inform the ‘actual’ practice 
II- To validate the 
fidelity index by 
assessing its 
psychometric 
properties 
(Study B, Chapter 7) 
1. To test the feasibility of use in primary research  
2. To determine its replicability for use by people with diverse backgrounds to 
inform its stability as a research tool 
3. To determine the coherence of items in the index to refine its structure and 
inform its reproducibility in future research  
4. To investigate the underlying dimensions of the fidelity construct within a 
behaviour change framework that the index can capture to inform its utility in 
explaining variations in smoking cessation outcomes 
III- To explore 
whether fidelity to a 
BI explains variation 
in quit rates 
(Study C, Chapter 8) 
1. To describe intervention fidelity to the BI used in the ASSIST study 
2. To assess provider consistency in practice behaviour over time 
3. To explore any association between provider fidelity to the BI and the patient 
quit rates, to explain the observed variation 
4. To explore the relationship between Adherence to intervention content and 
Quality of interaction, to generate hypotheses for appropriate mediation or 
moderation pathways 
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PART III- METHODS & RESULTS 
This section describes and discusses the methods and the results of the three linked studies conducted to 
achieve the three research objectives set out in previous section, respectively.  
 
There are three chapters in this section, each linked to one study: 
Chapter 6 presents Study A. It provides an overview of the approaches for developing and using 
fidelity indices. Based on this, I then describe the methods used in the study. I end the chapter by 
presenting the results and discussing strengths and limitations of the study. 
Chapter 7 presents Study B. It explains the design and methods of the primary investigation to 
test psychometric properties of the fidelity index and the literature used to inform these methods. 
I end the chapter by presenting the results and discussing strengths and limitations of the study. 
Chapter 8 presents Study C. It explains the design and methods of the secondary investigation to 
explore any association between the intervention fidelity and quit rates of a BI and the literature 
used to inform these methods. I end the chapter by presenting the results and discussing 
strengths and limitations of the study. 
 
 
 
  
 
Chapter 6. Study A: Development of the Fidelity Index 
This chapter presents the first study in a series of three linked studies. It describes the first of the two studies 
concerning development and validation of the fidelity index. These studies were closely linked, as the 
assessment of psychometric properties of the fidelity index was a sequential process in the development of a 
reliable measure. However, I have presented the development process first (study A) and separately from the 
psychometric testing (study B), for clarity. 
The rationale for developing and validating a quantitative measure of fidelity was to explore the 
variation in patient quit rates by testing its association with provider fidelity for BI. Study A 
builds on the research evidence established by literature presented in Chapter 1 on behaviour 
change science, and, on the possible sources of variation (Chapter 3) and intervention fidelity in 
Chapter 4.  
Measurement instruments that are collections of items combined into a composite score, and 
intended to reveal levels of theoretical variables not readily observable by direct means, are often 
referred to as scales (DeVellis, 2003). When items in such measurement instruments share a 
common cause, they constitute a ‘scale’, but when they share a common consequence, they 
constitute an ‘index’ (DeVellis, 2003). As fidelity is considered an intermediary variable in an 
interpretive evaluation model (refer to Figure 1.2, page 29), the quantitative measure of fidelity 
for a BI is referred to as the ‘fidelity index’ throughout the thesis. 
Study A (this chapter) and study B (Chapter 7) describe the methods used to develop the fidelity 
index and assess its reliability. Study C (Chapter 8) explores the relationship of quit rates with 
fidelity.   
6.1 CONSIDERATIONS IN DEVELOPING A FIDELITY INDEX 
Three key decisions influence the development of an index; defining the purpose of the index, 
developing a new index or adapting an existing one, and the level of theoretical description of 
intervention features. 
6.1.1 Purpose of Index 
The first step in developing a fidelity measure is to define its purpose. This would influence the 
approaches taken and methods used in its design. If the purpose is to develop an index for 
demonstrating intervention fidelity, then the approach will likely be more comprehensive 
(Borrelli, 2011), that is, identifying features of the intervention that are causally linked to theory 
and features that capture fidelity in a way that can be used to explain outcomes. In such cases, the 
researcher is more likely to consider multiple measures, to conduct detailed reliability studies, 
and to administer the fidelity index repeatedly (Bond et al., 2000b). Conversely, if the purpose of 
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the index is self-recording by the providers or for auditing services or for training in practice, 
where the goal is to ensure a certain basic level of adherence to an intervention programme, then 
a more pragmatic and less intense approach might be employed (Bond et al., 2000b). For this 
study the index will be developed for measuring fidelity that can be used as an intermediary 
variable to explain variation in smoking cessation, therefore a more comprehensive approach to 
its design will be adopted. 
6.1.2 Existing Indices 
Existing indices can be useful and inexpensive resources because these offer items validated 
through repeated studies (Streiner and Norman, 2008). However, a careful assessment of existing 
indices by searching literature on topics related to ‘fidelity’ and ‘behavioural interventions’ and 
speaking with experts in the field did not identify an index fitting my purpose. Some indices were 
developed to measure fidelity; however, they were inadequate for answering my research 
question (as discussed in section 4.1.3, chapter 4). These were designed either for training 
purposes or for assessing behaviour change strategies different from those used in the BI 
evaluated in my study. A brief account of the existing indices for intervention fidelity is given 
below.  
Behavioural and psychological intervention research provides elements of fidelity in a rating 
format e.g. intervention content, provider behaviour and competence, protocol drift etc. (Gearing 
et al., 2011). It does not, however, provide the specific features within each of these elements that 
would allow their proper measurement. Those that provide specific features within the broader 
elements of fidelity are unique to psychosocial (Clarke, 1998) and psychotherapy (Weisman et al., 
2002) interventions. Similarly, indices developed for educational and psychiatric practice are 
specific to the respective conditions under study (Dane and Schneider, 1998, Bond et al., 2000b). 
Other indices on behaviour change (as discussed in section 4.1.3, chapter 4) include competence 
rating scales i.e., The Cognitive Therapy Scale (Young and Beck, 1980) and the Motivational 
Interviewing Skill Code (Moyers et al., 2005), which are specific to provider competences 
concerning cognitive therapy for depression and motivational interviewing. The Behaviour 
Change Counselling Index (BECCI) (Lane et al., 2005) assesses change in provider behaviour 
before, during and after training, with a focus on knowledge acquisition. It is by far the closest 
index that matches with the behaviour change theories relating to provider competence for BIs of 
smoking cessation used in my study. Although the items can be adapted, the purpose of the 
BECCI, which is to assess knowledge acquisition of providers, differs altogether from evaluating 
provider fidelity for a BI. 
6.1.3 Description of intervention theory 
The degree to which intervention features are described theoretically determines the approach to 
item generation for an index, discussed below in 6.2 (Bond et al., 2000b).  
Chapter 6- Development of Fidelity Index
76 
 
Modified behaviour is an outcome of BIs (Michie and Johnston, 2012). Theory represents an 
integrated summary of the hypothesised causal processes involved in behaviour modification 
(Michie et al., 2008). The role of theory is, therefore, to identify the key concepts that are causally 
related to behaviour and are thus scientifically plausible targets for intervention (Michie et al., 
2009c). Most BIs are based on formal theories but even those that are not, assume and 
hypothesise that a course of action is a potential solution to a problem (Cane et al., 2012). Hence, 
a careful consideration of theories and their underlying causal assumptions is important to 
understand the likely processes of change targeted by an intervention when developing a new 
index to measure fidelity for linking with the outcome.  
Theories that explain behaviour and those that focus on the process of change, as detailed in 
Chapter 1, informed the design of BI in the ASSIST study. However, the study did not benefit 
from the taxonomies of BCTs, as these were not published at the time. Hence, the BI (used in 
ASSIST study) was theory-based, but its various features were not formally mapped to the 
theoretical constructs of behaviour change for smoking. Furthermore, the intervention features 
were not specified in a way that could be readily unpicked and rated separately. 
The BCTs could help label the intervention ingredients and explain the focus of behaviour 
change specific to behavioural determinants of smoking; hence providing theory-linked 
‘compositional features’ of intervention delivery.  
6.2 APPROACHES TO ITEM GENERATION 
Once the key conceptual decisions are made, the first step in index development is to generate the 
items. An item has two elements: the item stem, which is an ingredient of the intervention and 
the response scale, which is a set of response options that each ingredient is scored on (Bond et 
al., 2000b). In this thesis, the term ‘item stem’ is referred to as the ‘item’ which represents the 
compositional features of the fidelity index and the ‘response scale’ is called as such, representing 
the functional features of the fidelity index. 
A fidelity index is unique from other scales because the items can be built from intervention 
features (Gearing et al., 2011). One of the two approaches, described below (inductive vs. 
confirmatory), can aid construction of items from intervention depending on its level of 
specification and clarity in terms of theory (Bond et al., 2000b). 
6.2.1 Inductive approach 
If an intervention is not well-defined theoretically and its key features cannot be disentangled 
based on underlying causal mechanisms, then an inductive approach is considered best for 
generating items (Bond et al., 2000b). In an inductive approach, the key intervention features are 
discovered, using interviews and brainstorming with people, as well as observations, and content 
analyses of documents. This approach requires developing a coherent understanding of the 
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theoretical underpinning of the intervention for identification and definition of its important 
features and the generation of new items for the index. As the inductive approach is used when 
interventions are not well-based in theory, larger sample sizes, often more than 20 individuals 
might be required (Bond et al., 2000b).  
The Delphi technique, concept mapping (through focus groups), ethnography (through 
structured interviews), critical incidents technique, and content analysis are the different types of 
methods used to aid the inductive approach for generating items. Many of these methods are also 
used in the confirmatory approach, as described below. 
6.2.2 Confirmatory approach 
Confirmatory approach is used to specify intervention features that are already deeply rooted in 
theory (Bond et al., 2000b). This approach relies on well-established intervention theory and 
intervention resources such as the practice manuals that provide details on key intervention 
features. Confirmatory approach comprises of two types of techniques, the critical components 
technique and the expert consensus, described here: 
The critical components technique 
The critical components technique is used to generate items a priori (Bond et al., 2000b). This 
technique focuses on the activities of an intervention, rather than the broader underlying 
theoretical concepts. It is quite challenging as it requires sifting through the intervention 
features and identifying those that are measureable and representative of the construct (e.g. 
behaviour change) under scrutiny. Furthermore, it involves research to ensure that the selected 
intervention features have been shown empirically to be linked to theory (Streiner and Norman, 
2008). 
Expert consensus 
Often used in conjunction with the above technique is the process of inviting expert insight into 
the generated list of items and establishing the expert consensus on the content (Bond et al., 
2000b). The experts usually comprise intervention users and other individuals who are 
knowledgeable about the subject matter. This technique is discussed further in section 6.5, page 
82, under ‘content validation’. 
The selection of best approach (inductive or confirmatory) for constructing items of the fidelity 
index relies on the BI used in the ASSIST study and its specification using the theories of 
behaviour change.  
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6.3 DESCRIBING BEHAVIOURAL INTERVENTION USED IN THE ASSIST STUDY 
Here I outline the BI used in the ASSIST study and how its key features can be prepared for use 
in the fidelity index.  
The BI (briefly described in Appendix B) was developed in 2008. It used the World Health 
Organisation’s (WHO) ‘5As to quit’ model for structuring the counselling sessions (World 
Health Organisation, 2014c). Activities within 5As were designed, focusing on behaviour change 
theories, as described above in section 1.2.1 (Green and Murphy, 2014, Fishbein, 1979, Ajzen, 
1991, Prochaska and DiClemente, 1984) to assist smokers with their quit attempt. These 
activities can be easily divided into ‘compositional’ and ‘functional’ features as discussed in 
Chapter 4, to describe the content and delivery of the intervention (Figure 6.1). 
In the wider behaviour change literature ‘quality of 
intervention delivery’ equates with the notion of 
intervention provider competence (Lorencatto et al., 
2016). Using this concept the term ‘quality’ has often 
been used to ‘qualify’ intervention ingredients on 
‘how well’ these are delivered in practice. However, in 
my work, keeping true to the original idea of the 
‘quality of intervention delivery’ as distinct from the 
‘process of delivery’ (discussed below), I used the 
evidence-based competences (Michie et al., 2011b) 
required to deliver behavioural support to describe 
the ‘inter-personal aspects’ of the BI and called it 
‘Quality of interaction’. For the ‘content-based 
aspects’ of the BI, I used the BCTs developed for 
individual behaviour change for smoking cessation 
(Michie et al., 2011c) and called it ‘Adherence to BI 
content’. Both of these terms in my study represent 
the ‘compositional features’ of the index or the 
‘intended practice’. To ‘qualify’ each ingredient of the 
BI on ‘how well’ it is delivered, which I perceived as the ‘process of delivery’, a scoring criterion 
or scale is needed for each individual ingredient. This qualification of the ingredients is the 
essence of a quantitative measure for a complex intervention and forms the ‘functional features’ of 
the index and captures the ‘actual practice’. 
6.3.1 Behavioural Intervention ‘Content’ 
The 5As quit model (Table 6.1) summarises the activities that a health care provider could do to 
help a smoker quit tobacco use (World Health Organisation, 2014c). This model guides the 
Figure 6.1: Behavioural intervention 
content and delivery 
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provider through the process of talking to patients who are ready to quit smoking and delivering 
advice. The key features of the BI (Table 6.1) within the 5As quit model, in the ASSIST study, 
were built to facilitate patient-provider interaction in clinical settings, using an assessment 
questionnaire and pictorial messages (in the form of a flip-chart). 
Table 6.1: Behavioural Intervention used in ASSIST study 
5As quit Model Key features of Behavioural Intervention 
Ask (about tobacco use 
behaviour and history) 
1. Ascertain about tobacco use  
Advise (about consequences of 
tobacco use and quitting) 
2. Information about harms of smoking and benefits of quitting 
Assess (willingness to quit) 3. Assessments of dependency and motivation to stop 
4. Preparation for quit attempt  
Assist (in quitting) 5. Identifying the social/psychological or environmental cues that 
trigger a smoker’s desire to smoke and advising on ways to monitor and 
avoid these 
6. Assessing the withdrawal symptoms (i.e. the strong urges/cravings to 
smoke) and advising on ways to address and overcome these 
Arrange (follow-up) 7. Offering the BI leaflet as a reminder 
6.3.2 Behavioural Intervention ‘Delivery’ 
The BI flip-chart and the integrated questionnaire were designed for use in a specific way. Each 
slide in the flip-chart had a sketched scenario facing the patient and key messages on the back 
facing the provider to help them deliver the messages effectively. The interaction style of the 
provider described the way that the intervention is intended to be delivered, that is, delivery 
using three essential steps: 
Step1- asking the patient to describe the slide 
Step2- facilitating them with understanding the message 
Step3- clarifying concept and re-emphasizing the key message 
The interaction style was more complex than these 3 steps of delivery because the BI also 
involved a structured questionnaire interview, which would require defining the process of 
delivery of the assessment questions, in addition to the flip-chart slides.  
The processes involved in delivering BI ingredients form the ‘functional features’ of the index 
which would capture intervention fidelity. The integrity of the index in measuring fidelity relies 
heavily on defining these functional features based on provider interaction-style. This would give 
the fidelity index its quantitative ability to measure ‘actual practice’ assessed on the intended 
practice. 
6.4 APPROACHES TO SCORING OF ITEMS IN THE FIDELITY INDEX 
The goal for the fidelity index is to develop items and their corresponding response scales that 
will accurately capture the provider fidelity to intervention delivery. Each ingredient of the BI 
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identified and described using the taxonomies of behaviour change will qualify as an ‘item’ of the 
index and thus represent the ‘intended practice’ (as described in Chapter 4).  
After creating these items, the next step is to establish the ‘response scale’ for rating and scoring 
the items to capture ‘actual practice’. Developing the response scale would require careful 
consideration for this fidelity index, as it encompasses two levels of behaviour (Figure 6.2). The 
first level is the individual smoker behaviour (compositional features) that is targeted by the 
intervention to aid quitting. The second level is the provider behaviour in delivering the 
intervention or the interaction style (functional features). Whilst the first level (intended 
behaviour change of the target individual) can be captured within the structural formation of the 
index represented by items, the second level (provider practice or interaction style) needs 
anchoring within the scale points, by creating response options that accurately capture the ‘actual 
practice’ (as described in Chapter 4).  
 
Figure 6.2: Developing items and their corresponding response scales 
6.4.1 Establishing response scale points 
This step, crucial in the index development, relates to the precision of measurement of fidelity (or 
‘actual practice’) for a BI.  
Linking fidelity to outcomes requires indices to  have the ability to detect variation in delivery of 
the intervention (Nelson et al., 2012). Indices involving rating of items on a binary scale (e.g. 
implemented or not implemented) cannot detect sufficient variance in implementation to link 
these to outcomes (Nelson et al., 2012). Therefore, three, five or seven point ordinal scales are 
often used, to ensure that all relevant variability in intervention delivery practices for each item 
could be captured. 
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The following characteristics are important in devising a comprehensive yet precise response 
scale for use in research (Bond et al., 2000b): 
 A standard number of scale points for every item 
 Ordinal scale points approximating equal intervals between each option  
 Response scale points for each item. These can be numerical representing gradients or 
behaviourally anchored linking to specific behaviours or a set of behaviours. If the 
behavioural anchors do not include all of the possible response options, or if only part of 
the range of options captures all of the possible responses, then the scale is not sensitive. 
The response scale is more reliable for use by different coders if all response options have 
the potential of being chosen (Mowbray et al., 2003).  
 No gaps in the response alternatives (or options), and 
 No overlap in the response options 
Several methods have been introduced for coding intervention fidelity data  (Borrelli, 2011). The 
simplest method is to rate the occurrence or non-occurrence of intervention ingredients. A coder 
simply checks off the prescribed and proscribed ingredients that occur, while listening to an 
audio/video-tape or observing an intervention session. In most of the fidelity indices for 
psychological and behavioural interventions, each item was rated on a three point ordinal scale. 
For example, Gearing et al. (2011), in the comprehensive intervention fidelity guide, used: 
absent/minimal (score= 0), moderate (score= 1), and extensive (score= 2); and Clarke et al. 
(1998), in the fidelity scale for psychosocial therapy of depression, used: no adherence (score= 0), 
partial adherence (score= 1) and complete adherence (score= 2). 
Whilst the high and low ends of scale response options are often the easiest to develop, the 
middle options, that need to be independent yet meaningful, pose a challenge to define. (Bond et 
al., 2000b). Because few interventions are fully implemented as intended, or rarely, not adhering 
at all, it is often the middle alternatives on the response scale that might be crucial for capturing 
the variability in actual practice and thus the selectivity of the items (Bond et al., 2000b). Coders 
need to be able to differentiate between the response alternatives in the scale for a respective item 
stem, because, if the alternatives are too finely differentiated, then the coders may have a difficult 
time choosing one of them. On the other hand, if the response alternatives do not discriminate 
finely enough, coders might end up choosing the same option, in spite of their responses differing 
widely on the dimension (e.g. behaviour change) being measured (Bond et al., 2000b).  
An accepted way of objectively measuring intervention delivery processes in health services 
research and psychometrics is to utilise linear additive scales (Nunnally and Bernstein, 1994). 
These consist of scoring of the item stems based on an ordered response (ordinal categories) 
scale. The scores for each item are then summed up to give a total or ‘composite’ score for the 
entire index. 
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6.5 CHECKING ADEQUACY OF GENERATED ITEMS 
Once the fidelity index is formed, the next few steps relate to its field measurement, validity and 
reliability of use; all of which delineate its validation as a sound measure. The terms ‘face validity’ 
and ‘content validity’ are the technical descriptions of the judgement that the index looks 
reasonable and measures the intended concepts (Streiner and Norman, 2008). 
6.5.1 Content validation 
Once the items are listed, this step ensures that the index adequately covers the construct being 
measured (Streiner and Norman, 2008). The technical term for this is ‘content validation’ 
(described in section 6.5), although many theorists believe it should be replaced by more accurate 
descriptors such as, ‘content relevance’ or ‘content coverage’ (Messick, 1980).  
Content rating by experts on relevance and importance to context 
As noted in 6.2.2 above, ‘expert consensus’ has been used for a wide variety of purposes in health 
research, such as the development of practice guidelines for disease prevention and management 
(Bond et al., 2000b). While there are important differences between practice guidelines and 
fidelity indices, they are both developed for a common purpose: to inform provider practice (Bond 
et al., 2000b). Where guidelines are developed to standardise practice, fidelity indices are used to 
measure practice attributes.  
Building consensus depends on several factors: the selection of participants, selection and 
presentation of scientific information, the way in which the interaction is structured, and the 
method of synthesising individual judgements (Black et al., 1999). The principle qualitative 
research methods (Peters et al., 2013) for content validation include: the Delphi technique, 
nominal group technique and consensus development conference (Black et al., 1999).  
The ‘consensus development conference’ is an informal method that involves open meetings 
amongst experts, followed by private group discussions to reach agreement (Black et al., 1999). 
Sometimes recommendations are produced in a single meeting (Bond et al., 2000b). The ‘Delphi 
technique’ and the ‘nominal-group technique’ are comparatively formal approaches to consensus 
development, involving face-to-face meetings or mailings to a carefully chosen group of experts 
(Black et al., 1999).  
The advantage of using the Delphi technique over other consensus methods is that if experts are 
chosen carefully, they can be assumed to represent the most recent thinking in the area, giving 
the index developer access to the accumulated knowledge and experience. However, the method 
can prove to be disadvantageous if it does not reflect a range of opinions covering all aspects of 
the subject under study (Streiner and Norman, 2008). The Delphi technique can be administered 
in a group i.e. face-to-face, or during an individual consultation (aka modified Delphi technique) 
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(Black et al., 1999). Two to three rounds are likely to result in some convergence of individual 
judgements, while more than three rounds show little impact on agreement and might adversely 
affect the response rate (Black et al., 1999). 
Criteria for item selection based on content rating 
Expert consensus is usually obtained on the ‘importance’ i.e. the ingredients deemed essential for 
the index and the ‘intervention specification’ i.e. the clarity in describing the key intervention 
features as items (Peters et al., 2013). For indices where well-established specification methods 
(such as the taxonomy of BCTs) are used, expert consensus might only be required on 
‘importance’ of the items to be retained.    
To identify the items to retain in the index, it is also necessary to establish criteria for item 
inclusion based on the ratings given by the experts on relevance and importance of the items. 
There are no established rules for setting this criterion. Researchers have arbitrarily used the 
criterion that at least 50% of the experts rank an item as “very important” or “very relevant” 
(McGrew and Bond, 1995).  
6.5.2 Content pilot 
Content piloting is often undertaken to determine the ‘face validity’ of a tool. It focuses on 
respondent perceptions or other stake holders beliefs about the content of the index, rather than 
the empirical evidence by experts (Streiner and Norman, 2008). This ensures that the items on 
the surface tend to measure what they were designed to measure, that is, the items and their 
response scale retain their meaning (as intended by the researcher) when they are administered.  
Piloting the content of a new measure is critical in identifying problems with the sequence of the 
items, ambiguity in items, confusion in response alternatives, and other issues in its 
administration. For instance, if data are collected through an interview, a pre-test pilot gives an 
opportunity to the interviewer to practice asking the questions, as well as coding the responses. 
The goal of a content pilot is vast and often covers aspects from content clarity to unfolding field 
test errors; these include (Bond et al., 2000b): 
 Determining feasibility of data collection methods,  
 Giving observers/coders practice,  
 Identifying problems with the pace or placement of the items,  
 Identifying terminology or jargon problems,  
 Identifying whether the response scale options are appropriate, and  
 Assessing whether the provider has additional information that would be vital to the 
intervention fidelity, and, is not currently being covered by the index.  
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All of the above inform decisions in refining the content of the index and measurement 
procedures via identification of the problematic content (e.g. items with multiple meanings, 
double barrelled questions or misunderstood meaning of the items) and process issues (e.g. 
logistical or administrative challenges in the field etc.).  
6.6 AIMS OF STUDY 
“To develop an index to measure fidelity to a BI for smoking cessation” (described 
above in 5.1). 
The specific objectives of study A are to: 
 Describe the features of BI for smoking cessation, including its content and quality of 
interaction related aspects, to inform the ‘intended’ practice 
 Map these intervention features to theories of behaviour change utilising the taxonomies 
of BCTs to understand their mechanism of action or potential effectiveness 
 Formulate a rating scale for measuring fidelity to each intervention feature to inform 
the ‘actual’ practice 
6.7 METHODS 
The development of the fidelity index consisted of several sequential steps as depicted in Figure 
6.3, which illustrates the ‘structure’ (in blue) and ‘processes’ (in red) of intervention delivery.  
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Figure 6.3: Design of the fidelity index 
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6.7.1 Generating items for the fidelity index 
The fidelity index was based on the BI used in the ASSIST study- well-defined in theory; 
therefore a confirmatory approach was considered appropriate for item generation. Within this 
approach, the critical components technique was used to sift through the BI and pick intervention 
features. The 5As to quit model (World Health Organization, 2008) for smoking cessation 
provided the skeleton to the index, within which the key features of the BI (Table 6.1) were 
unpicked and specified using the taxonomies of BCTs (see next heading). 
6.7.2 Mapping items to theory 
As noted in Figure 6.3 (above), the ‘logic model’ of behaviour change (Figure 1.1, page 20) 
described in chapter 1, was used to map the BI ingredients in terms of the behavioural 
determinants and the BCTs likely to be influential.  
The taxonomies of behaviour change (Michie et al., 2011c) and competences (Michie et al., 
2011b) to deliver BIs for smoking cessation were used to specify BI ingredients. Features that 
were core to individual behaviour change (e.g. boosting patient motivation, maximising their self-
regulatory capacity etc.) were labelled to represent BI content for Adherence (Michie et al., 2011c). 
Features of provider competence (e.g. focus on emphasising patient choice within the bounds of 
evidence-based practice, focus on providing reassurance regarding treatment outcomes and 
tailoring interaction according to the patient needs) were labelled to delineate the Quality of 
interaction (Michie et al., 2011b). 
Hence, a list of items was assembled for ‘Adherence’ to BI content and ‘Quality’ of interaction 
forming the ‘compositional’ features of the fidelity index (Figure 6.4). These mapped features of 
the BI known as ‘items’ represented ‘intended practice’ and gave the index its necessary 
structure. 
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Figure 6.4: Compositional features of the index forming items 
6.7.3 Establishing a response scale for the items 
Similar to existing fidelity indices (Gearing et al., 2011, Clarke, 1998), a three point ordinal scale 
was chosen for each item; the scores against each item would then be summed up for all items in 
the index, to give a ‘composite index score’ (Nunnally and Bernstein, 1994), which makes it a 
linear additive scale. The psychometric properties of the linear additive index, both for Adherence 
to BI content and Quality of interaction, are presented in next chapter. 
The most important aspect, in establishing response scale points for the items was defining the 
anchors that help distinguish between the three point scale alternatives. 
Defining selection anchors 
As fidelity represented provider practice or process of delivery of the BI, it made sense to capture 
this behaviour using behavioural anchors. For example, if a response scale for an item ‘providing 
reassurance’ was 0= not implemented, 1=partially implemented and 2=fully implemented, the 
behaviourally anchored response options were defined as: 0= did not provide any reassurance, 1= 
listens and answers in yes and no but does not provide any constructive advice, and 2= gives 
constructive advice. For the flip-chart used in BI, this was done using the 3 steps (presented in 
Behavioural Intervention ‘Delivery’, page 79) for interaction style. For the patient assessment 
questions these anchors were defined based on the way the questions were asked. 
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Efforts were made to define scale response options that were exhaustive and mutually exclusive, 
to avoid any gaps or overlaps between alternative options. Similarly, middle alternatives of the 
response options were kept at equal intervals between the low and high end of the scale, to truly 
represent its ordinal value for rating items. 
Hence, each item was assigned a three point ordinal scale, with behaviourally anchored response 
options based on provider interaction style forming the ‘functional’ features of the fidelity index 
(Figure 6.5). The ‘response scale’ represented the ‘actual practice’. 
 
Figure 6.5: Functional features of the index forming response scales for corresponding items 
6.7.4 Content validation 
A modified Delphi procedure was carried out to validate the content of the fidelity index. The list 
of items with response scales was submitted via email (Appendix C.1) to three experts: a 
behavioural scientist, a smoking cessation provider and a smoking cessation expert.  
Content rating for each item was requested on importance using a Likert scale (1- very important 
to 4- not at all important). A maximum of two rounds were to be executed to conclude individual 
judgements and reach consensus, given the number of experts was small. In view of similar 
studies (McGrew and Bond, 1995), consensus on dropping an item from the list was considered if 
two of the three experts rated an item as “not at all important” or “not very important”. 
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6.7.5 Content pilot 
Field piloting of the index for ‘face validity’ was carried out in Islamabad in a tertiary care 
hospital housing a TB clinic, in December 2013. Field piloting involved observation of two 
patient-provider BI sessions, during which the coders rated each item on the fidelity index (for 
details on coders see Chapter 7, ‘Selection and training of coders’, page 115).  
6.8 RESULTS 
6.8.1 Items generated for the fidelity index 
Thirty-seven BI ingredients were identified from the ASSIST intervention resource (including 
flip-chart messages, the patient assessment questionnaire and the training manual), using the 
critical components technique. The list of these ingredients of BI is presented in Table 6.2. 
Table 6.2: List of ingredients or (items) identified from Behavioural Intervention 
5As quit Model Ingredients of Behavioural Intervention Item # 
Ask (about tobacco use behaviour 
and history) 
Assessing current and past smoking behaviour 
i. Pattern of smoking behaviour (Types of smoking? 
Smokers in vicinity? Children at home?) 
ii. Age when started smoking 
iii. Amount smoked 
1 
Advise (about consequences of 
tobacco use and quitting) 
Awareness about the various forms of tobacco smoked 
in the community 
2 
High blood pressure and heart disease 3 
Lung diseases like chronic cough, asthma, TB and 
cancer 
4 
Wastage of money, staining of teeth, gum problems 
and bad breath 
5 
Effects on children’s health: pneumonia, asthma etc. 6 
Effects on pregnancy: complications in pregnancy, low 
birth weight baby 
7 
Decide to quit, choose a quit date and utilize the money 
on better things 
8 
Social and economic benefits of quitting 9 
Assess (Willingness to quit) 
Current level of motivation to stop/willingness to quit 10 
Reasons for quitting e.g. health, cost, example for 
others, family’s health or other reason 
11 
Quit from today? If ‘No’, Quit within next five days? If 
‘No’, when will you be able to set a quit date? 
12 
Attempted quit in the past, Number and duration of 
past quit attempts, Time since last quit attempt 
13 
Factors that led back to smoking including social and 
physical factors (Social reasons: Family problems 
(tension), Smokers company, any other; Physical 
Symptoms: Craving, Indigestion, Insomnia, Headache, 
any other ) 
14 
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Assist (in quitting) 
Fagerstrom Test for Nicotine Dependence 15 
Setting quit date 16 
Hide reminders of smoking/ways of changing the 
physical environment to minimise exposure to smoking 
cues 
17 
Declare the house as ‘smoke free home’ 18 
Identify individual who can help support in quitting at 
home 
19 
Decide on telling people about stopping or keeping it 
private 
20 
Triggers and their management 
Trigger1: immediately after rising in the morning- 
Offer strategies to manage trigger 1 
21 
Trigger2: defecation- Offer strategies to manage 
trigger 2 
22 
Trigger3: eating meals- Offer strategies to manage 
trigger 3 
23 
Trigger4: free at home or feeling bored- Offer 
strategies to manage trigger 4 
24 
Trigger5: seeing others smoke- Offer strategies to 
manage trigger 5 
25 
Trigger6: offered smoking by others- Offer strategies 
to manage trigger 6 
26 
Trigger7: intense physical/mental work- Offer 
strategies to manage trigger 7 
27 
Trigger8: tense/anxious- Offer strategies to manage 
trigger 8 
28 
Withdrawals and their management 
Withdrawal1: Craving smoking- Offer strategies to 
manage withdrawal1 
29 
Withdrawal2: Restlessness/anger- Offer strategies to 
manage withdrawal2 
30 
Withdrawal3: Headache- Offer strategies to manage 
Withdrawal3 
31 
Withdrawal4: Insomnia- Offer strategies to manage 
withdrawal4 
32 
Withdrawal5: indigestion- Offer strategies to manage 
withdrawal5 
33 
Withdrawal6: Anorexia and constipation- Offer 
strategies to manage withdrawal6 
34 
Withdrawal7: Cough- Offer strategies to manage 
withdrawal7 
35 
Withdrawal8: Weight gain- Offer strategies to manage 
withdrawal8 
36 
Arrange (Follow-up) Give BI information leaflet to the patient and brief 
about it 
37 
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6.8.2 Mapping items to theory 
The 37 items identified in the previous step represent content of the BI, and another eight 
represent provider competence to effectively deliver BIs, making a total of 45 items representing 
‘compositional features’ of the index and the ‘intended’ practice for delivering BI.  
Both types of items will be scored for fidelity; content of the BI for Adherence and competence to 
deliver the BI for Quality.  
These 45 items were specified using 23 BCTs (Michie et al., 2011b, Michie et al., 2011c), which 
were further grouped in terms of the behavioural determinants (Table 6.3). 
 
Table 6.3: Items mapped to Behaviour Change Techniques and Behavioural Determinants  
Behavioural 
Determinants 
Behaviour Change 
Techniques (BCTs) 
Items  
 Adherence to content 
General aspects of 
the interaction (R) 
focusing on 
information 
gathering (I)  
*RC7: Information 
gathering and assessment 
1. Assessing current and past smoking 
behaviour 
i. Pattern of smoking behaviour (Types of 
smoking? Smokers in vicinity? Children at 
home?) 
ii. Age when started smoking 
iii. Amount smoked 
Specific focus on 
behaviour (B) and 
addressing 
motivation (M) 
BM1: Provide 
information on 
consequences of smoking 
and smoking cessation 
2. Awareness about the various forms of 
tobacco smoked in the community 
3. High blood pressure and heart disease 
4. Lung diseases like chronic cough, asthma, 
TB and cancer 
5. Wastage of money, staining of teeth, gum 
problems and bad breath 
6. Effects on children’s health: pneumonia, 
asthma etc. 
7. Effects on pregnancy: complications in 
pregnancy, low birth weight baby 
8. Decide to quit, choose a quit date and 
utilize the money on better things 
9. Social and economic benefits of quitting 
General aspects of 
the interaction (R) 
focusing on 
information 
gathering (I) 
RC7: Information 
gathering and assessment 
10. Current level of motivation to 
stop/willingness to quit 
11. Reasons for quitting e.g. health, cost, 
example for others, family’s health or other 
reason 
Specific focus on 
behaviour (B) and 
addressing 
BM6: prompt 
commitment from the 
client there and then 
12. Quit from today? If ‘No’, Quit within next 
five days? If ‘No’, when will you be able to 
set a quit date? 
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motivation (M) 
General aspects of 
the interaction (R) 
focusing on 
information 
gathering (I) 
RC7: Information 
gathering and assessment 
13. Attempted quit in the past, Number and 
duration of past quit attempts, Time since 
last quit attempt 
14. Factors that led back to smoking including 
social and physical factors (Social reasons: 
Family problems (tension), Smokers 
company, any other; Physical Symptoms: 
Craving, Indigestion, Insomnia, Headache, 
any other ) 
General aspects of 
the interaction (R) 
focusing on 
information 
gathering (I) 
RC7: Information 
gathering and assessment 
15. Fagerstrom Test for Nicotine Dependence 
Specific focus on 
behaviour (B) and 
maximising self-
regulatory 
capacity/skills (S) 
BS4: Facilitate goal 
setting 
16. Setting quit date 
Specific focus on 
behaviour (B) and 
maximising self-
regulatory 
capacity/skills (S) 
BS8: Advise on 
environmental 
restructuring  
17. Hide reminders of smoking/ways of 
changing the physical environment to 
minimise exposure to smoking cues 
18. Declare the house as ‘smoke free home’ 
Promote adjuvant 
activities (A) 
A2: Advise on use of 
social support 
19. Identify individual who can help support in 
quitting at home 
Specific focus on 
behaviour (B) and 
addressing 
motivation (M) 
BM2: Boost motivation 
and self-efficacy 
20. Decide on telling people about stopping or 
keeping it private 
Specific focus on 
behaviour (B) and 
maximising self-
regulatory 
capacity/skills (S) 
BS1: Facilitate barrier 
identification and 
problem solving 
BS3: Facilitate action 
planning /develop 
treatment plan 
21. Trigger1: immediately after rising in the 
morning- Offer strategies to manage 
trigger 1 
22. Trigger2: defecation- Offer strategies to 
manage trigger 2 
23. Trigger3: eating meals- Offer strategies to 
manage trigger 3 
24. Trigger4: free at home or feeling bored- 
Offer strategies to manage trigger 4 
BS1 & 3 ;  
BS11: Advise on avoiding 
cues for smoking 
BS12: Facilitate 
restructuring of social life 
25. Trigger5: seeing others smoke- Offer 
strategies to manage trigger 5 
26. Trigger6: offered smoking by others- Offer 
strategies to manage trigger 6 
BS1 & 3; 27. Trigger7: intense physical/mental work- 
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BS10: Advise on 
conserving mental 
resources 
Offer strategies to manage trigger 7 
BS1, 3 & 10; 
BS14: Teach relaxation 
techniques 
28. Trigger8: tense/anxious- Offer strategies 
to manage trigger 8 
General aspects of 
the interaction (R) 
focusing on general 
communication(C) 
RC10: Provide 
information on 
withdrawal symptoms 
29. Withdrawal1: Craving smoking- Offer 
strategies to manage withdrawal1 
30. Withdrawal2: Restlessness/anger- Offer 
strategies to manage withdrawal2 
31. Withdrawal3: Headache- Offer strategies 
to manage Withdrawal3 
32. Withdrawal4: Insomnia- Offer strategies to 
manage withdrawal4 
33. Withdrawal5: indigestion- Offer strategies 
to manage withdrawal5 
34. Withdrawal6: Anorexia and constipation- 
Offer strategies to manage withdrawal6 
35. Withdrawal7: Cough- Offer strategies to 
manage withdrawal7 
General aspects of 
the interaction (R) 
focusing on general 
communication(C)& 
Specific focus on 
behaviour (B) and 
maximising self-
regulatory 
capacity/skills (S) 
RC10;  
BS13: Advise on methods 
of weight control 
36. Withdrawal8: Weight gain- Offer 
strategies to manage withdrawal8 
General aspects of 
the interaction (R) 
focusing on general 
communication(C) 
RC6: Offer appropriate 
written material 
37. Give BI information leaflet to the patient 
and brief about it 
Quality of interaction 
General aspects of 
the interaction (R) 
focusing on general 
communication(C) 
RC1: Build general 
rapport 
 
38. Build general rapport: Establish a positive, 
friendly and professional relationship with 
the smoker and foster a sense that the 
smoker’s experiences are understood  
RC9: Explain 
expectations regarding 
treatment programme 
39. Explain expectations regarding treatment 
programme: Explain to the smoker the 
treatment program, what it involves, the 
active ingredients, and what it requires of 
the smoker 
RC4: Provide reassurance 
40. Provide reassurance: Give general 
reassurance to the smoker that his/her 
experiences are normal and time limited, 
and provide positive expectations of 
success based on experience with other 
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smokers in the same situation 
RC2: General practitioner 
communication 
approaches 
41. General practitioner communication 
approaches: (Elicit and answer questions) 
42. General practitioner communication 
approaches: (Use reflective listening) 
43. General practitioner communication 
approaches: (Summarising information and 
confirming client decisions) 
General aspects of 
the interaction (R) 
focusing on the 
delivery of the 
intervention (D) 
RC5: Tailor interactions 
appropriately 
44. Tailor interactions appropriately: Use 
relevant information from the client to 
tailor the behavioural support provided/ 
flexible adaptation that takes into account 
individual patient needs  
RC3: Emphasise choice 
45. Emphasise choice: Emphasise client choice 
within the bounds of evidence based 
practice 
* BCTs labels used in the taxonomies. For further details refer to (Michie et al., 2011b, Michie et al., 2011c) 
6.8.3 Establishing response scale for the items 
The response scale points, representing the ‘functional features’ of the fidelity index, and their 
behavioural anchors based on the interaction style of the provider, are described in Table 6.4.  
Behavioural anchors were defined separately for the flip-chart and patient assessment 
questionnaire. For the flip-chart, the anchors were defined in accordance with the 3-steps of 
interaction style. Within the patient questionnaire, anchors for assessment questions were 
defined, based on how the question was asked and whether full response was elicited using the 
probes provided. The Fagerström scale used for assessing nicotine dependence of the smoker was 
administered as part of the patient questionnaire; for this scale the anchors were defined based on 
how the scale was administered and if all responses within the scale were elicited (see Table 6.4). 
Eventually, the developed fidelity index comprised of two sub-indices, ‘Adherence’ having 37 items 
with a maximum score possible of 74 and ‘Quality’ having eight items with a maximum score 
possible of 16, both measuring two important aspects of fidelity. 
 
Table 6.4: Behavioural anchors for the response scale  
Interaction style Response scale  Behavioural Anchoring 
Flip-chart (for all slides)  
Step1- Asking the patient to describe 
0 = not implemented  
Consider not implemented if the 
provider ‘skips all 3 steps’ 
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the slide 
Step2- Facilitating them with 
understanding the message 
Step3- Clarifying/re-emphasizing the 
key message 
1= partially implemented 
Consider partially implemented if 
the provider ‘delivers 2 out of 3 
steps’ 
2= fully implemented 
Consider fully implemented if the 
provider ‘delivers all 3 steps’ 
Assessment questions  
(in patient questionnaire) 
0 = not implemented  
Consider not implemented if the 
provider ‘skips asking the question’ 
1= partially implemented 
Consider partially implemented if 
the provider ‘asks about the 
assessment question without eliciting 
a response using the categories given 
for that question’ 
2= fully implemented 
Consider fully implemented if the 
provider ‘asks about the assessment 
question and elicits response using 
the categories given for that question’ 
Nicotine dependence assessment 
scale(Fagerström) 
(consists of 6 questions;  in patient 
questionnaire) 
0 = not implemented  
Consider not implemented if the 
provider ‘skips the scale’ 
1= partially implemented 
Consider partially implemented if 
the provider ‘asks less than 6 
questions on the scale ’ 
2= fully implemented 
Consider fully implemented if the 
provider ‘asks all 6 questions’ 
6.8.4 Content Validation 
Out of the three experts, at least two rated all items as ‘very important’ or ‘somewhat important’ 
on the rating scale (see Appendix C.2). None of the experts rated any item as ‘not at all 
important’. Therefore, none of the items were excluded from the fidelity index. The Delphi 
procedure was, therefore, restricted to a single round, due to convergence among experts.  
6.8.5 Content pilot 
The piloting of the index revealed that some of the behavioural anchors used for defining the 
response options were not mutually exclusive. They required a clearer discrimination between 
‘not implemented’ and ‘partially implemented’. I also found that the ordering of items was not 
sequential for the coders to follow easily while rating audiotapes. Therefore, I made the following 
changes to the fidelity index in response to the content pilot: 
i. For “attempted quit in the past” (item 13); if the patient did not attempt, it was 
decided to code it as 2 (i.e. fully implemented); similarly for “factors that led back to 
smoking’ (item 14) a score of 2 was to be assigned, in case of no attempted quit in the 
past, because there was not any “not applicable” category in the response scale. 
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ii. For triggers and their management (items 21 to 28); again if the patient reported not 
having a trigger and the provider skipped the management for that specific trigger, 
it was decided to give that item a score of 2 (fully implemented). 
iii. In the “information gathering and assessment” (item 1), there were three main 
questions (1. Pattern of smoking behaviour: types of smoking, smokers in vicinity, 
children at home; 2. Age when started smoking; and 3. Amount smoked). It was 
decided that in instances where none of the three main questions were asked, a 0 
score would be given (i.e. not implemented). Previously this was not factored in the 
response options for this item that a provider might skip these questions altogether. 
iv. A part of this question (item 1) required verbalising or probing for different types of 
tobacco used by the patient. In an instance when the provider did not ask about the 
forms of tobacco use to elicit proper patient response (or rushed through the 
question), then it was decided to code these as 1 (i.e. partially implemented). 
v. Item 7 (“effects on pregnancy”) was not applicable in males; therefore the 
clarification was added to mention this in comments if this slide of the flip-chart was 
skipped by the provider. 
vi. Initially, the fidelity index was created in a Word document (Microsoft office 2010). 
Pilot coding revealed that it was not only difficult to sum all scores obtained on the 
response scales for each item in order to record composite index scores, but the 
method was also prone to errors in calculation. Therefore, it was decided to convert 
the fidelity index to an Excel spreadsheet (Microsoft office 2010) with built-in 
formulas for summing composite scores, both for Adherence and for Quality. 
vii. The ordering of the items in the index was changed to match the sequence in which 
the providers used the assessment questions and the flip-chart slides. 
The fidelity index that was developed and refined after content validation and field piloting is 
given in the Appendix C.3. 
6.9 DISCUSSION 
6.9.1 Summary of findings 
Extensive search of the literature for fidelity measurement of BIs showed that it was not possible 
to adapt pre-existing indices. These were designed either for training purposes or for assessing 
behaviour change strategies that differed from the ones being evaluated. Therefore, a new fidelity 
index was developed based on the BI from the ASSIST study.  
Critical components technique was used to select key intervention features and theoretically 
informed taxonomies were used to map these features. The mapped ingredients formed the core 
items of the index and thus represented the ‘intended practice’. Some of the items related to BI 
content representing Adherence (37 items), and others to the Quality of interaction (8 items). 
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These formed the compositional features of the fidelity index that could be adapted to patient 
needs, as discussed in Chapter 4.  
Each item in the index was designed for rating on a 3 point ordinal scale as fully, partially, or 
not, implemented. The response scale was behaviourally anchored based on provider interaction 
style and thus represented the ‘actual practice’. These form the functional features of the fidelity 
index that might be used for standardising the process of delivery of BIs, as discussed in Chapter 
4.  
Modified Delphi procedure indicated a strong agreement on item inclusion in the index by 
experts; therefore none of the items were dropped. Content pilot by coders after collecting data 
on patient-provider BI sessions resulted in re-phrasing and re-defining some of the behavioural 
anchors, leading to a refined fidelity index (Appendix C.3). 
6.9.2 Structure of the index  
The way in which individual items and the two sub-indices were designed to capture fidelity is 
discussed in this sub-section. 
Two aspects of fidelity: the adherence to content and the quality of interaction are used in the 
thesis. However, the question arises whether these should represent a single linear additive index 
or two sub-indices. Fidelity data from other studies (Borrelli, 2011, Miller and Binder, 2002, 
Perepletchikova and Kazdin, 2005) show that both adherence to content and competence to 
deliver an intervention need to be assessed, as there are low correlations between the two 
behaviours. Therefore, these might represent slightly different constructs of behaviour change 
and need to be created as distinct sets of criteria representing each aspect of fidelity. The two 
concepts are discrete for complex behavioural phenomenon; the competence to deliver a BI (e.g., 
empathy and communication style etc.) is distinct from provider adherence to its content, and 
both are likely to influence outcome measures (Borrelli, 2011). Having said that, both adherence 
and quality, albeit having unique features, are still conceptually similar (Carroll et al., 2007, 
Lorencatto et al., 2013a) and are often considered together in fidelity measures (Weisman et al., 
2002).  
A thorough account of intervention fidelity could involve multiple measures, even when only a 
single intervention is delivered once and described by only one change model, because most 
complex interventions have multiple key features (Nelson et al., 2012). Multiple measures or 
constructs within an index allow the flexibility of conducting different types of analyses; the 
overall fidelity scores could be associated with the outcomes to see how much they co-vary, or 
the outcomes could be associated with the measured constructs (of adherence or quality) to 
determine the proportion of variance explained by each (Nelson et al., 2012). Hence, to obtain full 
descriptions of intended activities of a BI as delivered, it is necessary to consolidate both 
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adherence and quality aspects of fidelity (Lorencatto et al., 2013c), that could be considered 
separately or combined for an overall fidelity score (Nelson et al., 2012).  
It is possible that some complex BCTs in the Adherence sub-index, such as ‘barrier identification 
and problem solving’ take longer to deliver than BCTs such as ‘providing reassurance’ in the 
Quality sub-index (Lorencatto et al., 2013a). Although weighting to account for the time taken to 
deliver each ingredient (or item) was not designed in the index, using the two sub-indices 
separately and in combination might allow for overall comparison between Adherence and 
Quality aspects. However, the relative weighting of each item in the index needs to be 
determined in future work.  
6.9.3 Validation of the index 
The methods used for content validation of the fidelity index are discussed in this sub-section. 
In this study, the modified Delphi technique differed from the standard technique due to the 
approach taken to administer the procedure (i.e. individual (independent opinion) versus group 
approach (face-to-face consultation)). Independent opinions of the experts were obtained via 
email, without carrying out any face-to-face consultations for discussion and disagreement. The 
generation of ideas individually eliminates the potential of ‘group thinking’ and minimises the 
introduction of bias in the process of item selection (Bond et al., 2000b). However, this could have 
limited the qualitative understanding of the items and the corresponding response scale by the 
experts, forcing them to choose numbers without open discussion. Delphi was originally devised 
to handle opinions rather than objective facts (Bond et al., 2000b). I believe that the modified 
Delphi was appropriate for this study because the items were well described using the 
taxonomies, making the rating exercise particularly objective.  
The Delphi procedure was restricted to a single round of consensus as there was rapid 
convergence between the experts on ratings of the index items. This might result because of the 
BI features being well mapped to the BCTs, leading to eliciting similar responses from the 
experts. Often content ratings of well-established theoretical models lead to experts rating the 
majority of items as “very important” (Bond et al., 2000b, Holter et al., 2004), resulting in 100% 
convergence in the first round, rendering a second round of ratings redundant (Mowbray et al., 
2003). Forced rating methods or rank ordering of items might present a solution to experts 
rating items similarly (Mowbray et al., 2003). However, these methods are most suited to studies 
where the requisite for designing an index is reduction of items. The focus of my research was 
not reduction of items, and therefore an all-inclusive approach for the items was taken at this 
stage of development of the fidelity index. 
The early convergence of expert consensus could also be due to the small group of experts who 
might be very similar in their approach, not generating enough variation in their ratings. 
Behavioural change taxonomies are a rapidly evolving but relatively new science, which is 
Chapter 6- Development of Fidelity Index
99 
 
extensively used within the UK but in early stages in other parts of the world. In this study, the 
three experts were similar in some respects, such as, being from the UK and being well-
acquainted with the taxonomies of BCTs and the strategies of behaviour change used in the 
ASSIST study, which were very similar to the cessation services in the UK. One expert was a 
behavioural scientist, another was a smoking cessation expert involved in regional cessation 
services and the third was a cessation advisor. A relatively small sample comprising three or four 
experts is often considered sufficient when using confirmatory approaches to item generation 
(Bond et al., 2000b). However, convergence might have varied if I had consulted a broader range 
of experts with different backgrounds, necessitating more than one round of Delphi procedure.  
6.9.4 Limitations and challenges 
A limitation of the study, as hinted in the previous point, was conducting the modified Delphi 
procedure with three experts. This was partly because there were only a small number of people 
who were experts in both behaviour change and smoking cessation and who were familiar with 
the behaviour change model used in the ASSIST study. Although the experts were three in 
number, they were diverse in their expertise by having experience in designing BIs for smoking 
cessation or delivering them in practice. One of the experts, in addition to being a behavioural 
scientist, was also experienced in scale development science.  
The major challenge encountered in Study A was conducting the patient-provider BI sessions at 
the TB clinic. The content pilot was planned to be conducted on at least five patient-provider 
interaction sessions of BI. However, conducting (30 to 50 minutes) long sessions in the busy 
outpatient department of the hospital incurred several challenges. Firstly, the provider did not 
have enough time to deliver the BI to the patients, due to the overwhelming number of patients 
attending the clinic. Similar findings have been reported from other smoking cessation studies in 
TB settings (Sereno et al., 2012). Secondly, the patients were also pushed for time, as they had 
been waiting for hours and were not willing to stay longer after check-up. Finally, there was the 
unavailability of a separate space to carry out observations of the BI sessions. The TB clinic was 
a single room where both the TB doctor and the paramedic sat, with some patients waiting inside 
and some queuing just outside the room. Due to these challenges, only two BI sessions were 
successfully conducted.  
The broader research and practice implications of the developed fidelity index are discussed in 
the final chapter (Chapter 9) of the thesis. 
6.10 CONCLUSION 
There were not any existing indices that could be adapted for fidelity measurement of a BI of 
smoking cessation. Therefore, a new index to quantify the adherence and quality aspects of 
fidelity was devised, using a comprehensive methodology. The items of the developed fidelity 
index were composed of the key features of a BI (used in ASSIST study) for smoking cessation 
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that was mapped to behaviour change theory, giving the index its necessary structure. The 
response scales of the items were behaviourally anchored to the interaction style of the providers 
who delivered the BI, representing the functional feature of the index. This anchored response 
scale provides the discrimination between ‘intended practice’ and the ‘actual practice’ of a 
provider concerning delivery of a BI. Thus, the definitions assigned to the behavioural anchors 
were crucial to determine how precisely the scale would measure the construct of fidelity for each 
item.    
The fidelity index was refined at this stage (end of study A), further to generation of items and 
response scale, by content validation and pilot in field. It was then ready for further validation for 
its psychometric properties, in study B.  
 
  
 
Chapter 7. Study B: Psychometric properties of the Fidelity Index 
This chapter describes the second study in a series of three linked studies. In the previous chapter, I described 
the methods used to develop a fidelity index (study A). The output was a theory-linked new measure of 
fidelity for BIs. The study presented here (study B) investigates how reliable the new fidelity index is, by 
assessing its psychometric properties. 
In the previous chapter, I described the methods used to develop an index for measuring fidelity 
to BIs of smoking cessation (study A). The fidelity index was constructed using sound 
methodology, content validated and piloted in the field. In this chapter I report study B, which 
comprised of a primary investigation, from which the data were used for two purposes: 1) for the 
psychometric validation of the fidelity index and 2) for exploring any association between 
intervention fidelity and quit rates (in study C).  
This chapter first provides the background literature on methods used for psychometric 
evaluation of an index to inform the study methodology, and then gives an outline of the study 
design, settings and methods used for the primary investigation and the statistical analyses. 
Finally, it presents the results of the psychometric validation of the fidelity index.  
7.1 METHODS FOR PSYCHOMETRIC VALIDATION OF AN INDEX 
Here I describe the methods used for carrying out a psychometric validation of an index. These 
methods informed the psychometric evaluation of the new fidelity index and the methodological 
approach suited to this purpose.  
7.1.1 Potential methods of observation for fidelity measurement 
Fidelity is a process measure and an intermediary outcome, the measurement of which requires 
multiple steps (to generate data and coding) before it is ready for use. Structured observations, 
self-record questionnaires and secondary extraction of routine data are some of the quantitative 
methods recommended for obtaining data on process variables (Moore et al., 2015).  The pros 
and cons of these methods are briefly discussed here. 
Structured observations 
In process evaluation, structured observation means monitoring intervention delivery (Eames et 
al., 2008) on the extent to which its ingredients are delivered, using a structured coding checklist 
(Moore et al., 2015). Observation methods are potentially useful for assessing variability in 
intervention delivery practices, providing accurate and objective accounts of the intervention 
implementation process (Moore et al., 2015). Two types of structured observation methods are 
described here that can be potentially used for collecting fidelity data: 
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Direct observation 
Direct observation methods are potentially highly objective for measuring the extent to which 
interventions are delivered as specified (Moore et al., 2015). These include on-site observations 
or recordings (audio/video) of the interaction sessions.  
Direct observations are more intrusive and can introduce a ‘Hawthorne’ effect, that is, if the 
provider knows that they are being watched, it can inevitably lead to a change in their target 
behaviour from the norm (Moore et al., 2015). Moreover, presence of an observer may adversely 
affect the patient-provider rapport building in the individual face-to-face intervention sessions. In 
such instances, examining audio or video recordings of the consultation sessions is advisable, as 
this might be less obtrusive. An added advantage of this type of observation is that the session 
recording could be rated by multiple observers (Moore et al., 2015), which makes it a preferred 
method for psychometric testing. Some disadvantages of the recording methods include their 
being labour intensive, requiring comprehensive training of the coders using these observations 
and generating a lot of data (Bond et al., 2000b).  
Indirect observation 
Other methods of monitoring intervention fidelity include interviews and record reviews (Bond et 
al., 2000b), such as provider self-record checklists (e.g. intervention content checklists, encounter 
logs). These methods of observation are expected to be less reliable than direct observation 
methods and have low correlations with objective measures (Carroll et al., 2000), but 
nevertheless they have been used in evaluative research to supplement objective data (Borrelli, 
2011).  
Provider self-record checklists often serve the purpose of a reminder for delivering the intended 
content of the intervention and for standardising practices (Bond et al., 2000b). Data from these 
checklists might be used to supplement direct methods of observation for fidelity measurement 
and for triangulation during analysis. However, direct methods are preferred in process 
evaluations, as indirect methods have shown low agreement, when used in conjunction  with each 
other (Bond et al., 2000b). Indirect methods are judged to be more useful in practice than in 
research, where the purpose of fidelity monitoring is to achieve a certain basic level of adherence 
to the intervention protocol (Bond et al., 2000b).  
Patient self-record questionnaire 
Patient self-record questionnaires (e.g. patient exit interviews) play a significant role in formative 
process evaluation, which precedes the effectiveness evaluation stage of an intervention. 
However, the structured observations appear to better capture patient-provider interaction and 
details on practice norms, which are more useful in interpretive process evaluation (Bond et al., 
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2000b). These concepts of formative and interpretive process evaluation have been discussed 
previously, in chapter 1 (1.5.2, page 26).  
Self-record questionnaires are inexpensive and have a potentially quick turn-around. However,  
these could have variable completion rates or respondents may misunderstand questions or 
might complete them hurriedly (Bond et al., 2000b). The use of patient self-record questionnaires 
in fidelity assessment often relate to non-intervention-specific process issues, such as patient 
perceptions of being listened to, (versus being rushed while receiving the intervention) and their 
satisfaction with the interaction session (Bond et al., 2000b), which are not the focus of the 
current study. In measuring fidelity using an index, this method could be subject to bias, as the 
respective patients may not provide a poor rating of their provider or they may not have 
sufficient knowledge and understanding of the techniques used or the response scale options for 
rating items (Bond et al., 2000b).  
Secondary extraction of routine data 
Data acquisition from routine practice can be useful for post-implementation monitoring and 
standardising provider practice. Record reviews generate potentially objective data, which are 
simpler to compile than structured observation methods. Potential pitfalls of data extraction from 
secondary sources include; data not being complete, data may not be accurate or up-to-date, data 
may not fit the research goals of the evaluator and data may be difficult to access, due to patient 
and provider confidentiality (Bond et al., 2000b). Although monitoring of intervention delivery 
using the fidelity index can be implemented post-evaluation during its scale-up, the data acquired 
might not be suitable for psychometric testing of the index (Bond et al., 2000b).  
7.1.2 Coding and rating of fidelity data 
Attention to the selection, training, and monitoring of coders for rating data using a fidelity 
measure is important (Schoenwald et al., 2011). Coding using a fidelity index for a BI can be 
complex, as it involves not only the ability to judge and score based on the functional features but 
also a generic understanding of the BCTs to be able to understand its compositional features.  
The researchers involved in a fidelity study can act as the coders themselves, or the coders can be 
selected from a pool of candidates independent of the study (Bond et al., 2000b). Nevertheless, 
independent coders are expected to provide less biased scorings of fidelity as they are less likely 
to be invested in obtaining findings consistent with the preconceived notions about intervention 
fidelity (Bond et al., 2000b). Still, there might be individual differences in the way the 
independent coders assign scores, such that apparent changes in fidelity scores might actually 
occur as a consequence of differences between the coders, rather than the provider fidelity 
(Schoenwald et al., 2011). Therefore, when selecting coders, it is important to consider their 
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skills regarding objectivity and critical thinking, in addition to their understanding of the topic 
under study (Bond et al., 2000b).   
Apart from the consideration of their characteristics, skills and understanding of the topic of 
study, coders must also receive comprehensive training on general coding procedures and on 
specific features of the fidelity index (Fowler, 1995). Other issues that need to be considered in 
training of coders include confidentiality and anonymity of data being coded. Amateur coders 
may be reliably trained to code the content of intervention manuals and session transcripts, using 
the taxonomies of BCTs, after receiving adequate training (Lorencatto et al., 2013b). However, in 
evaluations aimed at uniformity of providers’ practice across multiple sites, additional, more 
formal coding is usually required (Borrelli, 2011).  
A further consideration when coding fidelity data is to keep a log of important decisions made to 
reach consensus and to document convergence among coders (Black et al., 1999).  
7.1.3 Psychometric tests for index validation 
One of the two important factors to consider for psychometric evaluation of an index is the 
application of adequate tests depending on its stage of development. The key psychometric 
property of interest, at this stage of formation of the newly developed fidelity index, is its 
reliability. It is necessary to gather evidence that the index is measuring fidelity in a reproducible 
and replicable manner, before investigating whether it can measure the association of fidelity 
with quit rates, that is, its predictive validity (Streiner and Norman, 2008). These two stages are 
sequential in the validation of the fidelity index in terms of its properties, that is, whether it is 
reliably measuring fidelity or its structure needs further improvement before the scores obtained 
on fidelity could be linked to an outcome (quit rate) to assess if the index has predictive qualities. 
The second factor, which is connected to the reliability testing, is the appropriate sample size for 
carrying out the desired statistical analyses. 
Reliability testing 
Reliability testing provides evidence of the value of an index, by demonstrating whether the 
measurements of individuals at different instances, or by different coders, or by similar tests, 
produce the same results (Streiner and Norman, 2008). Reliability refers to the consistency of 
responses for a particular item in the index. It is the ratio of the variability between individuals to 
the total variability in the scores. In other words, it is the measure of the proportion of the 
variability in scores, which is due to the true differences between individuals or the same 
individuals at different time points. Reliability is expressed as a number between 0 and 1, with 0 
indicating no reliability, and 1 indicating perfect reliability (Streiner and Norman, 2008). Various 
authors have made different recommendations for the minimally acceptable level of reliability; 
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internal consistency measures are expected to exceed 0.8 and it might be reasonable to demand 
stability measures greater than 0.5 (Streiner and Norman, 2008). 
For examining the reliability of fidelity indices, a few terms and concepts are broadly defined, to 
understand the statistical considerations (presented in 7.3.10, under Analysis), as follows: 
Stability  
There are various ways of examining the replicability of a measure. For example; measurement of 
the degree of agreement between different coders (inter-coder reliability), the agreement between 
observations made by the same coder on two different occasions (intra-coder reliability) or 
observation on the patient on two occasions separated by some interval of time (test-retest 
reliability), and so forth (Streiner and Norman, 2008). If the focus of psychometric assessment for 
a particular measure, for example, is to see whether the measure can be reliably rated by different 
coders without their individual influence on its measurement ability, then only inter-coder 
reliability can be tested; otherwise if the focus varies, then one or all of these tests can be used to 
establish its stability and replicability for future use. 
The assessment of inter-coder reliability (also called inter-rater agreement) provides a way of 
quantifying the degree of agreement or disagreement between two or more coders, who make 
independent ratings about the characteristics of a set of subjects. This type of analysis utilises the 
classical test theory (described on page 108) and aims to determine how much of the variance in 
the observed scores is due to the variance in the true scores, after the variance due to 
measurement error between coders has been removed (Novick, 1966), such that 
Reliability (r) = 
𝜎𝑇 
2
𝜎𝑇 
2 +𝜎𝐸 
2  
Where 𝜎𝑇 
2  (sigma-squared T) is the variance of the true score and 𝜎𝐸 
2 is the measurement error.  
A number of statistical tests can be used to determine inter-coder reliability, depending on the 
types of measurement. These include percent agreement, inter-coder correlations (α-alpha and 
ICC- defined on page 44), Scott’s pi (π), Cohen’s kappa (κ), Fleiss’ kappa (K) and Krippendorf’s 
alpha (α). Krippendorff alpha has a number of benefits over percentage agreement and Kappa 
statistics methods that are popularly used for inter-coder reliability testing. This test can be used 
for any number of coders (and not just two) and for different kinds of variables (nominal, ordinal, 
interval, ratio, and more), unlike other inter-coder agreement tests. Unlike Kappa, it can be used 
for large or small sample sizes and has no minimum sample size requirements. Furthermore, it 
can be used for incomplete or missing data, as it uses a system of bootstrapping, where missing 
values are replaced with existing values samples from within the data set.  
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Reproducibility or coherence of items  
If the index has a relatively large number of items addressing the same underlying concept, then 
it is reasonable to expect that scores on each item would be correlated with scores on all other 
items, or there will be coherence between items of the index. Estimates of internal consistency 
(e.g. Cronbach alpha) represent the average of the correlations among all the items in a measure. 
However, these estimates do not take into account any day-to-day or between-coders variation, 
and thus, are likely to lead to an optimistic interpretation of the true reliability of the test 
(Streiner and Norman, 2008).  
Principal Components Analysis (PCA), is a statistical procedure that transforms a set of 
observations of possibly correlated variables into a set of values of linearly uncorrelated variables 
called principal components (Streiner and Norman, 2008). The number of principal components 
is less than or equal to the number of original variables. This transformation is defined in such a 
way that the first principal component has the largest possible variance (that is, accounts for as 
much of the variability in the data as possible), and each succeeding component in turn has the 
highest variance possible to the preceding components (described further in 7.3.10, page 121). 
PCA when conducted on items within every coder, could help identify those items that load 
together reliably across all coders, taking into account the between-coders variation, unlike 
estimates of internal consistency.  
Below is the general form of the formula to compute scores on the first component extracted in a 
PCA (Larry and Edward, 1999): 
C1 = 𝑏11(𝑋1) +  𝑏12(𝑋2) + ⋯ 𝑏1𝑝(𝑋𝑝) 
Where; 
C1 is the subject’s score on principal component 1 (the first component extracted) 
b11 …. b1p = the regression coefficient (or weight) for observed variables 11 to 1p, as used in 
creating the principal component 1 
X1….. Xp = the subject’s score on observed variables 1to p 
In the above example I presented two components, which is only hypothetical for description 
purposes. In reality, the ‘number of components extracted’ in a PCA is equal to the number of 
observed variables being analysed. In most analyses, only the first few components account for 
meaningful amounts of variance, so only these are retained and interpreted.  
Reliability in differentiating between providers based on their fidelity 
In addition to defining important terms for reliability testing, there are two theories for 
examining reliability of the measure, in terms of its ability to differentiate between various 
dimensions of the construct (fidelity) under study. In the current study, the dimension of interest 
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is the provider practice and it is important to understand which theory best fits the purpose of 
differentiating between provider practice. The two theories are briefly described here: 
 
‘Classical Test Theory’ 
In classical test theory, the observed score (X) from the measure is thought to be composed of a 
true score (T) that represents the subject’s score, obtained, assuming no measurement error, and 
an error component (E) that is due to measurement error (also called noise) (Lord, 1959, Novick, 
1966) , such that: 
Observed Score (X) = True Score (T) + Measurement Error (E) 
Measurement error (E) prevents one from being able to observe a subject’s true score directly, 
and may be introduced by several factors. For example, measurement error may be introduced 
by; imprecision, inaccuracy, or poor scaling of the items within an index (i.e., issues of internal 
consistency); instability of the index in measuring the same subject over time (i.e., issues of test-
retest reliability); and instability of the index when measurements are made between coders (i.e., 
issues of inter-coder reliability) (Streiner and Norman, 2008).  
Reliability coefficients (e.g. internal consistency and inter-coder reliability) in classical test theory 
tend to overestimate the replicable (true source of error) and underestimate the error variance in 
a set of scores. This is particularly a problem for measures in which the coders (e.g. trained 
observers) provide scores for participants based on observation of complex interactions such as 
those involving behaviour. With these coefficients, it is only possible to examine a single source 
of measurement error at a given time. Besides, it does not permit studying the interaction effects 
that occur among these different sources of error (Preuss, 2013).  
 
‘Generalizability Theory’ 
The other type of theory for testing index reliability for differentiating between various 
dimensions of fidelity is the ‘Generalizability theory’, which is often used to test reliability of a 
measure to enhance precision of its measurement. With coder-rated measures of observations, 
multiple sources of error variance (e.g. coders, items) can affect the replicability of the respective 
measures (Lakes and Hoyt, 2009).  
In contrast to the classical test theory, generalizability theory is more flexible and accurate in 
quantifying the extent to which the observed scores reflect error of measurement, rather than the 
characteristics of the individuals under study (Lakes and Hoyt, 2009). One of the principle 
advantages of using generalizability theory is that it simultaneously considers multiple sources of 
measurement error variance and provides separate variance estimates for each facet (or source of 
variation) not otherwise attributed to the object of measurement.  
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In generalizability theory the ‘true score’ is equal to the ‘universe score’- the hypothetical mean 
of all acceptable (i.e. interchangeable) observations. G-study is based on generalizability theory 
and computes the individual variance components, by incorporating all the plausible sources of 
error into a single analysis of variance. An important goal of measurement by G-study is to 
attempt to identify, measure, and thereby find strategies to reduce the influence of these 
(identified) sources on the measurement in question (Streiner and Norman, 2008). The G-study 
involves three sequential steps: 
i. Identification of important facets (sources) 
ii. Variance partitioning 
iii. Computation of coefficient of generalizability (g) 
In a G-study, error is equated with variance in observed scores that is attributable to the facets 
(e.g. the items, coders or measurement occasions) or sources of variance that are irrelevant to the 
dimensions of interest, as well as to unexplained variations in responding (i.e. the random error) 
(Lakes and Hoyt, 2009). The undifferentiated error term in classical test theory is partitioned in 
the G-study into components attributable to the main effect of each source, as well as interactions 
between the sources, and between sources and the object of measurement (which is the 
audiotapes nested in the providers). Finally, the g coefficient is computed using the variances 
obtained from variance partitioning analysis that represents the ratio of variance attributable to 
universe scores to the total observed score variance (i.e. universe variance plus variance 
attributable to all sources of error that contribute to variance in observed scores).  
 
Often, psychometric testing of an index would involve a mix of methods applying classical test 
theory and generalisability theory. Both have their advantages, depending on the research 
question and the psychometric property of interest for a given index. Therefore, for evaluating 
the functioning of the items in the fidelity index, I would summarise the quality of the overall 
index (composite fidelity scores) using descriptive statistics and the G-study. For assessing the 
quality of the individual items, I would use three different sources of information: item 
descriptive statistics for variance or ceiling or floor effects (defined in the Methods section), 
Krippendorff alpha to identify those items that were most easily agreed upon by all coders and 
the PCA to identify those items that load together reliably across all coders. 
Sample size considerations 
Determining the minimum number of data-points necessary for conducting an appropriate 
analysis is the first consideration in psychometric testing of a measure. If the intent is to conduct 
PCA to assess internal consistency, some authorities recommend a minimum sample of at least 
150 or 200 (Hinkin, 1995). However, many other psychometric studies of fidelity measures have 
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used samples in the range of 18-32 (Bond et al., 1997a, Bond et al., 2000a, Lucca, 2000) or fewer 
(Teague et al., 1995).  
Two factors considered important in determining the sample size for PCA are the total number 
(N) of participants and the ratio of participants to items (Osborne and Costello, 2004). There is a 
widely-cited rule of thumb that the participant to item ratio for such an analysis should be at 
least 10:1, but this recommendation is not supported by published research (Nunnally, 1978). A 
study suggested that a sample size between 50 and 100 was adequate for PCA to evaluate 
psychometric properties of measures of social constructs (Sapnas and Zeller, 2002). However, this 
study has been criticised for failing to explain the conditions in which it might be feasible to use a 
small sample size (de Winter et al., 2009). In a more recent work, it was concluded that a sample 
size between 10 and 50 was sufficient for two dimensions (e.g. Adherence and Quality) and 20 
items (Zeller and Martsolf, 2002). In psychometric analysis, the recommendations on absolute N 
and the N by item ratio have gradually been abandoned as misconceived (de Winter et al., 2009). 
In summary, the larger the sample, the more stable will be the statistical estimates of reliability. 
Caution should be taken when making extreme modifications in index or drawing strong con-
clusions in the instances where the study sample is small. 
7.2 AIMS OF STUDY 
“To validate the fidelity index by assessing its psychometric properties” (described above in 5.2). 
The specific objectives of study B are to: 
 Test the feasibility of use in primary research  
 Determine its replicability for use by people with diverse backgrounds, to inform its 
stability as a research tool 
 Determine the coherence of items in the index, to refine its structure and inform its 
reproducibility in future research  
 Investigate the underlying dimensions of the fidelity construct within a behaviour 
change framework that the index can capture, to inform its utility in explaining 
variations in smoking cessation outcomes 
7.3 METHODS  
7.3.1 Design 
The fidelity study was a cross-sectional design used to objectively measure intervention fidelity 
for a BI. 
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7.3.2 Study sample  
The fact that I wanted to use the fidelity scores (in study C) and same methods to ensure I could 
link back to the same providers and settings used in the ASSIST study, had some implications for 
the fidelity study settings:  
 Recruiting all those TB clinics that took part in the ASSIST study to enable exploration 
of the association between fidelity and quit rates. 
 Recruiting same providers (TB DOTS paramedics) who delivered BI in the ASSIST 
study, as this might ensure some consistency in the delivery of the BI.  
Therefore, feasibility of recruiting the same TB clinics and providers that were originally 
involved in the ASSIST study was assessed, by conducting an initial scoping exercise to ensure: 
 Whether all of the originally involved TB clinics continued to deliver the BI in routine 
practice after termination of the ASSIST study and if not, what should be the strategy to 
re-introduce BI for smoking cessation for the fidelity study 
 Identification of the same providers as were involved in the ASSIST study. A single TB 
DOTS paramedic is appointed at each TB clinic by the NTP in Pakistan. 
 Hiring the same research officers who were previously involved in the execution of the 
ASSIST study 
 Feasibility of using study equipment (described below) in TB clinics, as this was not 
previously tested in ASSIST study 
The findings of the scoping exercise are presented in results section.  
7.3.3 Setting and participants 
The 22 TB clinics, in intervention conditions, originally involved in the ASSIST study were 
approached for participation in the fidelity study. These were located in two districts (Jhang and 
Sargodha) of the Punjab province of Pakistan (Figure 7.1).  
Five out of the 22 TB clinics were secondary-care hospitals (called ‘Tehsil Headquarter 
hospitals’) while the rest were all PHCs (called ‘Rural Health Centres’). 
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Figure 7.1: TB clinics included in the ASSIST study 
Site (and provider) inclusion criteria 
All TB clinics (originally in the intervention conditions of the ASSIST study) were eligible to 
participate in the study on invitation. TB clinics that were involved in the control condition in 
the ASSIST study were excluded. Only those TB clinics, out of the 22, were included where the 
providers were willing to take part in the fidelity study.  
Patient inclusion criteria 
Consenting patients aged 18 years or older with suspected pulmonary TB (cough for > 2 weeks 
without any other cause) or newly diagnosed with TB who were also regular tobacco smokers 
(>1 cigarette or hookah session/day) attending TB clinics included in the study, were enrolled. 
Patients requiring hospitalization or urgent medical attention were excluded.  
Patient identification and recruitment 
TB patients who smoked were identified, per ASSIST study protocol, by the TB physicians (one 
per TB clinic) and referred to the providers, who were responsible for recruiting eligible and 
informed consenting patients in the study. 
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Consent procedures 
Voluntary informed consent was obtained from the patients for participation in the study by the 
providers, after giving them appropriate written and verbal information about the proposed 
study. (Providers’ consent was obtained by the research officers).  
An ink signature or a thumb impression, which is officially acceptable in Pakistan for those who 
cannot write, was obtained from those interested (patients), by going through a checklist on the 
consent form. The option was also given to consider the information for a week before agreeing 
to participate in the study.  
All information sheets and consent forms were translated into the local language of 
communication (i.e. Urdu) for administration. These are supplied as Appendices (Appendix D.1 
and Appendix D.2). 
Further details on informed consent are provided in section 7.3.11, page 123. 
7.3.4 Intervention 
The BI used in this study was the same as ASSIST study, described above in Chapter 6 and also 
in the Appendix B. The TB DOTS paramedics delivered the BI for smoking cessation to the TB 
patients, therefore, they are referred to as ‘providers’ of the BI throughout this thesis. 
7.3.5 Data variables 
Two-sets of data were obtained from the fidelity study: the flip-chart counselling for BI and the 
patient assessment questionnaire. These data were used to code the fidelity index. In addition, the 
questionnaire also produced data on provider self-record checklists. There was some overlap in 
sources of data used in studies B and C, so to make this easier to follow, I describe the main types 
of data and its sources collected in the fidelity study in Figure 7.2. 
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Figure 7.2: Sources of data collection in the fidelity study 
7.3.6 Data collection 
The data collection and coordination for this study was carried out through a local Non-
Governmental partner located in Islamabad that had established linkages with the Department of 
Health in the two districts and the National TB control programme.  
Audiotaping of the patient-provider BI interaction (included both the administration of 
assessment questionnaire and the flip-chart counselling) was undertaken by the providers, using 
a discrete device (see ‘study equipment’ below) during a four month period of data collection. A 
BI session in general was expected to last 30 to 40 minutes. 
7.3.7 Tools used for data collection 
Patient assessment questionnaire 
The patient assessment questionnaire (Appendix D.3) was translated into the local language of 
communication (i.e. Urdu). It was administered by the providers to collect information on patient 
demographics, tobacco use behaviour, nicotine dependence, willingness to quit, past quit history, 
the agreed quit date, and filling in the self-record checklist (refer to Chapter 8, Table 8.1).  
Fidelity study 
Flip-chart counselling 
(page 78) 
Advise - to quit 
Assist- in making a quit 
attempt 
Arrange- follow up contact 
with the patient 
(Study B) 
 
Questionnaire (page 78) 
Ask – about tobacco use (Study B) 
Assess- willingness to make a quit attempt 
and nicotine dependency (Study B) 
Self-record checklist (Study C) 
- Identifying and managing the triggers 
to smoke  
- Assessing and managing the 
withdrawal symptoms  
Patient characteristics (Study C) 
 
Fidelity index (coded)  
Fidelity measurement  
– Individual item scores and 
composite scores  
(Study B & C) 
- Scores by three independent 
coders (Study B) 
- Scores by consensus coding 
(Study C) 
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Study equipment 
Digital recorders for audiotaping BI sessions were given to the providers, who were trained on 
their proper use. The digital recorder selected for use in this study was the Zoom H2n handy 
recorder, which had the following features: 
 Five built-in microphones and four recording modes  
 The technology used covers a wide area while still capturing sound sources in the centre 
with clarity and definition, making it perfect for all types of live stereo recording   
 The H2n's built-in microphone provides two matched unidirectional microphones set at a 
90 degree angle relative to one another, optimum for most stereo recording applications  
 The H2n requires only 2 AA batteries, either alkaline or rechargeable NiMH. Battery life 
when using alkaline batteries is more than 20 hours, even during continuous recording. 
Alternatively, an AC adapter can be used that allows powering the H2n from any 
standard wall socket. 
 The H2n records directly to SD cards. It supports standard SD and SDHC cards, up to 
32 gigabytes. 
 The H2n USB port provides a digital output of the stereo mix and allows data to be sent 
to and from the computer. 
The selection of zoom H2n handy recorder for this study was done after much thought about the 
local settings of the current study and comparing field notes (described in 7.4.1, page 125) with a 
similar study on recording of patient-provider counselling sessions in a hospital setting, in the 
UK.   
7.3.8 Personnel 
The research officers were the focal persons in each district for monitoring and supervising study 
activities. They approached the TB providers to participate in the fidelity study, were involved in 
their training on the BI flip-chart and the assessment questionnaire, and were responsible for the 
day-to-day data collection, storage and its transfer tasks.  
The TB DOTS paramedics (the BI providers) were auxiliary nurses who follow a physician’s 
clinical directions on TB treatment. They record patient progress in TB registers, monitor direct 
administration of TB medications, and ensure clinical follow-up of patients in the TB clinics. In 
the fidelity study, these providers also recorded data on the patient assessment questionnaire and 
set up the equipment for audiotaping BI sessions.  
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7.3.9 Procedures 
Training of the research officers 
Two research officers were hired (one of whom was previously involved in ASSIST study) and 
trained on the study procedures to carry out the required data collection, data keeping, 
monitoring of the providers and transferring of the data, whilst maintaining anonymity of 
participants.   
The research officers were trained on the BI (6.3, page 78) by the lead researcher, who then 
trained the providers in the two districts. The training adhered to the BI manual and procedures 
used in the ASSIST study to minimise any influence of factors that might have altered provider 
practice over time.  
The research officers were involved in the content piloting (described in Chapter 6) of the fidelity 
index (in Islamabad). During the pilot, they carried out the audiotaping of patient-provider 
interactions using digital recorders, and shifted data to encrypted drive for secure transfer to the 
central office. This process of field testing helped identify and remedy any procedural, logistical 
or programmatic issues, in addition to training of the research officers on study procedures. 
Training of providers 
Full-day training was conducted for all providers in each district, at the district health office, on 
December 26, 2013 in Jhang and March 29, 2014 in Sargodha (see ‘project plan’ below). A 
provider, who was unable to attend the refresher training in Jhang, was trained in the respective 
TB clinic by the research officer, before starting patient enrolment.   
All participating providers were given refresher training by the research officers on delivering 
the BI using the flip-chart and completing the assessment questionnaires with the participating 
patients, exactly as they would have done in the ASSIST study. The training was based on the 
practice manual developed as part of the ASSIST study for providing BI.  
In addition, providers received orientation about the ethical issues concerning data safety, patient 
confidentiality and anonymity of collected data. They also received training on proper usage of 
study equipment (see page 114).   
Selection and training of coders 
Coders (three in number) were selected after interviewing from a pool of eligible candidates, who 
were bilingual (English and Urdu), obtained a Master’s degree in their respective field of study 
and preferably able to comprehend Punjabi (the local language at study sites). One coder was a 
doctor and a public health practitioner, the second was a social anthropologist with no prior 
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experience of health related research and the third was a doctor and an epidemiologist (the lead 
researcher of the current study).  
Full-day training was provided to the coders, by the lead researcher, using a BI coding manual 
(Lorencatto et al., 2013b). This manual is shown to effectively train inexperienced coders from 
multi-disciplinary professional backgrounds for reliably specifying intervention content, using 
the BCTs. The overall purpose of the fidelity index and each specific item within it, was also 
discussed in-depth with the coders during the training, along with practice exercises using two 
audiotapes recorded as part of the ‘content pilot’ (page 83) of the fidelity index in Study A: 
Development of the Fidelity Index. 
Process of coding fidelity data 
The audiotapes were played in a room where all three coders sat together, coding the BI sessions 
using the fidelity indices independently, but at the same time. The audiotapes of the BI sessions 
were in Punjabi and these were coded directly into English when scored using the fidelity index. 
The mean duration of each BI session delivered by each provider was also noted.  
For the consensus development process, if the coders disagreed on the rating of any item, this 
was logged and discrepancy resolved through discussion. At instances, this process involved 
clarity on the part of the case-definition or ‘behavioural anchoring’ (described in 6.7.3, page 87) 
underlying the response scale in discriminating scoring criteria of fidelity for BI ingredients. 
Each coder completed an independent fidelity index for each audiotape. A fourth fidelity index 
(consensus score) was also completed, containing scores after agreement by all coders for each 
item.  
Data entry  
The patient assessment questionnaire data was entered in a database created using SPSS 21 
software package. The same codebook as used originally in the ASSIST study was referred to for 
data entry. Data from the coded fidelity indices were also entered in an SPSS (version 21) 
database, for which a codebook was created to facilitate data entry. 
Data storage 
Audiotapes and the completed assessment questionnaires were transported by the research 
officers after completion at each TB clinic and secured in a locked cabinet in the district health 
office. Audiotapes were stored on encrypted USB drives by the research officers (using truecrypt, 
free encryption software). The completed set of audiotapes from each district was sent to the 
Islamabad office, via registered courier.  
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All data (in the raw form: hard copies and audiotapes) were stored using unique identifiers and 
not patient names, for e.g. Clinic (per provider) number, Recording (per patient) number. The list 
of TB clinic codes was only accessible by the lead researcher.  
Data stored in the encrypted drives and backed-up on the University of York computer is kept 
and analysed at the University of York. No other party would have access to the audiotapes or 
their content. The audiotapes are to be secured at the University of York for 5 years post-PhD 
study, to ensure availability of the data to answer any queries that arise from the thesis work and 
also the possibility of using it for post-doctoral opportunities. 
Project plan 
The project plan (Table 7.1) gives the timing of the various investigations and activities for the 
studies, A (Chapter 6), B (Chapter 7) and C (Chapter 8). 
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Table 7.1: Project plan 
Activities 2013 2014 2015 
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Develop project protocol                                
Ethics application to 1PMRC, Pakistan                                
Ethics application to 2HSRGC, York                                
Study A: Development of the Fidelity Index   X X X X X                         
Generating index items – page 84                                
Establishing response scale - page 87                                
Modified Delphi procedure- page 87                                
Content pilot- page 83                                
Study B: Psychometric properties of the Fidelity 
Index 
X X X X X X X X X X X X X X X X X X X X X X X         
Developing information sheets and consent forms- 
page 112 
                               
Feasibility of proposed work (incudes obtaining and 
testing study equipment)- 125 
                               
                                                     
1 Pakistan Medical Research Council 
2 Health Sciences Research Governance Committee 
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Hiring and training of Research Officers- page 112                                
Hiring and training of providers- page 112                                
Data collection (baseline)- page 113                                
Hiring and training of coders- page 115                                
Coding audiotapes- page 116                                
Data entry (fidelity index) & cleaning- page 116                                
Quit rates at 6-months (using 3CO monitor)               X X X X              
Statistical analysis (psychometric)- page 120                                
Study C: Explaining Variation in Quit                      X X X X X X X X X X X 
Data entry (questionnaire) & cleaning - page 116                                
Secondary data extraction (ASSIST study)- 156                                 
Data cleaning & merging datasets - page 158                                
Statistical analysis (explaining variation)- page 162                                
                                                     
3 Carbon Monoxide breath test monitor 
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7.3.10 Statistical considerations 
This section provides the sample size requirements for the reliability assessment of the fidelity 
index; these calculations were informal (considerations discussed in 7.1.3, page 108) and mainly 
derived from insights of expert psychometricians. Methods selected for the psychometric 
evaluation are also presented. 
Sample size 
It was anticipated that a total of at least 450 data-points would be collected, influenced by the 
number of TB clinics agreeing to participate in the study (as discussed above in 7.1.3, page 108). 
That is, if 15 TB clinics (out of the 22 approached agree to participate)* 10 audiotapes (TB 
patients enrolled) per TB clinic* 3 coders per audiotape (as proposed). 
On average, five to ten BI sessions (depending on the feasibility and practicality of audiotaping in 
these settings) were anticipated for recording at each TB clinic.  
Whilst in this study the sample size is driven by the participating TB clinics, it is still important 
to know if the sample was large enough to assess the stability and coherence of the fidelity index. 
Approximately 100 subjects were considered suitable for obtaining an estimate of coefficient α of 
0.7 with confidence interval of + 0.2 for an index with 45 items (Streiner and Norman, 2008). 
Similarly, assuming three coders rated the fidelity index on observed data, then approximately 
100 subjects would be required to obtain a sufficiently powered inter-coder reliability estimate of 
0.75 with standard error of + 0.05 (Streiner and Norman, 2008). 
Analysis 
Three types of reliability analyses were carried out for the fidelity index: inter-coder reliability, 
PCA and the G-study. PCA and inter-coder reliability were used to assess ‘individual item 
scores’, while the G-study was used for assessing the ‘composite index scores’. Descriptive 
statistics of the individual and composite scores were also calculated. All analyses were conducted 
using SAS (version 9.4, Cary, NC, USA); see Table 7.2, on page 123, for the SAS syntax of these 
tests. These methods are described below.  
Descriptive statistics for individual item and composite index scores 
A univariate analysis of the summary statistics for individual item scores and composite index 
scores (both for Adherence and Quality) was carried out for the three coder ratings, as well as for 
the fourth ‘consensus score’ (described in 7.3.4 on page 116). Mean, median and standard 
deviations were reported for the individual item scores.  
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Pearson’s correlation coefficients (Pearson’s r) were estimated for the two composite scores of the 
fidelity index (‘Adherence’ or A score and ‘Quality of interaction’ or Q score). Since there were 
only a few correlations and they were not independent, Pearson’s r was not conducted to draw 
inferences on the quality of composite scores but instead it was conducted to summarise these 
scores. Pearson’s r reflects the degree of linear relationship between two variables, and ranges 
from +1 to -1. For non-normally distributed scores, these need to be transformed before 
application of the test.  
Transformation of Pearson’s r for non-normally distributed scores: 
The formula for Fisher’s z’ transformation is z’= .5[ln (1+r) - ln (1-r)], where ln is the natural 
logarithm. Two relevantly important attributes of the z’ statistic are that it is normally 
distributed and it has a known standard error, which is used for computing the confidence 
intervals on Pearson’s r and the difference between the correlations (Lane, 2013). 
Pearson’s r coefficients were aggregated across coders, using Fisher’s z’ transformation to 
convert Pearson’s r to the normally distributed variable z’ across the coders, to give an overall 
reliability estimate. Fisher’s z’ estimates were averaged across the coders and transformed back 
to Pearson’s r, using the r to z’ table, for both A and Q scores.  
The scatter plots from the Pearson’s product moment correlation matrices were also displayed.  
Inter-coder reliability 
Inter-coder reliability estimates were computed for the individual item scores using Krippendorff’s 
alpha across the coders (with and without the consensus scores) to identify those items that were 
most easily agreed upon by all coders. The estimates without the consensus scores were used to 
judge the quality of the items. This helped judge the items that need to be kept in the final set. 
The estimates, including consensus scores, were used to discuss the added value of a consensus 
round in scoring by independent coders. 
The KALPHA macro (see Table 7.2, page 123) computes Krippendorff's alpha reliability estimate 
for judgments made at any level of measurement, any number of observers, with or without 
missing data (Hayes and Krippendorff, 2007).   
Principal Components Analysis (PCA) 
PCA was used to find the combination of items in the fidelity index which contained as much of 
the available information as possible (Motallebzadeh et al., 2007). PCA was undertaken chiefly to 
inform the structure of the index, by identifying those items that load reliably (together and 
separately for Adherence and Quality) across all coders. This was done by restricting the analysis 
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to load items on a single component to identify if any coder/item combinations did not load 
together.  
The PCA was further used to discriminate the dimensions of the underlying intervention 
‘content’ (refer to section 4.2.2, page 65) and cluster items together that correlate strongly with 
each other within these dimensions. This was done for the A scores, by restricting the analysis to 
five components, using Eigenvalues of >1 as a reference for component extraction.  
PCA was conducted in SAS Proc Factor (see Table 7.2, page 123), using an orthogonal pre-
rotation, which first rotates the item structure orthogonally and identifies maximal differences 
between these items, and then adjusts afterwards to a correlated item structure. Values of > 0.4 
were considered meaningful for the items that loaded on a component.  
Generalizability Study (G-study) 
A G-study was conducted to investigate the underlying dimensions (i.e. providers fidelity to BI) 
that the index measures. It involved three sequential steps: identification of important facets 
(sources) of variation, variance partitioning and computation of coefficient of generalisability (g). 
The G-study assessed the reliability of the fidelity index, in terms of measuring provider 
differences in intervention fidelity, which was explored using the generalizability theory. A two-
facet G study using a mixed models factorial ANOVA with random-effects (for SAS syntax: 
Table 7.2, page 123) was used to partition the variance components under the generalizability 
study with a nested design. In addition to the variance components, variance percentage, that is, 
each variance component as a percentage of the total variance (sum of all variance components in 
the model) was computed. This is recommended for models with multiple sources (Lakes and 
Hoyt, 2009) and aided interpretation of variance contributed by each source, allowing comparison 
with crude ICC (in sensitivity analysis below). The A and Q scores were analysed independently 
in the G-study. 
Further, three types of sensitivity analyses were explored for the g-coefficient: 
i. Crude ICC (intra-cluster correlation coefficient) for the provider differences 
ii. G-study excluding the consensus scores 
iii. G-study excluding providers with very low fidelity 
 
For the sensitivity analyses, ICC coefficients were computed, to indicate how much of the total 
variation in fidelity measurement was accounted for by the providers. These estimates were 
crude and not drawn from variance partitioning with other sources (facets) in the model. 
Therefore, the crude ICC would give a comparison for the amount of variation contributed by the 
providers with G-study estimates when other sources were accounted for in the model. As the 
consensus scores were considered the fourth coder in G-study, it was worthwhile to further 
explore how the g-coefficients changed on excluding these scores. Furthermore, it was decided to 
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exclude providers with very low fidelity as they showed very little variance in items to explore 
whether the providers with higher fidelity still varied in their practice.    
 
Table 7.2: SAS syntax for reliability tests 
Analysis SAS Syntax 
Krippendorff’s 
alpha 
The syntax (in SAS) used for the macro is:  
%kalpha (data = ….,judges=ITEM1coder1 ITEM1coder2 ITEM1coder3 
ITEM1 consensus, detail = 1, level = 2, boot = 2000);  
where judges is a list of variable names holding the names of the coders, level is the level of 
measurement (1 = nominal, 2 = ordinal, 3 = interval, 4 = ratio), detail is set to 1 if you desire to 
print the coincidence and delta matrices, and boot commands the number of bootstrap samples 
desired for inference.  
PCA The syntax used was:  
PROC FACTOR DATA=RESTRUCT  
METHOD=PRIN PRIORS=SMC SCREE ROTATE=PROMAX FLAG=.30 NFACT=1; 
Var Item1a Item2a …. Item37a; Run; 
G-study The syntax used was (Putka and McCloy, 2008): 
PROC MIXED data = CONCAT ALPHA=0.05 NOITPRINT METHOD=REML ASYCOV 
COVTEST;  
 class CODER_ID RECORDINGS HC; 
 MODEL A_SCORE=; 
 RANDOM HC RECORDINGS CODER_ID 
 RECORDINGS(HC) HC*CODER_ID; run; 
7.3.11 Ethics considerations 
The key ethical issues relating to the individuals participating in the study were dealt with as 
follows: 
Audiotaping of BI sessions and patient interviews  
Audio-taping of the BI sessions required obtaining informed consent both from the providers and 
the patients.  
Provider informed consent 
Providers were given both verbal and written information on the purpose of observing 
(audiotaping) their interaction sessions with the patients, before getting consent (Appendix D.1). 
The information sheet included the following: that taking part was entirely voluntary; the 
provider was not forced or obliged to allow audiotaping of any session; the provider’s identity 
and location would remain strictly confidential; non-participation in taping the session would not 
prejudice their employment; they had the right to withdraw consent at any time, including 
during the session and after the tape had been completed (data up to the point of consent only 
would be used in this case); tapes would only be viewed or heard by the research team members, 
and external reviewers in the expert panel if required.  
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Patient informed consent 
Patients were given both verbal and written information on the purpose of observing 
(audiotaping) their interaction sessions with the providers and the questionnaire led interviews, 
before getting consent (Appendix D.2). The information sheet included the following: that taking 
part was entirely voluntary; the taping of sessions was purely to assess or record the  provider 
intervention delivery practice; the patient was not forced or obliged to allow audiotaping of any 
session; the patient’s identity and location would remain strictly confidential; non-participation in 
taping the session would not prejudice their care, intervention or service offered; the patient had 
the right to withdraw consent at any time, including during the session and after the tape was 
completed, (data up to the point of consent only would be used in such cases); the patient had the 
right to listen to the tape after the session if desired; tapes would only be viewed or heard by the 
research team members, and external reviewers in the expert panel if required.  
Health risks to the researchers 
Assessment of the health risks to the research officers visiting the TB clinics for data collection 
and placement of appropriate actions for their safety was important. These research officers were 
employees of the government and already worked closely with the TB DOTs paramedics for 
disease reporting purposes, and were trained on taking appropriate precautionary steps before 
visiting a TB clinic. The lead researcher was not in direct contact with the TB patients during 
data collection. 
Safe keeping and confidentiality of data 
After induction, both research officers were introduced to the principles of confidentiality and 
informed consent and made aware of the study protocol and their obligations to follow it.  
Ethics Approvals 
Ethics approval for conducting the observational study was granted by the Health Sciences 
Research Governance Committee (HSRGC) at the University of York and locally by the National 
Bio-ethics Committee at Pakistan Medical Research Council (PMRC) - see Project plan (page 
116). 
7.3.12 Sponsorship 
The Bupa foundation highly commended the ASSIST study’s contribution to evidence-base in 
practice and awarded the research team with a small amount of prize money to be utilised for 
further work on the subject. This award money funded the activities of the observational study. 
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7.4 RESULTS 
7.4.1 Feasibility findings from the scoping exercise 
The research officers hired for the study approached all those providers who were originally 
involved in the ASSIST study. Most of these providers were working at the same TB clinic as 
before. Two providers in Sargodha had been transferred to nearby TB clinics, who upon request 
to the District Health Officer (in-charge of duty authorisation of all health care workers in the 
respective district), were authorised to work in their previous TB clinics (those originally 
involved in the ASSIST study) for the study duration. None of the providers at these TB clinics 
were able to sustain implementation of the BI for smoking cessation after the ASSIST study. 
Therefore, it was decided to run refresher training for the providers (described above in section 
7.3.9 on page 115). 
To elucidate the differences between digital recorders (audio and video) for practicability of use in 
a resource constrained setting (with frequent power cuts), a field consultation was undertaken in 
the UK, with a research team conducting audiotaping of patient-provider interactions. Audio-
taping with a particular recorder (Zoom H2n, see ‘Study equipment’ page 114) was found to have 
advantages over other types of audio recorders, as well as videotaping. Firstly, the battery life of 
the video recorder was insufficient for practical use in taping an average intervention session, and 
secondly, there were issues of adequate room size and placement of the video recorder at an angle 
to capture the patient and the provider; involving complex supplementary equipment and expert 
help in setting it up. This could install technical challenges in using the recording equipment by 
the providers. In contrast, audio recorders were found to be practical for observing long and 
multiple sessions, as battery time was extensive (up to two days for recording an average number 
of moderately long sessions). Also, there were no issues of room size and placement of equipment. 
7.4.2 Description of data and participants 
Nineteen of the 22 approached TB clinics (and providers) agreed to participate in the study and 
180 patients were enrolled to receive BI for smoking cessation (see Figure 7.3).  
Fidelity data was coded for 154 audiotapes (giving 462 data-points) that were considered eligible 
by 3 coders. The number of audiotapes per clinic ranged between four and 10; seven clinics 
completed 10 sessions, five completed nine sessions, three completed eight sessions and the rest 
completed six, five and four sessions, respectively.  
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Figure 7.3: Study Flow Chart 
  
TB clinics/providers approached (n= 22) 
Sargodha 
 
Jhang 
 
TB clinics/providers approached  
(n= 12) 
 
TB clinics/providers approached  
(n= 10) 
TB clinics/providers recruited (n= 9) 
TB patients/ suspects (n= 80) 
 
Reason for non-participation: 
n= 2 providers died; 
n=1 provider declined  
 
TB clinics/providers recruited (n= 10) 
TB patients/ suspects (n= 100) 
TB clinics/providers (n= 10) 
TB patients/ suspects (n= 100) 
 
TB clinics/providers (n= 9) 
TB patients/ suspects (n= 80) 
 
TB clinics/providers (n= 10) 
BI patient-provider sessions (n= 90) 
 
TB clinics/providers (n= 8) 
BI patient-provider sessions (n= 75) 
 
TB clinics/providers (n= 10) 
BI patient-provider sessions (n= 84) 
 
TB clinics/providers (n= 8) 
BI patient-provider sessions (n= 70) 
Audiotapes coded on fidelity index 
Audiotapes completed 
Participant recruitment 
Assessment Questionnaires completed 
Districts 
Reason for exclusion: 
n= 1, interference in BI delivery by RO; 
n= 10, flip-chart counselling done by RO 
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7.4.3 Descriptive statistics for individual item and composite index scores 
Individual item scores 
Items 10 and 12 did not have means close to the ends of the distribution (i.e. no floor or ceiling 
effects) but they had very little variance (refer to Table 7.3, on page 128). Floor effect, which 
means very close to the lowest value, and could potentially be one possible explanation for 
observed low variance was seen for items 39, 40 and 44.  
Note: Item 10 was ‘assessing the current level of motivation to stop/ willingness to quit’; item 12 
was ‘Eliciting a prompt commitment from the smoker on starting the quit attempt’; item 39 was 
‘explaining expectations regarding the intervention programme’; item 40 was ‘providing 
reassurance’; and item 44 was ‘tailoring interactions appropriately’. For a full list of items in the 
fidelity index, see Appendix C.3. 
Composite index scores 
The Pearson’s r value ranged from 0.88 to 0.98 for all four coders (including consensus scores) 
for ‘Adherence’ and from 0.85 to 0.94 for ‘Quality’ (refer to Table 7.4, on page 130), for composite 
index scores. The average correlation between different coders was 0.95 (0.92 without consensus 
scores) for ‘Adherence’; and 0.90 (0.87 without consensus scores) for ‘Quality’.  
The scatter plots present the positive linear trends between coders for the composite scores 
(Figure 7.4, on page 131).  
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Table 7.3: Descriptive statistics and inter-coder reliability estimates for individual item scores 
ITEM 
Coder 1 Score Coder 2 Score Coder 3 Score Consensus Score Krippendorff’s α (95% CI) 
Mean Median *SD Mean Median SD Mean Median SD Mean Median SD 
Including 
consensus scores 
Excluding 
consensus scores 
ADHERENCE  
Item1 1.29 1.00 0.55 1.27 1.00 0.55 1.28 1.00 0.57 1.27 1.00 0.55 .888 (.82-.95) .868 (.80-.93) 
Item2 1.35 1.00 0.70 1.23 1.00 0.78 1.24 1.00 0.78 1.27 1.00 0.79 .817 (.76-.87) .755 (.69-.82) 
Item3 1.34 1.00 0.69 1.20 1.00 0.76 1.11 1.00 0.76 1.25 1.00 0.73 .782 (.71-.84) .715 (.64-.79) 
Item4 1.37 2.00 0.73 1.27 1.00 0.79 1.19 1.00 0.79 1.27 1.00 0.78 .799 (.73-.87) .738 (.66-.81) 
Item5 1.33 1.00 0.72 1.16 1.00 0.76 1.11 1.00 0.77 1.23 1.00 0.77 .771 (.70-.83) .707 (.63-.78) 
Item6 1.39 2.00 0.73 1.30 2.00 0.80 1.20 1.00 0.77 1.26 1.00 0.81 .815 (.75-.87) .755 (.68-.82) 
Item7 1.24 1.00 0.77 1.18 1.00 0.83 1.16 1.00 0.83 1.17 1.00 0.81 .788 (.72-.85) .719 (.64-.79) 
Item8 0.99 1.00 0.82 0.97 1.00 0.86 0.95 1.00 0.85 0.97 1.00 0.86 .819 (.75-.88) .759 (.68-.83) 
Item9 0.97 1.00 0.89 0.92 1.00 0.89 0.88 1.00 0.87 0.92 1.00 0.90 .893 (.85-.93) .861 (.81-.90) 
Item10 1.92 2.00 0.39 1.88 2.00 0.47 1.86 2.00 0.52 1.90 2.00 0.45 .751 (.43-1.00) .675 (.34-.91) 
Item11 1.41 2.00 0.73 1.37 2.00 0.75 1.37 2.00 0.71 1.38 2.00 0.72 .825 (.76-.88) .782 (.71-.85) 
Item12 1.89 2.00 0.45 1.82 2.00 0.58 1.82 2.00 0.58 1.87 2.00 0.49 .625 (.28-.93) .519 (.18-.79) 
Item13 1.74 2.00 0.61 1.77 2.00 0.57 1.79 2.00 0.55 1.78 2.00 0.56 .789 (.67-.89) .734 (.61-.85) 
Item14 1.35 2.00 0.86 1.37 2.00 0.85 1.44 2.00 0.80 1.44 2.00 0.78 .781 (.69-.86) .729 (.63-.83) 
Item15 1.74 2.00 0.62 1.77 2.00 0.59 1.79 2.00 0.57 1.77 2.00 0.59 .914 (.82-.98) .885 (.78-.98) 
Item16 0.75 0.00 0.97 0.75 0.00 0.97 0.67 0.00 0.95 0.69 0.00 0.95 .818 (.70-.94) .774 (.63-.89) 
Item17 0.83 0.00 0.99 0.83 0.00 0.99 0.81 0.00 0.98 0.86 0.00 0.99 .891 (.79-.98) .856 (.73-.96) 
Item18 0.77 0.00 0.98 0.70 0.00 0.96 0.69 0.00 0.95 0.71 0.00 0.96 .891 (.78-.98) .858 (.74-.96) 
Item19 0.77 0.00 0.98 0.79 0.00 0.98 0.77 0.00 0.98 0.82 0.00 0.99 .911 (.83-.98) .890 (.79-.98) 
Item20 0.76 0.00 0.97 0.81 0.00 0.98 0.75 0.00 0.97 0.81 0.00 0.98 .884 (.77-.96) .862 (.75-.96) 
Item21 1.12 1.00 0.74 1.01 1.00 0.71 0.94 1.00 0.72 0.95 1.00 0.73 .735 (.64-.82) .678 (.58-.77) 
Item22 0.97 1.00 0.76 0.88 1.00 0.76 0.70 1.00 0.76 0.76 1.00 0.76 .718 (.63-.80) .640 (.54-.73) 
Item23 0.94 1.00 0.73 0.85 1.00 0.70 0.75 1.00 0.68 0.78 1.00 0.68 .751 (.67-.82) .681 (.59-.76) 
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Item24 0.99 1.00 0.72 0.91 1.00 0.71 0.70 1.00 0.66 0.77 1.00 0.67 .701 (.61-.78) .636 (.54-.72) 
Item25 0.92 1.00 0.72 0.88 1.00 0.72 0.71 1.00 0.66 0.71 1.00 0.66 .712 (.62-.79) .645 (.54-.73) 
Item26 0.84 1.00 0.74 0.81 1.00 0.71 0.64 1.00 0.65 0.66 1.00 0.66 .725 (.64-.80) .655 (.56-.74) 
Item27 0.89 1.00 0.76 0.73 1.00 0.72 0.66 1.00 0.65 0.67 1.00 0.67 .709 (.61-.80) .638 (.53-.74) 
Item28 0.83 1.00 0.75 0.73 1.00 0.71 0.56 0.00 0.64 0.57 0.50 0.62 .678 (.57-.78) .610 (.50-.71) 
Item29 0.63 0.00 0.73 0.55 0.00 0.71 0.51 0.00 0.70 0.51 0.00 0.68 .847 (.79-.91) .812 (.75-.87) 
Item30 0.58 0.00 0.70 0.51 0.00 0.67 0.42 0.00 0.62 0.47 0.00 0.65 .826 (.76-.89) .776 (.70-.85) 
Item31 0.61 0.50 0.68 0.57 0.00 0.68 0.47 0.00 0.57 0.50 0.00 0.61 .849 (.79-.91) .810 (.74-.87) 
Item32 0.60 0.00 0.71 0.51 0.00 0.68 0.41 0.00 0.63 0.47 0.00 0.65 .815 (.74-.88) .760 (.67-.84) 
Item33 0.62 0.00 0.70 0.62 0.00 0.72 0.45 0.00 0.64 0.53 0.00 0.67 .796 (.72-.87) .740 (.66-.82) 
Item34 0.60 0.00 0.67 0.56 0.00 0.72 0.49 0.00 0.64 0.49 0.00 0.64 .796 (.72-.86) .749 (.67-.83) 
Item35 0.55 0.00 0.65 0.51 0.00 0.67 0.45 0.00 0.65 0.43 0.00 0.61 .773 (.69-.85) .720 (.64-.80) 
Item36 0.50 0.00 0.62 0.44 0.00 0.64 0.40 0.00 0.60 0.40 0.00 0.58 .837 (.77-.90) .802 (.73-.87) 
Item37 0.44 0.00 0.83 0.43 0.00 0.82 0.39 0.00 0.79 0.41 0.00 0.81 .909 (.82-.98) .879 (.76-.97) 
QUALITY 
Item38 0.50 0.00 0.71 0.37 0.00 0.59 0.40 0.00 0.64 0.38 0.00 0.62 .709 (.60-.81) .632 (.52-.74) 
Item39 0.05 0.00 0.21 0.02 0.00 0.14 0.03 0.00 0.24 0.01 0.00 0.11 .157 (-.54-.72) .052 (-.60-.64) 
Item40 0.25 0.00 0.59 0.18 0.00 0.44 0.16 0.00 0.48 0.14 0.00 0.46 .566 (.40-.72) .481 (.31-.66) 
Item41 0.36 0.00 0.67 0.43 0.00 0.70 0.39 0.00 0.70 0.34 0.00 0.64 .781 (.69-.86) .741 (.65-.82) 
Item42 0.34 0.00 0.66 0.23 0.00 0.58 0.23 0.00 0.58 0.22 0.00 0.60 .769 (.66-.87) .737 (.63-.84) 
Item43 0.48 0.00 0.69 0.34 0.00 0.58 0.38 0.00 0.62 0.36 0.00 0.60 .755 (.65-.85) .679 (.57-.78) 
Item44 0.18 0.00 0.49 0.21 0.00 0.54 0.12 0.00 0.37 0.14 0.00 0.42 .765 (.63-.88) .729 (.58-.85) 
Item45 0.47 0.00 0.67 0.51 0.00 0.73 0.42 0.00 0.65 0.43 0.00 0.65 .743 (.65-.82) .692 (.60-.78) 
*SD is standard deviation 
Items highlighted in grey are those with SD < .50, showing little variance 
Items highlighted in mauve show low agreement 
Mean krippendorff’s α for Adherence was 0.80 and for Quality was 0.66 
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Table 7.4: Descriptive statistics and Pearson’s correlation for composite (A and Q) scores 
Scores 
Descriptive statistics Pearson’s *α (95% CI) 
Mean Median **SD A-Coder1 A-Coder2 A-Coder3 A-Consensus Q-Coder1 Q-Coder2 Q-Coder3 Q-Consensus 
A-Coder1 37.58 39.00 18.04 - .909 
(.877-.933) 
.880 
(.839-.912) 
.899 
(.864-.926) 
- - - - 
A-Coder2 35.91 35.50 17.47 - - .953 
(.936-.965) 
.973 
(.963-.981) 
- - - - 
A-Coder3 33.55 34.00 16.80 - - - .977 
(.968-.983) 
- - - - 
A-Consensus 34.66 34.00 17.50 - - - - - - - - 
Q-Coder1 2.61 1.00 3.59 - - - - - .868 
(.823-.902) 
.847 
(.796-.887) 
.873 
(.829-.906) 
Q-Coder2 2.29 1.00 3.31 - - - - - - .895 
(.858-.923) 
.943 
(.923-.958) 
Q-Coder3 2.15 0.00 3.42 - - - - - - - .933 
(.909-.951) 
Q-Consensus 2.03 1.00 3.27 - - - - - - - - 
*α is Pearson correlation statistic (Fisher’s z transformed) 
**SD is standard deviation 
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Figure 7.4: Scatterplots for Adherence and Quality 
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7.4.4 Inter-coder reliability 
Krippendorff provides a more conservative interpretation of the α coefficient than the 
conventional tests of inter-coder reliability, suggesting that conclusions should be discounted for 
variables with values of α < 0.67, tentatively made for α between 0.67 and 0.80, and definitely 
made for α > 0.80 (Krippendorff, 2004)(p. 241). For individual items, looking at Krippendorff’s α 
across the three independent coders, items 12, 22, 24 to 28, 38, 39 and 40 showed lower 
agreements, that is, α < 0.67 (refer to Table 7.3, on page 128). The overall mean Krippendorff’s α 
for individual items was 0.80 for ‘Adherence’ and 0.66 for ‘Quality’. Therefore, the fidelity index 
showed moderate (for Quality) to good (for Adherence) stability in rating by different coders.   
After including the consensus scores, the Krippendorff’s α for items 22, 24 to 28, and 38 increased 
to > 0.67, showing higher agreement. 
Note: Item 12 was ‘Eliciting a prompt commitment from the smoker on starting the quit attempt’; 
item 38 was ‘building general rapport’; item 39 was ‘explaining expectations regarding the 
intervention programme’; and item 40 was ‘providing reassurance’. Items 22 to 28 were about the 
‘identification and management of triggers’. For a full list of items of the fidelity index, see 
Appendix C.3. 
7.4.5 Principal Component Analysis (PCA) 
Item loadings for the fidelity index under a single component 
Item loadings across all 45 items of the fidelity index together, showed that about 52% (Eigen 
value 17.8) of the variance could be explained under a single component or dimension of the 
index (Refer to Table 7.5). Item loading values of > 0.4 were considered meaningful in measuring 
a single dimension for fidelity to the BI. 
Seven items (item 10, 12, 15, 16, 37, 39 and 40) showed loadings below the threshold of 0.4, 
consistently across the coders.  
Note: Item 10 was ‘assessing the current level of motivation to stop/ willingness to quit’; item 12 
was ‘Eliciting a prompt commitment from the smoker on starting the quit attempt’; item 15 was 
‘nicotine dependency’; item 16 was ‘setting quit date’; item 37 was ‘offering BI leaflet’; item 39 
was ‘explaining expectations regarding the intervention programme’. For a full list of items of 
the fidelity index, see Appendix C.3. 
Table 7.5: Item loadings for all 45 items of the fidelity index 
Individual items Coder 1 Coder 2 Coder 3 Consensus 
Item1 0.53 0.43 0.36 0.43 
Item2 0.73 0.66 0.68 0.73 
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Item3 0.66 0.66 0.75 0.73 
Item4 0.78 0.69 0.76 0.78 
Item5 0.75 0.63 0.73 0.72 
Item6 0.73 0.70 0.69 0.72 
Item7 0.70 0.53 0.64 0.66 
Item8 0.71 0.74 0.71 0.77 
Item9 0.74 0.71 0.79 0.80 
Item10 0.27 0.17 0.23 0.23 
Item11 0.66 0.43 0.46 0.43 
Item12 0.23 0.29 0.17 0.23 
Item13 0.39 0.37 0.42 0.44 
Item14 0.49 0.42 0.44 0.43 
Item15 0.28 0.17 0.10 0.16 
Item16 0.45 0.32 0.28 0.34 
Item17 0.67 0.56 0.49 0.57 
Item18 0.70 0.59 0.54 0.62 
Item19 0.63 0.56 0.52 0.56 
Item20 0.69 0.61 0.57 0.64 
Item21 0.73 0.72 0.72 0.69 
Item22 0.76 0.65 0.67 0.71 
Item23 0.78 0.74 0.74 0.79 
Item24 0.80 0.78 0.76 0.78 
Item25 0.82 0.74 0.80 0.84 
Item26 0.83 0.77 0.83 0.84 
Item27 0.76 0.76 0.82 0.80 
Item28 0.82 0.76 0.81 0.82 
Item29 0.75 0.79 0.74 0.76 
Item30 0.77 0.76 0.74 0.75 
Item31 0.75 0.75 0.69 0.73 
Item32 0.79 0.74 0.68 0.75 
Item33 0.77 0.74 0.74 0.75 
Item34 0.75 0.72 0.70 0.72 
Item35 0.73 0.69 0.70 0.70 
Item36 0.77 0.76 0.72 0.75 
Item37 0.12 0.23 0.28 0.27 
Item38 0.53 0.51 0.55 0.49 
Item39 0.30 -0.07 0.19 0.06 
Item40 0.41 0.37 0.27 0.32 
Item41 0.49 0.69 0.55 0.55 
Item42 0.50 0.46 0.45 0.41 
Item43 0.57 0.54 0.57 0.55 
Item44 0.27 0.47 0.40 0.32 
Item45 0.63 0.73 0.66 0.66 
Loading values > 0.4 were taken as meaningful  
Proportion variance under single component = 0.52 
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Item loadings for Adherence and Quality separately (single component extraction) 
Item loadings across 37 items for ‘Adherence’ and 8 items for ‘Quality’, showed that about 60% 
(Eigen value 16.4) and 91% (Eigen value 4.3) of the variance was explained by a single 
component under each sub-index, respectively (refer to Table 7.6 and Table 7.7). 
Five items (item 10, 12, 15, 16, and 37) for ‘Adherence’ showed loadings below the threshold of 0.4. 
For the ‘Quality’ item 39 did not load well. 
Note: Item 10 was ‘assessing the current level of motivation to stop/ willingness to quit’; item 12 
was ‘Eliciting a prompt commitment from the smoker on starting the quit attempt’; item 15 was 
‘nicotine dependency’; item 16 was ‘setting quit date’; item 37 was ‘offering BI leaflet’; item 39 
was ‘explaining expectations regarding the intervention programme’. For a full list of items of 
the fidelity index, see Appendix C.3. 
Table 7.6: Item loadings of the 37 items for Adherence 
Individual items Coder 1 Coder 2 Coder 3 Consensus 
Item1 0.53 0.42 0.36 0.43 
Item2 0.73 0.65 0.69 0.73 
Item3 0.66 0.65 0.74 0.71 
Item4 0.77 0.69 0.75 0.77 
Item5 0.74 0.62 0.73 0.71 
Item6 0.72 0.70 0.70 0.72 
Item7 0.70 0.54 0.66 0.67 
Item8 0.74 0.74 0.71 0.77 
Item9 0.73 0.70 0.78 0.79 
Item10 0.27 0.18 0.24 0.23 
Item11 0.66 0.44 0.47 0.45 
Item12 0.27 0.29 0.18 0.22 
Item13 0.39 0.38 0.43 0.44 
Item14 0.52 0.44 0.47 0.46 
Item15 0.27 0.18 0.12 0.17 
Item16 0.47 0.35 0.32 0.38 
Item17 0.70 0.61 0.54 0.61 
Item18 0.74 0.65 0.60 0.66 
Item19 0.67 0.61 0.59 0.61 
Item20 0.72 0.66 0.62 0.67 
Item21 0.71 0.70 0.70 0.67 
Item22 0.76 0.65 0.68 0.71 
Item23 0.78 0.73 0.74 0.79 
Item24 0.80 0.76 0.75 0.78 
Item25 0.82 0.74 0.80 0.84 
Item26 0.82 0.77 0.83 0.84 
Item27 0.76 0.75 0.82 0.80 
Item28 0.81 0.76 0.80 0.82 
Item29 0.76 0.79 0.74 0.76 
Item30 0.78 0.76 0.73 0.75 
Item31 0.75 0.77 0.70 0.74 
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Item32 0.78 0.75 0.68 0.76 
Item33 0.77 0.75 0.74 0.75 
Item34 0.77 0.72 0.70 0.71 
Item35 0.73 0.71 0.72 0.72 
Item36 0.78 0.78 0.73 0.76 
Item37 0.06 0.19 0.24 0.22 
Loading values > 0.4 were taken as meaningful 
Proportion variance under single component = 0.60 
 
Table 7.7: Item loadings of the 8 items for Quality 
Individual items Coder 1 Coder 2 Coder 3 Consensus 
Item38 0.66 0.74 0.83 0.76 
Item39 0.33 -0.01 0.46 0.17 
Item40 0.69 0.51 0.64 0.69 
Item41 0.85 0.86 0.90 0.90 
Item42 0.87 0.83 0.81 0.85 
Item43 0.77 0.75 0.78 0.81 
Item44 0.66 0.80 0.70 0.74 
Item45 0.74 0.76 0.74 0.68 
Loading values > 0.4 were taken as meaningful 
Proportion variance under single component = 0.91 
Item loadings for Adherence (multiple components extraction) 
Further exploration of components with Eigenvalues more than 1 for Adherence items, identified a 
total of five components (refer to Table 7.8, on page 137). At least one of the components 
explained 60%, the second: 11% and the third: 9% of the variance or information contained in the 
BI content, which formed the items of the Adherence sub-index (Table 7.9, on page 138). The five 
components extracted for the Adherence sub-index emerged showing the same structure across 
all different coders. 
Items 1 and 37 did not load well on any of the five components extracted. 
The five extracted components were (further discussed in section 7.5.3, page 146): 
 Component 1 included items 29 to 36, which are about ‘assessing and managing the 
nicotine withdrawal symptoms’ in the BI.  
 Component 2 included items 2 to 9, which are about ‘providing information on the 
consequences of smoking and stopping to smoke’ in the BI. 
 Component 3 included items 21 to 28, which are about ‘identifying and managing the 
triggers to smoke’ in the BI.  
 Component 4 included items 16 to 20, which comprised of ‘preparing for the quit 
attempt’ in the BI. 
 Component 5 included items 10 to 15, which relate to the ‘assessments of willingness to 
quit, nicotine dependency and quit attempt history’ in the BI.  
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Note: Item 1 was ‘smoking behaviour and history’ and item 37 was ‘offering the BI leaflet’. For a 
full list of items of the fidelity index, see Appendix C.3. 
 
The results from the PCA indicate that item loadings for the overall index and for the two sub-
indices explained considerable variance under a single component. This showed that majority of 
the items were measuring the same construct. The items that did not load well on PCA are 
discussed in the next section (7.5.3). 
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Table 7.8: Identifying the Principal Components for Adherence 
Individu
al items 
Loading 1 Loading 2 Loading 3 Loading 4 Loading 5 
C 1 C 2 C 3 C 4 C 1 C 2 C 3 C 4 C 1 C 2 C 3 C 4 C 1 C 2 C 3 C 4 C 1 C 2 C 3 C 4 
Item1 -0.02 -0.11 -0.02 -0.09 0.31 0.12 0.15 0.06 -0.1 0.3 -0.04 0.18 0.36 0.23 0.26 0.38 0.23 0.12 0.36 0.15 
Item2 -0.03 0 0.04 0.08 0.28 0.53 0.71 0.67 0.57 0.16 0.05 0.03 0.11 0.14 0.09 0.1 0.02 0.05 -0.06 0.07 
Item3 -0.15 -0.03 0.01 -0.02 0.28 0.76 0.84 0.76 0.59 -0.04 0.08 0.12 0.06 0.06 -0.08 -0.07 0.11 0.17 0.07 0.16 
Item4 0.01 -0.04 0.04 0.01 0.33 0.82 0.87 0.81 0.68 0 0 0.09 -0.1 0.1 -0.05 0.02 0.11 0.01 0.12 0.04 
Item5 -0.04 -0.03 -0.07 -0.02 0.37 0.77 0.85 0.81 0.66 -0.03 0.13 0.12 -0.04 0.09 -0.02 -0.01 -0.04 -0.01 0 -0.06 
Item6 0.03 0.04 0.03 0.05 0.3 0.94 0.88 0.93 0.72 0.02 -0.05 -0.04 -0.1 -0.06 -0.01 -0.03 -0.07 -0.06 0 -0.1 
Item7 -0.07 -0.09 -0.08 -0.12 0.28 0.86 0.83 0.93 0.73 0.04 0.05 0 -0.02 -0.07 0.05 0.04 -0.04 -0.06 -0.06 -0.04 
Item8 0.34 0.31 0.23 0.22 -0.13 0.46 0.52 0.52 0.56 0.11 0.08 0.09 0.21 0.03 0.07 0.14 -0.02 0.06 -0.04 -0.05 
Item9 0.22 0.19 0.17 0.16 -0.09 0.49 0.62 0.54 0.72 0.18 0.16 0.24 0.17 0.07 0.06 0.06 -0.11 -0.07 -0.14 -0.08 
Item10 0.02 -0.1 0.09 0 0.04 -0.05 0.04 0.03 -0.01 0.02 -0.03 0 -0.12 0.04 -0.1 -0.04 0.69 0.69 0.68 0.74 
Item11 -0.01 0.04 0 0.06 0.23 0.37 0.37 0.38 0.39 0.07 -0.01 -0.11 0.01 -0.12 0.07 0.1 0.38 0.43 0.39 0.34 
Item12 0 -0.02 0.08 0.01 0.04 -0.02 -0.07 -0.08 -0.07 -0.06 0.04 0.13 -0.01 0.16 -0.13 -0.1 0.64 0.63 0.65 0.74 
Item13 0.07 0.17 -0.04 0.07 -0.17 0.17 0.23 0.26 0.25 -0.11 0.12 0 0.01 -0.06 0.03 0 0.61 0.58 0.43 0.51 
Item14 0.08 0.12 -0.13 -0.03 -0.16 0.06 0.28 0.32 0.32 0.15 0.15 -0.06 0.16 -0.05 0.15 0.2 0.5 0.6 0.39 0.43 
Item15 -0.01 -0.1 -0.02 -0.01 0.18 -0.34 -0.32 -0.31 -0.35 0.37 0.03 0.03 0.25 0.16 0.3 0.34 0.47 0.39 0.53 0.48 
Item16 0.01 -0.06 -0.03 -0.05 -0.07 0.1 -0.17 0.01 -0.03 0.62 0.17 -0.04 0.66 -0.19 0.52 0.63 0.15 0.16 0.02 0.03 
Item17 0.09 0.14 0.05 0.07 0.01 -0.02 0 0.04 0.04 0.75 -0.05 -0.06 0.84 0.02 0.85 0.82 -0.03 -0.02 0.02 0.01 
Item18 0.09 0.26 0.09 0.17 0.09 -0.05 0.03 -0.07 -0.03 0.82 -0.06 -0.01 0.89 -0.07 0.9 0.88 -0.05 -0.06 -0.04 -0.06 
Item19 0.02 0.01 -0.07 -0.04 -0.05 0.09 0.11 0.1 0.12 0.84 0 -0.04 0.85 -0.01 0.9 0.86 -0.01 -0.04 -0.04 0.01 
Item20 0.04 -0.1 0.06 -0.03 0.07 0.16 0.15 0.12 0.08 0.84 -0.04 0.07 0.84 0.1 0.77 0.8 -0.07 -0.05 -0.01 -0.05 
Item21 0.19 0.25 0.09 0.06 0.63 0.2 0.05 0.04 0.16 0 0.68 0.75 -0.07 0.45 0 -0.05 -0.09 -0.1 -0.02 -0.06 
Item22 -0.09 0.01 0.02 -0.03 0.67 0.06 -0.01 0 0.16 0.17 0.75 0.76 0.19 0.6 0.08 0.12 0.04 0.02 -0.07 -0.01 
Item23 -0.07 0.08 -0.02 -0.01 0.83 0.15 -0.02 0.15 0.12 -0.06 0.84 0.81 0.07 0.69 0.03 -0.04 0 0.07 0.09 0.06 
Item24 0 0.23 0.06 0.09 0.88 0.15 0.09 0.03 0.04 -0.12 0.82 0.81 0.03 0.66 -0.13 -0.02 0.04 -0.02 0.03 0.02 
Item25 0.16 0.3 0.08 0.2 0.82 -0.01 0.09 0.09 0.05 -0.06 0.8 0.76 -0.06 0.65 -0.01 -0.06 0.04 -0.01 -0.04 0 
Item26 0.09 0.22 0.06 0.15 0.77 0.09 0.09 0.05 0.05 -0.03 0.82 0.77 0.08 0.65 0 0.03 0 0.02 0.01 0.01 
Item27 0.13 0.19 0.09 0.12 0.78 0.17 0.07 0.13 0.07 0.05 0.72 0.66 -0.04 0.56 0.13 0.09 -0.04 -0.06 -0.03 -0.05 
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Item28 0.12 0.23 0.16 0.16 0.88 -0.01 0.07 0.05 0.05 0.09 0.65 0.64 -0.06 0.59 0.07 0.14 -0.04 0.08 0.04 0.04 
Item29 0.8 0.87 0.84 0.85 0.01 0.03 -0.05 -0.04 0.05 0.01 0.08 0.08 0.08 0.02 0.03 0.01 0.01 -0.01 0.04 0.02 
Item30 0.88 0.82 0.86 0.9 0.05 0.05 0.09 0.05 0 -0.05 0.02 -0.04 0.02 0.06 -0.08 -0.01 0.02 -0.02 -0.04 -0.02 
Item31 0.92 0.96 0.84 0.9 0.03 0.01 0.1 0.12 0.02 -0.05 -0.04 -0.1 -0.07 -0.05 -0.02 -0.03 0.05 0.01 -0.03 -0.03 
Item32 0.89 0.9 0.81 0.92 0.02 -0.07 -0.04 -0.02 -0.01 0.04 0.01 -0.06 0.05 -0.06 0.05 0.03 0.04 0.15 0.06 0.1 
Item33 0.9 1.01 0.87 0.96 0 0.11 0.07 0.11 0.13 -0.12 0.05 -0.03 -0.04 -0.15 -0.09 -0.14 -0.06 -0.04 -0.04 -0.02 
Item34 0.94 0.85 0.9 0.91 0.09 -0.09 -0.03 -0.1 -0.08 0.04 0.03 0.1 -0.03 0.04 -0.04 -0.05 0.03 -0.04 -0.02 -0.03 
Item35 0.83 0.83 0.8 0.8 0.09 -0.03 -0.06 -0.03 -0.07 0.06 0.05 0.05 0.05 -0.02 0.08 0.05 0 -0.01 0.08 0 
Item36 0.79 0.74 0.73 0.74 0.07 -0.12 -0.01 -0.05 -0.03 0.25 -0.01 0.02 0.15 0.06 0.19 0.2 0.01 0.02 0.09 0.06 
Item37 -0.02 -0.21 -0.05 -0.15 0.03 -0.07 0.06 -0.03 0.02 -0.04 0.29 0.49 0 0.55 -0.08 -0.09 0.07 0.03 0.11 0.08 
C= Coder 
Colour codes: Component 1=mauve, Component 2=grey, Component 3=blue, Component 4= green, Component 5= yellow 
Loading values > 0.4 were considered meaningful 
 
 
Table 7.9: Variance explained by each Principal Component for Adherence 
Principal 
components 
Coder 1 Coder 2 Coder 3 Consensus 
Eigenvalue Proportion 
variance 
Eigenvalue Proportion 
variance 
Eigenvalue Proportion 
variance 
Eigenvalue Proportion 
variance 
Component 1 17.37 0.61 14.99 0.58 15.37 0.58 16.41 0.60 
Component 2 3.47 0.12 2.83 0.11 2.86 0.11 2.89 0.11 
Component 3 2.28 0.08 2.59 0.10 2.61 0.10 2.52 0.09 
Component 4 1.53 0.05 1.64 0.06 1.79 0.07 1.66 0.06 
Component 5 1.21 0.04 1.13 0.04 1.16 0.04 1.28 0.05 
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7.4.6 Generalisability study (G-study)  
Identification of important facets (sources) of variation 
Since the fidelity index was used to measure provider Adherence to BI content and Quality of 
interaction, independent of patient- and coder-variance, I was interested in the share of variance 
that is due to true differences between providers i.e. νh.  
The sources of variation identified for the G-Study that needed accounting for, in order to obtain 
the true differences between providers, were calculated: σ2r, σ2h, σ2i:h, σ2rh, σ2ri:h., as described in 
Table 7.10.  
Where,  
 A number of audiotaped sessions (n = 154; i) were obtained within a number of providers 
(n = 18; h) 
 The audiotaped sessions were nested within providers (i:h).  
 Each session was rated by three independent coders and a fourth consensus score, which 
makes this a r*(i:h) design (Brennan, 2001)(p.56).  
Table 7.10: Identification of important sources of variation  
Variance partitioning 
The variance partitioning yielded variation contributed by each of the σ2r, σ2h, σ2i:h, σ2rh, σ2ri:h, and 
the total variance presented in Table 7.11 for Adherence and Table 7.12 for Quality.  
  
Source of variability Type of variation Variation 
component 
Provider/TB clinic (h) Variance due to the differences in providers’ actual fidelity 
to BI 
𝜎ℎ
2 
Coder (r) Variance due to the coders’ differences (coder leniency) in 
scoring 
𝜎𝑟
2/4 
Coder * Provider (rh) Variance due to inconsistencies in different coders’ scoring 
of the same provider, averaging over patients (audiotapes). 
 𝜎𝑟ℎ
2 /4 
Patient: Provider (i:h) Variance due to individual differences of patients’ 
(audiotapes) nested within providers 
 𝜎𝑖:ℎ
2 /154 
Coder *Patient: Provider (ri:h) The residual or random error variance (i.e. any unanalysed 
facets of measurement that varied among providers) 
 𝜎𝑟𝑒𝑠
2 /(4*154) 
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Table 7.11: Variance partitioning for Adherence  
 
 
 
 
 
 
 
 
 
 
 
 
Table 7.12: Variance partitioning for Quality 
 
 
 
 
 
Computation of g-coefficient 
Once the variance components were calculated, these were computed to get the g-coefficient of 
reliability, using the following formula (Brennan, 2001): 
g =  
 
For Adherence: 
g =                                      235.01                                               = 0.985 
       235.01 + 1.97/4 + 8.64/154 + 11.64/4 + 9.49/4*154   
 
For Quality: 
 g =                                      8.27                                                   = 0.986 
        8.27+ 0.025/4 + 0.030/154 + 0.446/4 + 0.838/4*154   
):()():()()(
)(
22222
2
hrirhhirh
h



Source of variability Variation component Variance % 
Provider/TB clinic (h) 𝜎ℎ
2= 235.01 98.5 
Coder (r) 𝜎𝑟
2/4= 1.97/4= 0.49 0.20 
Coder * Provider (rh)  𝜎𝑟ℎ
2 /4= 11.65/4= 2.91 1.22 
Patient: Provider (i:h)  𝜎𝑖:ℎ
2 /154= 8.64/154= 0.056 0.02 
Coder * patient: Provider (ri:h)  𝜎𝑟𝑒𝑠
2 /(4*154)= 9.50/4*154= 0.015 0.006 
Total  238.48  
Source of variability Variation component Variance % 
Provider/TB clinic (h) 𝜎ℎ
2= 8.27 98.6 
Coder (r) 𝜎𝑟
2/4= 0.025/4= 0.006 0.07 
Coder * Provider (rh)  𝜎𝑟ℎ
2 /4= 0.446/4= 0.111  1.32 
Patient: Provider (i:h)  𝜎𝑖:ℎ
2 /154= 0.031/154= 0.0002 0.002 
Coder * patient: Provider (ri:h)  𝜎𝑟𝑒𝑠
2 /(4*154)= 0.838/4*154= 0.001 0.01 
Total 8.39  
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The results of the G-study indicate that the fidelity index reliably differentiates between 
providers based on their Adherence to BI content and the Quality of interaction. Percentage 
variance contributed by the providers was significantly high (98.5 for Adherence and 98.6 for 
Quality) accounting for other sources of variation.  
Sensitivity analyses for the g-coefficient 
Crude intra-cluster correlation (ICC) of provider differences 
For Adherence: 
𝜎ℎ
2= 248.99, Residual= 98.27 (determined from variance partitioning) 
ICC= 𝜎ℎ
2/𝜎ℎ
2 + 𝜎𝑟𝑒𝑠
2  (formula for calculating ICC) 
ICC=              248.99          = 0.72 
 248.99 + 98.27 
For Quality: 
𝜎ℎ
2= 8.62, Residual= 3.56 (determined from variance partitioning) 
ICC= 𝜎ℎ
2/𝜎ℎ
2 + 𝜎𝑟𝑒𝑠
2  (formula for calculating ICC) 
ICC=              8.62              = 0.71 
     8.62 + 3.56 
 
Note: These were calculated after excluding the consensus scores; therefore the numbers differ 
slightly from variance partitioning presented in Table 7.11 and 7.12 above. 
 
These results indicate that 72% (for Adherence) and 71% (for Quality) of the variation was 
contributed by providers in fidelity measurement, when other sources were not accounted for in 
the model. 
G-study excluding consensus scores 
For Adherence: 
g=                                      227.14                                        = 0.973 
       227.14 + 2.77/3 + 9.41/154 + 15.34/3 + 11.24/3*154   
For Quality: 
g =                                      8.126                                        = 0.974 
       8.126+ 0.008/3 +2.736/154 + 0.578/3 +1.008/3*154   
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G-study excluding providers with very low fidelity 
Further exploration of the variation in A and Q scores by providers (TB clinics) is presented in 
Table 7.13 and Figure 7.5. Based on these statistics, those providers having very low or zero 
scores were excluded from primary analysis for this sensitivity analysis.  
For A scores, the providers having a minimum score of 10 or less on any single session were 
excluded from the analysis (i.e. providers 4, 7, 24, 26 and 27). For the Q scores, most providers 
had 0 as the minimum score; therefore, selection was restricted to a maximum score of 5 or less 
out of the total of 16, to qualify for exclusion from the sensitivity analysis (i.e. providers 4, 7, 21, 
22, 24, 26, 27, and 28). G-study estimates after excluding these providers were as follows. 
For Adherence: 
g =                                      109.02                                                = 0.979 
           109.02 + 2.008/4 + 3.07/154 + 6.88/4 + 9.71/4*154   
For Quality: 
g =                                      9.67                                                  = 0.979 
       9.67+ 0.0468/4 +0.014/154 + 0.785/4 +1.228/4*154   
 
Table 7.13: Descriptive statistics of the A and Q scores by providers 
Provider 
 (TB clinic) 
Adherence score Quality score 
Mean (95% CI) Min Max Mean (95% CI) Min Max 
2 47.50 (43.79-51.21) 33 72 0.72 (0.14-1.31) 0 8 
3 43.85 (41.40-46.30) 29 61 7.98 (7.39-8.56) 4 11 
4 14.83 (12.87- 16.79) 0 22 0 0 0 
5 37.86 (33.74-41.98) 15 55 2.75 (2.38-3.12) 1 6 
7 17.06 (15.26-18.85) 9 29 0 0 0 
8 62.94 (59.51-66.36) 51 71 4.13 (2.55-5.70) 1 11 
9 59.23 (56.91-61.54) 43 72 2.33 (1.53-3.12) 0 10 
11 34.13 (29.20-39.05) 14 75 2.13 (1.36-2.89) 0 8 
19 43.06 (40.36-45.77) 29 57 11.06 (10.00-12.13) 5 15 
20 54.02 (52.11-56.29) 38 70 2.50 (1.57-3.43) 0 10 
21 35.16 (30.12-40.20) 14 61 0.81 (0.48-1.15) 0 3 
22 24.85 (20.72-28.98) 13 69 0.75 (-0.05-1.55) 0 10 
23 48.56 (42.64-54.48) 11 72 3.19 (2.22-4.15) 0 10 
24 11.17 (8.62-13.71) 1 21 0.04 (-0.04-0.13) 0 1 
25 31.85 (29.80-33.90) 15 42 1.53 (0.93-2.12) 0 6 
26 13.05 (11.18-14.92) 0 20 0.10 (-0.04-0.24) 0 1 
27 21.33 (17.96-24.69) 10 45 0.28 (0.08-0.47) 0 2 
28 34.19 (31.88-36.51) 17 46 0.67 (0.45-0.88) 0 2 
Note: Grey shaded statistics show lower fidelity 
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Figure 7.5: Mean A and Q scores by providers 
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7.5 DISCUSSION 
7.5.1 Summary of findings 
The three types of reliability tests performed on the fidelity index found that it was a reliable 
tool. The inter-coder reliability showed that the fidelity index was a stable tool that could be 
reliably scored by coders with varying skills and expertise. The Krippendorff’s alpha was 0.80 for 
Adherence, which is considered good and 0.66 for Quality, which is considered moderately 
acceptable. The items were coherent (as assessed by PCA) in measuring fidelity, overall and 
separately, for both Adherence and Quality. Item loadings from PCA across all 45 items showed 
that 52% of the variance was explained under a single construct (i.e. fidelity); 60% under 
Adherence for 37 items and 91% under Quality for eight items. This showed that the majority of 
the items were measuring a common construct. Seven items (1, 10, 12, 15, 16, 37 and 39) did not 
load well on single component and multi component extractions for the sub-indices on PCA. The 
G-study indicated that the index was highly reliable in differentiating between providers, based 
on their fidelity. The ICC estimates for the providers showed that more than 70% of the variation 
was contributed by the differences between providers’ practice of delivering the BI. 
Findings from each type of reliability testing are separately discussed below. 
7.5.2 Inter-coder reliability 
Items 12 (eliciting a prompt commitment to quit), 39 (explaining expectations regarding 
treatment) and 40 (providing reassurance) had an alpha score of α < 0.67 and also showed little 
observed variance in univariate analysis. Low variance alone showed that there was very little 
variation in the item and that the evaluated providers did not really differ.  
In addition to little observed variance, items 39 and 40 also showed a floor effect (very close to 
the lowest value). Floor and ceiling effects are indications that the item was not separating 
between the objects that were evaluated; all were good or bad. However, there is the potential 
that asking for less extreme (or more extreme) response alternatives would result in variation. 
That is, this could be an indication that the items were just "mis-calibrated" for the sample (too 
easy/ too difficult). Another alternative explanation for little observed variance with or without 
floor/ceiling effects could be that the item was not really relevant.  
When data was explored for causes of the floor effect, it was found that all the providers scored 
very low on these items and the coders agreed on this (coded ‘0 for not implemented’ in case of 
items 39 and 40; and ‘2= fully implemented’ in case of item 12). Therefore, it could be interpreted 
for items 39 and 40 that most providers did not adhere to these ingredients of the BI. It is 
worthwhile noting here that the lower Kripendorff’s alpha agreement between coders for these 
three items was because of the lack of variation (due to data being rated similarly), and not due to 
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the lack of agreement between the coders. Hence, these should not be excluded from the index 
based on the results of the inter-coder reliability, but should be explored in future analysis.  
In addition, items 22 to 28 and item 38 (relating to identification and management of the 
triggers) showed lower agreement (Krippendorff’s α ranging from 0.61 to 0.66) between the 
three coders. However, these items did not have little observed variance or floor/ceiling effects. 
When consensus scores were included as the fourth coder in analysis, these items showed higher 
agreement (α > 0.67), indicating that they had the potential of being particularly amenable to 
consensus exercise (described in 7.3.4, page 116). This raises the question of whether a consensus 
round of coding fidelity indices has an added value. As there is discrepancy in agreement 
estimates with and without consensus scoring, I believe that these scores should not be included 
in any kind of psychometric assessments of an instrument (fidelity index). However, these scores 
might still have value for use in regression analysis to explore the relationship of fidelity with 
quit rates (study C). An intervention evaluation study conducting fidelity measurement, where 
the focus is not on assessing psychometric properties of the measure, could benefit from 
consensus scores, as these are highly likely to be more accurate (based on judgements of three 
coders), compared to scoring by a single coder.     
This might be because the consensus was a process of convergence between the coders after 
resolving disagreements on independent ratings and when included in analysis showed higher 
agreement. It might also be that these items were more subjective, as they required tailoring to 
patient needs and were therefore more difficult to judge by the coders. Alternatively, these items 
might have been reflective of more than one underlying construct of the fidelity index. The rest 
of the items showed consistent results after excluding the consensus scores.  
7.5.3 Principal Component Analysis 
Item loadings for the fidelity index under a single component 
Items (10, 12, 15, 16, 37, 39 and 40) did not load well overall for the fidelity index (Table 7.5) and 
could be explained as: 
 Those items that showed little variance between the providers as these were ‘not 
implemented’ by the majority of them in this study. These (items 16, 37, 39 and 40) were 
rated consistently as 0= ‘not implemented’ by all coders. Item 16 was about setting the 
quit date, 37 was offering the BI leaflet, 39 and 40 were about explaining treatment 
expectations and providing reassurance. Out of the 154 audiotaped sessions, the numbers 
rated as ‘0’ (not implemented) for items 16, 37, 39 and 40 were 101, 122, 152 and 139, 
respectively. It could not, therefore, be concluded that these items were coherent or not 
with the rest of the items in the fidelity index.  
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 Items not loading well in spite of being implemented by majority of the providers. These 
were items 10, 12 and 15, relating to assessments of patient motivation/willingness to 
quit and nicotine dependency. These items might not be relevant to fidelity or these 
might indicate that the providers did not differ in their practice based on these items; that 
is, they implemented them in a standard way. These items seem to be describing 
something different from the rest of the 42 items of the fidelity index and would be 
candidates for dropping from the index.  
Note: For a full list of items of the fidelity index, see Appendix C.3. 
Item loadings for Adherence and Quality separately (single component extraction) 
Again, items 16, 37 and 39 could be explained not to have loaded well on a single construct due 
to being rated consistently across coders (Table 7.6) and items 10, 12 and 15 seem to be 
explaining something different from the rest of the 34 items in the Adherence sub-index.  
One peculiar finding from the item loadings, when performed separately for the two sub-indices, 
was that item 40 ‘providing reassurance’ (which did not load on the overall fidelity index) loaded 
well when extracted separately for the eight items under the Quality of interaction. The little data 
available on 15 audiotapes out of 139 consistently entered ‘0’s (not implemented) across the 
coders, showed that this item measured an aspect of Quality of interaction similar to the rest of the 
seven items in this sub-index. However, this item does not have much in common with the 
Adherence set of items and since those items are in the majority in the full index, which could be 
why the loadings of item 40 in the overall index analysis were lowered.   
Item loadings for Adherence (multiple components extraction) 
The five components (Table 7.8) extracted for Adherence could be matched roughly to five of the 
seven key features of the BI (see section 6.3, page 78). These BI features were ‘information about 
harms of smoking/benefits of quitting’; ‘assessments of dependency’; ‘preparation to quit’; 
‘management of triggers’; and of ‘withdrawals’. The rest of the two features concern 
‘Ascertaining about tobacco use’ and ‘Offering the BI leaflet’ represented by items 1 and 37.  
Item 1, although implemented by the providers, did not load well on any component and this 
might be explained by looking at its content within the BI. This item related to the ‘smoking 
behaviour and history’, which is part of a very general BCT concerning ‘information gathering 
and assessment’. It did not seem to measure the same thing as the rest of the items under 
Adherence and it did not explain enough variation within the sub-index to qualify as a separate 
component. Item 1 would be a candidate for dropping from the fidelity index on this basis. 
Item 37 ‘offering BI leaflet’, as discussed above, was rated as ‘0’ consistently by all coders, as it 
was not implemented by the providers and therefore did not have enough variance (or 
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information) to qualify as a separate component in the Adherence sub-index. On this basis, item 
37 should be kept in the fidelity index for determining item loading in other settings and overall 
index generalisability in future studies. 
Note: For a full list of items of the fidelity index, see Appendix C.3. 
7.5.4 G-study 
The crude ICC (0.70) showed less variation being explained by the providers than the variance 
estimates (Adherence = 0.985 and Quality = 0.986) from the G-study. This could mean that 
accounting for other sources of variance in the G-study allowed for a better estimate of each 
source’s contribution to the overall variation, whereas in the ICC the rest of the 30% variation 
was residual and could not be partitioned.  
7.5.5 Refinement of the fidelity index 
The focus of my study was not to produce a more parsimonious index but was to screen the items 
and describe their stability. However, some items did not load well on the PCA and these results 
can be used to eliminate redundancy in the items of the index. For index refinement, using 
psychometric findings, two things are considered important: items that were easily agreed upon 
by all coders and that also represented Adherence/Quality dimensions of the fidelity index as 
broadly as possible. 
Based on the results from the PCA, items 1 ‘smoking behaviour and history’, 10 ‘assessing the 
current level of motivation to stop/ willingness to quit’, 12 ‘Eliciting a prompt commitment from 
the smoker on starting the quit attempt’ and 15 ‘nicotine dependency’ might be considered for 
exclusion from the fidelity index. These were the items that did not load well, in spite of being 
implemented by the majority of the providers. Items (16 ‘setting quit date’, 37 ‘offering BI leaflet’, 
39 ‘explaining expectations regarding the intervention programme’ and 40 ‘providing 
reassurance’) that did not load well due to little observed variance (due to being coded similarly 
or ‘not being implemented’ by majority providers) showed weaker inter-coder reliabilities. These 
items might be useful in other contexts and therefore, worthwhile to be explored further.   
7.5.6 Limitations and challenges 
Limitations that cut across Study B and Study C are discussed in Chapter 9 (page 185). However, 
those limitations that are more specific to Study B and the challenges encountered during study 
set-up and data collection are presented here.  
Firstly, audiotaping was chosen for observation in this study because it was less intrusive, more 
feasible and more affordable than using videotaping. Videotaping allows examination of non-
verbal cues in patient-provider interaction (Borrelli, 2011), providing better information on 
Chapter 7- Validation of Fidelity Index
148 
 
patient-provider interaction to the overall variation in fidelity. However, given that the BCTs 
used in the fidelity index require some degree of verbalisation (e.g., ‘advise on,’ ‘facilitate,’ ‘offer’), 
video recording was less likely to add much information to the data collected in this study 
(Lorencatto et al., 2013a, Lorencatto et al., 2013b). This assumption is supported by the data 
from the current study, where it is evident that the Adherence items which required a higher 
degree of verbalisation (e.g. advise, facilitate, offer) scored better than the Quality items (e.g. 
build rapport, reassure, emphasise client choice and tailor interaction etc.), which were scored 
rather low. Videotaping might have benefited in picking up these more subjective and possibly 
non-verbal cues of the patient-provider interaction. This should be potentially explored in future 
studies using conversation analysis (an approach to studying social interaction, embracing both 
verbal and non-verbal conduct) on videotaped patient-provider interactions. 
Secondly, audiotaped BI sessions were directly coded from Urdu/Punjabi to English on the 
fidelity index. The standard for coding multi-language data is to transcribe all sessions and 
translate into English before coding (Small et al., 1999). However, the high costs and time 
required for translation and transcription of 154 audiotapes ranging from 30 to 50 minutes in 
duration was not possible within the resources allocated for this study. Besides, the coders in my 
study were bilingual and the coding process was more objective using the fidelity index than 
coding of BCTs from audiotapes. In the latter case, there might be more subjective judgements 
made for coding; therefore transcription and translation would seem to add value.  
Thirdly, the individual items in the index were not weighted for their relative contribution to the 
overall fidelity that would be measured by implementing the index. This was not possible to 
establish as part of the current study, due to design limitations (that is, cross-sectional data and 
small sample to item ratio). However, in future longitudinal studies the relative effectiveness or 
weight of each item might be determined where data on fidelity and longer term quit are 
captured. Until then, fidelity scores obtained by implementing the fidelity index should be 
standardised for the number of items in each sub-index, before using in inferential statistical 
models. 
Fourthly, there are limitations to inferences drawn from the generalisability analysis. The study 
might have missed contextual factors that could contribute to the overall variance. Such macro-
or meso-level contextual factors were not considered in this study, even though multiple sources 
of variance were accounted. These could be factors external to the intervention or even the 
intensity of training given to the coders or providers that (if included in analysis) would reduce 
the variance for the accounted sources. Furthermore, the coders’ rating and patient-provider 
interaction sessions contributed very low variance compared to the providers. It is unlikely that 
the low variance could be due to very consistent rating among the coders or their intense 
training and monitoring during coding. Besides, these differences were quite large and less likely 
to be ruled out, even if the coders had received intense training and had been monitored strictly 
during coding. To strengthen the findings of the G-study, a series of sensitivity analysis were 
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performed. The estimates of g-coefficients remained highly reliable after excluding the consensus 
scores and also after excluding the providers with very low fidelity.  
Finally, carrying out the fidelity study involved certain challenges, some of which led to 
deviations from the original study plan.  
The biggest challenge encountered was the unfortunate flooding of both Jhang and Sargodha 
districts due to the heavy and extended rainfall in India and Pakistan in September 2014. It not 
only displaced people (including patients enrolled in this study) but also led to a halt in all TB 
related care and activities. The TB clinics (most of which were flooded) could not resume 
activities for another six months. In addition, all health care workers (these include the providers 
in this study) were instated by the District Health Officer to conduct polio and measles 
campaigns and other necessary activities to help recovery from the floods in the area. The 
original plan was to collect self-reported quit status for the enrolled patients, verified using a 
Carbon Monoxide (CO) breath test. This would have provided prospective data for explaining 
variation in quit rates for Study C, and also to further test the predictive validity of the fidelity 
index as part of its psychometric testing (in Study B). However, these aspects of analyses were 
not actualised, due to not being able to follow-up study patients.  
The second challenge was that the new research officer (hired for data collection in Sargodha) 
conducted a few BI sessions by himself, hoping that this would expedite the data collection. This 
was a deviation from the protocol and led to exclusion of ten audiotaped sessions from the 
analysis. However, further supportive supervision prevented such events from occurring for the 
rest of the data collection period. 
Some technical challenges in recording sessions and transferring data were experienced. Initially, 
the plan was to upload audiotapes from the field via Google Drive (recommended by the IT 
support at the University) shared with the lead researcher. However, the audiotapes were too 
large to be uploaded and therefore, encrypted USB drives and secure cabinets for storing these 
(at the District Health Offices) had to be arranged. Other technical challenges involved 
recharging batteries, because there was no secure area in the clinic where the providers could 
leave the recorders to charge. They were then given extra alkaline batteries to use when the 
rechargeable batteries ran out. Furthermore, background noise was an issue in initial recordings 
as the TB clinics were very busy, even though the type of digital recorder used was designed to 
minimise surrounding noise. Therefore, the providers were advised to carry out the BI sessions 
in a separate and quieter place, which was also important to emphasise patient confidentiality but 
not always feasible. Although the audiotaping and transfer of data was pilot tested before starting 
the study, these issues only became apparent during the actual data collection in study sites. In 
future studies using observation methods for intervention fidelity, it is advisable to do pilot 
testing of procedures and equipment in the same settings/clinics where actual study data is to be 
collected.  
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7.6 CONCLUSION 
The devised index is a comprehensive and psychometrically reliable research tool for measuring 
fidelity to delivery of a BI for smoking cessation. Comprising 41 items under Adherence to content 
and Quality of interaction, (both aspects to capture intervention fidelity), it appears to be highly 
reliable for application by different coders with varying qualifications and skill sets. Moreover, 
the items (i.e. the theoretically informed ingredients of the BI) coherently measure a single 
construct; the intervention fidelity. In addition, the index reliably differentiates between 
providers capturing their variation in the practice concerning BI delivery.  
Items 16 ‘setting quit date’, 37 ‘offering BI leaflet’, 39 ‘explaining expectations regarding the 
intervention programme’ and 40 ‘providing reassurance’ of the fidelity index need further 
exploration in future studies, due to not being implemented by majority of the providers in this 
study so they could not be investigated definitively. 
Researchers are encouraged to use the fidelity index in future prospective studies evaluating BIs 
of smoking cessation for further validation and refinement. The fidelity index in this study was 
designed using taxonomies for smoking cessation; however, some of the BCTs are overarching 
with other healthy life-style behaviours, providing an avenue of exploring its use in similar BIs, 
in general.  
 
  
 
Chapter 8. Study C: Explaining Variation in Quit Rates 
This chapter describes the third study in a series of linked studies. In the previous two chapters, I described 
the methods used to develop a fidelity index (study A) and an observational study to test its psychometric 
properties (study B). The output of these two studies was a new measure of fidelity, validated for content 
and for psychometric properties- the fidelity index. The study presented here (study C) explores how scores 
obtained using the fidelity index can be used to explain variation in quit rates observed in the ASSIST 
study. 
The psychometric properties of the fidelity index tested in study B were found to be good. The 
index was reliable in its ability to be used by ‘amateur’ coders, measure the same construct (i.e. 
fidelity) and differentiate between providers based on their delivery of the BI. This last property 
of the index suggests that its scores can be used to explain variations in quit rates between 
different providers. Fidelity scores are considered implementation outcome variables (Peters et 
al., 2013) in studies where fidelity is the primary outcome. These are also used as the 
intermediate variables (Brownson et al., 2012, Proctor et al., 2011) in intervention-outcome 
research for interpreting the differential effect of complex interventions (Brownson et al., 2012, 
Proctor et al., 2011). In this study, fidelity score is used as an intermediate variable for exploring 
variation in quit rates. 
I used the prospective Fidelity study (study B) to test the psychometric properties of the index, 
derive fidelity scores and to explore any association between these scores and variation in quit 
rates (study C) observed in the ASSIST study (Appendix B), illustrated in Figure 8.1. This 
approach is supported by publications on refinements to the MRC framework (Campbell et al., 
2007b, Craig et al., 2008), and allows resources to be used efficiently to answer several research 
questions simultaneously. I took Fidelity study as the starting point (T1- in 2014) as my data is 
retrospectively linked to ASSIST study in the past (T2- in 2010).  
This chapter provides the background literature to inform study methodology, the methods used 
and results obtained for the secondary investigation to see if fidelity to a BI measured in 
providers (in study B), now explains residual variation in quit rates in the ASSIST study 
conducted four years earlier, but delivered by the same providers in the same settings.  
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Figure 8.1: Outline of secondary investigation -study C 
8.1 BACKGROUND 
I first outline the literature to inform the assumptions made while combining data from two 
different studies and the justification for the statistical methods used to assess the effect of fidelity 
on quit rates.  
8.1.1 Secondary analysis of existing data 
Secondary data analysis is a well-established methodology (Smith et al., 2011). Broadly speaking 
it is the analysis of data collected by someone else (Boslaugh, 2007, Koziol and Arthur, 2011). It 
can include any data that are examined to answer a research question other than the original 
hypotheses proposed in the study (Vartanian, 2010). For the current investigation, the data were 
not collected by someone else but by the members of the same research team, which can confuse 
it with primary data analysis (Cheng and Phillips, 2014). To clarify the approach undertaken, the 
term ‘secondary analysis of existing data’ is more befitting because it avoids the confusion of 
trying to decide whether the data used in an analysis is ‘primary data’ or ‘secondary data’ (Cheng 
and Phillips, 2014). 
Secondary analysis is commonly used on data from sources like national surveys, institutional 
records, websites and journal supplements etc. (Koziol and Arthur, 2011), which are usually large 
population-representative samples. In the current study, the datasets used were not population-
wide samples; however, they might be representative of patient-provider interaction in routine 
TB care settings in LMICs. In addition, ASSIST was a cluster RCT, of which the Fidelity study 
was a follow-on cross-sectional acquisition of data from the same settings and providers. The 
data from the ASSIST study is likely to be higher quality, given its robust design and 
biochemical verification (CO breath tests) of quit rates. Other advantages of using existing data 
in this study include; the data being clean (having been analysed for RCT reporting before) and 
my understanding of the data (having been involved in data collection for the ASSIST study). 
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There are two general approaches to analysing existing data; the ‘research problem driven’ 
approach and the ‘data driven’ approach (Cheng and Phillips, 2014). For the current study, data 
from the ASSIST study were used in conjunction with Fidelity study to answer an a priori 
research question, which has advantages over unplanned post-hoc or data-driven analysis 
(Curran-Everett and Milgrom, 2013). 
8.1.2 Analysing clustered data 
Repeated measures in longitudinal studies, multiple measures on the same subject, or studies in 
which subjects are grouped can lead to clustered data (Kirkwood and Sterne, 2003). Clustering of 
data might be necessary in pragmatic intervention or educational studies, where patients or 
students are clustered within clinics/schools. However, the statistical precision in analysing such 
data decreases, because the individuals within groups tend to be more similar, giving less unique 
information (Koziol and Arthur, 2011). Different statistical approaches exist for analysing 
clustered data (Kirkwood and Sterne, 2003): 
1. Calculating summary measures for each cluster, and analysing these summary 
measures using standard methods; 
2. Using robust standard errors to correct standard errors for clustering; 
3. Using random effects models, which explicitly model the similarity between 
individuals in same cluster; 
4. Using generalised estimating equations (GEE) which adjust both for standard 
errors and parameter estimates to allow for clustering. 
The data (described in 8.3.1) used in the current study is hierarchical, that is, individual patients 
are clustered within TB clinics (providers). Often such data can be analysed using multi-level 
models (2, 3 and 4 above), which are the recommended approach for dealing with data from 
complex sampling designs (Koziol and Arthur, 2011). However, in this study, individual patients 
were different at T1 and T2, even though the providers were the same individuals. This prevents 
linking of data at the individual level, allowing only cluster level (providers) linking of data 
between the two studies.  
8.1.3 Retrospective linking of data 
Secondary analysis of data merged from experimental trials and post-trial sources is often used 
for health services delivery research (Peters, 2009). However, it must be emphasized that these 
analyses are correlational and not causal (Nelson et al., 2012).  
Contrary to the original plan, I was unable to collect prospective data on quit rates in the Fidelity 
study, due to flooding in the study area (see above 7.5.6). These data would have been used for 
validating the retrospective quit rates from the ASSIST study and strengthened the case for 
causal inference from the association of fidelity with the quit rates. Therefore, the fidelity data at 
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T1 (Fidelity study) had to be retrospectively linked to quit rates at T2 (ASSIST study) to 
investigate the set study objectives (see 8.2); assuming that the provider practice remained 
unchanged over time. Ideally, providers would reproduce the exact conditions in Fidelity study at 
T1 as implemented originally in the ASSIST study at T2. However, learning by experience or 
training, recall bias, and true changes may have occurred in provider practice since the BI 
implementation in the ASSIST study, leading to fidelity at T1 being different from T2 (Engel 
and Schutt, 2012). This assumption needs to be tested for scientific plausibility, of retrospectively 
linking fidelity scores, by comparing an indicator of providers’ practice that was common 
between the two studies.  
The patient assessment questionnaire was administered in both studies (Appendix D.3), which 
included a self-record checklist (on content delivered for the BI) that was filled by the providers 
at both T1 and T2 (see Table 8.1 for checklist content). This self-record checklist of the 
providers might be used to establish the consistency in their practice behaviour between T1 and 
T2, and strengthen the case for linking data retrospectively. Potential tests to check consistency 
in provider behaviour (practice scores) between T1 and T2 are discussed below. 
Retrospective linking of data from multiple sources in the two studies is illustrated in Figure 8.2. 
 
Figure 8.2: Retrospective linking of data from multiple sources 
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8.1.4 Consistency in provider practice behaviour over time 
The degree to which these two measurements (practice scores) are related to each other could be 
checked by the test–retest reliability of the measure (Engel and Schutt, 2012). Test-retest reliability 
can be used to measure consistency over time or absolute agreement on a set criterion between 
two time-points. Decisions regarding the test for examining provider practice behaviour between 
T1 and T2 are dependent on whether to measure ‘absolute agreement’ or ‘consistency’ (Streiner 
and Norman, 2008).  
‘Absolute agreement’ is commonly used when a group of people rank something against an 
external set criterion e.g. students’ measurements of blood pressure when tested for accuracy 
against values obtained by an expert (Streiner and Norman, 2008). ‘Consistency’, on the other 
hand, has better value in determining whether the rank ordering for something among a group of 
people was the same when repeated (Streiner and Norman, 2008). The Kappa statistic, ICC 
(Streiner and Norman, 2008), and Altman and Bland method (Bland and Altman, 1986, Bland and 
Altman, 1999) are often used for absolute measure of agreement for test-retest reliability. 
However, in this study, testing whether the ordering of relative performance of the providers is 
preserved overtime is deemed important. Therefore, methods for agreement relative to the 
performance of providers at T1 and T2 are explored further.  
The practice score of the providers is a continuous summary (of patients) for each provider. 
When there are paired measurements (same provider at T1 and T2), the Pearson (product 
moment) correlation coefficient ‘r’ can be applied (Kirkwood and Sterne, 2003). If the variable of 
interest is not normally distributed, then its counterpart non-parametric tests (Kendall’s tau and 
Spearman’s rank correlations) can be used (Kirkwood and Sterne, 2003). Spearman’s rank 
correlation calculates ‘r’ between the ranks given to values of practice scores at T1 and T2, 
rather than between the original practice scores at T1 and T2, as Pearson’s r does. Kendall’s rank 
correlation (tau) compares the ranks of scores at T1 and T2 between each pair of observations for 
concordance (degree of similarity in a pair) and discordance (degree of dissimilarity in a pair). It 
simply calculates the ranks given to values of practice scores at T1 and at T2, such that higher 
values (and lower values) at both time-points are correlated, rather than pairing these values for 
the same providers. These rank tests might not be appropriate for checking concordance for the 
same providers paired at T1 and T2.  
A slightly different version of Kendall’s rank correlation is Kendall's W, also known as Kendall's 
coefficient of concordance (Kendall and Smith, 1939), which measures associations between 
ratings. It is a normalization of the statistic of the Friedman test used for one-way repeated 
measures analysis of variance by ranks and ranges from 0 (no concordance) to 1 (complete 
concordance), similar to other reliability coefficients. The procedure allows ranking of pairs of the 
same providers (depending on how the data is setup) and then considering the values of ranks by 
T1 and T2. Therefore, Kendall’s W seems to be the most appropriate test for checking if the 
ordering of provider practice was preserved over time. 
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8.2 AIMS OF STUDY 
The main purpose of the secondary investigation, in this study, is to assess whether fidelity index 
can be used to explain the variation in quit rates and to generate hypotheses for interpreting the 
effects of the BI on its cessation outcomes (refer to Figure 4.1: Interpretive Evaluation Model, 
page 55).   
Therefore, the study aim is;  
“To explore whether fidelity to a BI explains variation in quit rates” (described above in 5.2). 
The specific objectives of study C are to: 
 Describe intervention fidelity to the BI used in the ASSIST study 
 Assess provider consistency in practice behaviour over time 
 Explore any association between provider fidelity to the BI and the patient quit 
rates, to explain the observed variation 
 Explore the relationship between Adherence to intervention content and Quality of 
interaction, to generate hypotheses for appropriate mediation or moderation pathways 
8.3 METHODS  
8.3.1 Datasets 
As noted in Figure 8.2 (above), the data sources within the two primary studies were the patient 
assessment questionnaire, the patient-provider BI session audiotapes and the CO breath test for 
quit status in patients. Figure 8.3 describes the data extracted from each study before merging 
for analysis. The details of the datasets are given below. 
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Figure 8.3: Sources of data collection for secondary investigation 
ASSIST study data 
 Patient assessment questionnaire: contained information (recorded by the provider) on 
sociodemographic, smoking history and nicotine dependency, triggers and withdrawals 
assessments, management strategies offered for triggers and withdrawals (self-record 
checklist by the provider), CO measurement (quit status) at baseline, 1 month and 6 
month. 
*Note: Data were available for 22 providers (intervention arms) delivering BI for smoking 
cessation and 1299 patients.  
Fidelity study data 
 Patient assessment questionnaire: contained information (recorded by the provider) on 
sociodemographic, smoking history and nicotine dependency, triggers and withdrawals 
assessments, management strategies offered for triggers and withdrawals (self-record 
checklist by the provider). 
 Fidelity scores (obtained by implementing the fidelity index): a) Adherence score: 37 
items assessing adherence to BI content, with a maximum score possible of 74. b) Quality 
score: 8 items assessing essential skills or competence to deliver BI, with a maximum 
score possible of 16.  
*Note: Providers delivering BI were the same as in the ASSIST study, delivering the same 
intervention. However, data were available for 19 providers instead of the original 22 (as 
Secondary investigation 
ASSIST study (dataset) 
A. Practice scores (provider) 
- Identifying and managing the triggers to smoke  
- Assessing and managing the withdrawal 
symptoms  
B. Patient characteristics  
C. Patient quit rates 
 
Fidelity study (dataset) 
A. Practice scores (provider) 
- Identifying and managing the triggers to smoke  
- Assessing and managing the withdrawal 
symptoms  
B. Patient characteristics  
C Fidelity scores (from implementing fidelity index) 
- Individual item scores and composite index scores 
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described in chapter 7) and 180 patients. Fidelity scores were available for 18 of the 19 providers 
and 154 patients. 
8.3.2 Data variables 
In this study, some variables were defined based on how these were created in the original 
studies and some new variables were created from the existing ones, to retain their values when 
the unit of analysis changes from individual to cluster level. These were defined here. 
Fidelity scores  
These were the consensus scores (between the three coders) obtained by rating the fidelity index 
against the BI session audiotapes in the Fidelity study. These are composite scores for the two 
sub-indices; 37 items for Adherence with a maximum score (A score) of 74 achievable and 8 items 
for Quality with a maximum score (Q score) of 16 achievable.  
For use in this study, the fidelity scores were standardised by dividing by the number of items in 
each sub-index:  
A score (standardised) = Adherence score/37; 
Q score (standardised) = Quality score/8; 
The standardised A and Q scores were then summarised by computing averages of the scores 
obtained for all audiotaped sessions per provider, ready for merging.  
Patient quit rates 
This was the proportion of patients who quit smoking for each provider. The variable 
‘continuous abstinence’ was created originally in the ASSIST study, which was re-defined for use 
as ‘quit rate’ in the current study. 
Patient quit status was assessed using CO measurements at 1 and 6 month follow-up in the 
ASSIST study. A CO measurement of 9ppm or less classified a patient as quit from smoking 
(West et al., 2005). A binary abstinence measure (Yes/No) was created using this cut-off for both 
1 and 6 month measurements. ‘Continuous abstinence’ (Yes/No) from smoking was created by 
combining the binary abstinence for both 1 and 6 months, such that patients who were abstinent 
at both 1 and 6 months were considered as ‘quit’ and patients who smoked at any of the time-
points (1 or 6 month) were considered as ‘smokers’. The unit of analysis for ‘quit’ was ‘proportion 
quit’ at individual level, as used in the ASSIST study analyses.  
Summarising binary ‘quit’ outcome was not as straight forward as taking an average of all 
patients’ quit for the respective provider, as was the case with continuous variables. Averaging 
binary variables involved creating dummy variables; a variable with value 1 if quit and 0 if not, 
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and a separate variable with value 1 if smoker and 0 if not. The summary of each dummy variable 
(‘quit’ and ‘smoker’) for the respective provider would yield a count when summarised, that is, the 
number of patients who quitted (‘quit’ per provider) and the number of patients who remained 
smokers (‘smoker’ per provider). These count variables could have been used for provider-level 
analysis if the clusters (number of patients enrolled per provider) were equal in size. However, 
the cluster size varied in the ASSIST study between providers, ranging from 49 to 74. If the 
count variables (‘quit’ and ‘smokers’) were summarised at provider-level they would be unable to 
retain the actual unit of ‘proportion quit’, due to the varying cluster sizes. Therefore, to retain the 
unit of analysis (proportion quit) in unequal clusters, binomial proportions were computed for all 
patients per provider (Shoukri and Cihon, 1998).   
The binomial proportion for ‘quit rate’ was defined as “the proportion quit out of the total 
patients per provider”, with values lying between 0 and 1. The numerator for ‘quit rate’ was the 
number of patients who quit in a cluster and the denominator was the total number of patients in 
that cluster.  
Practice scores 
These were the scores representing provider practice behaviour, obtained from the self-record 
checklists used both in the ASSIST study and the Fidelity study (see Figure 8.3). These scores 
were used to check the assumption that provider practice behaviour remained unchanged 
between T1 and T2 to lend more validity to the retrospective linking of the two studies.  
The self-record checklist (see Table 8.1) was integrated for use with the BI flip-chart, by the 
providers, as they delivered behavioural support. It comprised multiple components, some 
representing the urge or symptom in the patient and others representing the management 
strategy for overcoming that particular urge or symptom advised by the provider. For most 
triggers and withdrawals, the number of strategies offered was three, but sometimes the provider 
tailored and offered an extra strategy, not originally part of the intended practice, which was 
coded as ‘other’.  
There were two variables for each trigger and withdrawal (16 in total) in the original datasets; 
however, for the purpose of the current analysis a single score representative of provider practice 
was needed. Therefore, a new composite indicator was created combining these variables to 
represent provider practice for delivering BI to the patient. Although both triggers and 
withdrawals relate to nicotine dependence, triggers are the (psychological) urges or desire to 
smoke and withdrawals are the (actual or physical) signs and symptoms an individual feels when 
they attempt to quit. Hence, separate practice scores were created, one for triggers and one for 
withdrawals, due to the slight differences in definitions of both terms.  
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Table 8.1: Self -record checklist of the provider 
Triggers Strategies to manage 
1 2 3 
Rising in the morning 
(immediately after) 
Take some drink (Juice, 
green tea, lassi) after you 
get out of bed 
Brush your teeth  Go for a walk 
Defecation Take some laxatives 
(Isbagol Husk) at night 
Take newspaper to toilet 
instead of cigarette 
- 
Eating Meals Take a chewing gum Go for a walk after 
meals 
Take a nap after 
lunch  
Relaxing/boredom at 
Home 
Take some dry 
fruit/grams 
Do gardening Have tea, Watch TV  
Seeing others smoking Take a chewing gum Advocate to the friends 
about the smoking 
harms 
Avoid smoker friends 
in the initial period 
Offered smoking  Refuse it straight away  Take chewing gum   Relax and take deep 
breathes 
Intensive Physical/ 
Mental work 
Take dry fruit Relax and take deep 
breaths  
Take small short 
breaks and have tea 
Tension/Anxiety Chat with colleagues Relaxing Exercises Offer Nimaz 
Withdrawals Strategies to manage 
Craving/Desire for 
cigarettes 
Take a glass of juice/ 
cold drink 
 Engage in conversation 
with a friend 
 
Take deep breadths 
and slowly breathe 
out 
Restlessness     
Irritability/ 
frustration/ Anger        
Take a glass of juice/ 
cold drink 
 Engage in conversation 
with a friend 
Take deep breadths 
and slowly breathe 
out 
Cough 
 
Take some throat 
soothers 
 Make a habit of 
morning walk 
Consult doctor if 
cough is troublesome 
Weight Gain  Take more fruits and 
vegetables in your diet  
Exercise daily Make a habit of 
morning walk 
Headache Take a pill for headache Engage in conversation 
with a friend 
Offer nimaz 
Insomnia Exercise daily Offer nimaz Consult doctor if not 
getting better 
Anorexia & 
Constipation 
Take plenty of 
fluids/vegetables/fruits 
Make a habit of morning 
walk 
If disturbing consult 
your doctor 
Indigestion/ Heart 
burn 
Take more fruits and 
vegetables. 
Make a habit of morning 
walk 
Consult doctor if not 
getting better 
 
The following steps were involved in generating the practice scores. 
Step 1 
Number of strategies offered per patient (see Table 8.1) per trigger and per withdrawal was 
combined to create the composite ‘indicator’, such that: 
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 If one strategy was offered for a trigger (or a withdrawal) it was coded as 1,  
 If two strategies were offered for a trigger (or a withdrawal) it was coded as 2, 
and, 
 If three or more strategies were offered for a trigger (or a withdrawal) it was 
coded as 3. 
 If a patient did not have a particular trigger (or a withdrawal), this was coded 
as ‘missing’ so as not to be counted in calculations.  
 If the patient had a trigger (or a withdrawal) but no management strategies 
were offered to them then it was coded as ‘0’ to indicate no management given.  
Step 2 
The sum of strategies offered per patient for all eight triggers and for all eight withdrawals was 
calculated for the indicators, such that: 
 Number of strategies (triggers) = ∑ strategies for Trigger1 to Trigger8;  
 Number of strategies (withdrawals) = ∑ strategies for Withdrawal1 to 
Withdrawal8 
Step 3 
This was the final step for generating the practice scores. The number of triggers and the 
number of withdrawals reported by the patients varied, therefore computing a score that was 
simply a summation of the number of strategies offered to each patient would not have captured 
the provider practice appropriately. As the strategies offered to a patient by the provider were 
relative to the number of triggers or the number of withdrawals that the patient had, it was 
sensible to standardise the indicator created in step 2 by using these numbers.  
Standardising the indicator also had clinical significance because the higher the number of 
triggers or withdrawals the patient had, the less likely they were to succeed in quitting. By 
standardising the indicator, the practice scores that were generated were better representative of 
provider practice, as they measured the self-recorded practice in terms of strategies offered to 
each patient relative to the number of triggers/withdrawals that the patient had. The 
standardisation process is as follows. 
 Total number of triggers (and of withdrawals) was calculated per patient: 
Number of triggers = ∑ Trigger1 to Trigger8 
Number of withdrawals = ∑ Withdrawal1 to Withdrawal8 
 The practice scores were calculated per patient: 
Practice score (T- trigger) = Number of strategies for triggers 
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               Number of triggers 
Practice score (W- withdrawal) = Number of strategies for withdrawals 
                      Number of withdrawals 
Definition of the practice scores 
The numerator for the practice scores (both for T and for W) was any combination of 0 to 23 or 
24; that is, the sum of all those strategies offered to the patient for the triggers/withdrawals (see 
Table 8.1) and the denominator was any range of 0 to 8 (number of triggers/withdrawals of the 
patient). The practice scores ranged between 0 and 3 and can be interpreted as;  
 ‘0’ - when the patient had one or more triggers (or withdrawals) but was 
offered nothing by the provider;  
 ‘1’ - when the patient was offered on average the same number of strategies as 
the number of triggers (or withdrawals) they had;  
 ‘2’ - when the patient was offered on average twice the number of strategies 
than the number of triggers (or withdrawals) they had; and, 
 ‘3’ - when the patient was offered on average three times the number of 
strategies than the number of triggers (or withdrawals) they had. 
The practice scores (both for T and for W) were summarised by computing averages of the 
scores obtained for all patients per provider.  
8.3.3 Data extraction and merging 
The data extracted from the ASSIST study included the binary (Yes/No) patient quit variable for 
1299 patients (for 22 providers) and the 16 variables from the self-record checklist. The data 
extracted from the Fidelity study (as part of my PhD research) included the consensus scores for 
fidelity (both for Adherence and for Quality) for 154 audiotaped sessions (for 18 providers) and the 
16 variables from the self-record checklist for 180 patients (for 19 providers). In addition, patient 
characteristics (e.g. age, gender etc.) collected by administering the patient assessment 
questionnaire were also extracted from both studies. 
Merging data requires a unique characteristic common between the two sources. The variables of 
significance in this study were hierarchical (patients clustered by providers). It was the providers 
who were common between the two time periods and so data were merged by provider IDs. 
8.3.4 Statistical analysis 
Summary statistics of patient characteristics, provider practice scores, fidelity to delivery of BI 
sessions and the variation in fidelity scores (by providers) were computed. Analysis was carried 
out to investigate consistency in providers’ practice behaviour between T1 and T2. In addition, 
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the association between fidelity and quit rates, as well as, the relationship between Adherence 
and Quality scores, were explored.  
All analyses were conducted using SAS (version 9.4, Cary, NC, USA); see Table 8.2, for the SAS 
syntax used in analysis. The methods are described below. 
Patient characteristics 
Patient sample characteristics for both studies (ASSIST and Fidelity study) were summarised for 
variables, including; age, gender, age of initiating smoking, duration of smoking, nicotine 
dependence score, quantity of smoking, form of smoking and quit attempt in the past. Mean (with 
Standard Deviation-SD) and median (with Inter-Quartile Range-IQR) were reported for 
continuous variables and percentages for categorical variables.  
Description of practice scores 
Simple descriptive statistics of the provider practice scores from both T1 and T2 were calculated 
as mean, minimum, median, maximum and variance. Scatterplots of the practice scores from the 
two studies were also generated, both for the triggers and the withdrawals. 
Description of fidelity 
Implementing the fidelity index (as outlined in Figure 8.3) generated data on provider fidelity for 
delivering the BI sessions. Summary statistics of these data to describe the variation in fidelity 
scores and the delivery of the 45 items (BI content) by the providers were reported as follows: 
Fidelity to BI delivery 
The proportion of patient-provider interaction sessions in which different BI ingredients 
(represented by the 45 items of the fidelity index) were delivered was calculated, showing the 
dose of BI delivered. 
Variation in Fidelity  
Intra-cluster variability was computed by taking averages of fidelity scores (both A and Q scores) 
and standard deviations (SD) per provider. An average of the mean fidelity scores across 
providers was taken to calculate the inter-cluster variability.  
Note: Summary statistics for fidelity scores were also presented in Chapter 7 (see Table 7.13 and 
Figure 7.5, pages 142-143) as part of Generalisability study, but these were not standardised 
scores. The fidelity scores used here were standardised for the number of items per sub-index 
(see ‘Fidelity scores’, page 158).  
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Examining consistency in provider practice over time 
For measuring concordance (degree of similarity in a pair) in provider practice scores between 
T1 and T2, Kendall’s W statistic was used, which can be interpreted in a similar way to a 
correlation coefficient r (see Table 8.2, on page 165, for the SAS syntax).  
If there is sufficient concordance between T1 and T2, this would give some empirical support to 
the hypothesis that the way in which the smoking cessation BI was delivered, in the ASSIST 
study, and the Fidelity study four years later, was similar. This would then justify explaining the 
extent to which fidelity measured in the Fidelity study could be used to explore and possibly 
explain variations in quit rates in the ASSIST study (as noted above in 8.1.3).  
Examining association between fidelity and quit rates 
Mean, minimum, median, maximum and variance were calculated for the fidelity scores and the 
quit rates. 2D and 3D plots of quit rates and fidelity scores were also presented.   
Binomial regression was carried out to analyse quit rates (dependent variable) for which fidelity 
scores (independent or explanatory variables), both for Adherence and for Quality, were used to 
explore the variation between providers; logit models with binomial link were considered 
appropriate (Zhao et al., 2001). Crude and adjusted estimates were computed. Odds Ratios (OR) 
and 95% confidence intervals were reported. Unlike logistic regression, estimated relative 
prevalence can be reported from binomial regression. Interaction between Adherence and Quality 
was also explored. However, only a model without considering effect modification yields adjusted 
relative prevalence (see Table 8.2, for the SAS syntax). Therefore, the odds of quitting in patients 
receiving BI were computed for provider Quality of interaction at varying levels of their 
Adherence to content (the A scores), to explain the interaction between these two covariates.  
Examining association between Adherence and Quality scores 
Further, simple linear regression was performed to look at the relationship between the 
Adherence scores and the Quality scores, to hypothesise possible mediation or moderation 
pathways. Non-normally distributed variables were log transformed for a better fit and for 
simpler interpretation of regression coefficients (see Table 8.2, for the SAS syntax). Log 
transformation codes values that are recorded ‘0’ as missing, therefore, Quality scores having ‘0’ 
values for five providers were inputted with ‘0.01’ to keep them in the regression model. 
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Table 8.2: SAS syntax for analytical statistics 
Analysis SAS syntax 
Kendall’s W The syntax (in SAS) used for the MAGREE macro is:  
%inc data A (ASSIST study); 
      %magree(data=A, 
              items=S, 
              raters=R, 
              response=Y); 
 
%inc data B (Observational study); 
      %magree(data=B, 
              items=S, 
              raters=R, 
              response=Y); 
Binomial 
Regression  
/*Crude regression estimates*/ 
proc genmod data=; 
model Number Abstinent/Number Total=Ascore/link=logit dist=binomial; 
run; 
proc genmod data=; 
model Number Abstinent/Number Total=Qscore/link=logit dist=binomial; 
run; 
 
/*Adjusting for Quality*/ 
proc genmod data=; 
model N_ABS/N_TOTAL= ASCORE QSCORE/link=logit dist=binomial; 
ESTIMATE 'OR OF ADHERENCE' ASCORE 1/EXP; 
ESTIMATE 'OR OF QUALITY' QSCORE 1/EXP; 
run; 
 
/*Interaction term*/ 
proc genmod data=; 
model N_ABS/N_TOTAL= ASCORE QSCORE ASCORE*QSCORE/link=logit dist=binomial 
TYPE3; 
run; 
Simple Linear 
Regression 
/*Log transformation of scores*/ 
DATA; 
SET; 
LnASCORE= log(ASCORE);   /* The natural logarithm (base e) */  
LnQSCORE= Log(QSCORE); 
RUN; 
 
/*Crude Regression coefficients*/ 
PROC REG DATA=; 
MODEL LnASCORE= LnQSCORE/ CLB; 
RUN; 
8.4 RESULTS 
8.4.1 Patient characteristics 
The majority of patient characteristics were similar in the two studies (Table 8.3), with higher 
numbers of past quit attempts seen in the Fidelity study.  
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Table 8.3: Participant characteristics in primary studies  
Characteristics Fidelity study ASSIST study 
Number of patients  180 1299 
Men, n (%) 179 (99.44) 1217 (94.78) 
Mean age, years (SD) * 42.92 (13.96) 40.55 (13.13) 
Mean age when started smoking, years (SD) 19.53 (7.87) 20.39 (6.64) 
Mean duration of smoking, years (SD) 23.25 (13.80) 20.22 (12.49) 
Median nicotine dependency score, n (IQR) ** 6.00 (4.00) 6.00 (3.00) 
Median cigarette and hookah smoked per day, n (IQR) 20.00 (10.00) 20.00 (18.00) 
Forms of smoking, n (%) 
Cigarette smokers  
Hookah smokers 
Dual smokers (Hookah + Cigarette) 
 
109 (62.64) 
23 (13.22) 
42 (24.14) 
 
840 (64.67) 
145 (11.16) 
314 (24.17) 
Attempted quit in past, n (%) 92 (51.11) 359 (27.74) 
*Standard Deviation 
** Inter-Quartile Range 
8.4.2 Description of practice scores 
The practice scores (for both triggers and withdrawals) from T1 and T2 concentrated near 1 
(Figure 8.4; Table 8.4), indicating that most providers offered one management strategy to their 
patients for each trigger (or each withdrawal) that the patient reported. 
 
Table 8.4: Descriptive statistics of practice scores at T1 & T2 
Practice scores N Min Median Max Average Variance 
T1 (Fidelity study) 
 
Triggers 
Withdrawals 
 
 
18 
15 
 
 
1.00 
1.04 
 
 
1.06 
1.11 
 
 
1.85 
1.67 
 
 
1.17 
1.18 
 
 
0.05 
0.04 
T2 (ASSIST study) 
 
Triggers 
Withdrawals 
 
 
22 
22 
 
 
1.00 
0.93 
 
 
1.07 
1.11 
 
 
2.77 
2.73 
 
 
1.19 
1.26 
 
 
0.14 
0.15 
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Figure 8.4: Scatterplots of ‘practice scores’ at T1 and T2 
 
Note: 18 and 15 providers completed the self-record checklist for triggers and withdrawals, 
respectively in the Fidelity study. 
8.4.3 Description of fidelity  
Fidelity to BI delivery  
Figure 8.5 is a graph illustrating the fidelity to the BI ingredients delivered overall. On the y-
axis are the BI ingredients (represented by the 45 items of the fidelity index) and on the x-axis 
are the percentages of patient-provider BI sessions. Green bars represent the percentage ‘fully 
implemented’, amber ‘partially implemented’ and red ‘not implemented’; the three response scale 
alternatives (described in 6.8.3) representing functional features of the fidelity index. 
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BI ingredients relating to assessment of nicotine dependence, readiness to quit and past quit 
history were fully implemented in more than 80% of the sessions (Figure 8.5). Information about 
harms of smoking, preparation and planning for the quit date were fully implemented in 30 to 
40% of the sessions. Triggers management was fully implemented in less than 20% of the 
sessions, and withdrawal symptoms management was fully implemented in less than 10% of the 
sessions. However, both triggers and withdrawals management was partially implemented in 30 
to 40% of the sessions. Ingredients relating to the Quality of interaction were the least 
implemented; fully implemented in less than 10%, and partially implemented in 10 to 20% of the 
delivered sessions.  
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Figure 8.5: Fidelity of delivery - percentage of patient-provider sessions delivered by BI ingredient 
  
1 11 21 31 41 51 61 71 81 91
Readiness to quit
Commitment to quit
Past quit
Nicotine dependence
Past history of quit attempts
Reason to quit
Harms of tobacco use: children health
Awarness about forms of tobacco use
Harms of tobacco use: Lung
Harms of tobacco use: $, oral health
Harms of tobacco use: pregnancy
Preparation and planning: hide reminders
Harms of tobacco use: BP and heart
Preparation and planning: social support
Preparation and planning: telling others
Benefits of quitting
Preparation and planning: declaring home smoke-free
Decide on quit date
Set quit date
Smoking behaviour
Trigger management: after rising
Information leaflet
Trigger management: defecation
Trigger management: eating meals
Trigger management: free or bored
Trigger management: seeing others smoke
Trigger management: intense work
Trigger management: offered smoke
Information on withdrawal: craving
Information on withdrawal: indigestion
Quality: Elicit and answer questions
Quality: Reflective listening
Information on withdrawal: restlessness
Information on withdrawal: insomnia
Quality: Emphasise choice
Information on withdrawal: anorexia and constipation
Trigger management: anxious
Quality: Build general rapport
Information on withdrawal: cough
Quality: Summarise information & confirm client decisions
Information on withdrawal: headache
Information on withdrawal: weight gain
Quality: Reassurance
Quality:Tailor interactions
Quality: Expectations regarding BI
Percentage of patient-provider sessions  
Fully implemented Partially implemented Not implemented
BI ingredients 
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Variation in Fidelity 
The average provider Adherence scores ranged from 0.31 (SD: 0.19) to 1.72 (SD: 0.16); a 
maximum score of 2 was possible (Table 8.5). Table 8.5 is arranged by the descending order of 
Adherence scores. The average provider Quality scores ranged from 0 to 1.38 (SD: 0.42); a 
maximum score of 2 was possible. 
The between-provider variability was 0.94 (SD: 0.44) for Adherence and 0.26 (SD: 0.38) for 
Quality. 
Note: Description of the providers was given in study B (see section 7.3.8). 
Table 8.5: Average fidelity scores within and between providers 
Provider 
ID 
Fidelity scores 
Mean (SD*) 
Number of 
patients 
Adherence Quality 
Intra-provider variability 
24 6 0.31 (0.19) 0 (0) 
26 5 0.36 (0.07) 0 (0) 
4 9 0.39 (0.16) 0 (0) 
27 10 0.41 (0.11) 0 (0) 
7 9 0.43 (0.14) 0 (0) 
22 10 0.62 (0.22) 0.03 (0.08) 
25 10 0.82 (0.17) 0.03 (0.05) 
11 10 0.93 (0.43) 0.26 (0.27) 
28 9 0.94 (0.19) 0.08 (0.06) 
21 8 0.96 (0.38) 0.09 (0.11) 
5 9 1.04 (0.36) 0.33 (0.11) 
19 8 1.14 (0.18) 1.38 (0.42) 
3 10 1.19 (0.22) 1.00 (0.22) 
23 8 1.20 (0.41) 0.23 (0.10) 
2 9 1.30 (0.28) 0.07 (0.17) 
20 10 1.48 (0.15) 0.31 (0.36) 
9 10 1.61 (0.18) 0.29 (0.29) 
8 4 1.72 (0.16) 0.50 (0.35) 
Inter-provider variability 
  0.94 (0.44) 0.26 (0.38) 
*SD is the standard deviation of the mean 
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8.4.4 Consistency in providers practice over time 
There was moderate to high consistency in provider practice concerning management of patient 
triggers (Kendall’s W: 0.69, p=0.06) and withdrawal symptoms (Kendall’s W: 0.75, p=0.03), 
between the two studies time-points. Kendall's coefficient of concordance was statistically 
significant for withdrawal management practice and borderline significant for trigger 
management practice, indicating stronger agreement than can be expected by chance alone 
(Table 8.6).  
 
Table 8.6: Kendall’s W for concordance between providers practice at T1 and T2 
Coefficient of concordance Practice score (Triggers) Practice score (Withdrawals) 
Kendall’s W 
(p-value for Friedman test) 
0.69 
(0.06) 
0.75 
(0.03) 
8.4.5 Association of fidelity scores with quit rates 
The median quit rates were 0.48 (range: 0.07-0.72), while the median fidelity scores were 0.95 
(range: 0.31-1.72) for Adherence and 0.09 (range: 0.00-1.38) for Quality (Table 8.7). Figures 8.6 
and 8.7 both do not show a linear relationship between the quit rates and the fidelity scores.  
 
Table 8.7: Descriptive statistics of quit rates and Fidelity (Adherence & Quality) scores 
Variable N Min Median Max Average Variance 
Proportion quit 22 0.07 0.48 0.72 0.43 0.04 
Adherence score 18 0.31 0.95 1.72 0.93 0.20 
Quality score 18 0.00 0.09 1.38 0.26 0.14 
 
 
Figure 8.6: 2D plot of Quit rates by Adherence and Quality scores 
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Figure 8.7: 3D plot of Quit rates by Adherence and Quality scores 
 
The results of the binomial regression (model 1, Table 8.8) indicate that an increase in the Quality 
of interaction with the patient led to a 50% increase in the quit rates by provider and the effect 
estimate was statistically significant (p < 0.05). An increase in the level of Adherence to BI content 
delivered to the patient led to a 24% decrease in the quit rates by provider, although the effect 
estimate was of marginal statistical significance (p = 0.055). 
When adjusted for Quality (model 2, Table 8.8), the association of Adherence with quit rates 
became statistically significant, though remaining negative. When adjusted for Adherence the 
association of Quality with quit rates became stronger (model 2, Table 8.8).  
Table 8.8: Effect of provider fidelity (Adherence & Quality) on patient quit rates 
Independent variable Odds ratio (95% CI) p-value (Wald Chi-Sq) 
Model 1: Crude effects 
Adherence score 0.76 (0.57-1.01) 0.0552 
Quality score 1.50 (1.06-2.12) 0.0226 
Model 2: Adjusted effects 
Adherence score (adj. for Quality) 0.55 (0.40- 0.77) 0.0005 
Quality score (adj. for Adherence) 2.15 (1.43- 3.24) 0.0002 
Model 3: Introducing the interaction term 
Adherence * Quality *- <0.0001 
* The interaction parameter estimate was -7.23 (-9.68 to -4.79), showing a negative interaction of high magnitude 
between Adherence and Quality in explaining quit rates 
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A negative interaction was found between Adherence and Quality (p<0.0001) when the 
interaction term (Adherence*Quality) was introduced (model 3, Table 8.8). This means that the 
association between one of the two co-variates (i.e. Adherence and Quality) and the quit rates 
decreases, if the other co-variate increases (Szklo and Nieto, 2007).  
This interaction was shown for Quality at varying levels of Adherence (Table 8.9), as computed 
from model 2 regression estimates (Table 8.8). These calculations found that at a good Quality of 
BI interaction with the patients, the patient quit rates decreased with increasing levels of 
Adherence for the provider.  
 
Table 8.9: Odds Ratios of quit for Quality of interaction at six levels of Adherence to BI content 
Level of 
Adherence 
(A score) 
Odds of quitting for good Quality at different 
levels of Adherence 
Odds Ratio 
0.31 e 0.2225 + (-0.595*0.31) + 0.765 2.23 
0.59 e 0.2225 + (-0.595*0.59) + 0.765 1.89 
0.87 e 0.2225 + (-0.595*0.87) + 0.765 1.60 
1.16 e 0.2225 + (-0.595*1.16) + 0.765 1.35 
1.44 e 0.2225 + (-0.595*1.44) + 0.765 1.14 
1.72 e 0.2225 + (-0.595*1.72) + 0.765 0.97 
Computation formula for Odds Ratio: e intercept + (log odds of Adherence * level of Adherence) + log odds of Quality 
e is exponentiation of the log odds 
8.4.6 Relationship between Adherence and Quality scores 
The scatter plots of the A and Q scores after log transformation showed better linear fit than 
without the log transformation (Figure 8.8).  
Further exploration of the relationship between Adherence and Quality indicated that a one 
percent increase in Quality of interaction with the patient was associated with a 2.7% increase in 
the level of provider’s Adherence to the BI content (Table 8.10).  
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Figure 8.8: Scatter plots of Adherence and Quality with and without log transformation 
Scatter plot of A score with Q score Scatter plot of log transformed A score with Q score 
  
  
Table 8.10: Association of Quality with Adherence 
Variable β- estimate  
(95% CI) 
p-value R-Square Standard Error 
Quality score* 2.70 (1.90- 3.50) <0.0001 0.76 0.37 
* Both Adherence Scores and Quality scores were log transformed for regression analysis, therefore, β- estimate was 
interpreted as percentage points. 
 
8.5 DISCUSSION 
The findings specific to study C are discussed here, however, any overarching issues between the 
three linked studies (Study A, B and C) are discussed in the final chapter of the thesis (Chapter 9). 
8.5.1 Summary of findings 
Overall, in the BI sessions recorded for the patient-provider interactions, the assessments of 
dependency and motivation to stop (patient questionnaire) were implemented in more than 80% 
of the sessions and the information about the harms of smoking and benefits of quitting in 30 to 
40%. The least implemented ingredients were related to triggers and withdrawals management 
and the Quality of interaction. Intra-cluster variability (i.e. between patients seen by the same 
provider) in fidelity scores was lower than the inter-cluster variability (i.e. between providers). 
Provider consistency in self-recording triggers and withdrawals management showed moderate 
to strong concordance between the Fidelity study and ASSIST study time-points.  
The quit rates observed in the ASSIST study were positively associated with the Quality of 
interaction, but negatively associated with Adherence to BI content observed in the Fidelity study. 
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An interaction was also found between Adherence and Quality in their effect on quit rates, which 
was negative in direction. In addition, provider Adherence to BI content was found to be positively 
associated with their Quality of interaction with the patients. 
8.5.2 Fidelity to BI 
Looking at the overall fidelity of the BI delivered by the providers, it is evident that some of the 
BCTs were better implemented than others. The four behavioural domains that the provider 
‘competences’ taxonomy targets (Michie et al., 2011b) were: (1) addressing motivation; (2) 
maximising self-regulatory capacity or skills; (3) adjuvant activities; and (4) general aspects of the 
interaction: delivery of the interventions, information gathering, or general communication.  
In the current study, the BCTs focusing on maximising self-regulatory capacity or skills and 
those focusing on general aspects of the interaction (including general communication and 
delivery of intervention) were least implemented. These BCTs broadly covered the BI 
ingredients on triggers, withdrawals, the management strategies offered and the quality of 
interaction. The BCTs that were most frequently implemented focused on information gathering 
(general aspects of the interaction) and addressing motivation. These BCTs covered mainly the 
BI ingredients on providing information about the harms of smoking and assessments of nicotine 
dependence, readiness to quit and past quit history.  
These results correspond to the most frequently observed  BCTs, in England’s Stop Smoking 
Services (Lorencatto et al., 2013a). In a fidelity study, Lorencatto et al. (2013a) observed that 
information gathering and assessments and addressing motivation were the most commonly 
implemented BCTs, whereas, maximising self-regulatory capacity or skills and delivery of 
intervention were implemented the least. This suggests a correspondence between the 
implementation of BI by providers in TB clinics in Pakistan with the stop smoking advisors in 
the UK.  
Some of the BCTs in the least implemented group in Fidelity study, (i.e. emphasise choice, 
confirm client decisions, advise on changing routine, and facilitate on relapse prevention) have 
been found to be associated with higher quit rates in the English Stop Smoking Services (Michie 
et al., 2011b). Therefore, these would be considered important BCTs, which if not implemented 
in a smoking cessation BI could have implications on patient outcomes. Most of these BCTs were 
implemented in less than 10% of all BI sessions in the Fidelity study, indicating the need to 
further investigate the factors affecting their implementation. Such factors may include the 
patient’s preferences, or provider competence and motivation.  
It is also a possibility that some of these BCTs were used selectively by the providers depending 
on the needs of the patient. A quantitative measure of BCTs (that need tailoring to patient needs) 
using an adherence scale may portray a simpler image of a rather complex interaction. Therefore, 
it is possible that the provider was delivering a good quality intervention, which did not 
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necessarily comply with the ingredients outlined in the fidelity index, leading to a lower fidelity 
score of the delivery being noted. Future interventions designed for behaviour change should 
consider specifying the BCTs that must always be delivered and those that can be selectively 
delivered. Furthermore, distinguishing between the fixed vs. variable intervention ingredients in 
BI design (Hawe et al., 2004, Durlak and DuPre, 2008, Firpo-Triplett and Fuller, 2012), as 
discussed in 4.1.4 (chapter 4), might address this issue in quantifying BCTs using a fidelity index, 
in future. 
Another factor promoting provider adherence to certain ingredients more than others might be 
related to the recording and reporting of BI ingredients as these were delivered. For example, the 
providers might have considered that the information gathering and assessment questions were 
more ‘important’ because they were required to record this information in the patient 
questionnaire. Although they also self-recorded their delivery of the triggers, withdrawals and 
the management strategies (the self-record checklist), they might still have believed that this was 
relatively not as important as the responses recorded from the patients. It is also possible that 
most of the providers in the Fidelity study found the least implemented BCTs ‘difficult’ to 
deliver. Effort or motivation is determined by both the importance of a task and the difficulty of 
achieving it (Wilson et al., 2015, Brehm and Self, 1989, Brehm et al., 1983). Importance of an 
action determines potential motivation (i.e. the amount of effort the provider is willing to put into 
intervention delivery), whereas, difficulty determines actual motivation (i.e. the amount of actual 
effort provider put into delivering the intervention) (Wilson et al., 2015).  
Interestingly, offering written materials (information leaflet) would be considered an easy to 
implement BCT; however, it was only implemented in about 20% of the BI sessions in the 
Fidelity study. Similarly, ‘setting a quit date’ was often not discussed (only in 35% of the BI 
sessions) which is an important behaviour change strategy for smoking cessation. This may 
partly be explained by these activities being discussed prior to or post audiotaping of the BI 
session, thus limiting their inclusion in fidelity index at the stage of coding. It is likely, given the 
setting of intervention delivery that when the provider identified a smoker TB patient s/he 
confirmed their willingness to participate in the study including if they were willing to quit 
within a week. They might have noted down the quit date prior to starting the audiotaping of the 
session because they mainly perceived the flipbook as the BI session and not the entire 
consultation from greeting the patient to their exit from the clinic. To confirm this finding, the 
data from ‘patient questionnaire’ (Fidelity study) pertaining to setting the quit date was explored 
and it was found that actually 58% of the patients set their quit date as ‘quit from today’, 31% as 
‘quit within 5 days’, 5% did not set a quit date and information was missing for 6% of the enrolled 
patients. The same would apply to the information leaflet (which was not recorded in the patient 
questionnaire) but it was designed to be given at the end of the flipbook interaction and the 
providers might have already stopped the audiotaping by that point, therefore, not capturing the 
Chapter 8: Explaining variation in outcomes 
177 
 
patient-provider interaction in its entirety. Post-analysis interviews with the providers might 
help understand some of these observations better.   
An important observation from these findings is that some of the BCTs delivered by the majority 
of the providers were not stable items in the fidelity index (as discussed in Chapter 7) and were 
found to be redundant on PCA. These items (1 ‘smoking behaviour and history’, 10 ‘assessing the 
current level of motivation to stop/ willingness to quit’, 12 ‘Eliciting a prompt commitment from 
the smoker on starting the quit attempt’ and 15 ‘nicotine dependency’) relate broadly to 
information gathering and assessments. These items were unable to describe enough variation 
under the fidelity construct and therefore might not be good indicators to represent fidelity of a 
BI. Whether these ingredients are also not effective BCTs in the interplay of causal mechanisms 
of behaviour change for smoking cessation, should be explored in future research.  
8.5.3 Consistency in providers practice over time 
Providers’ relative performance concerning BI delivery was found to be broadly consistent 
between the time-points of the two studies, to allow retrospective linking of fidelity scores with 
quit rates. This was based on the analysis of their self-record checklists completed in the two 
studies at T1 and T2. Although their practice was found to be consistent between the two time-
points, a few limitations of using data from a self-record checklist merit discussion here.  
First, the self-record checklists are not objective measures and are less reliable than direct 
methods of observation of provider behaviour (Carroll et al., 2000). Data obtained from such 
measures show low correlations with objectively captured data. However, these are considered to 
be good tools for supplementing objective data in evaluative research and for triangulation in 
analysis (Borrelli, 2011). In this study, the practice scores from the self-record checklist were 
used to test the degree of consistency, in terms of the relative ranking (number of strategies 
offered per trigger/withdrawal) of intervention options by the same providers at the two time-
points. As the scores are repeated measurements from the same providers, there are less chances 
of occurrence of a systematic error even if the providers knowingly self-recorded better practice 
than in the past.  
Second, self-record checklists could have variable completion rates and, when completed in 
patient-provider interaction settings, they have the potential of being completed hurriedly (Bond 
et al., 2000b). Particularly, looking at the self-record checklist (Table 8.1) in this study, providers 
checked (tick marked with a pen) those triggers or withdrawals that the patient had experienced, 
along with the strategies advised to them. When delivering a BI using an interactive flip-chart 
and completing the checklist at the same time, or after session completion, could potentially lead 
to missing information. Moreover, if the provider did not tick an item on the checklist (or forgot 
to do so), it wasn’t possible to confirm whether that item was not delivered or that it was missing 
information. However, in testing the concordance in providers’ relative performance, no 
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systematic differences were found between the two time-points that could have potentially 
invalidated the retrospective linking of data.  
8.5.4 Association of fidelity scores with quit rates 
Patient sample characteristics for the two studies were broadly similar, apart from ‘attempted 
quit in the past’, which was higher in the Fidelity study. This might be because these patients 
were on average 2 years older than the patients in ASSIST study and were smoking for a longer 
duration (on average 3 years) so potentially had more opportunity to try quitting smoking. The 
higher attempts at quitting could also be due to the change in the target population’s awareness 
about tobacco use during the four years in-between. However, at the time of study there were no 
tobacco cessation services being offered at the respective TB clinics or any known (to the 
providers) tobacco-related campaigns in the area. This could have been explored better through 
patient exit interviews or context analysis, which was outside the scope of the current research.  
Better Quality of interaction with the patients could be a non-specific effect, similar to the 
placebo effect, where higher patient quit might be due to the higher satisfaction on part of the 
patient. However, it is unsurprising that the effectiveness of the BI (higher smoking quit rates) 
was strongly influenced by the Quality of interaction with the patients in this study, given its 
development in counselling and clinical practice (Hardcastle et al., 2016). Quality of interaction, 
as measured using the fidelity index, was based on the inter-personal (Roth and Pilling, 2008) 
competences  noted in section 4.1.3 (chapter 4), for delivering a BI for smoking cessation (Michie 
et al., 2011b). A recent systematic review and meta-analysis of intervention fidelity for 
Motivational Interviewing (D O’Halloran et al., 2014), found that interventions with higher 
implementation of inter-personal BCTs produced larger effects on behaviour change than those 
with lower implementation of these BCTs. These data support my study findings and provide 
initial indication that the Quality of interaction with the patient might be paramount to the 
success of a behaviour change intervention for smoking cessation. 
The second important main effect in my model was the level of Adherence of the provider to the 
BI content; the increase in which had a negative influence on patient quit, even when adjusting 
for Quality of interaction. This unexpected finding might be due to any of the several reasons: it 
might be a spurious finding given the deficiencies in study design, or if it was internally valid it 
might not be externally valid, for example, it might just be attributed to an anthropological 
difference in the study population. Alternatively, it might be true that increase in the levels of 
Adherence, which means higher number of ingredients delivered (as measured using the fidelity 
index), actually reduced the effect of BI on patient quit.  
It might be hypothesised that due to the complexity of the behaviour change interventions, 
asking the providers to do too many things and deal with too many dimensions all at the same 
time, might possibly make the intervention longer and a tedious task (Boutron et al., 2008, 
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Sereno et al., 2012). Interventions implemented with higher levels of adherence have been shown 
to be associated with improved outcomes than those with poorer adherence, in other areas 
(Durlak and DuPre, 2008). A fidelity study of smoking cessation behavioural support (Lorencatto 
et al., 2013a) suggested no association of intervention adherence with the patient quit; it was a 
small sample from two smoking cessation service practices in the UK. However, a recent meta-
analysis of intervention theory suggests that “more is sometimes less” when it comes to 
promoting health behaviour change (Wilson et al., 2015), including smoking, diet and physical 
activity. The review (of 150 reports) found that a moderate number (as opposed to low or high 
number) of ingredients in a BI produced the highest level of change in behaviour. It suggests that 
an optimal number of ingredients would be low enough to prevent disengagement while being 
high enough to ensure the necessary level of motivation and effort to maximize compliance, and 
ultimately, change behaviour. Furthermore, the review estimates that intervention efficacy 
begins to decrease when interventions include a large number of behaviour change elements.    
This could also potentially make the intervention complex for the patients to understand and 
absorb the main (or important) take home messages, which should ideally be simpler. A large 
number of BCTs in an intervention are undoubtedly more demanding (Nigg and Long, 2012) and 
may possibly push the human limits of cognitive capacity and self-control (Baumeister et al., 
1994, Muraven and Slessareva, 2003); intervention effect, in such cases, may either plateau or 
decrease when more behaviour changes are required (Ornstein et al., 1993). In future studies, it 
might also be interesting to know the extent to which factors such as patient educational level 
might affect this phenomenon, given the patients in Fidelity study were from rural parts of 
Pakistan with lower than average global literacy rates (UNESCO Institute for Statistics). 
Finally, a negative interaction was found between Adherence and Quality. This interaction was 
explored out of interest to see whether the two co-variates interact because of the positive 
correlation between them (Table 8.10) and it was found that higher levels of Adherence reduces 
the effect of Quality on patient quit. While the interaction between content-based BCTs and 
inter-personal BCTs in the effectiveness of BIs has been implied in behaviour change research 
(Hardcastle et al., 2016), this negative relationship between the two, in terms of smoking 
cessation outcomes, has not been suggested in the past. As noted above, it might be argued that 
increase in Adherence or higher number of ingredients being delivered, reduces the ability of 
high Quality of interaction with the patient to positively affect their smoking quit, that is, volume 
or complexity ‘crowds out’ the effect of a good Quality interaction on quitting. Nevertheless, this 
does not mean that implementing higher number of BI ingredients compromises the Quality of 
interaction but that it attenuates the impact of Quality on patient quit, even though the Quality 
might have remained the same. Furthermore, 100% adherence to BI content has been contested, 
in the past, as a desirable goal for achieving high fidelity (Lorencatto et al., 2013a, Borrelli, 2011). 
A sample of English Stop Smoking Services, with high and moderate quit rates respectively, 
showed similar levels of adherence to BI content across the services (Lorencatto et al., 2013a). 
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The same study suggested that the quality of delivery does not necessarily mean higher 
adherence to content. The service with lower adherence to content (56%), as opposed to the 
service with higher adherence to content (69%), was potentially more effective in achieving 
higher patient quit. This was because the service with lower adherence to content actually had 
better quality of delivery (implementing 10 BCTs on average compared to 7 in the other service).  
8.5.5 Relationship between Adherence and Quality scores 
Providers Quality of BI interaction with the patient was positively associated with their 
Adherence to BI content. This suggests that the providers with better Quality of interaction 
(based on inter-personal BCTs) were more likely to Adhere to the BI content. However, this 
finding is contrary to the reports on these two aspects of fidelity (Adherence and Quality), 
showing low correlations between the two behaviours (Borrelli, 2011, Miller and Binder, 2002, 
Perepletchikova and Kazdin, 2005). This might be due to the way competence to deliver the 
intervention (presence or absence) was defined and assessed in these studies; compared to the use 
of taxonomies to specify content and the behaviourally anchored three point response scale used 
to quantify Quality in the fidelity index, in the current study. Empirically adherence to content 
and competence to effectively deliver an intervention might be considered independent 
dimensions of fidelity but, in practice, these were found to correlate quite highly in the Fidelity 
study. The extent to which these two aspects of fidelity correlate and their intermediary role in 
the mechanism of action of a BI needs to be examined in future research, with appropriate study 
designs and a representative sample.  
The hypotheses (research questions) generated from the preliminary analysis in this study that 
could help direct future research, in connection with smoking cessation, are outlined here and 
discussed further in Chapter 9. 
 What is the optimal number of ingredients (hence the BCTs) to target in a behavioural 
intervention for smoking cessation to achieve successful patient quit? 
 To determine whether briefer versions of the behavioural intervention tailored to 
the patient’s needs can achieve similar results to strictly adhered versions of the 
behavioural intervention 
 To determine the variable (content that might be tailored) and the fixed (process 
of delivery) features of the behavioural intervention 
 Whether quality of interaction can be improved to an extent that it is effective in 
achieving successful patient quit, independent of the number of ingredients delivered? 
 To determine the balance between adherence to behavioural intervention content 
and the quality of interaction where both complement each other’s effect  
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 To investigate whether adherence is a mediator or a moderator in the behaviour 
change intervention-outcome model 
 To investigate whether quality is a mediator or a moderator in the behaviour 
change intervention-outcome model 
 Whether adherence to behavioural intervention content is effective in achieving higher 
quit rates, independent of the duration of the patient-provider interaction? 
 To determine if the duration of the patient-provider interaction predicts patient 
smoking quit 
 To determine the relative weighting of each item (ingredient) based on the time 
taken to deliver each ingredient and its complexity (i.e. the number of BCTs 
included). 
8.5.6 Limitations and challenges 
This study had several limitations that merit discussion in this chapter; some cross-cutting issues 
on internal and external validity between studies A, B and C are discussed in the next chapter.  
Firstly, there were very few data-points (18 provider records), as cluster-level data were used in 
study, reducing the power of analysis. Moreover, the analysis was secondary and should be 
considered as exploratory in nature, rather than predictive of the association between fidelity for 
BI and patient smoking quit. Lastly, the study used data from a cross-sectional design (Fidelity 
study), and retrospectively linked it to an RCT design, thus limiting the establishment of 
causality and temporality of the derived effects. These points are discussed below. 
Few data-points 
The study was restricted to a small sample of providers as I wanted to investigate fidelity in the 
same providers as the ASSIST study to explore patient quit, which risked introducing Type II 
error in the analysis results. As noted above (see 7.5.6), I was unable to collect prospective data 
on quit rates in the Fidelity study, which could have been analysed at the individual level, 
accounting for clustering; giving the analysis more power and less chance of Type II error. In 
addition, I would have used the prospective quit rates to validate the retrospective quit rates 
(from the ASSIST study) by providers and analysed if provider fidelity contributed to the wide 
variation seen in quit rates, by teasing out those ingredients that worked and those that did not.   
Exploratory nature of the analysis 
Study C used data on observing fidelity in one set of patients (Fidelity study) and assumed (based 
on concordance in practice scores of providers) it is the same on a different set of patients from 
the past (ASSIST study), although the providers were the same individuals. Such analysis cannot 
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establish causality, and interpretations should be restricted to exploratory purposes, because this 
assumes that there was a manipulation of the independent variable (i.e. fidelity). This is an issue 
in general with cross-sectional designs, where the same individuals are not followed up 
longitudinally to allow assessment of direct manipulation of the independent variables, limiting 
the establishment of causality and temporality. I chose this design, because at this stage, there 
were outstanding questions to be resolved about the reliability of the new fidelity index (and its 
refinement), and the generation of hypotheses about the contribution of fidelity (whether it 
moderates or mediates) to intervention effect. The larger resources required for a prospective 
study could not, therefore, be justified. Moreover, a strength of the study was the use of a range 
of methods to extract different types of information, and to corroborate findings; allowing 
increased confidence in the findings from weaker study designs  (Campbell et al., 2007b). 
Establishing causality and temporality 
Drawing causal inferences from the secondary investigation was further complicated by the 
retrospective linking of fidelity to quit rates. Whilst retrospective data linkage requires fewer 
resources, it limits the options for measurement and for selection of comparison groups.  
As briefly noted before (in 8.5.3), the practice scores that were used to test this assumption were 
self-recorded by the providers and these might be subject to reporting bias. Providers may 
misrepresent their past behaviours and choices in order to appear more consistent with their 
current practice. Such retrospective linkage can introduce bias in the study estimates, especially 
when there is state dependence in respondent’s choices (Shachar and Eckstein, 2007). Specifically, 
observed persistence in retrospective data may be due to (a) true state dependence, (b) 
unobserved heterogeneity, and (c) retrospective bias in reporting previous practice (Heckman, 
1981).  
True state dependence, where behaviour relevant to future choices is altered as a consequence of 
experiencing an event, is unlikely in the case of providers filling the self-record checklist, as they 
were not intervened for skills training or professional capacity building on BIs between the two 
time-points. The unobserved heterogeneity is seen when individuals vary in certain unmeasured 
variables which could lead to a conditional relationship between future and past experience. 
However, in my study this type of state dependence is also very unlikely, given that the providers 
are the same individuals delivering the same intervention at the two time-points. Any 
unmeasured variables are not likely to be time dependent. Even though self-reporting bias could 
lead to non-concordance or lower concordance in ordering of the relative performance of the 
providers between the two time-points, it is less likely to be an effect of being observed 
(audiotaped) for intervention delivery (Adams et al., 1999). 
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8.6 CONCLUSION 
The ‘fidelity index’, developed (in study A) and validated (in study B) using suitable methods, was 
implemented to obtain fidelity scores for exploring variation in quit rates (study C). It is possible 
to reliably assess the fidelity (i.e. both Adherence and Quality) for a BI of smoking cessation and 
relate this to patient quit by providers.  
The negative association of Adherence (to BI content) with quit rates, which means delivering a 
higher number of BI ingredients reduced patient quit, implies that BI content might be simplified 
to maximise effective quit by optimising the number of behaviour change ingredients included in 
it. The positive effect of Quality of interaction of a BI suggests that it might be crucial to patient 
quit and may be as important as the number of BI ingredients delivered. My work suggests, and I 
must quote Trevor Sheldon, “it ain’t what you do but the way that you do it” (Sheldon, 2001), 
that acknowledges the increasing complexity of variation in outcomes of effectiveness studies. 
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PART IV- DISCUSSION 
In this final section, I discuss the strengths and limitations of the three studies. I also describe the 
methodological issues relevant to the development of a new index and its use for process evaluation. I end 
the thesis with implications of my work for research and practice and the future research directions. 
  
 
Chapter 9. Discussion and Conclusion 
In this chapter, I discuss the overarching issues with the design and the methods used in the three studies 
(study A, B and C). I provide a brief synopsis of key findings from these studies, and discuss their strengths 
and limitations using literature from previous pertinent work in the field. I then outline the crosscutting 
implications of developing a reliable measure of fidelity for a behavioural intervention and using it to 
explain variation in outcome for policy, practice and future research. 
In Appendix A, I summarised the evidence on association between smoking and TB and 
appraised the quality of this evidence based on GRADE scoring. At the beginning of my 
research, my focus was on epidemiology of smoking in TB patients. However, as my work 
progressed and I started gaining in-depth understanding of the behaviour change interventions 
for smoking cessation, I realised their significance in TB patients in LMICs and the knowledge 
gaps in optimal implementation of proven effective treatments. This is why I put the review on 
‘smoking in TB patients’ in appendix to this thesis because my focus has changed to intervention 
research and fidelity to BIs and it is better read as standalone evidence synthesis. 
In the first half of the thesis I described the potential significance of offering low cost smoking 
cessation interventions in TB patients and the relevance of integrating these in TB care in 
LMICs. I explored the literature and identified gaps in the evaluation of BIs for smoking 
cessation and limitations in their description of what works and how it works. I also provided the 
justification for developing a method that could help identify the ‘active ingredients’ of BIs, by 
capturing a complete and a clear account of patient-provider sessions. Identification of the 
ingredients of a BI that were delivered and how these were delivered to the patients and 
estimating their influence on the patient quit can be vital to the potential uptake and 
implementation of successful BIs for smoking cessation, in routine TB practice.  
My overall research goal was to investigate whether smoking quit rates were associated with the 
fidelity with which a BI for smoking cessation was delivered. Three studies were carried out to 
achieve the following specific research aims: 
 Development of an index to measure fidelity to a BI for smoking cessation  
 Validation of the fidelity index by assessing its psychometric properties  
 Exploration of whether fidelity to a BI explains variation in quit rates 
Study specific findings were discussed in previous chapters (chapter 6 - 8), and in the Appendix A 
for the systematic review. In this chapter, I describe the strengths of my research and discuss the 
overarching issues in the design and methods across the three studies and their limitations and 
then present my overall conclusions.  
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9.1 SUMMARY OF RESEARCH AND FINDINGS 
In the absence of pre-existing tools to quantify fidelity for BIs, I brought together the latest 
advances in behaviour change science and psychometrics to produce a reliable measure of fidelity 
and investigated its ability to accurately capture intervention fidelity. Key findings of this 
research are summarised here.  
9.1.1 Smoking in TB patients- evidence synthesis 
The evidence synthesis on ‘smoking in TB patients’ indicates that tobacco smokers were twice as 
likely to develop TB disease, suffer recurrent TB and die from TB, compared to non-smokers. 
However, the evidence on the association between tobacco smoking and acquiring TB infection 
was found to be weak.  
9.1.2 Study A- Development of the Fidelity Index 
Critical components technique was used to generate items of the fidelity index from the BI used 
in the ASSIST study that were mapped using the taxonomies of BCTs. Forty-five items- 37 for 
Adherence, and eight for Quality- were identified to represent ‘intended practice’ of the provider. 
A three point ordinal response scale that was behaviourally anchored rated each index item on 
fully, partially, or not, implemented, to represent ‘actual practice’ of the provider. Content 
validation by three experts showed a high level of agreement on all items for inclusion in the 
index. A pilot of the index resulted in re-phrasing and re-defining some of the behavioural 
anchors for the items scale. This was then consolidated into a new index for measuring 
intervention fidelity for a BI, which consisted of two main dimensions of ‘Adherence to content’ 
and ‘Quality of interaction’.  
9.1.3 Study B- Psychometric properties of the Fidelity Index 
The index was validated psychometrically and shown to be a good method for capturing 
significant variation in provider fidelity. The newly-developed fidelity index was found on inter-
coder reliability testing to be highly reliable for application by different coders. Moreover, the 
items of the index were coherent in measuring fidelity, as assessed by Principal Components 
Analysis. The two sub-indices (Adherence and Quality) could be used in isolation or in 
combination, as assessed by PCA performed separately for the two sub-indices and together 
under the overall fidelity construct. The Adherence sub-index clustered around five domains that 
map to five of the seven key features of the BI (‘information about harms of smoking/benefits of 
quitting’; ‘assessments of dependency’; ‘preparation to quit’; ‘management of triggers’; and 
‘withdrawals’), showing its ability to cluster BI content into its key aspects of behaviour change. 
In addition, Generalisability study showed it to reliably differentiate between providers by 
capturing the variation in their practice concerning BI delivery. 
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9.1.4 Study C- Explaining Variation in Quit Rates 
Overall in the BI sessions audiotaped for the patient-provider interaction, information gathering 
and assessments of nicotine dependence and past quit were implemented to a much higher degree 
than the triggers and withdrawal management and the Quality aspects. Based on the analysis for 
the assumption of consistency in provider practice (between Fidelity study and ASSIST study 
time-points), fidelity scores were retrospectively linking to quit rates.  
Regression analysis indicated that patient quit from the ASSIST study was positively associated 
with the same providers’ Quality of interaction but negatively associated with their Adherence to 
BI content, measured four years later. A negative interaction of high magnitude was also found 
between Adherence and Quality showing that an increase in one of these two covariates would in 
turn decrease the other’s effect on the quit rate and vice versa. I hypothesised that too many BI 
ingredients implemented in an intervention might negatively influence patient quit. Further 
regression analysis of Adherence with Quality suggested that the providers with better Quality 
of interaction (based on inter-personal BCTs) were more likely to Adhere to the BI content. 
9.2 STRENGTHS OF THE RESEARCH  
The strengths of this research are the development of an index for measuring fidelity of BI 
delivery that did not exist before, and its validation and application to explore variation in quit 
rates for the first time. This research uses a sound methodology by bringing together knowledge 
of behaviour change science and psychometrics to quantify the fidelity of BIs. This is the first 
time that the taxonomies of BCTs have been applied to develop an index for measuring fidelity. 
This is also the first time that provider fidelity for delivering a BI for smoking cessation has been 
studied in a LMIC, as part of routine TB care practice. Finally, this research informs the methods 
that can be used for process evaluation of BIs as a part of effectiveness evaluation, where the end-
point is not the process outcomes (i.e. fidelity) but is the impact of these process variables on 
patients’ quit rates. These strengths are discussed below. 
9.2.1 Originality 
TB and tobacco review 
Due to the lack of direct evidence of smoking cessation on health outcomes (like TB), I conducted 
a systematic review on the association of TB outcomes with smoking (as noted at the beginning 
of chapter; Appendix A). I used the GRADE criteria, which enables a systematic and transparent 
process to assess the quality of evidence and strength of association for a particular outcome 
across studies and reviews (GRADE Working Group, 2004). As the review included 
observational studies, the GRADE checklist for quality assessment was applied to each TB 
outcome using the Bradford Hill’s criteria (Meader et al., 2014). 
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To my knowledge, this is the first systematic review to provide strong evidence (of good quality) 
for the association of smoking with TB treatment outcomes including TB recurrence and 
mortality. It supports evidence from previous reviews on the strong association between smoking 
and developing TB disease. However, in contrast to the findings of the previous reviews, it 
suggests a weak association of smoking with latent TB infection (based on the quality of the 
studies).  
New fidelity index 
I was not able to identify an existing fidelity index or a scale that could be adapted or adopted for 
use in my investigation. Therefore, I conducted phased research to first develop a measure of 
intervention fidelity and establish its psychometric properties and then to implement the index to 
obtain fidelity scores for explaining quit rates.  
Whilst methods for labelling and coding of BIs using standard practice manuals for smoking 
cessation (Lorencatto et al., 2013a, Lorencatto et al., 2013b, Michie et al., 2011c, West et al., 
2010) and describing fidelity in general (Dane and Schneider, 1998, O’Donnell, 2008) existed, a 
measure that would quantify fidelity based on intervention theory did not exist. It is one thing to 
assess whether or not BI ingredients have been delivered and another to assess how well they 
have been delivered (Lorencatto et al., 2013b). So far, the focus on assessing fidelity in health 
services research and behaviour change science has mainly been on adherence to intervention 
ingredients or BCTs (presence or absence) (Lorencatto et al., 2013a, Hagger and Hardcastle, 
2014, Hardcastle et al., 2016). Recently, efforts have been made to develop methods for 
quantifying how well BI ingredients are delivered and move closer to measuring fidelity to 
delivery rather than only assessing adherence to content (Hardcastle et al., 2016, Farmer et al., 
2012, Tober et al., 2008).  
In existing indices (Young and Beck, 1980, Moyers et al., 2005, Lane et al., 2005), the focus has 
been on the overall adherence to BIs as stipulated in intervention protocols or practice manuals; 
these fidelity tools did not break BIs down into specific techniques (of behaviour change) and 
were, therefore, not fit-for-purpose means for the isolation and classification of BI ingredients. 
Furthermore, these tools were not designed to capture enough variation in the delivery of each 
intervention ingredient because of having nominal response scale options rather than ordinal that 
can be used to quantify the technique using behavioural anchors. The index developed in this 
study brings together two important aspects of fidelity (Adherence to BI content and Quality of 
interaction) in a single tool and teases out the specific behaviour change function of each 
ingredient using the taxonomies of BCTs (content- and competence- related). It is the first of its 
kind to enable quantification of these aspects of fidelity by using the behaviourally anchored 
response scales created for each individual item in the index. 
Chapter 9: Thesis Conclusion 
189 
 
Exploring variation in outcomes 
To understand how complex interventions achieve certain effects (insight into the ‘black box’ of 
the intervention) is possible by evaluating process variables with the outcomes (Hulscher et al., 
2003). Measuring fidelity is especially important in multi-site studies, where findings may vary in 
the magnitude of effect between sites (Bond et al., 2000b), as they did in the ASSIST study.  
Interventions implemented with higher fidelity have been shown to be associated with better 
outcomes than those with poor fidelity in other fields (Durlak and DuPre, 2008). However, a 
small sample of two English Stop Smoking Services with high and moderate quit rates showed 
similar levels of fidelity across the services (Lorencatto et al., 2013a). That study assessed fidelity 
using treatment manuals against patient-provider audiotapes and defined fidelity according to 
the criteria: <50% adherence to manual as ‘low’ and 80-100% adherence as ‘high’. My study is the 
first to investigate whether fidelity (level of Adherence and Quality of interaction) is associated 
with quit rates. It indicates that the Quality aspects of fidelity might be as or more important in 
the causal mechanism of behaviour change for successful quit in the patients. The extent to which 
differences in fidelity may help explain variation in quit rates needs to be examined in future 
research. 
My work can pave the way for future studies that tap into the mechanisms of behaviour change 
by identifying the individual BI ingredients that work and the likely candidate mediators. The 
fidelity index could potentially be used to identify the active ingredients of a BI. In addition, it 
provides a tool that researchers can utilise to measure fidelity for predicting outcomes of complex 
BIs.  
9.2.2 Rigour 
With guidance from the MRC framework for process evaluation, I brought together existing 
fidelity literature and the BI specification taxonomies, to inform the methods of my research. I 
used an interpretive evaluation model (Figure 1.2) to first capture the active ingredients of a BI 
for smoking cessation in a format that would allow scoring based on fidelity and then apply these 
scores to explore variations in patient quit rates. 
Methods used to develop the fidelity index 
The main strength of this work is the rigour of methodology to combine behavioural sciences 
and quantitative scale development methods in designing a reliable new measure of intervention 
fidelity. My work was broadly based on behaviour change for smoking cessation; it builds on and 
extends previous research on fidelity assessment of BIs (Lorencatto et al., 2013a, Lorencatto et 
al., 2013b, Michie et al., 2011b, Michie et al., 2011c). 
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The taxonomies of BCTs (Michie et al., 2011c, Lorencatto et al., 2013b, Michie et al., 2013), 
although used in previous studies (Lorencatto et al., 2013a, Lorencatto et al., 2013b) to describe 
BIs ‘compositionally’ have not been used to score the fidelity of BIs in relation to the 
‘functionality’ of its features. This later concept surpasses the simplicity in coding ‘present vs. 
absent’ for fidelity assessment and is a step forward in establishing a method for assessing the 
quality with which BCTs are delivered. In this study, I used the BCTs taxonomies to specify the 
BI content and therefore integrated the scale responses, based on process of delivery with each 
specified ingredient. Such integration or assimilation of an ordinal scale in a well-grounded 
behaviour change theory enabled the capture of the full account of fidelity’s contribution to 
behaviour change. Further, psychometric testing of the index supports this concept and suggests 
that the items of the index seem to measure fidelity, as captured via the response scale. 
Methods used for data collection 
The primary strength of the Fidelity study was that it generated data grounded in direct 
observation of patient-provider interaction sessions (Bell and Kravitz, 2014). Survey interviews 
and record reviews or exit interviews (as proxy measures of patient-provider interaction) often 
do not agree with each other or with direct observations of the actual visit (Carroll et al., 2000).  
A related strength is that patient-provider interaction was studied naturalistically because the BI 
sessions were delivered by the TB providers in their clinics during routine TB care of the 
patients, offering the opportunity to capture patient-provider interactions independent of the 
research. This is in sharp contrast to most experimental intervention studies, in which 
independent variables are manipulated to create the situations studied (Bell and Kravitz, 2014).  
Furthermore, the Adherence and Quality scores (from the Fidelity study) were free of reporting 
bias, as these were obtained by rating fidelity using audiotapes of the patient-provider BI 
sessions. Similarly, the quit rates (from the ASSIST study) were based on CO reading rather than 
self-reports giving objective measurement of patient quit status at 6 months post-intervention.  
9.2.3 Importance 
TB and Tobacco review 
The findings from the evidence synthesis on smoking in TB patients will inform policy makers 
and TB managers of the importance of smoking cessation in TB patients. This might particularly 
be useful when drawing conclusions from evaluations of smoking cessation interventions that 
usually only report quit outcomes and not the differential impact on TB outcomes. 
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Application of behaviour change science and intervention delivery in the LMICs 
Although the BI used in ASSIST study was found to be highly effective in helping patients 
successfully quit smoking in TB clinics (Siddiqi et al., 2013), the taxonomies of BCTs have not 
been used to code interventions used in the context of countries like Pakistan. Whether these 
taxonomies reliably code BIs outside of the English Stop Smoking Services is yet to be 
established. However, as noted in study C (8.5.2), the most frequently delivered BCTs 
(information gathering and assessments, and addressing motivation) and the least delivered 
BCTs (maximising self-regulatory capacity or skills and delivery of intervention) by the 
providers in TB clinics in Pakistan correspond to the implementation of the BI by stop smoking 
advisors in the UK (Lorencatto et al., 2013a, Lorencatto et al., 2013b). This suggests that the 
implementation of BIs for smoking cessation, the provider fidelity to delivery and related 
challenges in the LMICs (like Pakistan) might be very similar to the HICs.  
Use of process variables as intermediate factors to explain variation in outcomes 
Fidelity has been referred to as the ‘methodological strategy’ used to enhance the reliability and 
validity of complex interventions (Bellg et al., 2004). The revised MRC guidance on development 
and reporting of complex interventions (Craig et al., 2008) recommends integrating process and 
outcome evaluations (Oakley et al., 2006a), tailoring to local contexts (Campbell et al., 2007a), 
and making greater use of the insights provided by theory of complex adaptive systems (Shiell et 
al., 2008). The guidance recommends achieving high fidelity in a pilot phase before proceeding to 
a full RCT, which however, does not happen in real-life, given the limited resources (for a full 
pilot phase); resulting in variations in delivery of the intervention or infidelity in RCTs of 
complex interventions (Knittle, 2014).  
The variation in outcomes, as seen in the ASSIST study, are common in evaluations of complex 
interventions and most researchers attempt to explain this variation by factors related to study 
design and measures of effectiveness, paying little attention to further investigation of the 
process of intervention delivery (Hardeman et al., 2008, Bellg et al., 2004, Borrelli et al., 2005). 
Process evaluation, which means exploring the way the intervention was delivered, could provide 
valuable insights into variable impact. The MRC framework for process evaluation (Moore et al., 
2015) outlines formative or developmental research approaches (Carroll et al., 2007, Linnan and 
Steckler, 2002, Grant et al., 2013), which focus mainly on refinement of novel interventions, 
considering fidelity as a process outcome. My research, however, focuses on informing a method 
for using process variables, such as fidelity, as the intermediate factors in explaining outcomes of 
effectiveness of complex interventions.  
In effectiveness evaluations, fidelity is considered as an intermediate factor with the sole purpose 
of explaining other important outcomes like smoking cessation, which are the prime target of the 
intervention (Brownson et al., 2012, Proctor et al., 2011). I therefore adapted the key functions of 
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process evaluation defined by MRC (as described in Chapter 1, Figure 1.2 on page 29) and 
applied interpretive rather than formative research approaches to develop a mechanism to 
quantify fidelity and use it for investigating variation in quit rates. These concepts are described 
in chapter 1 (see 1.5.2), and further recount is given here. 
Interpretive research illuminates the mechanism of action of intervention theory and enhances 
understanding of its impact or worth (Stetler et al., 2006). This is the first step that enables 
evaluators to move beyond description of fidelity (Moore et al., 2015) and use it as an 
independent variable that contributes to the effectiveness of the intervention (Peters et al., 2013). 
I conducted a post-trial process evaluation of the BI for smoking cessation used in the ASSIST 
study to interpret the wide variation in quit rates, and proposed a system beyond describing 
intervention fidelity that could potentially identify ‘active ingredients’ and measure the 
contribution of fidelity to intervention effectiveness.  
9.3 LIMITATIONS OF THE RESEARCH 
The study specific limitations have been discussed in previous chapters (for study A, B and C). 
The crosscutting limitations affecting the internal and the external validity of the overall 
research are discussed here.  
9.3.1 Internal validity 
The index was based on an extensive review of the literature on psychometrics and concepts of 
behaviour change. In choosing which areas of the literature to review (and which to exclude); I 
pre-determined the form the index was likely to take. For example, although I considered that 
patient responsiveness and receipt in a BI was important, I restricted my review to elements of 
fidelity directly targeting provider practice and attitude in delivering the intervention, as that 
was the focus of my research. Moreover, I did not consider the wider literature on the theory of 
the psychological processes involved in changing behaviour that might not be covered fully by 
the taxonomies of behaviour change. Incorporation of these additional theories could further 
refine the fidelity index (in future) and improve its practical value. Particularly, the ‘Quality of 
interaction’ aspects relating to provider ‘competences’ (Michie et al., 2011b) or ‘relational 
techniques’ (used in Motivational Interviewing) could be further improved, as the number and 
description of behaviours and techniques is expanded in the future (Hardcastle et al., 2016). In 
addition, new BCTs are emerging very quickly and more comprehensive taxonomies might be 
produced (Michie et al., 2014-2017) in the future that can be used for defining the items in the 
fidelity index more precisely and for adding new items. However, using the current taxonomies 
there might be a chance that some important behaviour change features are missing from the 
index.  
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A limitation in the research design overall is the inability to control for confounders contributing 
to the variation in quit rates. There are multiple reasons for this, including: fewer data-points not 
allowing multi-variable regression; observations of study subjects without contemporaneous 
controls; and no data on context-related factors that might influence intervention delivery. In my 
study, a number of potentially confounding sources could include the factors extrinsic to the 
intervention, like the attributes of the provider, the wider context at the meso-and-macro level or 
factors related to patient responsiveness. In determining the potential association of fidelity with 
quit rates, therefore, I could have overestimated and/or missed effects. However, some of these 
factors at the provider-level were explored as part of the ASSIST study (described in chapter 3; 
Table 3.1 and Table 3.2), which were found not to have contributed to the variation seen in the 
quit rates. The broader context level factors could be explored using validated tools for context 
evaluation (Bergström et al., 2015), in future studies. 
9.3.2 External validity 
Another limitation of the study deals with the generalisability of the results. The Fidelity study 
was conducted in TB clinics (situated in primary and secondary health care centres) in two 
districts of the Punjab province in Pakistan. Using a resource intensive method like direct 
observation of patient-provider sessions is not practically possible in a national sample of 
providers and patients (Bell and Kravitz, 2014). Nonetheless, I feel that the provider practice in 
this multi-centre study was structurally similar to TB clinic settings in other LMICs. 
Furthermore, the implementation pattern of BCTs indicated that provider practice behaviour in 
this study was quite similar to the stop smoking advisors in the UK (as discussed in chapter 8). 
However, the findings from this research are less likely to be representative of people’s 
behaviour, cultural practices and attitudes towards smoking. Ultimately, this weakness can be 
managed through the replication of research by investigators across diverse settings.  
As I was interested in variation between providers and not just a high level of fidelity, this might 
have been affected by providers showing low fidelity or scoring on those items that were least 
implemented by the majority of the providers. The results from the Generalisability study (see 
7.4.6) showed that a considerable amount of variation in the fidelity measurement could be 
attributed to the providers. Further sensitivity analysis, excluding those providers with very low 
fidelity, retained the same results. Overall, the fidelity measured in this study for most 
ingredients was low to moderate. BI ingredients relating to ‘setting quit date’, ‘offering BI 
leaflet’, ‘explaining expectations regarding the intervention programme’ and ‘providing 
reassurance’ were negligibly implemented by the providers. However, these were not excluded 
from the index as these might be important in fidelity measurement (of other BIs) and should be 
evaluated in future research to make the approach more generalizable.  
A further threat to the representativeness of the study is the possibility of reactivity (Bell and 
Kravitz, 2014), also called the ‘Hawthorne effect’ or ‘observer effect’. The concern is that the 
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patients and the providers might alter their interaction behaviour, knowing that they were being 
observed. In comparison to the ASSIST study, the current study observed patient-provider BI 
sessions by audiotaping, which could have resulted in improved providers’ fidelity (Bell and 
Kravitz, 2014). Therefore, these sessions may not be representative of typical practice, although 
research shows that the effect of being observed (passively) wears off quickly (Bell and Kravitz, 
2014). In addition, the observation that BCTs as simple as ‘offering a BI leaflet’ were not 
implemented might suggest that the providers were less likely to be subject to the Hawthorne 
effect. However, these sessions are likely to represent a best case scenario, and therefore 
overestimate rather than underestimate fidelity (Lorencatto et al., 2013a). Moreover, the 
competences to deliver the intervention are unlikely to be affected by observation, even though 
adherence to BI content might improve under such circumstances. In the case where all providers 
improved their fidelity to BI compared to the past practice, this would lead to dilution of effect 
with quit rates which are from the ASSIST study, when providers were not being observed.  
9.4 APPLICATIONS OF THE FIDELITY INDEX IN PRACTICE AND IN RESEARCH   
A fidelity index, if designed appropriately and found to be reliable and valid has multiple 
potential uses, not only as a research tool but also in policy and practice. Some uses of the fidelity 
index to inform research and practice from defining interventions, to keeping track of future 
adaptations, assessing adherence, understanding the ‘black box’, to refining theory, are 
highlighted here.  
9.4.1 Defining intervention 
Use of a fidelity index offers numerous advantages for smoking cessation practices. The fidelity 
index might help optimise a BI for scale up in LMICs where, due to resource limitations, it is 
desirable to integrate cessation within existing programmes. In these settings, the policy makers 
and public health managers are often more interested in a variety of options for active 
intervention ingredients that can be delivered in a shorter time and yet retain an acceptable 
overall effectiveness of the intervention.  
If used in routine practice, on TB surveillance data, it might help local practices to link 
implemented intervention ingredients with the patient outcomes later in their treatment course 
and to tailor delivery of BIs for smoking cessation for the respective settings. Although routine 
monitoring of cessation services cannot establish causality, descriptive information about changes 
in the intervention ingredients delivered and observed outcomes over time can be useful in 
identifying trends that co-occur. 
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9.4.2 Keeping track of future adaptations 
In psychiatric rehabilitation research, fidelity measures have been used to map out the theoretical 
domains of the intervention and also to define model adaptations or modifications from the 
original intervention (Bond et al., 2000b). Hence, following the same model, the newly developed 
fidelity index for BIs of smoking cessation can also be used to define and describe adaptations to 
original intervention ingredients. Adaptations or deviations would be easier to identify and 
record using the fidelity index which links each item to the underlying model of behaviour 
change. For instance, the fidelity index could be used to differentiate between individuals given 
less intense behavioural support, compared with those given more intense treatment and take a 
more pragmatic stance to reporting findings, rather than controlling conditions to achieve high 
fidelity to an intense BI programme.  
9.4.3 Monitoring and training 
Fidelity assessment can be used to make the content of time-limited interventions more 
structured and focused (Lorencatto et al., 2013a), as opposed to practice manuals. The use of 
fidelity indices can be extended to the optimal scale-up of interventions nationwide, where 
implementation problems such as widely disparate services between administrative levels might 
occur, often falling short of the original effectiveness of the intervention as a result (Bond et al., 
2000b). Fidelity measures can also function as self-recording tools by the providers of cessation 
services to monitor and document intervention adherence overtime.  
In addition to the intervention ingredients, the fidelity index could be used to identify specific 
skills and competences of providers for delivering BIs. The Quality of interaction aspect of the 
index can assess the weaknesses and strengths of the providers, in terms of their behaviour 
change competences. This could facilitate and help direct the focus of provider training on 
specific skills and competences (Lorencatto et al., 2013a).  
9.4.4 Understanding the ‘black box’ of the intervention 
Behavioural change interventions often face the challenge of being translated from complex 
behavioural mechanisms into routine clinical practice by health care providers who are not very 
familiar with the science of behaviour change. Often, providers of such complex interventions are 
left with the resource for delivering the intervention and a list of activities. A fidelity index can 
potentially be used as a research dissemination strategy (Bellg et al., 2004), by giving the 
providers a deconstructed map of activities linked to behaviour change mechanisms that could 
help them understand why they are doing each activity and how they might tailor it to the 
patient needs, without losing focus of the mechanism of change.  
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Explaining variation 
Assessing intervention fidelity gives researchers more confidence in their findings from 
effectiveness evaluations (Bellg et al., 2004). Whether the associations found are plausible or not 
influences causality according to the Bradford Hill approach (Schünemann et al., 2011). 
Determining fidelity could help establish causality for the clinically or behaviourally plausible 
outcomes. If an evaluation of a new intervention shows significant results but fidelity is not 
monitored, it is difficult to establish whether the outcomes were due to effective intervention 
content or other factors that may have been unintentionally added to or omitted from the 
intervention (Cook et al., 1979). On the contrary, if the evaluation of an intervention shows no 
effect and the fidelity is not monitored, it is difficult to establish if the outcomes were due to 
ineffective intervention content or lack of fidelity to intervention delivery (Moncher and Prinz, 
1991). In the former, assessing fidelity to intervention features can prevent ineffective 
interventions from being scaled-up, saving governments, providers and patients from high cost, 
whereas, in the latter case, it can prevent potentially promising interventions from being 
discarded prematurely (Bellg et al., 2004). 
Furthermore, complex interventions research can benefit from specifying intervention content 
and explaining individual differences in outcomes between various practices. An extension of the 
CONSORT statement for non-pharmacological treatments recommends reporting of the precise 
details of the intervention as it was implemented, the method of standardisation of the 
intervention between providers, details of assessing adherence of the providers with the 
intervention protocol and description of the different components of the intervention ,including 
the procedures for tailoring the interventions to individual participants (Boutron et al., 2008). 
Further work on descriptions of complex interventions (Hoffmann et al., 2014) recommend 
including detailed accounts of what works, what does not work, what works less and how it 
works etc. in reporting of effectiveness studies.  
Differential effectiveness of various ingredients 
The fidelity index provides a theoretical framework which can be utilised in research designed to 
understand the mechanisms of change for smoking cessation. An important use of the fidelity 
index in effectiveness studies is to identify the active ingredients of an intervention that actually 
predict quit rates (Bond et al., 2000b).  
In the fidelity index, intervention ingredients that are theoretically mapped are represented by 
items of the index making its compositional features (for details see Chapter 6). How these 
intervention ingredients are delivered in reality represents fidelity of the providers and is 
captured by the response scale for each item. Demonstrating empirically that an item of the index 
is an ‘active ingredient’ (or effective in changing a particular behaviour) requires obtaining 
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individual item associations with a criterion measure, that is, quit rate in case of smoking 
cessation, while controlling for confounders and moderators (Bond et al., 2000b).  
Therefore, discriminating effective parts of the intervention from those that are not likely to 
work in a given context is possible using the fidelity index. The current work on this fidelity 
index paves the way for research that taps into these mechanisms using appropriate research 
designs; further discussed below in section 9.5.  
9.4.5 Theory testing and refinement 
Fidelity measurement can help determine the extent to which the effects seen are due to specific 
behavioural functions or due to factors non-specific to the intervention or deviations from the 
intervention protocol (Nigg, 2002). Unless the intervention fidelity is measured, it is difficult to 
establish the extent to which intervention theory is the prime mechanism of the observed 
behaviour change (Bellg et al., 2004).  
The fidelity index could enable researchers to identify the active ingredients of their 
interventions; this could give them an opportunity to refine the intervention and describe its 
content, in terms of the current reporting standards (Boutron et al., 2008, Hoffmann et al., 2014). 
In addition, it would give researchers an insight into the Quality of interaction of the BI and help 
them identify those skills and competences that were more or less effective. Moreover, the 
analysis of sub-indices scores (Adherence to content and Quality of interaction) might determine 
the effect of the intervention (content) apart from the effects related to the Quality aspects (Bellg 
et al., 2004). 
9.5 RECOMMENDATIONS FOR FUTURE RESEARCH 
Future research should further validate the fidelity index, develop shorter versions, develop item 
bank for intervention fidelity, test the hypotheses generated from this work, identify the active 
ingredient of BIs and investigate the effect of smoking cessation on TB outcomes.  
9.5.1 Further validation of the index 
Prospective longitudinal studies can be used to test the predictive validity of the fidelity index, 
that is, to establish whether the fidelity measured by implementing the index predicts quit rates. 
The analysis of the psychometric properties of the fidelity index was insufficient for items which 
were not implemented by the majority of the providers in the Fidelity study and thus could not 
be investigated thoroughly. Further psychometric testing of the index, including coherence of 
items using PCA, should evaluate these items (16 ‘setting quit date’, 37 ‘offering BI leaflet’, 39 
‘explaining expectations regarding the intervention programme’ and 40 ‘providing reassurance’) 
when data are available from other contexts and settings. These evaluations will determine 
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whether these items are redundant or if they are not measuring fidelity to behaviour change and 
should be dropped from the index. 
Furthermore, the index was developed in one setting and around a particular smoking cessation 
BI. To improve the generalisability of the fidelity index, it should be tested in other settings and 
populations and validated for HICs as well as LMICs.  
9.5.2 Developing a shorter version 
Developing a simpler and shorter version of the fidelity index for providers (self-monitoring), 
managers (supervision and training), routine auditing of services and research is an important 
next step. The fidelity index is complex and has multiple items that cannot be used readily 
outside research purposes. It needs to be simplified for application in routine practice. The 
psychometric testing and content validations of the shorter versions of the fidelity index should 
be conducted in future studies.  
9.5.3 Developing item bank for intervention fidelity  
Developing an item bank (Hahn et al., 2010) for intervention fidelity by adding new items and 
dimensions to the fidelity index can help intervention evaluators and researchers use readily 
available items for measuring fidelity, tailored to their respective interventions. Items could be 
selected from the bank to form customized short indices, or can be administered in a sequence 
and length determined by the researcher (Cella et al., 2007). Although far from perfect, such item 
banks can form a common definition and understanding of behavioural mechanisms concerning 
smoking cessation and other health behaviour change. From a practical perspective, re-writing 
and re-testing an item, adding more items, re-testing a bank after some modifications, or splitting 
up a bank into units that are more unidimensional require time and resources. The purpose of 
such item banks is to have a common metric and range for measuring a construct and a shared 
meaning and understanding across users. 
9.5.4 Identifying ‘active ingredients’ of a Behavioural Intervention 
As described above, identification of the active ingredients of an intervention relies on individual 
item associations with the outcome, which is not possible in commonly used experimental and 
intervention research designs. Establishing such associations would require larger sample sizes 
and comparative designs. Prospective longitudinal studies and effectiveness studies (Piper et al., 
2016), using multi-phase optimisation strategy (Baker et al., 2016), to systematically test the 
effect of the presence or absence of individual items (or BCTs mapped to the items) on smoking 
behaviour, and the Quality aspects that mediate the effect, can move the field forward in 
providing mechanistic explanations (Hardcastle et al., 2016).  
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In addition, a mere ‘absent’ vs ‘present’ distinction is inadequate in capturing the natural variance 
in the effect of the active ingredients and processes by which the intervention leads to behaviour 
change (Hardcastle et al., 2016). The ordinal response scale of each item in the designed fidelity 
index would allow the quantification and ordering of an active ingredient in terms of how well it 
was implemented (i.e. fully-, partially- or not-implemented). This can be tested in large 
implementation-effectiveness hybrid studies, possibly using factorial designs.  
9.5.5 Hypotheses testing 
Future experimental or intervention research using longitudinal designs should test the 
hypotheses generated in this study. These (as described in Chapter 8) are the following: 
 What is the optimal number of ingredients (hence the BCTs) to target in a behavioural 
intervention for smoking cessation to achieve successful patient quit? 
 Whether quality of interaction can be improved to an extent that it is effective in 
achieving successful patient quit, independent of the number of ingredients delivered? 
 Whether adherence to behavioural intervention content is effective in achieving higher 
quit rates, independent of the duration of the patient-provider interaction? 
9.5.6 Effect of smoking cessation on TB outcomes 
Future studies should investigate the effectiveness of BIs for smoking cessation on TB outcomes. 
One issue that is vital to the design of successful smoking cessation interventions in routine TB 
practice is to determine the optimal number of behavioural change elements to target. To close 
this gap in integration of BIs for smoking cessation within existing TB programmes in LMICs, 
future studies could potentially build on my work and utilise the fidelity index.  
An effectiveness-implementation hybrid study, ‘Tobacco cessation within TB programmes: A 
‘real’ world solution for countries with dual burden of disease’ (ISRCTN43811467) is underway, 
which I am privileged to be coordinating. This is a four year (2015 to 2019) multi-country, multi-
site RCT, funded by the European Union's Horizon 2020 research and innovation programme, 
which will not only assess smoking cessation effects on TB treatment outcomes but will also 
investigate the fidelity to delivery of the behavioural intervention. This study could potentially 
investigate the hypotheses generated from my work and further the research on the subject. 
9.6 REFLECTION ON THE CONTEXTUAL USE OF THE FIDELITY INDEX 
The fidelity index was designed based on a single BI for smoking cessation, which was mapped to 
23 BCTs using the taxonomies of behaviour change. Some of these BCTs were used more than 
once (see Appendix C.3). The index is currently structured (from left to the right columns) as 
behavioural determinant, BCT, item, and the response scale. Modifications in elements on the left 
means less effect on the reliability and more effect on reliability as you move to elements on the 
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right. Contextually this means that if we group items together by the BCTs or the behavioural 
determinants and assess the fidelity the index might still hold good psychometric properties 
established in this study. However, if it comes to modifying the items for which the response 
scales have been specifically devised than the overall reliability of the index could potentially 
decline. Having said that, the two sub-indices can be used separately and the findings of the PCA 
analysis for the Adherence sub-index (Table 7.8 and  
 
Table 7.9) could be used wisely to separate out the five principal components. As long as the five 
principal components (described under ‘Item loadings for Adherence (multiple components 
extraction)’ on page 146) are used the items within these can be dropped or modified without 
affecting the variation explained by each principal component too much. However, reliability 
needs to be re-evaluated if new items are added to the fidelity index. 
Nevertheless, the fidelity index developed in this study provides a reliable strategy to be used as 
a guideline to develop and refine quantitative measures for BI fidelity in future. 
9.7 CONCLUSION 
A new index for measuring fidelity for BIs of smoking cessation was developed and found to be 
reliable. Fidelity, as measured using the index, was associated with quit rates; where Quality of 
interaction was found to positively and Adherence to BI content negatively affect quit rates.   
The fidelity index could be a useful tool for exploring and possibly explaining variation in 
outcomes of smoking cessation. The application of scales such as the fidelity index can contribute 
to process evaluation of BI programmes in research and their quality improvement in practice, 
aiming to optimise care delivery and maximise effective outcomes. The development and 
refinement of such fidelity measurement methods should be the focus of future research in health 
behaviour change.  
The granularity of measuring fidelity to delivery of a BI containing multiple ingredients and the 
quality aspects of the interaction with the patient demonstrated in this study provides a 
foundation for generating evidence that can inform targeted future training programmes, 
continuing professional development and efforts to integrate within existing programmes. 
Researchers in the field of smoking cessation and other health behaviour change are encouraged 
to use and build on the fidelity index work.  
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APPENDICES 
Appendix A. SMOKING IN TB PATIENTS- EVIDENCE SYNTHESIS 
This section provides a review of the literature on association between smoking and TB outcomes. It appraises 
the position of this evidence using a reliable grading tool that can assess the strength of association and 
confidence in the ‘estimated effect,’ as opposed to the ‘true effect’ across studies for a given outcome. I describe 
the methods I used to carry out this review of the effects of smoking on risk of acquiring TB infection, 
developing TB disease and on TB recurrence and mortality, and present my findings. I also discuss the 
limitations of the review and next steps.  
It is important to understand the epidemiology of TB in light of emerging risk factors and life styles 
beginning to dominate LMICs, before we go to cessation. For example, in sub-Saharan Africa where 
smoking rates have been very low is about to hit a smoking epidemic with profound effects on TB 
and other diseases. In order to utilise the teachable moments in a TB clinic to help TB patients make 
a quit attempt and sustain it in the long-term, a better understanding of how smoking cessation 
interventions work is required. An integral question then arises about the epidemiological link 
between TB and tobacco smoking; necessary to disentangle the TB disease specifics that are 
influenced by smoking.   
A growing body of evidence demonstrates that tobacco smoking increases the risk of acquiring TB 
infection and developing TB disease. In TB patients, continued smoking leads to poorer treatment 
outcomes and mortality. However, this evidence is not sufficient to enable policy makers and 
practitioners to make informed decisions on integrating effective smoking cessation interventions in 
TB care settings. Firstly, the evidence on the association between smoking and each outcome of TB 
(e.g. latent TB, active TB, TB mortality, TB relapse etc.) has not been synthesised across different 
reviews and latest studies. Secondly, the quality of evidence from separate studies has not been rated 
overall or accounted for in interpreting results.  
To my knowledge, the latest systematic reviews on smoking and TB association were conducted in 
2007. The subject is in dire need of synthesising evidence from these reviews by including additional 
epidemiological studies that have been conducted since 2007, as well as providing clear cut 
conclusions based on the quality of evidence. This is not an attempt to conduct another systematic 
review and meta-analysis to generate new estimates for the association between smoking and TB 
outcomes. In fact it is a synthesis of information from existing reviews and additional observational 
studies to date, to provide clearer inferences of the derived estimates (of the effect of smoking on TB 
outcomes), based on the quality assessment of the evidence.   
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OBJECTIVE 
My overall research aim is, to investigate whether the evidence on association between smoking and 
outcomes of TB (latent TB, active TB, TB mortality, and TB recurrence) is of sufficient quality.   
The specific objectives are to: 
i. Synthesize evidence across systematic reviews and epidemiological studies 
ii. Critically appraise the quality of this evidence  
METHODS 
Criteria for considering studies for this review 
Type of studies 
This evidence synthesis includes reviews as well as primary epidemiological studies on the 
association of smoking with TB. 
Type of participants 
Tobacco smoking primarily affects the lungs and therefore the focus of this review will remain 
pulmonary TB. Studies included in this review were conducted in adults with pulmonary TB. 
Types of outcome measures 
The following outcomes are of interest in the association between active smoking (exposure) and TB:  
Latent TB infection 
Individuals with latent TB infection do not feel unwell and do not have any symptoms. They are 
infected with Mycobacterium tuberculosis, but do not have TB disease (Centers for Disease control, 
2014). The only sign of TB infection is a positive reaction to the tuberculin skin test or TB blood 
test. Such individuals are not infectious and cannot spread TB infection to others. Overall, without 
treatment, about 5 to 10% of those infected will develop TB disease at some time in their lives 
(Centers for Disease control, 2014). About half of those who develop TB will do so within the first 
two years of infection. 
Active TB disease 
In some people, TB bacteria overcome the defences of immune system and begin to multiply, 
resulting in the progression from latent TB infection to TB disease (Centers for Disease control, 
2014). Some people develop TB disease soon after infection, while others develop TB disease later, 
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when their immune system becomes weak. Individuals with TB disease are considered infectious and 
may spread infection to others. TB disease is a serious condition and can lead to death if not treated. 
TB mortality 
This is defined as the cause of death designated as being due to TB (Slama et al., 2007). 
TB recurrence 
Recurrent TB, often called TB relapse, is an indicator of TB treatment outcome. Recurrent TB cases 
are defined as those previously treated for TB, that were declared cured or treatment completed at 
the end of their most recent course of treatment, and are again diagnosed with an episode of TB 
(either a true relapse or a new episode of TB caused by reinfection, also known as ‘recurrence’) 
(World Health Organisation, 2014a). 
Type of exposure 
Smoking 
For the scope of this particular evidence review, the following case definition for smoking is 
considered: active tobacco smoking (including cigarettes, water-pipe, hand-rolled cigarettes, cigars 
or pipes), exposure (including current, past or ever smoking) versus non-exposure; either self-
reported smoking status or bio-chemically verified (via CO or cotinine measurement) or both. 
Search methods for identification of studies 
Relevant studies were identified by searching Medline via Ovid. Database searching was conducted 
in two subsequent steps.  
Step 1- for the synthesis of evidence from reviews- involved systematically searching and identifying 
published reviews of smoking and TB association in literature.  
Step 2- for updating the evidence from these reviews- involved systematically searching and 
identifying additional primary epidemiological studies on smoking and TB association, published 
since the last date of the database search mentioned in the reviews identified in step 1.  
Bibliographies of selected articles were also searched for relevant studies. The main keywords and 
phrases used included; tobacco use, smoking, tuberculosis, mortality, infection, disease, treatment 
outcomes, relapse and recurrence, which were sourced from previous reviews (Bates et al., 2007, Lin 
et al., 2007, Slama et al., 2007). Searches (for review articles) were limited to Abstracts, in English, 
and from January 1985- July 2015. For the primary studies, the searches were restricted to 
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Abstracts, in English, and from 2005- July 2015. The detailed search strategies are provided in 
Tables A.1 and A.2 below. 
Given the limitations of resources and time for this work, article searching was restricted to English 
language, full text availability and Medline database only. 
 
A.1: Search strategy output for reviews on Tobacco and TB (1985-2015) 
 
 
 
A.2: Search strategy output for additional studies on Tobacco and TB (2005- 2015) 
Step Search syntax Results 
1 "Tobacco Use"/ or Tobacco/ 24975 
2 Smoking/ 126901 
3 Tuberculosis, Pulmonary/ or Latent Tuberculosis/ or Tuberculosis/ 
or Mycobacterium tuberculosis/ 
143038 
4 1 or 2 147686 
5 3 and 4 627 
6 limit 5 to (abstracts and English language and full text and yr="2005 
-Current") 
56 
 
Data collection and analysis 
Selection of studies 
The criteria for identifying the studies for evidence synthesis are provided separately for the reviews 
and primary epidemiological studies on the smoking and TB association, followed by the information 
that was extracted. 
Inclusion criteria for Reviews on smoking and TB: 
 Systematic reviews published between 1985 and Jul 2015 
Step Search syntax Results 
1 "Tobacco Use"/ or Tobacco/ 24975 
2 Smoking/ 126901 
3 Tuberculosis, Pulmonary/ or Latent Tuberculosis/ or Tuberculosis/ 
or Mycobacterium tuberculosis/ 
143038 
4 1 or 2 147686 
5 3 and 4 627 
6 limit 5 to (abstracts and English language and "review articles" and 
yr="1985 -Current") 
35 
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 Systematic reviews focusing primarily on smoking forms of tobacco  
 Systematic reviews reporting on at least one of the (above) defined outcomes (of TB) 
Inclusion criteria for Primary studies on smoking and TB: 
 Studies published between 2005 and Jul 2015  
 Epidemiological studies; cohort, cross-sectional or case-control studies 
 Studies focusing primarily on smoking forms of tobacco  
 Studies reporting a risk estimate (e.g. relative risk, odds ratio or hazard ratio) and confidence 
intervals (CI) for at least one of the (above) defined outcomes (of TB) 
Exclusion criteria: 
Studies/reviews primarily focusing on smokeless tobacco or second-hand smoke or with no clearly 
defined TB related outcomes or not reporting a risk estimate or reporting on subjects with 
comorbidities (e.g. diabetes or HIV or lung cancer) were excluded. 
Data extraction and management 
Information from all studies (including the systematic reviews) was extracted in a standardised way. 
A uniform template was used to extract data on: category of TB outcome, study design, location, 
population/setting, measures of outcome and exposure, number analysed, effect estimates, adjusted 
confounders and dose-response gradient. For the systematic reviews, data on heterogeneity effect 
and publication bias were also extracted.  
Synthesis of evidence and quality appraisal 
The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach 
was taken to synthesise effects of smoking on TB outcomes from identified studies and draw sound 
conclusions based on the quality of this evidence (GRADE Working Group, 2004).  
GRADE enables a systematic and transparent process to assess the quality of evidence and strength 
of association for a particular outcome across studies and reviews. Initially, GRADE was restricted 
for use in clinical trials with outcomes for key treatment interventions. In recent years, however, its 
use has been extended to non-randomised studies, by including considerations arising from the 
Bradford Hill’s criteria for causation (Schünemann et al., 2011). In the current evidence synthesis, a 
GRADE table is presented for each outcome of interest that identifies the basis of judgements made 
about the quality and the score assigned. An initial four points are awarded to evidence that is 
largely based on RCTs, and 2 points to evidence based on observational studies. The points are then 
upgraded or downgraded based on quality assessment criteria (the GRADE checklist, discussed 
below). An overall GRADE score (from 4 to 0) based on the assessment of the quality of evidence for 
a particular outcome is achieved by this process.  
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The GRADE checklist for quality assessment was applied to each TB outcome using the Bradford 
Hill’s criteria (where applicable) within each of its five items (Meader et al., 2014). The five items 
(detailed in Appendix A.9) of the checklist are:  
i. Study limitations (study design, temporality, and risk of bias);  
ii. Inconsistency (overlapping confidence intervals, direction of effect, heterogeneity);  
iii. Indirectness (objective vs. subjective outcome measure, direct comparisons, coherence, 
biological plausibility and specificity);  
iv. Imprecision (strength of association, median sample size, number of included studies);  
v. Publication bias and other considerations (dose-response gradient, adjustment for key 
confounders).  
The GRADE approach for assessing quality of evidence for the association between smoking and TB 
infection, disease, mortality and recurrence involved the following procedures: 
1.  A-priori ranking of “high (4)” to randomized controlled trials and “low (2)” to observational 
studies 
2. “Downgrading” initial ranking based on limitations of study design, inconsistency, indirectness, 
imprecision or publication bias 
3. “Upgrading” initial ranking based on large effect size, dose-response gradient and adjustment for 
main confounders 
4. Final grade assigned for the quality of evidence as “high”, “moderate”, “low” or “very low” for each 
outcome of interest. Interpretation of the ranks of the quality of evidence is provided in Table A.3 
(Schünemann et al., 2011).  
5. Conclusion based on the quality of evidence and consideration of other factors that impact on the 
strength of association  
A.3: Final GRADE ranking 
High      ⊕⊕⊕⊕ There is high confidence that the true effect lies close to that of the estimate of the 
effect 
Moderate   ⊕⊕⊕ There is moderate confidence in the effect estimate: the true effect is likely to be close 
to the estimate of the effect, but there is a possibility that it is substantially different 
Low               ⊕⊕ There is limited confidence in the effect estimate: the true effect may be substantially 
different from the estimate of the effect 
Very low            ⊕ There is little confidence in the effect estimate: the true effect is likely to be 
substantially different from the estimate of the effect 
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RESULTS  
Description of studies (reviews and additional primary studies) 
Database searching, for Step 1, led to the identification of three relevant systematic reviews (Bates et 
al., 2007, Lin et al., 2007, Slama et al., 2007) (Figure A.4; Appendix A.10). Thirty-four studies were 
included in these systematic reviews collectively on TB outcomes and active (current or ever) 
smoking (Appendix A.10 & Appendix A.11). Step 2, database searching for additional primary 
studies, published after 2005, led to identification of another nine studies (Lindsay et al., 2014, Horne 
et al., 2012, Rao et al., 2012, Brunet et al., 2011, Wen et al., 2010, Jee et al., 2009, Wang and Shen, 
2009, Gajalakshmi and Peto, 2009, d'Arc Lyra Batista et al., 2008) (Appendix A.10 & Appendix 
A.11). Further bibliography searching of the included studies identified four relevant studies 
(Thomas et al., 2005, Al-Darraji et al., 2015, Adib et al., 1999, Pednekar and Gupta, 2007) for 
inclusion in the evidence synthesis (Appendix A.10 & Appendix A.11).   
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A.4: Flow diagram of identified reviews and additional primary studies  
Information on outcome in studies  
Number of reviews identified through 
database search (n= 35) 
Records screened (n= 34) 
Duplicates (n= 1) 
Records excluded 
Not reporting on outcomes of interest (n= 20) 
Not ‘systematic’ reviews (n= 9) 
Full text articles not found (n= 2) Full-text articles assessed for eligibility 
(n= 3) 
Number of primary studies in the 
reviews (n= 34) 
Systematic reviews: Year 1985 to 2015 
Records screened (n= 54) 
Duplicates (n= 2) 
Number of studies identified through 
database search (n= 56) 
Records excluded; 
Not reporting on outcomes of interest (n= 25) 
Not ‘epidemiologic’ studies (n= 11) 
Studies on patients with comorbidities (n= 4) 
Study already included in the reviews (n= 1) 
Full-text articles assessed for eligibility 
(n= 9) 
Number of studies identified through 
other sources (n= 4) 
Primary studies included in evidence 
synthesis (n= 47) 
Primary studies: Year 2005 to 2015 
Latent TB infection 
(n= 11) 
Active TB disease 
(n= 29) 
TB mortality 
(n= 8) 
Recurrent TB 
(n= 4) 
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Evidence for Latent TB infection 
There were 11 studies on the association between smoking and acquisition of TB infection; one of 
which was case-control (Anderson et al., 1997) and remaining were cross-sectional in design (Table 
A.5). Smokers were more likely to have latent TB infection compared to the non-smokers; odds ratio 
(OR) of latent TB infection ranged between 1.73 (95%CI: 1.46-2.04) and 1.83 (95%CI: 1.49-2.23) for 
the systematic reviews (Bates et al., 2007, Lin et al., 2007, Slama et al., 2007).  
There was no evidence of heterogeneity between these studies by looking at the I-squared statistics 
in the three systematic reviews and the overlapping of confidence intervals (CI) around the effect 
estimates for the additional primary studies. The only outlier was Brunet et al. (2011), a cross-
sectional study done in South Africa that reported OR of 0.64 (95%CI: 0.14-2.79); the study used 
objective measures, of TB infection (Interferon Gamma Release Assays- IGRA) and smoking (serum 
cotinine) as opposed to Tuberculin Skin Test (TST) positivity  for TB infection and self-reported 
smoking in other studies. However, the number analysed for TB infection was very small i.e. 108 
individuals. The largest effect (OR: 2.8; 95%CI: 1.6-5.2) was seen in Hussain et al. (2003), which was 
a cross-sectional study conducted in prisoners, in Pakistan, using TST for TB infection and self-
reported smoking status.  
The magnitude of the median sample size (> 300 participants) and the number of included studies (> 
10 studies) was considered high, according to the GRADE checklist. Publication bias was not 
observed for the studies included on TB infection in the three systematic reviews. 
A dose-response gradient was observed for acquisition of TB infection with both the quantity and 
the duration of smoking (Hussain et al., 2003, Den Boon et al., 2005, Anderson et al., 1997, Horne et 
al., 2012). 
The true effect of tobacco smoking on acquisition of TB infection may be substantially different from 
the estimate of the effect, which is approximately double the odds of acquiring TB infection among 
smokers than non-smokers, according to the systematic reviews. This evidence for the association 
between smoking and TB infection remains rather limited, especially considering temporality could 
not be established, due to the lack of longitudinal observational studies. 
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A.5: Synthesis of evidence for the association between smoking and TB infection 
 Rating Adjustment to score 
Q
u
a
li
ty
 a
ss
e
ss
m
e
n
t 
No. of studies/ starting score 11 observational 2 
F
ac
to
rs
 d
ec
re
as
in
g
 c
o
n
fi
d
en
ce
 
Limitation in study design 
(Temporality) 
Serious 
(10 cross-sectional, 1 case-
control, studies) 
-1 
Inconsistency 
(Heterogeneity in point estimates, 
CI’s, direction of effect) 
None serious1 0 
Indirectness 
(Biological plausibility, 
Generalizability, outcome not a 
surrogate measure, direct 
comparison) 
Serious2 -1 
Imprecision 
(Strength of association, magnitude 
of median sample size, magnitude 
of included studies, outcome a 
common event) 
None serious 0 
Publication bias None serious 0 
F
ac
to
rs
 
in
cr
ea
si
n
g
 
co
n
fi
d
en
c
e 
Large effect Weak evidence3 0 
Dose-response Moderate evidence +1 
Mitigated bias and confounding Moderate evidence4 +1 
Final GRADE score of quality of evidence 2 
S
u
m
m
a
ry
 o
f 
fi
n
d
in
g
s 
Quality of evidence Low                 ⊕⊕ 
Conclusion 
Due to the lack of 
temporality data (weak 
study designs) the 
credibility of observed 
association remains 
limited. 
1 Heterogeneity between primary studies and within systematic reviews was considered 
2 Both TB infection and smoking in majority of the studies are assessed using surrogate measures or self-reporting 
3 Weak evidence- not all effect sizes >2 or < 0.5 and significant  
4 Adjustment for main confounders (i.e. age, gender and SES) in majority studies  
Abbreviations: SES, Socio-economic status; OR, Odds ratio 
 
Evidence for active TB disease  
There were 29 studies on the association between smoking and developing active TB (Table A.6); 
two of which were prospective cohort (Leung et al., 2004, Jee et al., 2009), five cross-sectional and 
remaining were case-control designs (for details refer to Appendix A.10). Smokers were more likely 
to develop TB disease compared to the non-smokers; the effect estimates of developing active TB 
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disease ranged between 2.01 (95%CI: 1.63-2.48) and 2.33 (95%CI: 1.97-2.75) for the systematic 
reviews (Bates et al., 2007, Lin et al., 2007, Slama et al., 2007).  
There was moderate evidence of heterogeneity (I2: 40-60%) between these studies by looking at the 
heterogeneity statistics of pooled studies in the three systematic reviews and the overlapping of CIs 
around the effect estimates for the additional primary studies. The effect estimates of three studies 
(Shetty et al., 2006, Brunet et al., 2011, Brown and Campbell, 1961) showed negative association, but 
were statistically non-significant. One of these studies was a cross-sectional design and the other two 
were case-controls, with sample sizes ranging between 200 and 400. A large effect of smoking on TB 
disease was seen in two case-control studies; Tekkel et al. (2002): OR 4.62 (95%CI: 2.44-8.73), and 
Gupta et al. (2001): OR 4.42 (95%CI: 2.55-7.66). Both cohort studies showed moderate to high effect 
size estimates; OR of 2.87 (95%CI: 2.00-4.11) in Leung et al. (2004), and Hazards Ratio (HR) of 1.4 
(95%CI: 1.3-1.4) in Jee et al. (2009).  
The magnitude of the median sample size (> 300 participants) and the number of included studies (> 
10 studies) was considered high, according to GRADE checklist. Publication bias was not observed 
for the studies included on TB infection in the three systematic reviews. 
A dose-response gradient was observed for the increase in risk of developing TB disease both with 
increasing quantity (Leung et al., 2004, Gajalakshmi et al., 2003, Gupta et al., 2001, Dong et al., 
2001, Wang et al., 2005, Alcaide et al., 1996, Adelstein and Rimington, 1967, Lowe, 1956, Wang and 
Shen, 2009, Jee et al., 2009) and duration (Yu et al., 1988, Buskin et al., 1994, Ariyothai et al., 2004, 
Lienhardt et al., 2005, Kolappan and Gopi, 2002) of smoking. 
From grading evidence on the association between tobacco smoking and active TB disease, there is 
high confidence that the true effect lies close to that of the estimate of the effect, which is 
approximately double the odds of developing TB disease among smokers over non-smokers, 
according to the systematic reviews. Therefore, strong evidence supports that tobacco smoking 
increases the risk of developing TB disease. 
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A.6: Synthesis of evidence on the association between smoking and TB disease 
 Rating Adjustment to score 
Q
u
a
li
ty
 a
ss
e
ss
m
e
n
t 
No. of studies/ starting score 29 observational 2 
F
ac
to
rs
 d
ec
re
as
in
g
 c
o
n
fi
d
en
ce
 
Limitation in study design 
(Temporality) 
None serious 
(5 cross-sectional, 22 case-
control, 2 cohort studies) 
0 
Inconsistency 
(Heterogeneity in point estimates, 
CI’s, direction of effect) 
Serious1 -1 
Indirectness 
(Biological plausibility, 
generalizability, outcome not a 
surrogate measure, direct 
comparison) 
None serious2 0 
Imprecision 
(Strength of association, magnitude 
of median sample size, magnitude 
of included studies, outcome a 
common event) 
None serious 0 
Publication bias None serious 0 
F
ac
to
rs
 
in
cr
ea
si
n
g
 
co
n
fi
d
en
c
e 
Large effect Moderate evidence3 +1 
Dose-response Moderate evidence +1 
Mitigated bias and confounding Moderate evidence4 +1 
Final GRADE score of quality of evidence 4 
S
u
m
m
a
ry
 o
f 
fi
n
d
in
g
s 
Quality of evidence High        ⊕⊕⊕⊕ 
Conclusion 
Strong evidence that 
tobacco smoking 
increases the risk of 
developing TB disease 
1 Moderate statistical heterogeneity (i.e. 40- 60%) between studies estimates 
2 Diagnosis of TB disease (Sputum smear microscopy or culture) is a direct measure while smoking status remains self-
reported in most studies 
3 Moderate evidence- effect sizes >2 or < 0.5 for majority studies/meta-analysis included and significant; OR ranged 
between 2.0 and 2.3, statistically significant for the systematic reviews 
4 Adjustment for main confounders (i.e. age, gender, alcohol use, region, BCG scar and SES) in majority studies 
Abbreviations: SES, Socio-economic status; OR, Odds ratio; BCG, Bacillus Calmette–Guérin 
Evidence for TB mortality 
There were 8 studies on the association between smoking and TB mortality; four prospective cohort 
and four case-control studies (Table A.7). Smokers were more likely to die from TB disease 
compared to the non-smokers; the OR of dying from TB ranged between 2.00 (95%CI: 1.14-3.49) and 
2.24 (95%CI: 1.34-3.73) for the systematic reviews (Bates et al., 2007, Lin et al., 2007, Slama et al., 
2007). 
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There was high heterogeneity (I2: >60%) between the mortality studies pooled in the systematic 
reviews. However, all studies had statistically significant (positive) associations in the direction of 
effect between smoking and death due to TB. The highest effect estimates were observed in 
Gajalakshnmi et al. (2003): OR 4.5 (95%CI: 4.0-5.0), Wen et al. (2010): HR 4.19 (95%CI: 1.8-9.7), and 
Gupta et al. (2005): OR 3.31 (95%CI: 1.34-8.16).  
The magnitude of the median sample size was high (> 300 participants) and the number of included 
studies was moderate (5-10 studies), according to the GRADE checklist. Publication bias was not 
assessed for the studies included on TB mortality in the three systematic reviews. 
A dose-response gradient was observed for TB mortality with both the quantity (Jee et al., 2009, 
Lam et al., 2001, Liu et al., 1998, Pednekar and Gupta, 2007) and the duration of smoking (Lin et al., 
2007). Cause of death was established in two studies by death certificates; one relied on verbal 
autopsy and the rest on records from hospitals and thenational statistics database. In a cohort of 
British doctors, a Relative Risk (RR) of 2.8 with a dose-response gradient for quantity smoked (RR 
for those who smoked more than 25 cig/day was 5 (Slama et al., 2007)) was observed for TB 
mortality, compared to lifetime non-smokers (Doll, 1999). The study was not included in the 
evidence synthesis as it did not provide the CIs around the risk estimates and was not a direct report 
of the cohort study. 
From grading evidence on the association between tobacco smoking and TB mortality, there is high 
confidence that the true effect lies close to that of the estimate of the effect, which is approximately 
double the odds of dying from TB among smokers over non-smokers. Therefore, strong evidence 
supports that tobacco smoking increases the risk of dying from TB. 
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A.7: Synthesis of evidence on the association between smoking and TB mortality 
 Rating Adjustment to score 
Q
u
a
li
ty
 a
ss
e
ss
m
e
n
t 
No. of studies/ starting score 8 observational 2 
F
ac
to
rs
 d
ec
re
as
in
g
 c
o
n
fi
d
en
ce
 
Limitation in study design 
(Temporality) 
None serious 
(4 cohort, 4 case-control 
studies) 
0 
Inconsistency 
(Heterogeneity in point estimates, 
CI’s, direction of effect) 
Serious1 -1 
Indirectness 
(Biological plausibility, 
generalizability, outcome not a 
surrogate measure, direct 
comparison) 
None serious2 0 
Imprecision 
(Strength of association, magnitude 
of median sample size, magnitude 
of included studies, outcome a 
common event) 
None serious 0 
Publication bias None serious 0 
F
ac
to
rs
 
in
cr
ea
si
n
g
 
co
n
fi
d
en
c
e 
Large effect Moderate evidence +1 
Dose-response Moderate evidence +1 
Mitigated bias and confounding Moderate evidence3 +1 
Final GRADE score of quality of evidence 4 
S
u
m
m
a
ry
 o
f 
fi
n
d
in
g
s 
Quality of evidence High        ⊕⊕⊕⊕ 
Conclusion 
Strong evidence that 
tobacco smoking 
increases the risk of TB 
mortality 
1 High statistical heterogeneity (i.e. > 60%) between studies estimates 
2 Moderate evidence- effect sizes >2 or < 0.5 for majority studies/meta-analysis included and significant; OR ranged 
between 2.0 and 2.2, statistically significant for the 3 systematic reviews 
3 Adjustment for main confounders (i.e. age, gender and SES) in majority studies  
Abbreviations: SES, Socio-economic status; OR, Odds ratio 
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Evidence for TB recurrence 
None of the systematic reviews reported pooled estimates for the association between smoking and 
TB recurrence. There were 4 primary studies (all cohort in design) included in the evidence 
synthesis for this association (Table A.8).  
There was no evidence of heterogeneity between studies; effect estimates for all studies were 
statistically significant and in the direction of the effect between smoking and the risk of recurrence. 
The OR reported in three of the studies were, 3.1: 95% CI, 1.6-6.0 (Thomas et al., 2005), 2.53: 
95%CI, 1.23-5.21 (d'Arc Lyra Batista et al., 2008) and 2.48: 95%CI, 1.04-5.89 (Leung et al., 2004). 
One study (Jee et al., 2009) reported a Hazards Ratio of 1.3 (95%CI: 1.2-1.4), which can be considered 
high as HR is a risk ratio and could only be approximated to OR when the event is rare. However, 
TB recurrence is not a rare event; relapse rates of 18.1% among smokers and 7.3% among non-
smokers are observed, of which 77% of cases occur in the first six months of follow-up after 
treatment completion (Thomas et al., 2005). 
The magnitude of the median sample size was high (> 300 participants) and the number of included 
studies was small (< 5 studies), according to the GRADE checklist. Publication bias could not be 
assessed as the only systematic review (Slama et al., 2007) reporting on TB recurrence studies did 
not conduct meta-analysis of these studies. A dose-response gradient was observed for the quantity 
smoked and risk of TB recurrence in Jee et al. (2009). The study by Thomas et al. (2005) used 
sputum smear microscopy and culture to confirm TB recurrence at 6, 12 and 18 months post-TB 
treatment and cure of the patient, while the rest of the studies used retreatment after a completed 
treatment for active TB in the past.  
From grading evidence on the association between tobacco smoking and TB recurrence, there is 
high confidence that the true effect lies close to that of the estimate of the effect, which is 
approximately double the odds of recurrence of TB among smokers than non-smokers. Therefore, 
strong evidence supports that tobacco smoking increases the risk of re-infection and/or relapse from 
TB. 
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A.8: Synthesis of evidence on the association between smoking and TB recurrence 
 Rating Adjustment to score 
Q
u
a
li
ty
 a
ss
e
ss
m
e
n
t 
No. of studies/ starting score 4 observational 2 
F
ac
to
rs
 d
ec
re
as
in
g
 c
o
n
fi
d
en
ce
 
Limitation in study design 
(Temporality) 
None serious 
(All prospective cohort 
designs) 
0 
Inconsistency 
(Heterogeneity in point estimates, 
CI’s, direction of effect) 
None serious 0 
Indirectness 
(Biological plausibility, 
generalizability, outcome not a 
surrogate measure, direct 
comparison) 
None serious 0 
Imprecision 
(Strength of association, magnitude 
of median sample size, magnitude 
of included studies, outcome a 
common event) 
Serious1 -1 
Publication bias None serious 0 
F
ac
to
rs
 
in
cr
ea
si
n
g
 
co
n
fi
d
en
c
e 
Large effect Moderate evidence2 +1 
Dose-response Moderate evidence +1 
Mitigated bias and confounding Moderate evidence3 +1 
Final GRADE score of quality of evidence 4 
S
u
m
m
a
ry
 o
f 
fi
n
d
in
g
s 
Quality of evidence High        ⊕⊕⊕⊕ 
Conclusion 
Strong evidence that 
tobacco smoking 
increases the risk of TB 
recurrence 
1 Less than 5 studies  
2 Moderate evidence- effect sizes >2 or < 0.5 for all studies 
3 Adjustment for main confounders (i.e. age, gender, alcohol and SES) in majority studies  
Abbreviations: SES, Socio-economic status 
 
DISCUSSION 
Summary of main results 
Tobacco smokers are twice as likely to develop TB disease, suffer recurrent TB and die from TB, 
compared to non-smokers. However, the evidence on the association between tobacco smoking and 
acquiring TB infection was found to be weak. According to the GRADE scores, the evidence for 
active TB disease, TB mortality and TB recurrence was ranked as high quality, while the evidence 
for latent TB infection was ranked as low quality. This study supports the findings from previous 
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reviews on the association of smoking with TB disease. Unlike previous reviews that were unclear 
about the association of smoking and TB mortality (Bates et al., 2007), my study provides concrete 
evidence on this association and fills the gap in knowledge. An important finding of this review is 
that the association of smoking with TB infection is weak, which has been judged on the meta-
analysis estimates of Odds Ratios ranging between 1.5 to 2 in previous reviews (Bates et al., 2007, 
Lin et al., 2007). This study also provided the evidence for the association between smoking and TB 
recurrence for the first time, which was found to be strong and of good quality. TB recurrence has 
not been evaluated in previous reviews of smoking and TB outcomes. 
Overall completeness and applicability of evidence 
The high grade of the quality of association between smoking and TB disease, mortality and 
recurrence across all available evidence allows a higher confidence in interpreting the estimates of 
effect. For the given outcomes, high quality of the effect estimate  means that the true effect of 
smoking on these three outcomes lies close to the observed effect, which is found to be moderate to 
strong (an OR of 2) (Craun and Calderon). The longitudinal studies (especially prospective cohort) 
on the effect of smoking on these three TB outcomes lend credibility to the already established 
temporal and causal associations. On the other hand, the low quality of evidence on acquisition of TB 
infection gives limited confidence in the observed effect estimates, as they might differ substantially 
from the true effect. This is mainly because there was a single longitudinal study (case-control) and 
no prospective cohort studies that could establish the temporal association between smoking and TB 
infection. However, this finding should not be taken as evidence of no association, because four of the 
studies in the review found a dose-response gradient (i.e. a higher risk of acquiring TB infection with 
larger exposure), which makes a causal association more plausible.  
Smoking adversely impacts a variety of other TB-related outcomes that were not covered in the 
current review. Smoking affects individuals with latent TB infection by triggering their progression 
to develop active TB disease (Alcaide et al., 1996) or reactivation of TB. Furthermore, smokers 
encounter more severe TB disease, with numerous and bigger infiltrates (cavitation) (OR 1.9; 95%CI: 
1.6 to 2.3) and greater likelihood of hospitalization (OR 1.8; 95%CI: 1.5 to 2.2) than non-smokers 
(Altet-Gomez et al., 2005). In addition, the duration of conversion of sputum smear (from positive to 
negative for mycobacterium TB) is prolonged in TB patients who also smoke tobacco (Onyebujoh et 
al., 1999). These outcomes are also of significance from a public health point of view and suggest 
opportunistic cessation treatment by targeting all of the patients attending TB clinics (e.g. TB 
suspects) and not just those diagnosed with TB. 
The current evidence synthesis was restricted to active smoking and its effect on TB outcomes. 
However there is now evidence that passive smoking (aka Second-Hand Smoking (SHS)) also 
influences TB disease and worsens its outcomes (Patra et al., 2015). The association between SHS 
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and the risk of TB infection and disease was systematically reviewed and published in a peer review 
journal (Dogar et al., 2015) by myself and colleagues. 
Potential biases of the review 
There are several potential limitations of this evidence synthesis study. Firstly, limited database 
searching and language restrictions might have led to exclusion of important primary studies. 
However, to minimise this bias, an extensive bibliography searching of all the identified studies was 
carried out. Second, there is possibility of misclassification of both exposure (tobacco smoking) and 
outcome status (TB outcomes of interest). Active smoking assessment relied majorly on self-reports 
in almost all of the studies, which may not be an accurate account of smoking status in some 
individuals (West et al., 2007). Furthermore, some studies only measured ‘current smoking,’ without 
accounting for the duration of smoking to date, which may be subject to reverse causation. TB 
patients are often diagnosed months after they first experience the respiratory symptoms, leading 
many of them to stop smoking even before they are diagnosed. This might be explained by the fact 
that several studies (McCurdy et al., 1997, Shetty et al., 2006, Crampin et al., 2004) showed a 
stronger effect of ‘former smoking’ compared to ‘current smoking’ on TB. The use of a surrogate 
measure (the TST) for all but one study of TB infection, might also lead to misclassification of 
outcome status, depending on the cut-offs of induration used.  
Research implications 
Prospective cohort studies, with objective measures of TB infection, are required to establish its true 
causal association with smoking. Moreover, future studies should utilise highly sensitive and specific 
objective measures (e.g. serum cotinine testing) for smoking assessment. There is strong evidence 
that tobacco smoking not only leads to active TB disease but also adversely affects TB treatment 
outcomes like recurrence and death, which can be offset by timely and appropriate action to target 
TB patients for smoking cessation. Although the strength of association for tobacco smoking and TB 
disease/mortality/recurrence was found to be moderate to high, the implication for population 
health in LMICs is critical. Given the high prevalence of smoking in these countries, which has been 
consistently rising over time, a considerable portion of the global burden of TB may be attributed to 
smoking (Pai et al., 2007).  
CONCLUSION 
There is strong evidence that tobacco smoking increases the risk of developing active TB disease, the 
risk of its recurrence and the risk of death from it. However, its association with the risk of latent TB 
infection is found to be weak and the quality of evidence remains limited. Prospective longitudinal 
studies can strengthen the evidence on association between smoking and TB infection, in future. 
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More importantly, integration of smoking cessation services within TB care and management 
(targeting TB disease, recurrence and mortality) is an urgent consideration. This can only be 
achieved if the need to integrate smoking cessation services into TB care and management services is 
realised and incorporated into current policies and initiatives rolled out by LMICs burdened with 
TB.   
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A.9: GRADE checklist for Quality Assessment 
Study limitations (Risk of Bias) 
1) Was random sequence generation used (i.e. no potential for selection bias)? 
 Yes 
 No 
 Unclear 
2) Was allocation concealment used (i.e. no potential for selection bias)? 
 Yes 
 No 
 Unclear 
3) Was there blinding of participants and personnel   (i.e. no potential for performance bias)? 
 Yes 
 No 
 Unclear 
4) Was there blinding of outcome assessment (i.e. no potential for detection bias)? 
 Yes 
 No 
 Unclear 
5) Was an objective outcome used? 
 Yes 
 No 
6) Were more than 80%4 of participants enrolled in trials included in the analysis (i.e. no potential 
reporting bias)? 
 Yes 
 No 
 Unclear 
7) Were data reported consistently for the outcome of interest (i.e., no potential selective reporting)? 
 Yes 
 No 
                                                     
4 80% drop out is given as an example here a different proportion can be used depending on the context of the systematic 
review area 
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 Unclear 
8) No other biases reported? (i.e. no potential of other bias) 
 Yes 
 No 
9) Did the trials end as scheduled (i.e not stopped early)? 
 Yes 
 No 
 
Inconsistency5 
1) Point estimates did not vary widely? 
 Yes 
 No 
2) To what extent did confidence intervals overlap? 
 Substantial overlap  
(all confidence intervals overlap at least one of the included studies point estimate) 
 Some overlap 
(confidence intervals overlap but not all overlap at least one point estimate) 
 No overlap 
(At least one outlier: where the confidence interval of some of the studies do not overlap with 
those of most included studies) 
3) Was the direction of effect consistent? 
 Yes 
 No 
4) What was the magnitude of statistical heterogeneity (as measured by I2)? 
 Low (e.g.  I2 <40%) 
 Moderate (e.g. I2 40-60%) 
 High (e.g. I2 >60%) 
5) Was the test for heterogeneity statistically significant (p<0.1)? 
 Not statistically significant 
                                                     
5 Reviewers may choose to use estimates from a subgroup analysis which may explain the inconsistency but should be 
cautious that such a explanation of heterogeneity may be due to the play of chance 
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 Statistically significant 
 
Indirectness 
1) Were the populations in included studies applicable to the decision context? 
 Highly applicable 
 Applicable 
 Poorly applicable 
2) Were the interventions in the included studies applicable to the decision context? 
 Highly applicable 
 Applicable 
 Poorly applicable 
3) Was the included outcome not a surrogate outcome? 
 Yes 
 No 
4) Was the outcome timeframe sufficient? 
 Sufficient 
 Insufficient 
5) Were the conclusions based on direct comparisons? 
 Yes 
 No 
 
Imprecision 
1) Was the confidence interval for the pooled estimate not consistent with benefit and harm? 
 Yes 
 No 
2) What is the magnitude of the median sample size? 
 High (e.g. 300 participants) 
 Intermediate (e.g. 100-300 participants) 
 Low (e.g. <100 participants) 
3) What was the magnitude of the number of included studies? 
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 Large (e.g. >10 studies) 
 Moderate (e.g. 5-10 studies) 
 Small (e.g. <5 studies) 
4) Was the outcome a common event (e.g. occurs more than 1/100)? 
 Yes 
 No 
 Not applicable (i.e. not a dichotomous outcome) 
Further optional question for those engaged in guideline development6 
5) Was there no evidence of serious harm associated with treatment? 
 Yes 
 No 
 
Publication Bias (other considerations) 
1) Did the authors conduct a comprehensive search? 
 Yes 
 No 
2) Did the authors search for grey literature? 
 Yes 
 No 
3) Authors did not apply restrictions to study selection on the basis of language? 
 Yes 
 No 
4) There was no industry influence on studies included in the review? 
 Yes 
 No 
5) There was no evidence of funnel plot asymmetry? 
 Yes 
                                                     
6 This reflects GRADE guidance that guideline developers may use a less stringent threshold for judging imprecision of an 
intervention’s benefits when there is no evidence of harm compared with when judging the benefits of an intervention 
where there is strong evidence of harm 
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 No 
 Unclear 
6) There was no discrepancy in findings between published and unpublished trials? 
 Yes 
 No 
 Unclear 
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A.10: Data extraction from reviews and primary studies 
Category 
Study 
design 
Study 
Locatio
n 
Populatio
n/ 
setting 
Measure of 
disease outcome 
Measure of 
exposure 
Sample 
size  
Effect 
estimate 
(95% CI) 
Heterog
eneity 
(I-sq; p-
value) 
Adjusted 
confounde
rs 
Dose 
response 
gradient 
Publicat
ion bias 
TB 
infection 
Review 
Lin et al. 
2007 
 -  - 
TST cut-off 5mm 
= 2 studies; 
TST cut-off 
10mm = 4 
studies 
Current smoking= 
4 studies; 
Ever smoking= 2 
studies 
(all self-reports) 
 -  
OR:  
TST cut-off 
5mm = 2.08 
(1.53-2.83); 
TST cut-off 
10mm = 
1.83 (1.49-
2.23) 
0% 
Alcohol, 
SES 
N/A 
None 
detected 
TB 
disease 
Clinical TB 
disease diagnosed 
on sputum smear 
microscopy 
and/or CXR 
Current smoking= 
13 studies; 
Ever smoking= 2 
studies 
Former smoking= 
1 study; 
(all self-reports) 
OR: 2.01 
(1.63-2.48) 
63.7% 
Alcohol, 
SES, Type 
of study, 
Mode of 
diagnosis 
TB 
mortality 
Reporting TB 
mortality- no 
strict definition 
used 
 -  
OR: 2.00 
(1.14-3.49) 
98.7% none Yes 
not 
assessed 
TB 
infection 
Review 
Bates et 
al. 2007 
 -   -  
TST cut-off 
10mm= 5 studies; 
Current smoking= 
2 studies; 
Ever smoking= 2 
studies 
Former smoking= 
1 study 
(all self-reports) 
 -  
RR: 
1.73 (1.46-
2.04) 
 p-
value= 
0.71 
none N/A 
None 
detected 
TB 
disease 
TB disease 
diagnosed by 
sputum smear 
microscopy or 
culture or 
notification 
Current smoking= 
7 studies; 
Ever smoking= 4 
studies 
Former smoking= 
1 study 
(all self-reports) 
RR: 2.33 
(1.97-2.75) 
p-value= 
0.04 
None 
detected 
TB 
mortality 
Death certificate 
or verbal autopsy 
 -  
RR: 2.15 
(1.38-3.35) 
p-value= 
<0.001 
not 
assessed 
TB Review Slama et  -   -  TST (cut-off not Current smoking= 4729 OR:  p-value= none N/A Not 
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infection al. 2007 specified) 3 studies; 
Ever smoking= 2 
studies 
(all self-reports) 
1.76 (1.47-
2.12) 
0.525 assessed 
TB 
disease 
Clinical TB 
disease diagnosed 
on sputum smear 
microscopy, 
culture and/or 
CXR and 
response to anti-
TB drugs 
Current smoking= 
14 studies; 
(all self-reports) 
159854 
OR: 2.28 
(1.77-2.95) 
p-value= 
<0.001 
TB 
mortality 
Death certificate 
or verbal autopsy 
or medical 
records verifying 
death due to TB 
 -  67168 
OR: 2.24 
(1.34-3.73) 
p-value= 
<0.001 
TB 
infection 
case-
control 
Anderson 
et al. 1997 
USA Prisoners 
TST cut-off 
10mm 
Self-reported 
current smoking 
293 (116 
HIV+ve) 
OR: 1.78 
(0.98-3.21) 
 -  
Age, living 
conditions, 
gender, 
alcohol, 
HIV, 
contact 
with TB 
patient, 
BMI 
Yes (for 
both 
duration 
and 
quantity) 
 -  
TB 
infection 
cross-
section
al 
DenBoon 
et al. 2005 
South 
Africa 
High risk 
Urban 
communit
y 
TST cut-off 
10mm 
Self-reported ever 
smoking 
2347 
OR: 1.77 
(1.33-2.35) 
 -  
Same 
address 
clustering, 
age gender, 
SES, BMI 
Yes (Dose 
response 
observed 
on pack 
years) 
 -  
TB 
infection 
cross-
section
al 
Hussain 
et al. 2003 
Pakistan Prisoners 
TST cut-off 
10mm 
Self-reported 
current smoking 
425 
OR: 2.8 (1.6-
5.2) 
 -  
Education, 
duration of 
imprisonm
ent, 
crowding 
of cell, age, 
SES, BCG  
Yes 
(Quantity) 
 -  
TB 
infection 
cross-
section
al 
Plant et 
al. 2002 
Vietnam 
Vietnames
e 
immigran
ts 
TST cut-off 
10mm 
Self-reported ever 
smoking 
1395 
OR: 1.53 
(1.13-2.09) 
 -  
Age, 
gender, TB 
contact, 
living 
No   -  
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condition, 
SES 
TB 
infection 
cross-
section
al 
McCurdy 
et al. 1997 
USA 
Migrant 
farm 
workers 
TST cut-off 
10mm 
Self-reported 
current and former 
smoking 
296 
OR: 1.87 
(0.73-4.8) 
 -  
Birthplace, 
age, gender 
Not 
assessed 
 -  
TB 
infection 
cross-
section
al 
Solsona et 
al. 2001 
Spain 
Homeless 
shelter 
TST cut-off 5mm 
Self-reported 
current smoking 
447 
OR: 1.72 
(1.02-2.86) 
 -  
Age, 
gender, 
alcohol, 
BCG 
Not 
assessed 
 -  
TB 
infection 
cross-
section
al 
Adib et al. 
1999 
Lebanon Prisoners TST cut-off 8mm 
Self-reported 
current smoking 
3931 
OR: 1.2 (1.1-
1.3) 
 -  
Residence 
area, age, 
gender, 
occupation, 
duration of 
imprisonm
ent 
Not 
assessed 
 -  
TB 
infection 
cross-
section
al 
Horne et 
al. 2012 
USA 
Populatio
n based 
National 
survey 
TST cut-off 
10mm 
Self-reported 
current smoking 
verified by serum 
cotinine testing 
3843 
OR: 1.76 
(1.06-2.94) 
 -  
Birthplace, 
age, 
gender, 
SES, TB 
contact, 
Education, 
BCG, 
race/ethnic
ity 
Yes (in 
ethnic 
subgroups) 
 -  
TB 
infection 
cross-
section
al 
Al-Daraji 
et al. 2015 
Malaysia 
Prison 
staff 
TST cut-off 
10mm 
Self-reported 
current smoking 
420 
OR: 1.94 
(1.17-3.22) 
 -  
Age, 
alcohol, 
duration of 
work, 
current 
post  
Not 
assessed 
 -  
TB 
infection 
cross-
section
al 
Lindsay et 
al. 2014 
USA 
Populatio
n based 
National 
survey 
TST cut-off 
10mm 
Self-reported 
current smoking 
verified by serum 
cotinine testing 
938 
OR: 
2.31(1.17-
4.55) 
 -  
Age, 
gender, 
SES, race, 
birthplace, 
household 
size, TB 
contact 
Not 
assessed 
 -  
TB 
infection 
cross-
section
al 
Brunet et 
al. 2011 
South 
Africa 
TB 
suspects 
IGRA 
(Quantiferon TB 
gold) 
serum cotinine 
levels 
108 
OR: 0.64 
(0.14-2.79) 
 -  
Age, 
gender 
alcohol, 
SES, HIV 
Not 
assessed 
 - 
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status 
TB 
disease 
Sputum smear 
microscopy and 
culture; CXR 
410 
OR: 0.63 
(0.38-1.03) 
 -  
Age, 
alcohol, 
SES, 
previous 
TB 
 - 
TB 
disease 
Cohort 
Leung et 
al. 2004 
Hong 
Kong 
Clients of 
the 
elderly 
health 
services 
TB confirmed by 
microscopy, CXR 
or histology 
Self-reported 
current smoking 
252 
OR: 2.87 
(2.00-4.11) 
 -  
Age, 
gender, 
alcohol, 
SES, living 
conditions, 
comorbiditi
es 
Yes 
(Quantity) 
 - 
TB 
recurrence 
Self-reported 
active TB with 
history of cured 
TB 
42659 
OR: 2.48 
(1.04-5.89) 
 - 
Not 
assessed 
 - 
TB 
disease 
case-
control 
Shetty et 
al. 2006 
India 
TB 
outpatient
s and 
controls 
were their 
relatives 
TB diagnosed per 
NTP guidelines 
Self-reported 
current smoking 
378 
OR: 0.80 
(0.34-1.89) 
 -  
Age, 
gender, 
alcohol, 
SES, living 
conditions, 
comorbiditi
es, biomass 
fuel use 
Not 
assessed 
 -  
TB 
disease 
case-
control 
Lienhardt 
et al. 2005 
Gambia, 
West 
Africa 
TB 
patients 
and 
controls 
were from 
their 
household
s and 
communit
y 
TB confirmed by 
microscopy 
Self-reported 
current smoking 
2325 
OR: 2.54 
(1.77-3.66) 
 -  
Age, 
gender, 
alcohol, 
SES, BCG, 
comorbiditi
es, TB 
contact 
Yes 
(duration) 
 -  
TB 
disease 
case-
control 
Wang et 
al. 2005 
China 
TB 
patients 
and 
neighbour
hood 
controls 
TB confirmed by 
microscopy 
Self-reported 
current smoking 
474 
OR: 1.54 
(1.16-2.04) 
 -  
Age, 
gender, 
SES 
Yes 
(Quantity) 
 -  
TB 
disease 
case-
control 
Aryothai 
et al. 2004 
Thailand 
TB 
inpatients 
and 
controls 
from 
TB confirmed by 
microscopy, CXR 
or histology 
Self-reported 
current smoking 
200 
OR: 2.70 
(1.04-6.97) 
 -  
Age, 
alcohol, 
living 
conditions, 
BCG, 
Yes (for 
both 
duration 
and 
quantity) 
 -  
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outpatient
/inpatient 
from 
other 
departme
nts 
comorbiditi
es, TB 
contact, 
BMI 
TB 
disease 
case-
control 
Kolappan 
et al. 2002 
India 
TB 
patients 
and 
controls 
were from 
the 
communit
y 
TB confirmed by 
microscopy or 
culture 
Self-reported 
current smoking 
665 
OR: 2.24 
(1.27-3.04) 
 -  Age 
Yes (for 
both 
duration 
and 
quantity) 
 -  
TB 
disease 
case-
control 
Tekkel et 
al. 2002 
Estonia 
TB 
patients 
and 
controls 
were from 
populatio
n registry 
TB diagnosed per 
WHO European 
guidelines 
Self-reported 
current smoking 
496 
OR: 4.62 
(2.44-8.73) 
 -  
Age, 
gender, 
region, 
SES 
none  -  
TB 
disease 
case-
control 
Dong et 
al. 2001 
China 
TB 
patients 
and 
controls 
were from 
the 
communit
y 
TB confirmed by 
microscopy 
Self-reported 
current smoking 
348 
OR: 1.65 
(1.00-2.73) 
 -  
Age, 
gender, 
region, 
SES, 
alcohol, 
living 
conditions, 
BCG, 
comorbiditi
es, TB 
contact, 
BMI, dust 
Yes 
(Quantity) 
 -  
TB 
disease 
case-
control 
Gupta et 
al. 2001 
India 
TB 
patients; 
chest 
clinic and 
healthy  
controls 
TB confirmed by 
microscopy, CXR 
or treatment 
response 
Self-reported ever 
smoking 
400 
OR: 4.42 
(2.55-7.66) 
 -  
Age, 
gender, 
SES, TB 
contact 
Yes 
(cumulative 
exposure) 
 -  
TB 
disease 
case-
control 
Alcaide et 
al. 1996 
Spain 
TB 
patients; 
TST +ve 
TB confirmed by 
microscopy, CXR 
or TST +ve 
Self-reported 
current smoking 
92 
OR: 3.60 
(1.50-7.20) 
 -  
Age, 
gender, 
SES 
Yes 
(Quantity) 
 -  
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controls 
TB 
disease 
case-
control 
Crampin 
et al. 2004 
Malawi 
TB 
patients 
and 
controls 
were from 
the 
communit
y 
TB confirmed by 
microscopy or 
culture 
Self-reported 
current smoking 
606 
OR: 1.3 (0.7-
2.4) 
 -  
Area, 
gender, 
age, HIV 
none  -  
TB 
disease 
case-
control 
Leung et 
al. 2003 
Hong 
Kong, 
China 
TB 
patients; 
controls 
from 
household 
survey 
TB confirmed by 
microscopy, CXR 
or histology 
Self-reported 
current smoking 
8686 
OR: 2.13 
(1.46-3.11) 
 -  none none  -  
TB 
disease 
case-
control 
PerezPadi
lla et al. 
2001 
Mexico patients 
TB confirmed by 
microscopy or 
culture 
Self-reported 
current smoking 
833 
OR: 1.5 (1.0-
2.3) 
 -  
urban and 
rural 
residence, 
crowding, 
education, 
biomass 
fuel use, 
income 
none  -  
TB 
disease 
case-
control 
Tocque et 
al. 2001 
UK 
TB 
patients; 
controls 
from GP 
database 
TB confirmed by 
microscopy or 
culture 
Self-reported 
current smoking 
310 
OR: 2.33 
(1.40-3.88) 
 -  none none  -  
TB 
disease 
case-
control 
Toledo et 
al. 2000 
Brazil 
HIV 
patients 
  
Self-reported 
current smoking 
477 
OR: 1.3 (1.0-
1.6) 
 -  none none  -  
TB 
disease 
case-
control 
Adelstein 
et al. 1967 
UK 
Mass X-
ray 
volunteer
s 
TB confirmed by 
CXR 
Self-reported 
current smoking 
73287 
OR: 4.55 
(2.4-8.6) 
 -  none 
Yes 
(Quantity) 
 -  
TB 
disease 
case-
control 
Shah et al. 
2003 
Pakistan prisoners     75 
OR: 1.59 
(0.44-5.37) 
 -  none    -  
TB 
disease 
cross-
section
al 
Yu et al. 
1988 
China 
Sanitary 
workers 
TB confirmed by 
microscopy or 
CXR  
Self-reported 
current smoking 
30268 
OR: 2.17 
(1.29-3.68) 
 -  
TB contact, 
housing 
area, type 
of work 
Yes 
(Quantity) 
 -  
TB 
disease 
case-
control 
Lowe et 
al. 1956 
UK patients 
TB confirmed by 
notification 
Self-reported 
current smoking 
2179 
OR: 1.61 
(1.27-2.02) 
 -  none 
Yes 
(Quantity) 
 -  
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TB 
disease 
case-
control 
Lewis et 
al. 1963 
UK 
TB 
inpatients 
and 
controls  
inpatient 
from 
other 
departme
nts 
TB confirmed by 
microscopy 
Self-reported 
former smoking 
200 
OR: 1.01 
(0.55-1.85) 
 -  alcohol none  -  
TB 
disease 
case-
control 
Brown et 
al. 1961 
Australia 
TB 
inpatients 
and 
controls  
inpatient 
from 
surgical 
service 
not mentioned 
Self-reported 
current smoking 
200 
OR 0.95 
(0.45-2.02) 
 -  alcohol none  -  
TB 
disease 
case-
control 
Gajalaksh
mi et al. 
2003 
India urban 
TB confirmed by 
self-report 
Self-reported ever 
smoking 
1122 
OR: 2.90 
(2.60-3.30) 
 -  
Age, SES, 
smokeless 
tobacco 
Yes 
(Quantity) 
 -  
TB 
mortality 
TB patients and 
household 
controls 
Death due to TB 
confirmed by vital 
statistics records 
and/or verbal 
autopsy 
33220 
OR: 4.5 (4.0-
5.0) 
 -  
Not 
assessed 
 -  
TB 
disease 
cross-
section
al 
Gupta et 
al. 1997 
India 
rural and 
urban 
TB confirmed by 
microscopy, CXR 
Self-reported 
current smoking 
707 
OR: 1.38 
(0.80-2.39) 
 -  age none  -  
TB 
disease 
cross-
section
al 
Shah et al. 
1959 
India staff 
TB confirmed by 
MMR 
Self-reported 
current smoking 
439 
OR: 2.70 
(1.37-5.29) 
 -  none none  -  
TB 
disease 
cross-
section
al 
Rao et al. 
2012 
India 
Marginali
sed tribal 
group 
TB confirmed by 
microscopy or 
culture 
Self-reported 
current smoking 
9538 
OR: 1.8 (1.3-
2.5) 
 -  
Age, 
gender, 
alcohol 
Not 
assessed 
 -  
TB 
disease 
Cohort 
Jee et al. 
2009 
Korea 
Korean 
Cancer 
Preventio
n study- 
adult 
males 
TB confirmed by 
CXR 
Self-reported 
current smoking 
8657 
HR: 1.4 (1.3-
1.5) 
 -  
Age, 
alcohol, 
BMI 
Yes 
(Quantity) 
 -  
TB 
mortality 
National 
statistics office 
records for cause 
of death 
659 
HR: 1.58 
(1.27-1.97) 
 -   -  
TB 
recurrence 
Self-reported 
confirmed by 
prior 
6218 
HR: 1.3 (1.2-
1.4) 
 -   -  
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hospitalisation 
for active TB 
TB 
disease 
case-
control 
Wang et 
al. 2009 
China 
TB 
patients 
and 
controls 
were from 
the 
communit
y 
not specified 
Self-reported 
current smoking 
1839 
OR: 1.93 
(1.51-2.48) 
 -  
Age, 
gender, 
alcohol, 
education 
Yes (for 
both 
duration 
and 
quantity) 
 -  
TB 
disease 
case-
control 
Gajalaksh
mi et al. 
2009 
India 
TB 
patients 
and 
controls 
were from 
the 
communit
y 
TB confirmed by 
criteria of state 
TB clinics  
Self-reported 
current smoking 
2912 
RR: 2.7 (2.2-
3.3) 
 -  
Age, 
education 
Not 
assessed 
 -  
TB 
mortality 
Cohort 
Gupta et 
al. 2005 
India 
adults 
from 
voters list 
Death due to TB 
confirmed by 
municipal 
corporation 
records 
Self-reported ever 
smoking 
99570 
OR: 3.31 
(1.34-8.16) 
 -  
Age, 
gender, 
SES 
Not 
assessed 
 -  
TB 
mortality 
case-
control 
Sitas et a. 
2004 
South 
Africa 
TB 
patients 
and 
controls 
who died 
due to 
causes 
other than 
smoking 
Death due to TB 
confirmed by 
death notification 
form 
Self-reported  
smoking 5 yeaqrs 
prior to death 
1538 
OR: 1.61 
(1.23-2.11) 
 -  
Age, 
gender, 
SES, race 
Not 
assessed 
 -  
TB 
mortality 
case-
control 
Lam et al. 
2001 
Hong 
Kong 
TB 
patients 
from 
death 
registry 
and live 
controls 
Death due to TB 
confirmed by 
death certificate 
Self-reported ever 
smoking 
13251 
OR: 2.54 
(1.24-5.22) 
 -  
Age, 
gender, 
SES 
Yes 
(Quantity) 
 -  
TB 
mortality 
case-
control 
Liu et al. 
1998 
China 
TB 
patients 
and 
Death due to TB 
confirmed by 
administrative/m
Self-reported ever 
smoking 
99481 
OR: 1.42 
(1.33-1.52) 
 -  
Age, 
gender, 
region, 
Yes 
(Quantity) 
 -  
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controls 
who died 
due to 
causes 
other than 
smoking 
edical records 
and verbal 
autopsies 
urban/rura
l 
TB 
mortality 
Cohort 
Wen et al. 
2010 
China 
Standard 
medical 
screening 
program 
Death due to TB 
confirmed by 
death records in 
national database 
Self-reported 
current smoking 
90580 
HR: 4.19 
(1.8-9.7) 
 - 
Age, 
gender 
none  - 
TB 
mortality 
Cohort 
Mangesh 
et al. 2007 
India 
adults 
from 
voters list 
Verbal autopsy 
Self-reported ever 
smoking 
81443 
RR: 2.12 
(1.70-2.66) 
 - none 
Yes 
(Quantity) 
 - 
TB 
recurrence 
Cohort 
Thomas 
et al. 2005 
India 
TB 
patients 
Sputum smear 
micropscopy and 
culture to 
confirm at 6, 12 
and 18 months 
post cure 
Self-reported 
current smoking 
503 
OR: 3.1 (1.6-
6.0) 
 - 
Drug 
compliance 
and drug 
sensitivity 
Not 
assessed 
 - 
TB 
recurrence 
Cohort 
D'Arc 
Batista et 
al. 2008 
Brazil 
TB 
patients 
A patient who 
started second 
treatment during 
their follow-up 
for first 
treatment 
Self-reported 
current smoking 
711 
OR: 2.53 
(1.23-5.21) 
 - 
Year of 
entry in 
cohort, 
area of 
residence 
Not 
assessed 
 - 
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A.11: List of included studies in evidence synthesis 
TB Infection 
(Anderson et al., 1997, McCurdy et al., 1997, Adib et al., 1999, Den Boon et al., 2005, Hussain et 
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Appendix B. OVERVIEW OF ASSIST STUDY 
STUDY BACKGROUND 
Pakistan features in both the top ten high-burden TB and top ten high-burden tobacco use 
countries (World Health Organization, 2009). It has one of the highest TB burdens worldwide, 
with approximately 500,000 incident cases and 100,000 deaths annually (World Health 
Organisation, 2014b). Smoking is also prevalent in Pakistan.  
STUDY POPULATION AND SETTING 
ASSIST was conducted in 33 TB clinics/clusters (each with a catchment population ranging 
between 30,000- 450,000) in Pakistan between 2010 and 2011 that enrolled 1955 TB suspects 
who were also smokers (Siddiqi et al., 2013).  
One TB paramedic was appointed per cluster (TB clinic) and was responsible for delivering 
behavioural support for smoking cessation to the patients attending that clinic. 
STUDY DESIGN 
ASSIST was an effectiveness cluster RCT trial that showed the effect of a behavioural support 
intervention (with and without bupropion) delivered by the TB DOTS paramedics in achieving 
sustained abstinence from smoking by the TB suspects at 6 months.  
INTERVENTION AND CONTROL 
Those who consented to participate in the trial were randomized to three groups: patients in one 
group received two brief behavioural support sessions (BSS group), patients in the second group 
received two brief BSS plus 7 weeks of bupropion therapy (BSS+ group), and patients in the 
control group received usual care. Given the lack of any routine advice or educational materials 
in Pakistan, a self-help leaflet on smoking cessation was offered to all participants (for details, 
refer to the Supplement 2: ‘Tobacco Leaflet’, available at 
http://annals.org/article.aspx?articleid=1684852; Siddiqi et al., 2013).  
The intervention sessions consisted of two structured patient-provider interaction sessions based 
on the WHO’s “5 As quit model”: Ask- about smoking behaviour and history; Advise- about the 
consequences of smoking and cessation; Assess- willingness to quit smoking; Assist- in planning 
to quit smoking; and Arrange- follow up. The intervention was delivered by TB DOTS 
paramedics, following one full day’s training on intervention protocol and delivery tools, using a 
flipbook resource developed for this purpose (for details, refer to the Supplement 1: ‘Tobacco 
Cessation Desk Guide: Five Steps to quit’, available at 
http://annals.org/article.aspx?articleid=1684852; Siddiqi et al., 2013).  
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Two sessions were delivered; one pre-quit and the other coinciding with the quit date. The aim of 
the first 30 minute session was to assist a smoker who was willing to set a quit date (a week after 
the first contact), by encouraging them to see themselves as a non-smoker, planning for their quit 
day and preparing them for the initial stages of the quit attempt. The second 10 minute session 
was scheduled for the patient’s quit date and provided an opportunity for follow-up and review of 
progress. The content of the interactive sessions was designed to deliver information about the 
harms of tobacco smoking, such as effects on pregnancy and lung diseases, the social and 
economic benefits of stopping, identification of the social/psychological or environmental cues 
that trigger a smoker’s desire to smoke and advice on ways to address and overcome these. 
Similarly, assessing the withdrawal symptoms (i.e. the strong urges/craving to smoke) was done 
during the session, and advice given on ways to address and overcome these.  
In addition to BSS, participants in the BSS+ group also received sustained-release bupropion, 75 
mg/day for the first week and 150 mg/day thereafter for six more weeks.  
PRIMARY OUTCOME 
The primary end-point was continuous smoking cessation at six months after the quit date, 
defined as an expired carbon monoxide (CO) measurement of 9 ppm or less (according to the 
Russell standard) at the 1- and 6-month follow-up visits.(West et al., 2005) 
STUDY FINDINGS 
Both treatment conditions led to 8-9 fold increase (BSS+: RR 9.3, 95%CI: 4.0-21.6; BSS: RR 8.5, 
95%CI: 3.7-19.6) in continuous smoking abstinence compared to the control (Table B.1).  
B.1: Continuous smoking abstinence at 6 months- ASSIST trial (2010- 2011) Pakistan 
Trial arm No. Abstinent/ N 
(%) 
Relative Risk  
(95% CI) 
7ICC 
Behavioural support + bupropion (BSS+) 275/606 (45.4) 9.3 (4.0- 21.6) 
0.28 Behavioural support alone (BSS) 254/620 (41.0) 8.5 (3.7- 19.6) 
Usual care control 52/615 (8.5) 1 
 
 
                                                     
7 Intra-Cluster correlation Coefficient 
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Appendix C. APPENDICES TO CHAPTER 6 
C.1: Letter to the experts for modified Delphi procedure 
Hi 
Thanks for agreeing to participate in the Delphi procedure. 
The fidelity criterion under development is specific to a behavioural support intervention 
delivered for smoking cessation to patients in primary health care settings, in Pakistan. The 
intervention was found to be highly effective in achieving smoking cessation in the patients. 
Nevertheless, there were wide differences between the cessation rates of various health clinics, 
where the intervention was delivered. My PhD work relates to these findings and a way forward 
in describing these differences. 
I am attaching the fidelity criterion checklist and the scale plan (outlining the intervention 
dimensions) for your reference. We are at the step 4 of establishing the 'fidelity criterion'. As you 
will see in the scale plan, the behavioural support intervention is based on the World Health 
Organisation's 5 steps to quit model (5 A's: Ask, advise, assess, assist and arrange). At the time 
this intervention was developed the taxonomy of the behavioural change techniques (BCT) for 
smoking cessation (by Susan Michie and colleagues) was not established. I have linked each 'item' 
of the intervention with the BCTs. Once the fidelity criterion is finalized, I am hoping to record 
sessions on behavioural support intervention and score these using the developed fidelity 
criterion. The data will be used to test the tool's reliability and validity.  
Now when you open the item pool for the fidelity criterion matrix, the first column describes 
what the item corresponds to (in the questionnaire or the flip-chart), in the original intervention. 
Some of the items are about the adherence to the intervention content, while others assess the 
competence (quality of delivery). The 2nd, 3rd and 4th columns are the BCT code, its description 
and the underlying domain of behaviour change. The 5th (item) and the 7th (last column on 
expert rating of item) are mainly concerned with you. Looking at each of the item, you have to 
decide on their importance in assessing fidelity of a behavioural support intervention for smoking 
cessation delivered in a primary health care setting; you will need to rate these on a scale of 4: 
(very, somewhat, not much, or not at all important). Once you and other experts return the 
checklist to me, I will drop those items rated by at least two experts as 'not at all important' or 
‘not much important’ and then re-send it to you for the next round and so on. I anticipate 
achieving the required consensus on important items in two to three rounds. 
Please let me know if you have any questions. 
Many thanks 
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C.2: Experts rating on ‘importance’ of items for measuring fidelity 
Behavioural 
Determinants 
Behaviour 
Change 
Techniques 
(BCTs) 
BCTs description Items Response scale 
Experts rating 
(1= very important,  
2= somewhat important, 
3= not much important, 
4= not at all important ) 
1 2 3 4 
ADHERENCE  
Step 1- ASK (Status of Tobacco use) 
General aspects 
of the 
interaction (R) 
focusing on 
information 
gathering (I) 
RC7: 
Information 
gathering and 
assessment 
Any information 
gathering that provides 
the practitioner with 
the knowledge needed 
from the client for 
appropriate BCT to be 
delivered.  
 * Assess current and 
past smoking behaviour 
1. Assessing current and past 
smoking behaviour 
i. Pattern of smoking behaviour 
(Types of smoking? Smokers in 
vicinity? Children at home?) 
ii. Age when started smoking 
iii. Amount smoked 
0= not implemented 
(skips all 3) 
1= partially implemented 
(asks about the patterns of smoking behaviour, age of 
starting smoking and the amount smoked without 
eliciting a response using categories given in the 
questionnaire) 
2= fully implemented 
(asks about the above and elicits response using 
categories given in the Qx; about the type of smoking 
by asking them  to choose from cigarette, hookah, bidi, 
cigar or other; appropriately captures the current 
amount of smoking form used) 
*|| |   
Step 2- ADVISE (Risks of tobacco use and benefits of cessation).   
The flip book slides are designed to be used in a specific way; while the sketch on each slide faces the patient, the written material is facing the provider to help them deliver the message effectively. Each 
slide is designed to be delivered in three essential steps: 
1-      Ask the patient to describe the slide 
2-      Facilitate patient with understanding the message in the slide 
3-      Clarify/re-emphasise the key message in the slide 
Specific focus 
on behaviour 
(B) and 
BM1: Provide 
information 
on 
 
 
2. Awareness about the various 
forms of tobacco smoked in the 
community 
0= not implemented (skips the slide) 
1= partially implemented (delivers 2 out of 3 steps) 
2= fully implemented ( all 3 essential steps) 
| ||   
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addressing 
motivation (M) 
consequences 
of smoking 
and smoking 
cessation 
 
 
Give, or make more 
salient information about 
the harm caused by 
smoking and the benefits 
of stopping; distinguish 
between the harms from 
smoking and nicotine; 
debunk myths about low 
tar and own roll cigarettes 
3. High blood pressure and heart 
disease 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| ||   
4. Lung diseases like chronic cough, 
asthma, TB and cancer 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| ||   
5. Wastage of money, staining of 
teeth, gum problems and bad breath 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
 || |  
6. Effects on children’s health: 
pneumonia, asthma etc. 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| ||   
7. Effects on pregnancy: 
complications in pregnancy, low 
birth weight baby 
0= not implemented 
(if skipped, please mention in the comments if the 
patient was a male) 
1= partially implemented 
2= fully implemented 
( same as above) 
| ||   
8. Decide to quit, choose a quit date 
and utilize the money on better 
things 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| ||   
9. Social and economic benefits of 
quitting 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
 || |  
Step-3: ASSESS (Willingness to quit) 
General aspects 
of the 
interaction (R) 
focusing on 
information 
gathering (I) 
RC7: 
Information 
gathering and 
assessment 
Any information 
gathering that provides 
the practitioner with the 
knowledge needed from 
the client for appropriate 
BCT to be delivered.  
* Assess current readiness 
10. Current level of motivation to 
stop/willingness to quit 
0= not implemented 
2= implemented 
|||    
11. Reasons for quitting e.g. health, 
cost, example for others, family’s 
health or other reason 
0= not implemented 
1= partially implemented 
(asks about the reasons for quitting without eliciting a 
response using categories given in the questionnaire) 
2= fully implemented 
|||    
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and ability to quit (asks about the above and elicits response using 
categories given in the Qx) 
Specific focus 
on behaviour 
(B) and 
addressing 
motivation (M) 
BM6: prompt 
commitment 
from the client 
there and then 
Encourage the smoker to 
affirm or re-affirm a 
strong commitment to 
start, continue or restart 
the quit attempt 
12. Quit from today? If ‘No’, Quit 
within next five days? If ‘No’, when 
will you be able to set a quit date? 
0= not implemented 
2= implemented 
|||    
General aspects 
of the 
interaction (R) 
focusing on 
information 
gathering (I) 
RC7: 
Information 
gathering and 
assessment 
Any information 
gathering that provides 
the practitioner with the 
knowledge needed from 
the client for appropriate 
BCT to be delivered.  
* Assess past history of 
quit attempts 
13. Attempted quit in the past, 
Number and duration of past quit 
attempts, Time since last quit 
attempt 
0= not implemented 
1= partially implemented (asks  1 out of the 3 Q’s) 
2= fully implemented (asks all 3 Q’s) 
| ||   
14. Factors that led back to smoking 
including social and physical factors 
(Social reasons: Family problems 
(tension), Smokers company, any 
other; Physical Symptoms: Craving, 
Indigestion, Insomnia, Headache, 
any other ) 
0= not implemented 
1= partially implemented 
(asks about the reasons to start again without eliciting 
a response using categories given in the questionnaire) 
2= fully implemented 
(asks about the above and elicits response using 
categories given in the Qx) 
| ||   
Step-4: ASSIST (in the quitting) 
General aspects 
of the 
interaction (R) 
focusing on 
information 
gathering (I) 
RC7: 
Information 
gathering and 
assessment 
Any information 
gathering that provides 
the practitioner with the 
knowledge needed from 
the client for appropriate 
BCT to be delivered.  
*  Assess nicotine 
dependence 
15. Fagerstrom Test for Nicotine 
Dependence 0= not implemented 
1= partially implemented 
(asks less than 6 Q’s on the scale) 
2= fully implemented 
(completes the scale by asking all 6 Q’s) 
| | |  
Specific focus 
on behaviour(B) 
and maximising 
self-regulatory 
capacity/skills 
(S) 
BS4: Facilitate 
goal setting 
Help the smoker to set a quit 
date and goals that support 
the aim of remaining 
abstinent 
16. Setting quit date 
0= not implemented 
2= implemented 
|||    
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Specific focus 
on behaviour 
(B) and 
maximising 
self-regulatory 
capacity/skills 
(S) 
BS8: Advise 
on 
environmental 
restructuring 
Advise on ways of 
changing the physical 
environment to minimize 
exposure to smoking cues 
(e.g. removing ashtrays 
from the house) or to 
provide cues to sustain 
quitting 
17. Hide reminders of smoking/ways 
of changing the physical 
environment to minimise exposure 
to smoking cues 
0= not implemented 
2= implemented 
|| |   
18. Declare the house as ‘smoke free 
home’ 
0= not implemented 
2= implemented 
 |||   
Promote 
adjuvant 
activities (A) 
A2: Advise on 
use of social 
support 
Advise on or facilitate 
development of social 
support from friends, 
relatives, colleagues or 
“buddies” 
19. Identify individual who can help 
support in quitting at home 0= not implemented 
2= implemented 
| | |  
Specific focus 
on behaviour 
(B) and 
addressing 
motivation (M) 
BM2: Boost 
motivation 
and self-
efficacy 
Give encouragement or 
bolster confidence in 
ability to stop. Can include 
telling the person that 
they can successfully stop 
smoking, arguing against 
self-doubts, and asserting 
that they can and will 
succeed. 
20. Decide on telling people about 
stopping or keeping it private 
0= not implemented 
2= implemented 
| | |  
 
 
 
 
Specific focus 
on behaviour 
(B) and 
maximising 
self-regulatory 
capacity/skills 
BS1: Facilitate 
barrier 
identification 
and problem 
solving 
BS3: Facilitate 
action 
planning 
/develop 
treatment 
plan 
∎ Help the smoker to 
identify general barriers 
(e.g. susceptibility to 
stress) that might make it 
harder to stay off 
cigarettes and develop 
general ways of 
addressing and 
overcoming these, and 
increasing facilitators (e.g. 
by generating alternative 
courses of action and pros 
and cons of each and 
weighing them up) 
21. Trigger1: immediately after 
rising in the morning- Offer 
strategies to manage trigger 1 
0= not implemented (skips the slide) 
1= partially implemented (2 out of 3 steps delivered) 
2= fully implemented ( all 3 essential steps) 
| ||   
22. Trigger2: defecation- Offer 
strategies to manage trigger 2 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| | |  
23. Trigger3: eating meals- Offer 
strategies to manage trigger 3 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| | |  
24. Trigger4: free at home or feeling 
0= not implemented 
1= partially implemented 
| | |  
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(S) ∎ Work with the smoker 
to generate a clear quit 
plan, including 
preparations for the quit 
attempt 
bored- Offer strategies to manage 
trigger 4 
2= fully implemented 
( same as above) 
BS1 & 3 ;  
BS11: Advise 
on avoiding 
cues for 
smoking 
BS12: 
Facilitate 
restructuring 
of social life 
In addition to BS1 & 3 ; 
∎ Give specific advice on 
how to avoid being 
exposed to social or other 
cues for smoking (e.g. 
staying away from places 
where people smoke)  
∎ Advise on ways of 
changing social 
interactions with family, 
friends, and colleagues so 
that they support, rather 
than interfere with, the 
goal of remaining 
abstinent 
25. Trigger5: seeing others smoke- 
Offer strategies to manage trigger 5 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| ||   
26. Trigger6: offered smoking by 
others- Offer strategies to manage 
trigger 6 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| ||   
BS1 & 3; 
BS10: Advise 
on conserving 
mental 
resources 
In addition to BS1 & 3; 
Advise on ways of 
minimizing stress and other 
demands on mental resources 
(activities that require mental 
effort) 
27. Trigger7: intense 
physical/mental work- Offer 
strategies to manage trigger 7 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| ||   
BS1, 3 & 10; 
BS14: Teach 
relaxation 
techniques 
In addition to BS1, 3 & 10; 
Teach specific relaxation 
techniques and how and 
when to apply them 
28. Trigger8: tense/anxious- Offer 
strategies to manage trigger 8 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
|| |   
General aspects 
of the 
interaction (R) 
focusing on 
general 
RC10: Provide 
information 
on withdrawal 
symptoms 
 
 
 
29. Withdrawal1: Craving smoking- 
Offer strategies to manage 
withdrawal1 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
|||    
30. Withdrawal2: 
0= not implemented 
1= partially implemented 
|||    
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communication
(C) 
 
Describe to the smoker 
what are, and are not, 
nicotine withdrawal 
symptoms, how common 
they are, how long they 
typically last, what causes 
them, and what can be 
done to alleviate them 
Restlessness/anger- Offer strategies 
to manage withdrawal2 
2= fully implemented 
( same as above) 
31. Withdrawal3: Headache- Offer 
strategies to manage Withdrawal3 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| ||   
32. Withdrawal4: Insomnia- Offer 
strategies to manage withdrawal4 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
|| |   
33. Withdrawal5: indigestion- Offer 
strategies to manage withdrawal5 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| ||   
34. Withdrawal6: Anorexia and 
constipation- Offer strategies to 
manage withdrawal6 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| | |  
35. Withdrawal7: Cough- Offer 
strategies to manage withdrawal7 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
| | |  
General aspects 
of the 
interaction (R) 
focusing on 
general 
communication
(C)& Specific 
focus on 
behaviour (B) 
and maximising 
self-regulatory 
capacity/skills 
(S) 
RC10;  
BS13: Advise 
on methods of 
weight 
control 
 
In addition to RC10; 
Advise on ways of 
minimising weight gain 
that do not increase 
motivation to smoke (e.g. 
take exercise, carry 
around “healthy snacks”) 
36. Withdrawal8: Weight gain- 
Offer strategies to manage 
withdrawal8 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
|| |   
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Step-5: ARRANGE (follow-up) 
General aspects 
of the 
interaction (R) 
focusing on 
general 
communication
(C) 
RC6: Offer 
appropriate 
written 
material 
Distinguish what are, and are 
not, appropriate written 
materials and offer/direct 
clients to these in ways that 
promote their effective use 
37. Give BI information leaflet to the 
patient and brief about it 
0= not implemented 
2= implemented 
| ||   
QUALITY 
 
 
 
General aspects 
of the 
interaction (R) 
focusing on 
general 
communication
(C) 
RC1: Build 
general 
rapport 
 The provider introduces him/herself to the patient and 
takes time to ease the patient by asking about their day 
(e.g. how was their day, health etc.; how was the travel to 
the centre; how are they doing) and appreciating their 
participation (e.g. by thanking them for taking time out 
and how useful their participation is).  
 Pays complete attention to the patient when s/he is 
talking without cutting their talk short.  
∎ Listens to the patient after asking a question and gives 
them enough time to answer back.  
∎ If the patient drifts from the topic the provider politely 
reminds the patient to focus on the topic without 
disregarding their talk. 
 Gives them feedback, prompts or probes, taking part in 
the discussion (e.g. encouraging the patient, verbally 
responding to patient’s concerns at the right time, 
showing concern for patient’s issues and negative 
experiences relating to smoking/cessation). 
38. Build general rapport: Establish a 
positive, friendly and professional 
relationship with the smoker and 
foster a sense that the smoker’s 
experiences are understood  
0= not implemented 
(does not make any effort 
to build rapport with the 
patient) 
1= partially 
implemented 
2= fully implemented  
(makes all of the 
described examples of 
efforts to build rapport 
with the patient) 
|| |   
RC9: Explain 
expectations 
regarding 
treatment 
programme 
∎ Does the provider remind the patient of the information 
provided earlier about the intervention (before consent)? 
Explaining to the patient that the treatment program 
consists of five steps, Ask, Advise, Assess Assist, and 
Arrange/ the management to help you change your 
smoking habit.  
∎ Before each step does he take a moment to give a brief 
introduction to what is going to happen now? Taking the 
39. Explain expectations regarding 
treatment programme: Explain to 
the smoker the treatment program, 
what it involves, the active 
ingredients, and what it requires of 
the smoker 
0= not implemented 
1= partially 
implemented 
2= fully implemented 
|||    
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patient along and making an effort that the key 
intervention messages are being understood as intended. 
RC4: Provide 
reassurance 
If the patient has experienced unsuccessful quit attempts 
or other negative experiences relating to smoking in the 
past, the provider: 
∎ Tells them that it’s ok 
∎ Reassures them that this is normal when individuals try 
to quit on their own 
∎ Encourages them to be persistent and carry on with 
their attempt as this is time limited 
∎ Reassures them that with assistance through smoking 
cessation programme they are more likely to have a 
successful outcome 
∎ Provides examples from other smokers’ experiences 
who were successful in quitting 
40. Provide reassurance: Give 
general reassurance to the smoker 
that his/her experiences are normal 
and time limited, and provide 
positive expectations of success 
based on experience with other 
smokers in the same situation 
0= not implemented 
(does not provide any 
reassurance) 
1= partially 
implemented 
(listens and answers in 
‘Yes’ and ‘No’ but does 
not give any constructive 
advice) 
2= fully implemented 
(gives constructive 
advice) 
| ||   
RC2: General 
practitioner 
communicatio
n approaches 
∎ Is the provider supporting his questions with clear 
prompts to get the right information out of the patient e.g. 
when he asks, “What is your monthly household income?”  
If the patient says 10000, the provider confirms from him 
if this is his cumulative household income of all working 
individuals at home or his alone. Then he clarifies with the 
patient that he needs to tell about the cumulative 
household income. 
∎ Does he prompt the patient to give views on smoking, 
smoking cessation and any aspects of this behavioural 
support programme e.g. asking the patient, “Do you feel 
confident about this programme that it will help you in 
quitting smoking”. 
41. General practitioner 
communication approaches: (Elicit 
and answer questions) 
0= not implemented 
1= partially 
implemented 
2= fully implemented 
|| |   
Adopt a style of interaction that involves listening 
carefully to the smoker and where appropriate reflecting 
back to the smoker key elements of what s/he is saying 
e.g. the patient says, “When I don’t smoke I have a very 
heavy feeling after meals”. So the provider should respond 
by saying, “You mean to say that when you attempt 
quitting smoking you get indigestion”. 
42. General practitioner 
communication approaches: (Use 
reflective listening) 
0= not implemented 
1= partially 
implemented 
2= fully implemented 
|| |   
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Provide a summary of information exchanged and 
establish a clear confirmation of decisions made and 
commitments entered into at each step and also at the end 
e.g. the provider reconfirms the quit date with the patient 
and arranges the follow up date reaffirming the milestones 
agreed upon during intervention session. 
43. General practitioner 
communication approaches: 
(Summarising information and 
confirming client decisions) 
0= not implemented 
1= partially 
implemented 
2= fully implemented 
|| |   
General aspects 
of the 
interaction (R) 
focusing on the 
delivery of the 
intervention 
(D) 
RC5: Tailor 
interactions 
appropriately 
Use relevant information from the client to tailor the 
behavioural support provided/ flexible adaptation 
that takes into account individual patient needs 
44. Where appropriate and needed, 
the provider, tailors the BI according 
to the patients’ needs e.g. in original 
trial some providers recommended 
the use of “cardamom” for chewing 
in place of “chewing gum”, due to 
limited availability of chewing gums 
in those areas. 
0= not implemented 
1= partially 
implemented 
2= fully implemented 
|| |   
RC3: 
Emphasise 
choice 
While delivering the management strategies for dealing 
with various triggers and withdrawals the provider 
emphasises patient’s choice in the type of strategy that 
best suits their needs rather than imposing the strategy 
s/he think best. If the patient is not particularly 
responsive then the provider emphasises each 
management option available and prompts the patient to 
choose rather than just reading out the options and 
deciding for the patient him/herself. 
45. Emphasise choice: Emphasise 
client choice within the bounds of 
evidence based practice 0= not implemented 
1= partially 
implemented 
2= fully implemented 
|| |   
* Tally represents each expert 
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C.3: The Fidelity Index 
Fidelity Index 
TB clinic ID 
  
Recording number 
  
Name of Coder 
*Please insert your name here   
Date of Coding 
  
Coder ID 
  
Total recording duration 
* please enter the total amount of time 
(hours/mins) which it took to complete coding   
  
Q#; Slide 
# 
Behavioural 
Determinants 
BCT code: 
label  
BCT description/ 
Operational definition 
Items 
(ingredients of BI) 
Response scale  Score Comment 
ADHERENCE 
Step 1- ASK (Status of Tobacco use) 
Section1A, 
1B, 2A 
and 2B 
General aspects of the 
interaction (R) 
focusing on 
information gathering 
(I) 
RC7: 
Information 
gathering and 
assessment 
Any information gathering 
that provides the 
practitioner with the 
knowledge needed from the 
client for appropriate BCT 
to be delivered.  
 * Assess current and past 
smoking behaviour 
1. Assessing current and past 
smoking behaviour 
i. Pattern of smoking 
behaviour (Types of 
smoking? Smokers in 
vicinity? Children at 
home?) 
ii. Age when started 
smoking 
iii. Amount smoked 
0= not implemented 
(skips all 3) 
1= partially implemented 
(asks about the patterns of smoking behaviour, age of 
starting smoking and the amount smoked without 
eliciting a response using categories given in the 
questionnaire) 
2= fully implemented 
(asks about the above and elicits response using 
categories given in the Qx; about the type of smoking 
by asking them  to choose from cigarette, hookah, 
bidi, cigar or other; appropriately captures the 
current amount of smoking form used) 
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Step 2- ADVISE (Risks of tobacco use and benefits of cessation).   
The flip book slides are designed to be used in a specific way; while the sketch on each slide faces the patient, the written material is facing the provider to help them deliver the message effectively. Each 
slide is designed to be delivered in three essential steps: 
1-      Ask the patient to describe the slide 
2-      Facilitate patient with understanding the message in the slide 
3-      Clarify/re-emphasise the key message in the slide 
S 1 
Specific focus on 
behaviour (B) and 
addressing motivation 
(M)  
BM1: Provide 
information on 
consequences 
of smoking and 
smoking 
cessation 
Give, or make more salient 
information about the harm 
caused by smoking and the 
benefits of stopping; 
distinguish between the 
harms from smoking and 
nicotine; debunk myths 
about low tar and own roll 
cigarettes 
2. Awareness about the various 
forms of tobacco smoked in 
the community 
0= not implemented (skips the slide) 
1= partially implemented (delivers 2 out of 3 steps) 
2= fully implemented ( all 3 essential steps) 
    
S 2 
3. High blood pressure and 
heart disease 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 3 
4. Lung diseases like chronic 
cough, asthma, TB and 
cancer 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 4 
5. Wastage of money, staining 
of teeth, gum problems and 
bad breath 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 5 
6. Effects on children’s health: 
pneumonia, asthma etc. 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 6 
7. Effects on pregnancy: 
complications in pregnancy, 
low birth weight baby 
0= not implemented 
(if skipped, please mention in the comments if the 
patient was a male) 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 7 
8. Decide to quit, choose a quit 
date and utilize the money on 
better things 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 8 
9. Social and economic benefits 
of quitting 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
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Step-3: ASSESS (Willingness to quit) 
Section3A, 
Q-1. 
General aspects of the 
interaction (R) 
focusing on 
information gathering 
(I) 
RC7: 
Information 
gathering and 
assessment 
Any information gathering 
that provides the 
practitioner with the 
knowledge needed from the 
client for appropriate BCT 
to be delivered.  
* Assess current readiness 
and ability to quit  
10. Current level of motivation 
to stop/willingness to quit 
0= not implemented 
2= implemented 
    
Section 
3B. 
11. Reasons for quitting 
 
e.g. health, cost, example for 
others, family’s health or 
other reason 
0= not implemented 
1= partially implemented 
(asks about the reasons for quitting without eliciting 
a response using categories given in the 
questionnaire) 
2= fully implemented 
(asks about the above and elicits response using 
categories given in the Qx) 
    
Section 
3A 
Specific focus on 
behaviour (B) and 
addressing motivation 
(M) 
BM6: prompt 
commitment 
from the client 
there and then 
Encourage the smoker to 
affirm or re-affirm a strong 
commitment to start, 
continue or restart the quit 
attempt 
12. Quit from today? 
If ‘No’, Quit within next five days? 
If ‘No’, when will you be able to 
set a quit date? 
0= not implemented 
2= implemented 
    
Section 
3C. 
General aspects of the 
interaction (R) 
focusing on 
information gathering 
(I) 
RC7: 
Information 
gathering and 
assessment 
Any information gathering 
that provides the 
practitioner with the 
knowledge needed from the 
client for appropriate BCT 
to be delivered.  
* Assess past history of quit 
attempts 
13. Attempted quit in the past 
Number and duration of past quit 
attempts 
Time since last quit attempt 
0= not implemented 
1= partially implemented (asks  1 out of the 3 Q’s) 
2= fully implemented (asks all 3 Q’s) 
    
14. Factors that led back to 
smoking including social and 
physical factors 
Social reasons: Family problems 
(tension), Smokers company, any 
other 
Physical Symptoms: Craving, 
Indigestion, Insomnia, Headache, 
any other  
0= not implemented 
1= partially implemented 
(asks about the reasons to start again without 
eliciting a response using categories given in the 
questionnaire) 
2= fully implemented 
(asks about the above and elicits response using 
categories given in the Qx) 
    
Step-4: ASSIST (in the quitting) 
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Section 
4A. 
General aspects of the 
interaction (R) 
focusing on 
information gathering 
(I) 
RC7: 
Information 
gathering and 
assessment 
Any information gathering that provides 
the practitioner with the knowledge 
needed from the client for appropriate 
BCT to be delivered.  
*  Assess nicotine dependence 
15. Fagerstrom Test for Nicotine 
Dependence 
0= not implemented 
1= partially implemented 
(asks less than 6 Q’s on the scale) 
2= fully implemented 
(completes the scale by asking all 6 Q’s) 
    
Section 
4C. 
Specific focus on 
behaviour (B) and 
maximising self-
regulatory 
capacity/skills (S) 
BS4: Facilitate 
goal setting 
Help the smoker to set a quit date and 
goals that support the aim of remaining 
abstinent 
16. Setting quit date 
0= not implemented 
2= implemented 
    
S 8 (is text 
only) 
Specific focus on 
behaviour (B) and 
maximising self-
regulatory 
capacity/skills (S) 
BS8: Advise on 
environmental 
restructuring  
Advise on ways of changing the physical 
environment to minimize exposure to 
smoking cues (e.g. removing ashtrays 
from the house) or to provide cues to 
sustain quitting 
17. Hide reminders of 
smoking/ways of changing 
the physical environment to 
minimise exposure to smoking 
cues 
0= not implemented 
2= implemented 
    
18. Declare the house as ‘smoke 
free home’ 
0= not implemented 
2= implemented 
    
Promote adjuvant 
activities (A) 
A2: Advise on 
use of social 
support 
Advise on or facilitate development of 
social support from friends, relatives, 
colleagues or “buddies” 
19. Identify individual who can 
help support in quitting at 
home 
0= not implemented 
2= implemented 
    
Specific focus on 
behaviour (B) and 
addressing motivation 
(M) 
BM2: Boost 
motivation and 
self-efficacy 
Give encouragement or bolster 
confidence in ability to stop. Can include 
telling the person that they can 
successfully stop smoking, arguing 
against self-doubts, and asserting that 
they can and will succeed. 
20. Decide on telling people about 
stopping or keeping it private 
0= not implemented 
2= implemented 
    
S 9 
Specific focus on 
behaviour (B) and 
maximising self-
regulatory 
capacity/skills (S) 
BS1: Facilitate 
barrier 
identification 
and problem 
solving 
∎ Help the smoker to identify general 
barriers (e.g. susceptibility to stress) that 
might make it harder to stay off 
cigarettes and develop general ways of 
addressing and overcoming these, and 
21. Trigger1: immediately after 
rising in the morning 
- Offer strategies to manage 
trigger 1 
0= not implemented (skips the slide) 
1= partially implemented (2 out of 3 
steps delivered) 
2= fully implemented ( all 3 essential 
steps) 
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S 10 
 
BS3: Facilitate 
action planning 
/develop 
treatment plan 
increasing facilitators (e.g. by generating 
alternative courses of action and pros 
and cons of each and weighing them up) 
∎ Work with the smoker to generate a 
clear quit plan, including preparations 
for the quit attempt  
22. Trigger2: defecation 
- Offer strategies to manage 
trigger 2 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 11 
23. Trigger3: eating meals 
- Offer strategies to manage 
trigger 3 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 12 
24. Trigger4: free at home or 
feeling bored 
- Offer strategies to manage 
trigger 4 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 13 
BS1 & 3 ;  
 
BS11: Advise 
on avoiding 
cues for 
smoking 
 
BS12: Facilitate 
restructuring 
of social life 
In addition to BS1 & 3 ; 
∎ Give specific advice on how to avoid 
being exposed to social or other cues for 
smoking (e.g. staying away from places 
where people smoke)  
∎ Advise on ways of changing social 
interactions with family, friends, and 
colleagues so that they support, rather 
than interfere with, the goal of 
remaining abstinent 
25. Trigger5: seeing others smoke 
- Offer strategies to manage 
trigger 5 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 14 
26. Trigger6: offered smoking by 
others  
- Offer strategies to manage 
trigger 6 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 15 
BS1 & 3; 
 
BS10: Advise 
on conserving 
mental 
resources 
In addition to BS1 & 3; 
Advise on ways of minimizing stress and 
other demands on mental resources 
(activities that require mental effort) 
27. Trigger7: intense 
physical/mental work  
- Offer strategies to manage 
trigger 7 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 16 
BS1, 3 & 10; 
 
BS14: Teach 
relaxation 
techniques 
In addition to BS1, 3 & 10; 
Teach specific relaxation techniques and 
how and when to apply them 
28. Trigger8: tense/anxious  
- Offer strategies to manage 
trigger 8 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 18 
 
 
 
 
 
 
 
 
 
 
 
 
29. Withdrawal1: Craving 
smoking 
- Offer strategies to manage 
withdrawal1 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
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S19 
 
 
 
 
 
 
 
 
General aspects of the 
interaction (R) 
focusing on general 
communication(C) 
 
 
 
 
 
 
 
 
RC10: Provide 
information on 
withdrawal 
symptoms 
 
 
 
 
 
 
 
 
Describe to the smoker what are, and are 
not, nicotine withdrawal symptoms, how 
common they are, how long they 
typically last, what causes them, and 
what can be done to alleviate them 
30. Withdrawal2: 
Restlessness/anger  
- Offer strategies to manage 
withdrawal2 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 20 
31. Withdrawal3: Headache 
- Offer strategies to manage 
Withdrawal3 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 21 
32. Withdrawal4: Insomnia  
- Offer strategies to manage 
withdrawal4 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 22 
33. Withdrawal5: indigestion  
- Offer strategies to manage 
withdrawal5 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
Q-C4. S23 
34. Withdrawal6: Anorexia and 
constipation  
- Offer strategies to manage 
withdrawal6 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 24 
35. Withdrawal7: Cough  
- Offer strategies to manage 
withdrawal7 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
S 25 
General aspects of the 
interaction (R) 
focusing on general 
communication(C)& 
Specific focus on 
behaviour (B) and 
maximising self-
regulatory 
capacity/skills (S) 
RC10;  
 
BS13: Advise 
on methods of 
weight control 
In addition to RC10; 
Advise on ways of minimising weight 
gain that do not increase motivation to 
smoke (e.g. take exercise, carry around 
“healthy snacks”)  
36. Withdrawal8: Weight gain  
- Offer strategies to manage 
withdrawal8 
0= not implemented 
1= partially implemented 
2= fully implemented 
( same as above) 
    
Step-5: ARRANGE (follow-up) 
Section 
4D. 
General aspects of the 
interaction (R) 
focusing on general 
communication(C) 
RC6: Offer 
appropriate 
written 
material 
Distinguish what are, and are not, 
appropriate written materials and 
offer/direct clients to these in ways that 
promote their effective use 
37. Give BSS information leaflet 
to the patient and brief about 
it.  
0= not implemented 
2= implemented 
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Total coding score (*add the score for each item and enter the composite score for Adherence) 0   
QUALITY 
 
Behavioural 
Determinants 
BCT code: 
label  
BCT description/ 
Operational definition 
Items 
(ingredients of BI) 
Anchored scale  Score Comment 
  
General aspects of 
the interaction 
(R) focusing on 
general 
communication(C) 
RC1: Build 
general 
rapport 
Establish a positive , 
friendly and professional 
relationship with the 
smoker and foster a sense 
that the smoker’s 
experiences are 
understood 
38.     
 The provider introduces him/herself to the patient and takes 
time to ease the patient by asking about their day (e.g. how was 
their day, health etc.; how was the travel to the centre; how are 
they doing) and appreciating their participation (e.g. by 
thanking them for taking time out and how useful their 
participation is).  
 Pays complete attention to the patient when s/he is talking 
without cutting their talk short.  
∎ Listens to the patient after asking a question and gives them 
enough time to answer back.  
∎ If the patient drifts from the topic the provider politely 
reminds the patient to focus on the topic without disregarding 
their talk. 
 Gives them feedback, prompts or probes, taking part in the 
discussion (e.g. encouraging the patient, verbally responding to 
patient’s concerns at the right time, showing concern for 
patient’s issues and negative experiences relating to 
smoking/cessation). 
0= not implemented 
(does not make any effort to 
build rapport with the patient) 
1= partially implemented 
2= fully implemented  
(makes all of the described 
examples of efforts to build 
rapport with the patient) 
    
RC9: Explain 
expectations 
regarding 
treatment 
programme 
Explain to the smoker the 
treatment program, what 
it involves, the active 
ingredients, and what it 
requires of the smoker 
39.   
∎ Does the provider remind the patient of the information 
provided earlier about the intervention (before consent)? 
Explaining to the patient that the treatment program consists of 
five steps, Ask, Advise, Assess Assist, and Arrange/ the 
management to help you change your smoking habit.  
∎ Before each step does he take a moment to give a brief 
introduction to what is going to happen now? Taking the 
patient along and making an effort that the key intervention 
messages are being understood as intended. 
0= not implemented 
1= partially implemented 
2= fully implemented 
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RC4: Provide 
reassurance 
Give general reassurance 
to the smoker that 
his/her experiences are 
normal and time limited, 
and provide positive 
expectations of success 
based on experience with 
other smokers in the 
same situation 
40.    If the patient has experienced unsuccessful quit attempts 
or other negative experiences relating to smoking in the past, 
the provider: 
∎ Tells them that it’s ok 
∎ Reassures them that this is normal when individuals try to 
quit on their own 
∎ Encourages them to be persistent and carry on with their 
attempt as this is time limited 
∎ Reassures them that with assistance through smoking 
cessation programme they are more likely to have a successful 
outcome 
∎ Provides examples from other smokers’ experiences who were 
successful in quitting  
0= not implemented 
(does not provide any 
reassurance) 
1= partially implemented 
(listens and answers in ‘Yes’ and 
‘No’ but does not give any 
constructive advice) 
2= fully implemented 
(gives constructive advice) 
    
General aspects of 
the interaction 
(R) focusing on 
general 
communication(C) 
RC2: General 
practitioner 
communicatio
n approaches 
 Elicit and answer 
questions 
41.     
∎ Is the provider supporting his questions with clear prompts 
to get the right information out of the patient e.g. when he asks, 
“What is your monthly household income?”  If the patient says 
10000, the provider confirms from him if this is his cumulative 
household income of all working individuals at home or his 
alone. Then he clarifies with the patient that he needs to tell 
about the cumulative household income. 
∎ Does he prompt the patient to give views on smoking, 
smoking cessation and any aspects of this behavioural support 
programme e.g. asking the patient, “Do you feel confident about 
this programme that it will help you in quitting smoking”. 
0= not implemented 
1= partially implemented 
2= fully implemented 
    
Use reflective listening 
42.   Adopt a style of interaction that involves listening carefully 
to the smoker and where appropriate reflecting back to the 
smoker key elements of what s/he is saying e.g. the patient says, 
“When I don’t smoke I have a very heavy feeling after meals”. 
So the provider should respond by saying, “You mean to say 
that when you attempt quitting smoking you get indigestion”. 
0= not implemented 
1= partially implemented 
2= fully implemented 
    
Summarising information 
and confirm client 
decisions 
43.   Provide a summary of information exchanged and establish 
a clear confirmation of decisions made and commitments entered 
into at each step and also at the end e.g. the provider reconfirms 
the quit date with the patient and arranges the follow up date 
reaffirming the milestones agreed upon during intervention 
session. 
0= not implemented 
1= partially implemented 
2= fully implemented 
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General aspects of 
the interaction 
(R) focusing on 
the delivery of the 
intervention (D) 
RC5: Tailor 
interactions 
appropriately 
Use relevant information 
from the client to tailor 
the behavioural support 
provided/ flexible 
adaptation that takes into 
account individual patient 
needs 
44.     Where appropriate and needed, the provider, tailors the 
BSS according to the patients’ needs e.g. in original trial some 
DOTS facilitators recommended the use of “cardamom” for 
chewing in place of “chewing gum”, due to limited availability of 
chewing gums in those areas. 
0= not implemented 
1= partially implemented 
2= fully implemented 
    
RC3: 
Emphasise 
choice 
Emphasise client choice 
within the bounds of 
evidence based practice 
45.   While delivering the management strategies for dealing 
with various triggers and withdrawals the provider emphasises 
patient’s choice in the type of strategy that best suits their needs 
rather than imposing the strategy s/he think best. If the patient 
is not particularly responsive then the provider emphasises each 
management option available and prompts the patient to choose 
rather than just reading out the options and deciding for the 
patient him/herself. 
0= not implemented 
1= partially implemented 
2= fully implemented 
    
Total coding score (*add the score for each item and enter the composite score for Quality) 0   
                Key               
1. Q#; Slide#: These are for reference to the BI flip-chart and patient questionnaire (copies attached). 
2. Behavioural Determinants: presents  the underlying behavioural domain for the BCTs 
3. And 4. BCT code and label and description: This is the BCT’s code. Each BCT has a code in the taxonomy. The BCT labels and definitions from the taxonomy have been placed in the coding framework for 
reference purposes.  
5. Item: This is the content of the Behavioural Intervention, in the form/wording that it was delivered in. Each item in its row has been linked to the columns 1, 2, 3 and 4. 
6. And 7.  Scoring: Description of each scoring criteria is provided in the scale. If the given BCT has never been used, please circle ‘0’. If the given BCT has partially been implemented, please circle ‘1’ and if 
fully implemented then circle ‘2’. 
8. Comments: Please list any necessary comments or points of clarification 
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Appendix D. APPENDICES TO CHAPTER 7 
D.1: Provider information sheet and consent form 
 
 
 
 
You are being asked to participate in an important follow on study of the ASSIST trial conducted 
between 2010- 2011in Sargodha and Jhang districts. The study will explore the various aspects 
of DOTS paramedics’ characteristics and competences that might contribute to the variation 
observed in smoking cessation outcomes in patients between these centres. Composite data will 
be used to validate a fidelity criterion for future guidance of implementation of behavioural 
support interventions for smoking cessation in similar settings.  
Keep the information sheet for your records. After receiving the completed consent form, you 
will be asked to deliver the interactive flip-book intervention session (that was previously 
delivered by you as part of the smoking cessation intervention in the ASSIST trial) to the TB 
suspects presenting to the TB clinic and this session will be video recorded. The intervention 
session is expected to last 30 to 40 minutes in total; two to three complete sessions will be 
recorded. This will be followed by an interview questionnaire (lasting 15- 20 minutes) that will 
be filled by the research officer to record some of your characteristics and competences. 
You are free to choose whether or not to participate in this study. The taping of sessions is 
purely to record the intervention process, you are not forced or obliged to allow video-taping of 
any session. You can withdraw consent at any time, including during the session and after the 
tape has been completed, in which case the video recording for your session will be erased by the 
lead researcher. The interview is also completely voluntary; you may choose not to participate or 
not to answer any specific question at any point during the interview.  
There is no known possible risk or discomfort that you can encounter connected to the activities 
in this study. The research through this study will benefit the wider research evidence base by 
providing understanding of the factors that are important for an effective and standardised 
implementation of a complex smoking cessation programme in the settings of primary and 
secondary health care centres. 
Your identity and location in this study will remain strictly confidential. The results of the study, 
including data, may be published for scientific purposes but will not give your name or include 
any identifiable references to you. 
Your contact information will be kept confidential and will only be used to contact you regarding the 
study. 
If you have any questions or would like further information, please contact: 
Research student Omara Dogar, E: ofd500@york.ac.uk 
Department of Health Sciences 
The University of York 
Thank you 
  
Please read this document carefully. 
We would like to invite you to take part in a research study. Before you decide whether to take part it is 
important for you to understand why the research is being done and what it will involve.  Please take 
time to read the following information carefully. Please ask us if there is anything that is not clear. If 
you decide you would like to take part please return the signed Paramedic Consent Form to the 
Research officer.  
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Study Title: Can Fidelity to a Behavioural Intervention explain outcomes in Smoking Cessation? 
 
Provider CONSENT FORM 
To be completed by the TB paramedic 
Please tick    )√(  the boxes if you agree with the following statements. 
1. I confirm that I have read and understood the Information Sheet for Paramedics for 
the above study and have had the opportunity to ask questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason.  
3. I understand that my delivery of the intervention session will be video/audio taped 
followed by a questionnaire interview and that my identity and location will be kept 
confidential.  
4. I understand that the data from the tapes and interview will be accessed by the 
researchers. I give permission for these individuals to have access to my records.   
5. I understand that my name will not be linked with the research materials, and I will 
not be identified or identifiable in any reports that result from the research.   
6. I agree to take part in the above study. 
 
Your Name (please print)                          
 
Your Signature                                                Date 
Address                         Telephone number 
                  (Including dialing code) 
 
                                                                                                              Mobile number  
 
 
Signature of person obtaining consent                                                       Date 
       
 
 
Your contact information will be kept confidential and will only be used to contact you regarding 
the study. 
If you have any questions or would like further information, please contact: 
Research student Omara Dogar, E: ofd500@york.ac.uk 
 
Department of Health Sciences 
The University of York 
 
Thank you 
 
Health centre ________________________ 
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D.2: Patient information sheet and consent form 
 
 
 
 
You are being asked to participate in a research study designed to explore various factors related to a 
smoking cessation program delivered in the TB clinic of the health centres to better inform the utilisation 
of this program in these and similar settings in other countries. 
Keep the information sheet for your records. After receiving the completed consent form, you will be asked 
to participate in an interactive flip-book delivered intervention session to assist you with stopping smoking 
and this session will be video recorded. The intervention session will be delivered by the DOTS TB 
paramedic at your health centre. The intervention session is expected to last 30 to 40 minutes in total.  
You are free to choose whether or not to participate in this study. The taping of sessions is purely to 
record the intervention process, you are not forced or obliged to allow video-taping of any session. You can 
withdraw consent at any time, including during the session and after the tape has been completed, in which 
case the video recording for your session will be erased by the lead researcher.  
There is no known possible risk or discomfort that you can encounter connected to the activities in this 
study. The research through this study will benefit the wider research evidence base by providing 
understanding of the factors that are important for an effective and standardised implementation of a 
complex smoking cessation programme in the settings of primary and secondary health care centres. 
Your identity and location in this study will remain strictly confidential. The results of the study, including 
data, may be published for scientific purposes but will not give your name or include any identifiable 
references to you. 
Your contact information will be kept confidential and will only be used to contact you regarding the 
study. 
If you have any questions or would like further information, please contact: 
Research student Omara Dogar, E: ofd500@york.ac.uk 
Department of Health Sciences 
The University of York 
 
Thank you 
  
Please read this document carefully. 
We would like to invite you to take part in a research study. Before you decide whether to take part it is 
important for you to understand why the research is being done and what it will involve.  Please take 
time to read the following information carefully. Please ask us if there is anything that is not clear. If 
you decide you would like to take part please return the signed Patient Consent Form to the TB 
DOTS facilitator.  
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Study Title: Can Fidelity to a Behavioural Intervention explain outcomes in Smoking Cessation? 
 
Patient CONSENT FORM 
To be completed by the TB paramedic 
Please tick    )√(  the boxes if you agree with the following statements. 
1. I confirm that I have read and understood the Information Sheet for 
Participants for the above study and have had the opportunity to ask 
questions. 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason.  
3. I understand that my therapy/intervention session will be video/audio taped and that 
my identity and location will be kept confidential.  
4. I understand that the tapes will be accessed by the researchers. I give permission for 
these individuals to have access to my records.     
5. I understand that my name will not be linked with the research materials, and I will 
not be identified or identifiable in any reports that result from the research.   
6. I agree to take part in the above study. 
 
 
Name (please print)                          
 
Participant signature/thumb impression                  Date 
Address                         Telephone number 
                  (Including dialing code) 
 
                                                                                                              Mobile number  
 
 
Signature of person obtaining consent                                                       Date 
       
 
 
Your contact information will be kept confidential and will only be used to contact you regarding 
the study. 
If you have any questions or would like further information, please contact: 
Research student Omara Dogar, E: ofd500@york.ac.uk 
 
Department of Health Sciences 
The University of York 
 
Thank you 
 
Health centre ________________________ 
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D.3: Patient assessment questionnaire (ASSIST study) 
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GRADE Grading of Recommendations, Assessment, Development, and Evaluation 
HIC High-Income Countries 
HSRGC Health Sciences Research Governance Committee 
ICC Intra-cluster Correlation Co-efficient 
IGRA Interferon Gamma Release Assay 
INF-gamma Interferon gamma 
KALPHA Kripendorff’s alpha 
LMIC Low-and-Middle Income Countries 
MRC Medical Research Council 
NRT Nicotine Replacement Therapy 
NTP National Tuberculosis Programme 
OR Odds Ratio 
PCA Principal Components Analysis 
PHC Primary Health Care 
PMRC Pakistan Medical Research Council 
RCT Randomised Controlled Trial 
RE-AIM Reach Effectiveness Adoption Implementation Maintenance 
SHS Second-Hand Smoking  
SPIRIT Standard Protocol Items: Recommendations for Interventional Trials 
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TDF Theoretical Domains Framework 
TIDieR Template for Intervention Description and Replication 
TNF Tumour Necrosis Factor 
TST Tuberculin Skin Test 
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